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ABSTRACT 
 
     Crystal engineering, or non-covalent synthesis in the solid state, requires an 
understanding of intermolecular forces, and the hydrogen bond has become a reliable 
non-covalent tool in the construction of supramolecular architectures.  In the same way 
that synthetic chemists refer to a “yield” to quantify a desired product, crystal engineers 
typically determine the successful formation of a supramolecular product according to the 
frequency or occurrence of preferred intermolecular interactions between molecules 
under certain reaction conditions, thus, the supramolecular yield. These non-covalent 
reactions can be effectively carried out using supramolecular reagents (SR’s). 
     A family of ditopic bis-imidazol-1-yl/benzimidazol-1-yl compounds were synthesized 
and used as SR’s in combination with a variety of dicarboxylic acids to produce binary 
solids in 100% yield through the primary acid···imidazol-1-yl/benzimidazol-1-yl synthons 
even in the presence of potentially disruptive intermolecular interactions.  We 
furthermore noted that secondary C–H···O interactions within and between 1-D chains 
were of equal structural importance based upon an analysis of the metrics displayed by 
these interactions.  The use of these SR’s as ligands with neutrally charged metal 
complexes was also investigated. 
     SR’s containing benzimidazol-1-yl and carboxamide moieties were synthesized and 
combined with two different carboxylic acids to make ternary solids through 
acid···benzimidazol-1-yl and carboxamide···acid hydrogen bonds using a hierarchical 
approach – the best donor-best acceptor, second best donor-second best acceptor 
guidelines.  These SR’s were also employed as ligands for high-yielding syntheses of 
linear metal complexes where neighboring complexes are linked via 
carboxamide···carboxamide hydrogen bonds. 
     Asymmetric SR’s possessing two different N-heterocycles were synthesized and 
employed in the construction of ternary supermolecules with a high degree of structural 
selectivity and specificity when introduced to two different carboxylic acids.  The 
stronger acid interacts at the more basic site, while the weaker acid hydrogen-bonds with 
the less basic nitrogen atom.  Finally, an SR containing three different binding sites was 
designed and synthesized with the aim of producing quaternary co-crystals.     
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and used as SR’s in combination with a variety of dicarboxylic acids to produce binary 
solids in 100% yield through the primary acid···imidazol-1-yl/benzimidazol-1-yl synthons 
even in the presence of potentially disruptive intermolecular interactions.  We 
furthermore noted that secondary C–H···O interactions within and between 1-D chains 
were of equal structural importance based upon an analysis of the metrics displayed by 
these interactions.  The use of these SR’s as ligands with neutrally charged metal 
complexes was also investigated. 
     SR’s containing benzimidazol-1-yl and carboxamide moieties were synthesized and 
combined with two different carboxylic acids to make ternary solids through 
acid···benzimidazol-1-yl and carboxamide···acid hydrogen bonds using a hierarchical 
approach – the best donor-best acceptor, second best donor-second best acceptor 
guidelines.  These SR’s were also employed as ligands for high-yielding syntheses of 
linear metal complexes where neighboring complexes are linked via 
carboxamide···carboxamide hydrogen bonds. 
     Asymmetric SR’s possessing two different N-heterocycles were synthesized and 
employed in the construction of ternary supermolecules with a high degree of structural 
selectivity and specificity when introduced to two different carboxylic acids.  The 
stronger acid interacts at the more basic site, while the weaker acid hydrogen-bonds with 
the less basic nitrogen atom.  Finally, an SR containing three different binding sites was 
designed and synthesized with the aim of producing quaternary co-crystals.     
 i
TABLE OF CONTENTS 
 
 
List of Figures…………………………………………………………………………..iv 
List of Schemes…………………………………………………………………………xii 
List of Tables…………………………………………………………………………...xv 
Acknowledgments……………………………………………………………………...xvii 
Dedication……………………………………………………………………………...xviii 
 
Chapter 1: Introduction to crystal engineering 
1.1 Introduction………………………………………………………………………...1 
1.2 Historical context of crystal engineering…………………………………………..2 
1.3 Intermolecular interactions………………………………………………………...4 
1.4 Strategies employed in crystal engineering………………………………………..16 
1.5 Goals…………………………………………………………………………….…24 
 
Chapter 2: Is conformational flexibility in a supramolecular reagent advantageous 
for high-yielding co-crystallization reactions? 
2.1 Introduction………………………………………………………………………..29 
2.2 Experimental……………………………………………………………………....32 
2.3 Results……………………………………………………………………………..35 
2.4 Discussion………………………………………………………………………....43 
2.5 Conclusions………………………………………………………………………..47 
 
Chapter 3: Directed assembly of ditopic imidazoles/benzimidazoles and dicarboxylic 
acids into co-crystals via selective O−H…N hydrogen bonds 
3.1 Introduction………………………………………………………………………..50 
3.2 Experimental………………………………………………………………………53 
3.3 Results……………………………………………………………………………..60 
3.4 Discussion…………………………………………………………………………72 
3.5 Conclusions………………………………………………………………………..77 
 
 ii
 
Chapter 4: [(Benzimidazol-1-yl)methyl]-benzamides as supramolecular reagents for 
binary and ternary co-crystals 
4.1 Introduction………………………………………………………………………...80 
4.2 Experimental……………………………………………………………………….82 
4.3 Results……………………………………………………………………………...91 
4.4 Discussion…………………………………………………………………………103 
4.5 Conclusions………………………………………………………………………..108 
 
Chapter 5: [(Benzimidazol-1-yl)methyl]-benzamides as ligands for high-yielding 
inorganic-organic supramolecular synthesis 
5.1 Introduction………………………………………………………………………..111 
5.2 Experimental………………………………………………………………………115 
5.3 Results……………………………………………………………………………..118 
5.4 Discussion…………………………………………………………………………127 
5.5 Conclusions………………………………………………………………………..128 
 
Chapter 6: Organizing M(II)(acac)2 complexes into infinite 1-D chains using ditopic 
imidazole/benzimidazole ligands and hydrogen-bond analogues 
6.1 Introduction………………………………………………………………………..131 
6.2 Experimental………………………………………………………………………134 
6.3 Results……………………………………………………………………………..136 
6.4 Discussion…………………………………………………………………………143 
6.5 Conclusions………………………………………………………………………..145 
 
Chapter 7: Asymmetric supramolecular reagents for binary and ternary co-crystals 
7.1 Introduction………………………………………………………………………..148 
7.2 Experimental………………………………………………………………………150 
7.3 Results……………………………………………………………………………..157 
7.4 Discussion…………………………………………………………………………170 
7.5 Conclusions………………………………………………………………………..172 
 iii
 
Chapter 8: A continued study of binary and ternary co-crystals using asymmetric 
supramolecular reagents 
8.1 Introduction………………………………………………………………………..175 
8.2 Experimental………………………………………………………………………176 
8.3 Results……………………………………………………………………………..179 
8.4 Discussion…………………………………………………………………………181 
8.5 Conclusions………………………………………………………………………..184 
 
Chapter 9: The quest for quaternary co-crystals 
9.1 Introduction……………………………………………………………………….186 
9.2 Experimental……………………………………………………………………....187 
9.3 Results…………………………………………………………………………….189 
9.4 Discussion………………………………………………………………………...190 
9.5 Conclusions and future work……………………………………………………..191 
 
Appendix 1…………………………………………………………………………....194 
Appendix 2……………………………………………………………………………224 
 
 
 
 
 
 
 iv
LIST OF FIGURES 
 
Chapter 1 
 
Figure 1.1 Solid-state reactivities of α- and β-cis-cinnamic acid…. ………………….2 
 
Figure 1.2 Partial positive and negative charges associated with 
the hydrogen atom (H), the donor atom (D), and the acceptor atom 
(A) in a hydrogen bond………………………………………………………………....5 
 
Figure 1.3 Hydrogen bonds have an angular dependence, θ and φ……………………5 
 
Figure 1.4 Schematic representation of a typical hydrogen-bond 
potential………………………………………………………………………………...6 
 
Figure 1.5 Schematic potential energy curves and distance distributions 
in crystals for moderate hydrogen bonds (a and b) and (c) weak 
hydrogen bonds………………………………………………………………………...7 
 
Figure 1.6 Co-crystals of (a) 4-aminobenzoic acid 3,5-dinitrobenzoic 
acid (1:1) and (b) 2-amino-4-chloro-6-methylpyrimidine benzoic 
acid (1:1)……………………………………………………………………………….9 
 
Figure 1.7 Examples of graph set notation in hydrogen-bond patterns……………….10 
 
Figure 1.8 Parallel arrangement of two dipoles, separated by distance r……………..11 
 
Figure 1.9 Dipole-induced dipole interaction formed when a polar  
molecule (solid circle) induces a dipole moment on a non-polar 
molecule (dashed circle)……………………………………………………………….11 
 
Figure 1.10 Induced dipole-induced dipole interaction formed between 
two non-polar molecules………………………………………………………………12 
 
Figure 1.11 Representative model of two π-systems interacting in a 
face-to-face fashion…………………………………………………………………....13 
 
Figure 1.12 Point charges for an atom that contributes one electron 
to the π-system………………………………………………………………………...14 
 
Figure 1.13 Interaction between two π-atoms as a function of their  
orientation……………………………………………………………………………..14 
 
Figure 1.14 Possible orientations for the π···π interactions between 
polarized π-systems, where R1 and R2 are polarizing groups………………………....15 
 v
Figure 1.15 Geometry of the face-to-face stacking interaction in the 
crystal structure of tetramethyl-p-benzoquinone………………………………………16 
 
Figure 1.16 The carboxylic acid dimer synthon involving two 
Centrosymmetrically related O−H···O hydrogen bonds…………………………….....17 
 
Figure 1.17 Supramolecular synthons based on Cl···Cl and N···Br 
intermolecular interactions………………………………………………………….....17 
 
Figure 1.18 Examples of homomeric synthons containing self- 
complementary hydrogen bonds in the (a) carboxamide and (b) 
oxime dimer motifs…………………………………………………………………….17 
 
Figure 1.19 Example of a heteromeric supramolecular synthon 
containing two different types of hydrogen bonds in the carboxylic 
acid···carboxamide dimer……………………………………………………………...18 
 
Figure 1.20 The carboxylic acid···pyridine and (b) carboxamide··· 
pyridine supramolecular synthons……………………………………………………..18 
 
Figure 1.21 Zero-dimensional structures in the (a) benzoic acid dimer 
and (b) benzoic acid···pyridine heteromeric system……………………………….......19 
 
Figure 1.22 An infinite linear chain formed upon the assembly of 
terephthalic acid molecules……………………………………………………………19 
 
Figure 1.23 An infinite zig-zag chain formed by the assembly of 
isophthalic acid molecules……………………………………………………………..20 
 
Figure 1.24 Infinite linear chain formed from Ag(I) and 4,4’-bipyridine 
using coordination bonds……………………………………………………………....20 
 
Figure 1.25 Infinite one-dimensional chain formed from Ag(I) ions and  
3-aldoximepyridine ligands through coordination and hydrogen bonds……………....21 
 
Figure 1.26 An infinite two-dimensional honeycomb sheet formed from  
the assembly of trimesic acid molecules……………………………………………....21 
 
Figure 1.27 A two-dimensional square grid formed by Ni(II) ions and 
4,4’-bipyridine ligands………………………………………………………………...22 
 
Figure 1.28 A two-dimensional inorganic-organic hybrid sheet formed 
from Ni(II) ions and 4-oximepyridine via coordination and hydrogen 
bonds…………………………………………………………………………………...22 
 
Figure 1.29 Discrete three-dimensional architecture based on metal ions 
 vi
and organic ligands…………………………………………………………………….23 
 
Figure 1.30 Construction of a porous, three-dimensional framework 
using a copper paddle-wheel cluster and 1,3,5,7-adamantane tetra- 
carboxylic acid via coordination bonds………………………………………………..23 
 
Figure 1.31 Three-dimensional diamondoid framework formed from 
adamantane-1,3,5,7-tetracarboxylic acid molecules connected by 
the carboxylic acid synthon……………………………………………………………24 
 
Figure 1.32 Three-dimensional architecture formed from trigonal 
Ag(I) ions and isonicotinamide ligands through coordination and 
hydrogen bonds………………………………………………………………………..24 
 
Chapter 2 
 
Figure 2.1 Thermal ellipsoid plots (50% probabilities) and labeling  
schemes for 1-6………………………………………………………………………..38 
 
Figure 2.2 Infinite one-dimensional motif in 1……………………………………….39 
 
Figure 2.3 Extended one-dimensional chain in 2 showing water  
molecules inside the loops…………………………………………………………….40 
 
Figure 2.4 Infinite one-dimensional chain in the crystal structure of 3………………40 
 
Figure 2.5 Infinite one-dimensional hydrogen-bonded chain in the  
crystal structure of 4…………………………………………………………………...41 
 
Figure 2.6 Infinite one-dimensional ladder motif in 5………………………………..42 
 
Figure 2.7 Infinite undulating 1-D motif in the crystal structure of 6  
obtained through capping of outer carboxyphenoxy moieties with  
DMF molecules……………………………………………………………………….43 
 
Figure 2.8 Powder XRD patterns for (a) 4 (simulated); (b) TCPT:bipya  
1:1 (experimental); and (c) TCPT:bipya 1:2 (experimental)………………………….46 
 
Chapter 3 
 
Figure 3.1 Thermal ellipsoid plots (50% probabilities) and labeling  
schemes for 7-20 (a-n)………………………………………………………………...64 
 
Figure 3.2 Extended 1-D chain in 10…………………………………………………65 
 
Figure 3.3 Extended 1-D supramolecular chain in 11………………………………..66 
 vii
 
Figure 3.4 Infinite hydrogen-bonded 1-D chain in 12………………………………..67 
 
Figure 3.5 Infinite hydrogen-bonded chain in 13…………………………………….67 
 
Figure 3.6 1-D hydrogen-bonded chain in 14………………………………………...68 
 
Figure 3.7 1-D chain in 15……………………………………………………………69 
 
Figure 3.8 Primary hydrogen-bonded motif in 16……………………………………69 
 
Figure 3.9 Infinite two-dimensional sheet in 17 resulting from  
N−H···O hydrogen bonds between 5-aminoisophthalic acid molecules  
in adjacent one-dimensional chains…………………………………………………...70 
 
Figure 3.10 Extended chain in the crystal structure of 18……………………………71 
 
Figure 3.11 Extended supramolecular chain in 19……………………………………71 
 
Figure 3.12 1-D supramolecular assembly in 20……………………………………..72 
 
Figure 3.13 Representative powder XRD patterns of co-crystals in  
(a) 13 and (b) 14.  The top and bottom patterns in each case correspond  
to simulated and experimental respectively…………………………………………...73 
 
Figure 3.14 Relationship between intrachain and interchain C=O···H  
angles versus C···O distances in crystal structures 10-20.  Inset: The  
angular dependence of intrachain and interchain C−H···O interactions  
as defined by φ and θ respectively…………………………………………………….76 
 
Chapter 4 
 
Figure 4.1 Thermal ellipsoid plots (50% probabilities) and labeling  
schemes for 21-28……………………………………………………………………..95 
 
Figure 4.2 Infinite 1-D ribbon in the crystal structure of 21………………………….96 
 
Figure 4.3 Extended 1-D motif in the crystal structure of 22………………………...96 
 
Figure 4.4 Extended 2-D sheet in the crystal structure of 23………………………...97 
 
Figure 4.5 Extended 1-D ribbon in 24………………………………………………..98 
 
Figure 4.6 Local environment around a water-bridged R 34 (10)  
hexameric unit in the crystal structure of 25 generated by hydrogen  
bonds between 4-[(2-chlorobenzimidazol-1-yl)methyl]-benzamide and  
 viii
water molecules……………………………………………………………………….99 
 
Figure 4.7 Extended view of the crystal structure of 25 showing the  
interconnections of R 34 (10) motifs……………………………………………………100 
 
Figure 4.8 Hydrogen-bond driven assembly of a four-component  
supermolecule in the crystal structure of 26…………………………………………..101 
 
Figure 4.9 Infinite 1-D ladder motif in the crystal structure of 26  
showing interactions between neighboring supermolecules………………………….101 
 
Figure 4.10 Trimeric supermolecule in the crystal structure of 27…………………..102 
 
Figure 4.11 Ternary compound in the crystal structure of 28………………………..102 
 
Figure 4.12 1-D chain in 28 resulting from interactions between  
adjacent ternary compounds………………………………………………………….103 
 
Figure 4.13 Simulated (top) and experimental (bottom) powder  
XRD patterns for (a) 26 (first crop) and (b) 26 (second crop).  The  
reaction was carried out in a 1:2 stoichiometry, and the only material  
left over is unreacted 4-nitrobenzoic acid…………………………………………….107 
 
Figure 4.14 Simulated (top) and experimental (bottom) powder  
XRD patterns for (a) 27 (first crop) and (b) 27 (second crop)………………………..107 
 
Chapter 5 
 
Figure 5.1 Thermal ellipsoid plots (50% probabilities) and labeling  
scheme for 29-34 (a-f)………………………………………………………………..121 
 
Figure 5.2 Linear cationic assembly in 29.  Tetrafluoroborate anions  
and solvent molecules are omitted for clarity………………………………………...122 
 
Figure 5.3 Extended one-dimensional ladder motif in 30.  [BF4]-  
anions removed for clarity……………………………………………………………123 
 
Figure 5.4 Interconnection of adjacent one-dimensional ladders in 30  
through disordered tetrafluoroborate anions………………………………………….123 
 
Figure 5.5 Infinite two-dimensional sheet in 31 formed from catemeric 
carboxamide···carboxamide hydrogen bonds and  π···π interactions…………………124 
 
Figure 5.6 Infinite 1-D chain in 32 formed from N−H···O/O−H···O  
hydrogen bonds……………………………………………………………………….125 
 
 ix
Figure 5.7 2-D sheet in 33 formed from N-H···O hydrogen bonds and  
π···π interactions………………………………………………………………………126 
 
Figure 5.8 Extended 1-D assembly in 34 held together by dimeric 
carboxamide···carboxamide hydrogen bonds and π···π interactions………………….127 
 
Chapter 6 
 
Figure 6.1 Thermal ellipsoid plots (50% probabilities) and labeling  
scheme for 35-39 (a-e).  Whenever appropriate, hydrogen atoms  
were removed for clarity……………………………………………………………...138 
 
Figure 6.2 0-D structure in 35 formed by two Cu(II)(acac)2  
complexes bridged by one 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]- 
benzene ligand………………………………………………………………………..139 
 
Figure 6.3 Infinite 1-D ladder in 35 obtained through interactions  
between acetylacetonato oxygen atoms and bridging water molecules………………139 
 
Figure 6.4 Infinite 1-D coordination polymer in 36 formed through  
coordination of bridging ligands and Cu(II)(hfacac)2 centers………………………...140 
 
Figure 6.5 Extended 1-D coordination polymer in 37 afforded through  
coordination of bridging ligands to the axial sites of Cu(II)(DBM)2  
centers………………………………………………………………………………...141 
 
Figure 6.6 Extended view of 37 showing π···π interactions between  
the aromatic rings of 2-methylbenzimidazol-1-yl moieties of adjacent  
1-D chains…………………………………………………………………………….141 
 
Figure 6.7 1-D chain in 38 formed by dimeric carboxamide···carboxamide  
hydrogen bonds.  THF molecules interact with anti- N−H protons of  
carboxamide moieties…………………………………………………………………142 
 
Figure 6.8 One-dimensional supramolecular chain in 39 showing  
interactions with THF solvent molecules……………………………………………..143 
 
Chapter 7 
 
Figure 7.1 Hydrogen bonding between the disordered water molecule  
and 3-(benzimidazol-1-yl)methylpyridine in 40……………………………………...159 
 
Figure 7.2 Hydrogen-bonded unit in 41……………………………………………...159 
 
Figure 7.3 Four membered ring formed in 41………………………………………..160 
 
 x
Figure 7.4 Three-component hydrogen-bonded motif in 42…………………………160 
 
Figure 7.5 1:1 Binary co-crystal in 43………………………………………………..161 
 
Figure 7.6 Primary motif in the crystal structure of 44………………………………162 
 
Figure 7.7 Hydrogen-bond motif in 45……………………………………………….162 
 
Figure 7.8 Ionic compound in the crystal structure of 46…………………………….163 
 
Figure 7.9 Charged-assisted hydrogen bonds and π···π interactions in  
the crystal structure of 47……………………………………………………………..164 
 
Figure 7.10 Hydrogen-bonded pattern in 48.  A water molecule  
provides a hydrogen-bond bridge between one carboxylic acid moiety  
and the pyridyl nitrogen atom of the SR……………………………………………...164 
 
Figure 7.11 1-D chain in the crystal structure of 48………………………………….165 
 
Figure 7.12 1:1 Motif in the crystal structure of 49…………………………………..166 
 
Figure 7.13 2:1 Co-crystal in 50……………………………………………………...166 
 
Figure 7.14 One of two ternary supermolecules in the crystal structure  
of 51 (both have the same connectivity).  The best hydrogen-bond donor  
binds to the best hydrogen-bond acceptor and the second-best donor binds  
to the second-best acceptor……………………………………………………………167 
 
Figure 7.15 The ternary supermolecule in the crystal structure of 52. The  
best hydrogen-bond donor binds to the best hydrogen-bond acceptor and  
the second-best donor binds to the second-best acceptor……………………………..168 
 
Figure 7.16 One of the two sets of ternary supermolecule in 53, which  
contains the expected hydrogen-bond connectivities…………………………………168 
 
Figure 7.17 The ternary supermolecule in the crystal structure of 54.  
The best hydrogen-bond donor binds to the best hydrogen-bond acceptor  
and the second-best donor binds to the second-best acceptor………………………...169 
 
Figure 7.18 Ternary co-crystal in 55…………………………………………………170 
 
Chapter 8 
 
Figure 8.1 IR spectrum of a ternary co-crystallization attempt indicative  
of co-crystal formation involving 4-[(2-methylbenzimidazol-1-yl)methyl]- 
imidazol-1-ylbenzene, 4-iodobenzoic acid, and pentamethylbenzoic acid,  
 xi
29, pointing out to the two broad O−H···N bands at 2492 cm-1 and 1942  
cm-1…………………………………………………………………………………...182 
 
Chapter 9 
 
Figure 9.1 Binary co-crystal in 56…………………………………………………...190 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xii
LIST OF SCHEMES 
 
Chapter 2 
 
Scheme 2.1 The carboxylic acid···pyridine synthon…………………………………...29 
 
Scheme 2.2 Representation of a two-dimensional hexagonal motif  
formed from a three-fold symmetric SR and a ditopic base through  
hydrogen bonds.  D = hydrogen-bond donor, A = hydrogen-bond  
acceptor………………………………………………………………………………...30 
 
Scheme 2.3 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine (TCPT)…………………....31 
 
Scheme 2.4 Two different possible conformations of TCPT: (a) the  
high-symmetry ∆-conformation and (b) the low-symmetry  
φ-conformation………………………………………………………………………...38 
 
Chapter 3 
 
Scheme 3.1 The carboxylic acid···pyridine synthon…………………………………..50 
 
Scheme 3.2 N-substituted imidazoles and benzimidazoles denoting  
labeled nitrogen atoms………………………………………………………………...52 
 
Scheme 3.3 The (a) COOH···Im and (b) COOH···Bzim synthons  
indicating the best and second-best hydrogen-bond donor/acceptor  
couples………………………………………………………………………………...53 
 
Scheme 3.4 Alternative heteromeric O−H···N/C−H···O motifs in the  
(a) COOH···Im and (b) COOH···Bzim intrachain interactions………………………..75 
 
Scheme 3.5 Intrachain (horizontal) and interchain (vertical) C−H···O  
contacts represented by dashed lines………………………………………………….75 
 
Chapter 4 
 
Scheme 4.1 A few examples of hydrogen-bond based synthons  
employed in crystal engineering………………………………………………………80 
 
Scheme 4.2 (a) Isonicotinamide, a supramolecular reagent.  (b)  
Ternary supermolecules formed from a “strong” carboxylic acid,  
isonicotinamide, and a “weak” carboxylic acid through carboxylic  
acid···pyridine and carboxamide···carboxylic acid hydrogen bonds…………………..81 
 
Scheme 4.3 New supramolecular reagents based on (a) 3- and (b)  
4-substituted [(benzimidazol-1-yl)methyl]-benzamides……………………………....82 
 xiii
Scheme 4.4 Possible hydrogen-bond motifs between carboxamide  
moieties, (a) dimer and (b) catemer…………………………………………………..104 
 
Chapter 5 
 
Scheme 5.1 Ditopic and tritopic imidazol-1-yl/benzimidazol-1-yl  
ligands used in the construction of coordination polymers…………………………..111 
 
Scheme 5.2 Comparison of C−N−C angles in (a) benzimidazol-1-yl-  
and (b) pyridyl-containing ligands……………………………………………………112 
 
Scheme 5.3 (a) Hydrogen-bond linked and (b) covalently-linked  
extended ligands………………………………………………………………………113 
 
Scheme 5.4 Comparison of (a) [(benzimidazol-1-yl)methyl]-benzamide  
ligands and (b) nicotinamide………………………………………………………….114 
 
Chapter 6 
 
Scheme 6.1 M(II)(acac)2 complexes showing accessible axial  
coordination sites……………………………………………………………………..132 
 
Scheme 6.2 Ditopic imidazol-1-yl/benzimidazol-1-yl ligands used  
in coordination chemistry…………………………………………………………….132 
 
Scheme 6.3 A comparison between (a) a ditopic benzimidazol-1-yl  
ligand and (b) a hydrogen bond-linked analogue based upon a  
4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide supramolecular  
dimer………………………………………………………………………………….133 
 
Chapter 7 
 
Scheme 7.1 Proposed strategy for ternary supermolecules based upon  
asymmetric (a)-(c) pyridyl-benzimidazol-1-yl and (d) pyrimidyl- 
benzimidazol-1-yl supramolecular reagents (SR’s)…………………………………..149 
 
Scheme 7.2 Classification of binary structures resulting from  
supramolecular reactions between carboxylic acids and asymmetric  
pyridyl-benzimidazol-1-yl and pyrimidyl-benzimidazol-1-yl SR’s.   
The values in parentheses indicate the number of structures obtained  
in each case…………………………………………………………………………...170 
 
Chapter 8 
 
Scheme 8.1 Asymmetric SR’s, (a) 4-[(benzimidazol-1-yl)methyl]- 
imidazol-1-ylbenzene, and (b) 4-[(2-methylbenzimidazol-1-yl)methyl]- 
 xiv
imidazol-1-ylbenzene………………………………………………………………….175 
 
Scheme 8.2 Possible combinations in binary experiments involving  
imidazol-1-yl-benzimidazol-1-yl SR’s and co-crystallizing agents…………………...183 
 
Scheme 8.3 Possible combinations in ternary experiments involving  
imidazol-1-yl-benzimidazol-1-yl SR’s and co-crystallizing agents…………………...184 
 
Chapter 9 
 
Scheme 9.1 Proposed strategy for quaternary supermolecules based  
upon an asymmetric SR, 3-[2-(2-methylimidazol-1-yl)benzimidazol-1-yl]-
methylpyridine………………………………………………………………………...186 
 
Scheme 9.2 A few possible SR’s for the directed assembly of  
quaternary supermolecules……………………………………………………………192 
 
 
 xv
LIST OF TABLES 
 
Chapter 2 
 
Table 2.1 Hydrogen-bond geometries for 1-6…………………………………………36 
 
Chapter 3 
 
Table 3.1 Hydrogen-bond geometries for 10-20………………………………………61 
 
Chapter 4 
 
Table 4.1 Hydrogen-bond geometries for 21-28………………………………………92 
 
Chapter 5 
 
Table 5.1 Selected bond distances and angles for 29-34……………………………...119 
 
Table 5.2 Hydrogen-bond geometries for 29-34……………………………………...119 
 
Chapter 6 
 
Table 6.1 Selected bond distances and angles for 35-39……………………………..137 
 
Table 6.2 Hydrogen-bond geometries for 38 and 39…………………………………137 
 
Table 6.3 Five-coordinate versus six-coordinate Cu(acac)2 complexes  
in the CSD with axial nitrogen-containing ligands……………………………………144 
 
Chapter 7 
 
Table 7.1 Hydrogen-bond geometries for 40-55……………………………………...158 
 
Chapter 8 
 
Table 8.1 IR data for binary and ternary co-crystallization experiments  
carried out using 4-[(benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene  
and several co-crystallizing agents……………………………………………………180 
 
Table 8.2 IR data for ternary co-crystallization experiments with 4-[(2-
methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene and various  
co-crystallizing agents………………………………………………………………...181 
 
Chapter 9 
 
Table 9.1 Hydrogen-bond geometries for 56…………………………………………189 
 xvi
Table 9.2 IR data for products from quaternary co-crystallization  
reactions involving 3-[2-(2-methylimidazol-1-yl)benzimidazol-1-yl]- 
methylpyridine and carboxylic acids…………………………………………………190 
 
Table 9.3 Calculated pKa values of a few possible SR’s for  
quaternary supermolecules……………………………………………………………192 
 
 
 
 
 
 xvii
ACKNOWLEDGMENTS 
 
     First and foremost, I give thanks to our loving God for giving me the patience and 
perseverance to endure the challenges in my life. 
     To my family who has been there for me in every step of the way, and for your love 
and endless support in all my endeavors. 
     To Professor Christer Aakeröy, thank you so much for your patience and guidance 
during my education here at Kansas State University.  You have taught me to become a 
better scientist and a better person. 
     To the Aakeröy group, both past and present, thanks for all the great times we had 
together, both inside and outside of lab.  I have really enjoyed working with you all. 
     To the faculty, staff, and graduate students of the Department of Chemistry here at 
Kansas State University, especially to Dr. John Desper and Dr. Tanya Young, thank you 
both for your expertise and for taking the time to assist me in various aspects of my 
research. 
     To my advisory committee, Professor Eric Maatta, Professor Chris Culbertson, 
Professor Gary Pierzynski, and Professor Shuting Lei, thank you for all your suggestions 
and input towards my education. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xviii
DEDICATION 
 
     I dedicate this dissertation to my family – my mom and dad, Virginia Urbina and 
Joaquin Urbina, Sr., my brother Adrian, and my sisters, Sheryl and Jacqueline, as well as 
to my uncle Eusebio Urbina.  I also dedicate this to my best friend Angelo Aguilar, his 
wife Lizette Aguilar, and son, Dimitri Aguilar.  Finally, I dedicate this to the most special 
person in my life, Maria Llinas. 
 
     Mom and dad – I would have not been here without your unconditional love and 
support.  Thank you for believing in me and for encouraging me whenever things seemed 
impossible.  I love you both very much. 
     Adrian, Sher, and Jackie – You have all been a source of inspiration in my life and, 
despite the fact that we were far away, I always had you all on my mind.  I love you all.   
     Tio Chebo – Without your help I would not have achieved my endeavors.  I thank you 
so much for your support in my education. 
     Angelo – You have become a very special person in my life, and I will never forget 
the great times we have spent together.  Thanks for being there for me in every way, and 
for making my stay here a whole lot easier and enjoyable.  There is no doubt that you will 
also achieve your goals in life. 
     Liz and Dimitri – I have very much enjoyed your company and cherished your 
kindness.  In the near future we will meet again, and we will continue the good times that 
we have spent together. 
     Mary – Without you I would not have been where I am today.  You have inspired me 
in every way and have made me realize that everything is possible in life.  You have also 
been with me in good and bad times.  I love you very much. 
           
 
 1
Chapter 1 
 
Introduction to crystal engineering  
 
 
1.1 Introduction 
 
Crystal engineering can be defined as “…the understanding of intermolecular 
interactions in the context of crystal packing and in the utilization of such understanding 
in the design of new solids with desired physical and chemical properties.”1  It is 
analogous to disciplines such as civil engineering, whereby building blocks are carefully 
selected by design to construct functional architectures.  However, crystal engineering 
employs molecular building blocks, which are assembled via intermolecular forces to 
produce functional solid materials.  Crystal engineering stems from supramolecular 
chemistry, which is “chemistry beyond the molecule.”2,3  Inspired by the delicate non-
covalent forces that Nature effectively utilizes to hold complex biomolecules together, 
crystal engineering and supramolecular chemistry seek not only to mimic such natural 
systems, but also to create new materials possessing specific physical and chemical 
properties (i.e. non-linear optical, magnetic, porous, catalytic, etc.).4,5,6  To arrive at these 
materials, supramolecular, intermolecular, or non-covalent synthesis7 is involved, 
making use of non-covalent or intermolecular interactions.8,9 
Contrary to non-covalent synthesis, covalent synthesis involves the use of the 
covalent bond to connect atoms into molecules.  The covalent bond is a complex but still 
a well-studied connector, possessing high directionality, strength over a short distance, as 
well as versatility in molecular synthesis.10  In fact, covalent synthesis has been mastered 
such that even large, biological molecules have been made, for example, Vitamin B12.2 
Therefore, the covalent bond is both predictable and reliable for molecular synthesis. 
Can the same level of predictability and reliability be attained from intermolecular 
interactions?  At this point, it is difficult to foresee the assembly of molecules held 
together by intermolecular forces in the solid state.  Since crystal packing depends on a 
subtle balance of intermolecular interactions, even the smallest change in the structure of 
the molecular building block can significantly affect the outcome of the extended crystal 
structure.11,12  In addition, intermolecular forces are weaker than covalent forces, which 
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further make crystal structure prediction a formidable task.  Despite these challenges, 
crystal engineering is developing at a rapid pace with the goals of better understanding 
and studying the nature of intermolecular interactions, the roles these interactions play in 
the construction of extended crystal structures, and the physical and chemical properties 
of these ordered structures. 
 
1.2 Historical context of crystal engineering 
 
Light-induced or photochemical reactions of organic molecules in the solid state, such 
as the photodimerization of cinnamic acids, the reversible photochromy of the anils of 
salicylaldehyde, fulgides, and tetrachloronaphthoquinone, were well established by the 
early 20th century.13  However, the relationship between the photochemistry of organic 
compounds and the resulting molecular stereochemistry was poorly understood.  This 
problem prompted the use of the term “crystal engineering”, which was first introduced 
by Schmidt and co-workers at the Weizmann Institute in 1964.1,13  At the time, Schmidt 
was investigating the interrelationship between the photodimerization reactions of cis-14 
and trans-15cinnamic acid derivatives and their packing motifs in the solid state.  Cis-
cinnamic acid adopts two distinct crystal packing modes, the α- and β-forms.  An 
example of the types of photodimerization reactions of cinnamic acid derivatives in the 
solid state studied by Schmidt is the [2+2] cycloaddition of the double bonds in two α-
cis-cinnamic acid molecules to form a cyclobutane dimer, while the same reaction with 
β-cis-cinnamic acid yields the trans-isomer, Figure 1.1.13  
HO2C
hv• 
CO2H
Ph CO2H
HO2C Ph
+
CO2H
α-type ī-dimer + trans-isomer 
___________________________________________________________________________________
HO2C
HO2C
hv
// 
CO2H
trans-isomer 
Ph Ph
HO2C CO2H
β-type 
Figure 1.1  Solid-state  reactivities of α- and β-cis-cinnamic acid. 
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Contrary to the solid state, photodimerization reactions in solution yield products of 
different stereochemistries, and if a product possessing a particular stereochemistry is 
desired, it would be difficult to separate this product from the rest of the mixture.  As a 
result, there is no stereochemical control over these reactions in solution.  This 
disadvantage of photodimerization reactions in solution has prompted extensive studies 
of the same reactions in the solid state because they occur with minimal atomic or 
molecular movement (i.e. topochemical reactions).1  Furthermore, the desired 
stereoisomer (ī-dimer) can be obtained by employing the α-form of cis-cinnamic acid in 
the above example, thus suggesting a high degree of control of the photodimerization 
reaction in the solid state, and hence the birth of modern crystal engineering. 
     In the case of cinnamic acid, light of λ = 302 nm is required to induce 
photodimerization, and the quantum yield was determined to be 0.7.  No difference was 
observed in the photosensitivity of the α- and β- forms of cinnamic acid.  The 
photodimerization reaction is thought to occur in two steps: 1) formation of an excited 
monomer molecule from a monomer molecule in the ground state upon irradiation with 
ultraviolet light, and 2) attack of the excited monomer molecule on a ground state 
molecule, Equations 1.1 and 1.2.13                                                                                      
M hv M*
M*   + M M2
                            (1.1)
                  (1.2)
 
     These photochemical reactions, Schmidt reasoned, further occurred if the center-to-
center distances between the π-electron clouds of C=C double bonds of neighboring 
molecules were between 3.5 and 4.2 Å, and that the stereochemistry at the nearest-
neighbor double bonds were either antiparallel (related by a crystallographic center of 
symmetry) or parallel (related by a translation axis).  If the p-orbitals of the π-systems in 
the two C=C double bonds are misaligned, or if they are too far away for overlap, 
photodimerization does not occur upon irradiation. These conditions for 
photodimerization reactions to occur in the solid state upon ultraviolet irradiation became 
known as the topochemical rules.13   
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      Schmidt suggested the evolution of solid-state photochemistry to occur in four 
phases: 1) the phase of the topochemical principle; 2) the phase of the locus of the solid-
state reaction; 3) the phase of crystal engineering; and 4) the phase of systematic solid-
state photochemistry.13  According to Schmidt, it is the phase of crystal engineering that 
is essential towards understanding the roles of intermolecular forces in the crystal 
structures of organic compounds: “The systematic development of our subject will be 
difficult if not impossible until we understand the intermolecular forces responsible for 
the stability of the crystalline lattice of organic compounds…any rational development of 
the physics and chemistry of the solid state must be based upon a theory of molecular 
packing; since the molecules studied are complex, the theory will most likely be 
empirical for some time yet.  Rules are now becoming available in what I would regard 
as phase three, the phase of crystal engineering.”13  
      Since Schmidt, modern crystal engineering has developed quickly with the advent of 
modern crystallographic techniques such as the use of four-circle diffractometers and 
charged-coupled device (CCD) instruments.  As a result, modern crystal engineering has 
expanded to study intermolecular forces in the solid state, as well as structure prediction, 
control, and analysis.  In addition, it incorporates the synthesis of crystalline materials for 
applications in the pharmaceutical and petrochemical industries, as well as in 
environmental remediation.10 
    
1.3 Intermolecular interactions 
 
     Intermolecular forces, particularly hydrogen bonds, are essential for the structural 
stability and function of biological systems; in fact, without them life would be 
impossible.16  Most intermolecular interactions are electrostatic in nature, and can be 
classified according to strength and directionality for crystal engineering purposes.10  
These intermolecular forces comprise hydrogen bonds and van der Waals forces (dipole-
dipole, dipole-induced dipole, induced dipole-induced dipole, π···π interactions). 
 
1.3.1 Hydrogen bonds 
 
1.3.1.1 What constitutes a hydrogen bond? 
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     A hydrogen bond can be defined as D−H···A where D and A are atoms that have 
electronegativities higher than hydrogen, such as carbon, nitrogen, phosphorus, oxygen, 
sulfur, selenium, fluorine, chlorine, bromine, and iodine.17  The hydrogen bond is mainly 
electrostatic in nature, where the hydrogen atom has a partial positive charge, δ+, while 
the more electronegative atoms each have a partial negative charge, δ-, Figure 1.2. 
      δ-          δ+      δ- 
                       D ⎯ H ---- A 
Figure 1.2 Partial positive and negative charges associated with the hydrogen atom (H), 
the donor atom (D), and the acceptor atom (A) in a hydrogen bond. 
 
The atom that forms a covalent bond with hydrogen is known as the donor atom.  
Meanwhile, the atom that forms a hydrogen bond with hydrogen is the acceptor atom.  
Depending on the electronegativity of the donor and acceptor atoms, hydrogen bonds can 
be strong, medium, or weak.  Two important criteria towards the formation of a hydrogen 
bond need to be considered: 1) hydrogen-bond geometry involving distance and 
direction, and 2) the energy associated with the hydrogen bond.18  
 
1.3.1.2 Hydrogen-bond geometry 
 
     A hydrogen bond can be described as a vector quantity that has both magnitude and 
direction, Figure 1.3.  In order for an interaction to be considered a hydrogen bond, 
certain geometric criteria need to be met.  For instance, the interatomic distances H···A 
and D···A, and the angle θ are useful to determine whether or not a certain interaction is a 
hydrogen bond.  The H···A−X angle φ and the planarity of the DHAX system are also 
valuable indicators, particularly for strong hydrogen bonds.4,19  
 
  
D H
A Xθ φ 
 
Figure 1.3 Hydrogen bonds have an angular dependence, θ and φ. 
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Typical values for the H···A distance in N−H···O bonds are 1.80 to 2.00 Å and 1.60 to 
1.80 Å for O−H···O bonds.  Angles θ and φ range from about 150-160˚ and about 120-
130˚ respectively.4,19  When considering the distances for H···A and D···A in some 
hydrogen bonds whose potential energy minima of electrostatic attractive and repulsive 
forces arise at intermolecular distances greater than the sum of their van der Waals radii, 
it is necessary to allow for more relaxed values.  To illustrate this concept, a typical 
hydrogen-bond potential energy curve is shown in Figure 1.4. 
 
 
 
 
Figure 1.4 Schematic representation of a typical hydrogen-bond potential.20 
 
d0 represents hydrogen-bond distances at the equilibrium distance, or at the distance 
where the energy is at a minimum.  Thus, when the distance d is greater than d0, an 
attractive force is observed.  Conversely, a repulsive force is observed when d is less than 
d0.  The total energy of a hydrogen bond (Etot) constitutes electrostatic (Eel), polarization 
(Epol), charge transfer (Ect), dispersion (Edisp), and exchange repulsion (Eer) forces.  Out of 
all these constituents, Eel decreases the least with increasing distance (-r-3 for dipole-
dipole and -r-2 for dipole-monopole interactions).  As a result, Eel dominates any 
hydrogen bond potential energy curve, even at long distances.  In the case of strong and 
moderate hydrogen bonds, the hydrogen-bond potential is deep enough (< -20 kJ mol-1) 
to keep hydrogen-bond distance distributions within the sum of the van der Waals radii of 
the donor and acceptor atoms.  However, for weak hydrogen bonds, the hydrogen-bond 
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potential is not deep enough (≤ -2 kJ mol-1), thus allowing for a large distribution of 
hydrogen-bond distances greater than the sum of the van der Waals radii of donor and 
acceptor atoms, Figure 1.5.   
 
 
 
Figure 1.5 Schematic potential energy curves and distance distributions in crystals for 
moderate hydrogen bonds (a and b) and (c) weak hydrogen bonds.20 
 
The relaxed values for weak hydrogen bonds range from 1.40-2.20 Å and 2.50-3.00 Å for 
H···A and D···A respectively, and the electrostatic attribute of the hydrogen bond is 
accounted for.4  Ideally, the values of θ should approach linearity or 180˚; however, this 
is not usually the case because the number of possible spatial configurations with the 
D−H···A angle in the range θ to (θ + dθ) is proportional to sin θ.  As a result, the average 
value for θ is about 165˚.4  The directionality of hydrogen bonds also depends on φ.  This 
angle can be identified with the orientation of electron lone pairs of acceptor atoms.  For 
example, oxygen atom lone pair lobes of carbonyl (C=O) groups are in the R2C=O plane 
and form angles of about 120˚ with respect to the C=O bond.  Another example is 
provided by thiocarbonyl groups, in which sulfur atom lone pairs form an angle of only 
105˚ with the C=S bond.20  When the acceptor atom is a cyano nitrogen atom, the lone 
pair forms an angle closer to 180˚ with respect to the C≡N bond.   
 
1.3.1.3 Strength of hydrogen bonds 
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     The strength of hydrogen bonds is primarily governed by the electronegativities of 
both the donor and acceptor atoms participating in the interaction.  For example, the 
energies for O−H···O and N−H···O hydrogen bonds range from 20 to 40 kJ mol-1.19  In 
general, when the donor and acceptor atoms are neutral, hydrogen-bond strength 
corresponds to energies between 20-65 kJ mol-1.20  This range is typical of medium-
strength hydrogen bonds, while for weaker hydrogen bonds such as C−H···O interactions 
the energies are between 2-20 kJ mol-1.19  When the donor and acceptor atoms in a 
hydrogen bond are ionic (i.e. as a result of proton transfer), hydrogen-bond strength can 
increase to 40-190 kJ mol-1, and is thus defined as a strong hydrogen bond.  Covalent 
bonds are usually stronger than hydrogen bonds, with energies between 100-400 kJ mol-1, 
although the strongest of hydrogen bonds can be greater than the weakest of covalent 
bonds.20  Hydrogen-bond energies are calculated in the gas phase in which the hydrogen 
bond is formed between dimers.20  In addition, hydrogen-bond energies can be 
determined experimentally by mass spectrometry, in which an equilibrium constant Kc 
can be obtained from the ratio of hydrogen-bonded dimers to monomers in the gas phase.  
In particular, bond dissociation energies (∆H˚D) can be obtained from the temperature 
dependence of the equilibrium constant for the formation of hydrogen-bonded dimers.  
Hydrogen-bonded dimers as ions have also been studied by mass spectrometry.21,22,23  
 
1.3.1.4 General hydrogen-bond rules 
 
     It is convenient to have a set of guidelines at hand when predicting hydrogen-bond 
patterns in the solid state.  A Cambridge Structural Database (CSD) analysis of hydrogen-
bond patterns indicates preferred hydrogen-bond motifs and hydrogen-bond selectivity 
for certain functional groups or for sets of functional groups.  From this analysis came 
about the formulation of three general hydrogen-bond rules.24  The first rule was 
developed by Donohue upon observation of only a handful of organic crystal structures: 
all acidic hydrogens available in a molecule will be used in hydrogen bonding in the 
crystal structure of that compound.25  This rule is the most useful of all the hydrogen-
bond rules.  The second and third rules were formulated by Etter based on her work on 
organic co-crystals: all good acceptors will be used in hydrogen bonding when there are 
available hydrogen-bond donors, and the best hydrogen-bond donor and the best 
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hydrogen-bond acceptor will preferentially form hydrogen bonds to one another.24,26,27  
These rules are based on energetically favorable types of hydrogen bonds and also reflect 
crystal packing patterns of organic crystal structures.  Since the rules were obtained as a 
result of preparing organic co-crystals, it is necessary to provide a definition for an 
organic co-crystal. 
     An organic co-crystal is a crystalline compound containing two or more neutral 
organic components held together by hydrogen bonds.24  Thus, if an organic crystalline 
material contains ionic organic components, it is not a co-crystal.  The individual 
components in a co-crystal can have varying numbers of hydrogen-bond donor and 
acceptor sites, and depending on their donating and accepting abilities a particular 
hydrogen-bond pattern is formed.  In addition, organic co-crystals can be homomeric 
(containing two or more identical hydrogen-bond patterns) or heteromeric (containing 
two or more different hydrogen-bond patterns).  Co-crystals are usually prepared by slow 
evaporation of solutions containing stoichiometric mole ratios of the components.  
However, they can also be made by grinding the two solid components together, whereby 
a co-crystal phase is formed from the mixture.  As a result, solvent is not necessary in the 
preparation of co-crystals.24  Examples of co-crystals are 4-aminobenzoic acid 3,5-
dinitrobenzoic acid (1:1), Figure 1.6(a), and 2-amino-4-chloro-6-methylpyrimidine 
benzoic acid (1:1), Figure 1.6(b).24 
 
(a)
O
N
O
N
O
O
OO
H
H H
N
O
O
O
O
OO
HH
OO
N N
O
O
H
O O
N
O
N
O
H
O O
O
O
N
NN
O O
H H
O O
O
O
O
O
N
HH
O
N
O
    (b) 
N N
N
HH
NO
ClH3C
N
N
HH
O
H
O
O
H
CH3Cl
 
 
 
Figure 1.6 Co-crystals of (a) 4-aminobenzoic acid 3,5-dinitrobenzoic acid (1:1) and (b) 
2-amino-4-chloro-6-methylpyrimidine benzoic acid (1:1). 
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1.3.1.5 Graph set notation 
 
     Etter formulated a useful method for describing hydrogen-bond patterns in crystal 
structures based on graph set notation.24,27  These patterns can be classified according to 
one of four descriptors: chains (C), rings (R), dimers (D), or intramolecular (S).  
Following these descriptors, the number of hydrogen-bond acceptors (superscript) and 
donors (subscript) are designated.  The total number of atoms involved in the motif is 
then provided in parentheses, Figure 1.7. 
 
                                   G ad (n) 
 
                      O
N H
H
                         
N
O
H
H
O
H N
H  
                              C(4)                                                            R 22 (8) 
 
                      
O H N
                                 
O
H
OH3C
 
                             
                                 D                                                             S(6) 
 
Figure 1.7 Examples of graph set notation in hydrogen-bond patterns. 
 
1.3.2 Van der Waals forces 
 
     Van der Waals forces are attractive in nature, and include dipole-dipole interactions, 
dipole-induced dipole interactions, induced dipole-induced dipole interactions, and π···π 
interactions.   
 
1.3.2.1 Dipole-dipole interactions 
 
     The potential energy of interaction between two polar molecules is a complicated 
function comprising the dipole moments of the two molecules and the angle, θ, between 
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them.28  When the two dipole moments are parallel, Figure 1.8, the potential energy can 
be described by Equation 1.3.     
  
 
µ1 
µ2 
θ 
 r 
 
Figure 1.8 Parallel arrangement of two dipoles, separated by distance r. 
 
   V = µ1µ2f(θ)             f(θ) = 1 – 3 cos2θ            (1.3) 
                                           4πε0r3 
 
µ1 and µ2 represent the dipole moments of the two molecules, r is the distance between 
them, θ is the angle between the two dipoles, and ε0 is the permittivity of a vacuum.  
Equation 1.3 applies to polar molecules in a fixed, parallel arrangement in a solid. 
 
1.3.2.2 Dipole-induced dipole interactions 
 
     A polar molecule with dipole moment µ1 can also induce a dipole µ2* in a neighboring 
non-polar molecule.  The resulting dipoles are attracted together, Figure 1.9.28 
 
 
• • µ1 µ1 µ2* 
 
Figure 1.9 Dipole-induced dipole interaction formed when a polar molecule (solid circle) 
induces a dipole moment on a non-polar molecule (dashed circle). 
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Consequently, the average interaction energy between the two dipoles can be described 
by Equation 1.4 
 
   V = - C               C = µ12α'2                                           (1.4) 
                                             r6                        πε0 
 
where µ1 is the permanent dipole moment of the polar molecule, α'2 is the polarizability 
volume of the non-polar molecule, r is the distance between the two molecules, and ε0 is 
the permittivity of a vacuum. 
 
1.3.2.3 Induced dipole-induced dipole interactions 
 
     Non-polar molecules can also induce dipoles on each other, even though neither 
molecule has a permanent dipole moment.  The resulting interaction stems from the 
transient dipoles that all molecules possess due to changes in the instantaneous positions 
of electrons.  The electrons in one molecule can arrange themselves in such a way as to 
produce an instantaneous dipole moment µ1*.  This dipole then produces an electric field 
that polarizes another molecule to induce an instantaneous dipole moment µ2*, Figure 
1.10.28 
 
µ1* µ2* • • • • 
 
Figure 1.10 Induced dipole-induced dipole interaction formed between two non-polar 
molecules. 
 
Induced dipole-induced dipole interactions are also called London dispersion forces.28  
The potential energy, V, of this interaction is given in Equation 1.5 
 
   V = -C              C = 2 α'1α'2 I1I2                     (1.5) 
                                            r6                     3           I1+I2 
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where α'1 and α'2 are the polarizability volumes of the two non-polar molecules, I1 and I2 
are the ionization energies of the two molecules, and r is the separation between the two 
molecules. 
     Dipole-induced dipole and induced dipole-induced dipole interactions decrease more 
with increasing separation (r-6) than dipole-dipole interactions (r-3) because both the r-3 
dependence of the magnitude of the induced dipole and the r-3 dependence of the 
potential energy of interaction between the dipoles are accounted for.  Dipole-dipole 
interactions are the most dominant at longer distances of the above van der Waals forces. 
 
1.3.2.4 π···π interactions 
 
     Interactions specific to aromatic π-systems have also been observed.  These 
interactions are essential in Nature, since they stabilize the double helical structure of 
DNA and are the basis for the tertiary structures of proteins.29  In the same way that 
hydrogen bonds meet geometric criteria, π···π interactions are also defined by geometric 
factors.  Perhaps the most reliable geometric parameters for establishing π···π interactions 
were formulated as a result of experimental studies of porphyrin-porphyrin interactions.29   
     Figure 1.11 illustrates a simple model of two interacting π-systems.  
  
      
+
-
-
-
-
+
Repulsion
                                                                  
 
Figure 1.11 Representative model of two π-systems interacting in a face-to-face 
fashion.29 
  
This system consists of a positively charged σ-layer situated between two negatively 
charged π-electron clouds.  If two π-systems stack directly on top of each other, a 
repulsive interaction is manifested.  In order to better represent the electrostatic charge 
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distribution of a π-system, a set of point charges is employed for each atom involved in 
the system, Figure 1.12. 
-1/2
+1
-1/2
δ 
Figure 1.12 Point charges for an atom that contributes one electron to the π-system.29 
 
A charge of +1 is given for each carbon atom at its nucleus in a π-system, and two 
charges of -½ at a distance, δ, above and below the plane of the π-system.  This distance 
was set at 0.47 Å based on the experimental value of the quadrupole moment of 
benzene.29  This value for δ can be approximated for other π-systems. 
     Based on the above representation of π-systems, the preferred geometries of π···π 
interactions can be considered.  When two π-atoms interact at a fixed vertical distance of 
3.4 Å,30 they can be oriented according to Figure 1.13.   
 
Figure 1.13 Interaction between two π-atoms as a function of their orientation.29 
 
When the two π-atoms are oriented in a face-to-face fashion (angle = 0, offset = 0), 
repulsion is observed; however, when one π-atom is rotated by up to 90˚ with respect to 
the other, an attractive geometry is formed.  Another attractive geometry is formed when 
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one π-atom is offset laterally with respect to the other.  These results for non-polarized π-
systems can be summarized with three rules: (1) π···π repulsion dominates in a face-to-
face π-stacked geometry; (2) π···σ attraction dominates in an edge-on or T-shaped 
geometry; and (3) π···σ attraction dominates in an offset π-stacked geometry.29  
     These rules can be validated by experimental evidence from the crystal structures of 
simple aromatic compounds.  Both types of attractive geometries are observed in the 
crystal structures of kekulene and [18]annulene.29  The predicted π-stacked geometries 
for kekulene were also calculated by summing the electrostatic interactions and van der 
Waals contributions over all the atoms.  The calculated kekulene-kekulene interaction 
energy at the most favorable geometry is -146 kJ mol-1.29  These results suggest that 
crystal structures of aromatic compounds are useful for understanding π···π interactions. 
     In the presence of polarizing groups (i.e. electron donors and acceptors), π···π 
interactions can adopt six possible orientations, Figure 1.14. 
         
R1
R1R2
R2 R1
R1
R2R2
R2
R2R1
R1
Orientation 1                      Orientation 2                        Orientation 3
R2R2
R1
R1
R2
R2
R1
R1
R1
R1
R2R2
Orientation 4                       Orientation 5                       Orientation 6  
Figure 1.14 Possible orientations for the π···π interactions between polarized π-systems, 
where R1 and R2 are polarizing groups. 
 
      Based on the above three rules, offset stacking (orientations 3-6) are attractive, while 
face-to-face stacking geometries (orientations 1 and 2) are repulsive.  However, a fourth 
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rule can be formulated to predict π···π interactions in the presence of polarizing groups: 
π-overlap can be favorable in cases where the atoms at the site of contact are π-deficient, 
and unfavorable when the atoms at the site of contact are π-rich.29  Thus, the first 
scenario predicts attractive face-to-face stacking in orientation 2.  Experimental evidence 
of the fourth rule is validated in the crystal structure of tetramethyl-p-benzoquinone, 
Figure 1.15.29 
      
OO
O
O  
Figure 1.15 Geometry of the face-to-face stacking interaction in the crystal structure of 
tetramethyl-p-benzoquinone.29 
 
1.4 Strategies employed in crystal engineering 
 
     In the same way that covalent synthesis employs protocols to construct complex 
organic molecules from simpler building blocks, non-covalent synthesis involves the use 
of methodologies to construct supramolecular architectures.  However, the strategies used 
in non-covalent synthesis have still not reached the same level of structural predictability.  
Even though strategies are still being developed to construct predictable assemblies, one 
important advance in crystal engineering has been the use of supramolecular synthons to 
build various types of extended architectures.19  
 
1.4.1 Supramolecular synthons 
 
     Supramolecular synthons have been defined as “substructural motifs which 
incorporate the chemical and geometrical characteristics of intermolecular 
interactions…They are spatial combinations of intermolecular interactions which can be 
recognized clearly as design elements for solid-state architecture.”4  These synthons are 
distinct from intermolecular interactions in that they are derived from designed 
combinations of interactions and are not the same as the interactions themselves.19  An 
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example of a supramolecular synthon is the carboxylic acid dimer, which comprises two 
centrosymmetrically related C=O···H−O hydrogen bonds, Figure 1.16. 
 
R
O
O H O
R
OH
 
 
Figure 1.16 The carboxylic acid dimer synthon involving two centrosymmetrically 
related O−H···O hydrogen bonds. 
 
Despite the strict distinction between supramolecular synthons and intermolecular 
interactions, there are cases when both the chemical and geometric aspects of 
intermolecular interactions are intimately linked, thus allowing for interactions such as 
Cl···Cl or N···Br to be regarded as supramolecular synthons, Figure 1.17.19  
Cl Cl N Br
 
Figure 1.17 Supramolecular synthons based on Cl···Cl and N···Br intermolecular 
interactions. 
  
     Supramolecular synthons based on intermolecular interactions can either be 
homomeric or heteromeric motifs.  There are instances when homomeric motifs are 
formed from two identical centrosymmetrically related hydrogen bonds, such as the 
carboxylic acid dimer motif.  Other synthons that contain self-complementary hydrogen 
bonds are the carboxamide dimer and oxime dimer motifs, Figure 1.18. 
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 (a)                                                             (b)     
Figure 1.18 Examples of homomeric synthons containing self-complementary hydrogen 
bonds in the (a) carboxamide and (b) oxime dimer motifs. 
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Heteromeric supramolecular synthons constitute intermolecular interactions formed from 
two different chemical moieties.  An example of such a synthon is illustrated in Figure 
1.19. 
R1
O
O H O
H N
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Figure 1.19 Example of a heteromeric supramolecular synthon containing two different 
types of hydrogen bonds in the carboxylic acid···carboxamide dimer. 
 
Heteromeric motifs are not only limited to strong interactions; they can also arise from a 
combination of strong and weak interactions.  These types of synthons can be formed 
using heterocycles that contain weakly acidic hydrogens on carbon atoms ortho- to the 
hydrogen-bond acceptor atom.  For example, when a carboxylic acid moiety comes in 
contact with a pyridyl moiety, the carboxylic acid-pyridine supramolecular synthon is 
formed, Figure 1.20(a). 
 
(a)
R
O
O H N
H
  (b) 
R
N
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H  
 
Figure 1.20 (a) The carboxylic acid···pyridine and (b) carboxamide···pyridine 
supramolecular synthons. 
 
The carboxylic acid-pyridine synthon is formed from a combination of strong O−H···O 
and weak C−H···O hydrogen bonds.  A similar type of synthon can be designed using a 
carboxamide moiety in place of a carboxylic acid group, Figure 1.20(b). 
     The above supramolecular synthons are only examples of a library of synthons that 
can be employed in crystal engineering to construct zero-, one-, two-, and three-
dimensional supramolecular architectures. 
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1.4.2 Zero-dimensional structures 
 
      The simplest supramolecular architecture is a zero-dimensional structure, which is a 
discrete system consisting of molecules held together by supramolecular synthons.  An 
example of a zero-dimensional structure is the benzoic acid dimer, Figure 1.21(a).19 
 
 
O
O H O
OH O
O H N
H
(a)                                                                     (b)  
Figure 1.21 Zero-dimensional structures in the (a) benzoic acid dimer and (b) benzoic 
acid···pyridine heteromeric system. 
 
Zero dimensional structures can also involve heteromeric synthons such as carboxylic 
acid···pyridine, which is illustrated in the benzoic acid···pyridine heteromeric system, 
Figure 1.21(b). 
 
1.4.3 One-dimensional architectures 
 
     Zero-dimensional structures can be extended to infinite one-dimensional chains, 
ribbons, and ladders.  This extension is accomplished upon the assembly of molecules 
possessing at least two recognition sites.  The shape of one-dimensional chains depends 
on the angle between the recognition sites.  For instance, terephthalic acid contains two 
carboxylic acid moieties separated by 180˚ with respect to each other, and upon assembly 
of these molecules, a linear chain is formed, Figure 1.22.31 
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Figure 1.22 An infinite, linear chain formed upon the assembly of terephthalic acid 
molecules. 
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Isophthalic acid also forms an infinite one-dimensional chain; however, since the angle 
between the two carboxylic acid groups is 120˚, the resulting chain adopts a zig-zag 
pattern, Figure 1.23.32  
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Figure 1.23 An infinite zig-zag chain formed by the assembly of isophthalic acid 
molecules. 
 
     The assembly of one-dimensional architectures is not only limited to hydrogen bonds.  
Coordination bonds formed from a metal ion with linear coordination geometry and 
bifunctional organic ligands can also be employed to construct one-dimensional chains.  
For example, the combination of Ag (I) metal ions and 4,4’-bipyridine affords an infinite, 
linear chain via coordination bonds, Figure 1.24.33 
 
N N Ag N N Ag N N
 
 
Figure 1.24 Infinite, linear chain formed from Ag (I) and 4,4’-bipyridine using 
coordination bonds. 
 
     It is also possible to generate one-dimensional assemblies through a combination of 
coordination and hydrogen bonds.34,35  A ligand containing both a coordination site and a 
hydrogen-bond moiety can be used in conjunction with a metal ion possessing a linear 
coordination geometry whereby the coordination site on the ligand forms a coordination 
bond to the metal ion and the hydrogen-bond moiety interacts with another ligand via 
hydrogen bonds.  An example of an infinite, one-dimensional chain that employs such a 
strategy is constructed from Ag (I) and 3-aldoximepyridine, Figure 1.25.35 
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Figure 1.25 Infinite one-dimensional chain formed from Ag (I) ions and 3-
aldoximepyridine ligands through coordination and hydrogen bonds. 
 
1.4.4 Two-dimensional sheets 
 
     Two-dimensional architectures arise when molecules possess at least one more 
recognition site, thus further expanding a one-dimensional system.36  In the case of 
trimesic acid, which contains one more carboxylic acid moiety than isophthalic acid, the 
cross-linking of chains formed by isophthalic acid fragments yields an infinite two-
dimensional honeycomb sheet, Figure 1.26.37 
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Figure 1.26 An infinite two-dimensional honeycomb sheet formed from the assembly of 
trimesic acid molecules. 
 
     Two-dimensional supramolecular architectures have also been constructed using 
coordination bonds.  In particular, two-dimensional square grids have been assembled 
employing metal ions with square planar or octahedral coordination geometries and 
bifunctional organic ligands.  In the case of Ni(II) ions and 4,4’-bipyridine ligands, a two-
dimensional square grid is formed upon coordination at the equatorial sites of the metal 
ions, Figure 1.27.38 
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Figure 1.27 A two-dimensional square grid formed by Ni(II) ions and 4,4’-bipyridine 
ligands. 
 
     Two-dimensional architectures have also been synthesized through a combination of 
coordination and hydrogen bonds.39,40  For example, inorganic-organic hybrid sheets have 
been prepared using Ni(II) ions and 4-oximepyridine, whereby the pyridine nitrogen on 
each ligand is coordinated to the equatorial sites of the metal ion while the oxime moiety 
forms O−H···O hydrogen bonds, Figure 1.28.40 
 
Figure 1.28 A two-dimensional inorganic-organic hybrid sheet formed from Ni(II) ions 
and 4-oximepyridine via coordination and hydrogen bonds.40 
 
1.4.5 Three-dimensional architectures 
 
     Three-dimensional architectures are the most sophisticated of supramolecular systems 
in crystal engineering because they require extensions of building blocks in all three 
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spatial coordinates.  Simultaneously, they also find the most application in porous and 
catalytic materials due to the pores or cavities created in these materials.  These three-
dimensional systems can be constructed into discrete or infinite architectures.  Discrete 
architectures usually adopt polyhedral or high-symmetry forms, and can be built from a 
combination of metal ions and organic ligands, both possessing specific geometries, 
through coordination bonds, Figure 1.29.41    
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Figure 1.29 Discrete three-dimensional architecture based on metal ions and organic 
ligands. 
 
Infinite architectures can be built from metal ions and organic ligands via coordination 
bonds, which in many cases can also be structurally robust and highly porous.42  For 
example, the combination of a copper paddle-wheel cluster with adamantane-1,3,5,7- 
tetracarboxylic acid affords a porous, three-dimensional framework, Figure 1.30.43 
 
Figure 1.30 Construction of a porous, three-dimensional framework using a copper 
paddle-wheel cluster and 1,3,5,7-adamantane tetracarboxylic acid via coordination 
bonds.43 
 
     Infinite three-dimensional architectures can also be constructed from organic building 
blocks via hydrogen bonding.19,44,45  In the crystal structure of adamantane-1,3,5,7-
tetracarboxylic acid, a three-dimensional diamondoid structure is formed, in which the 
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carboxylic acid moieties are arranged tetrahedrally about the adamantyl center, Figure 
1.31.46  
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Figure 1.31 Three-dimensional diamondoid framework formed from adamantane-
1,3,5,7-tetracarboxylic acid molecules connected by the carboxylic acid synthon. 
 
     There are also cases when three-dimensional architectures are constructed from a 
combination of coordination and hydrogen bonds, although they are rare.6,47,48,49  An 
example of such architectures involves the use of Ag(I) ions and isonicotinamide ligands, 
in which Ag(I) ions adopt a trigonal geometry and each Ag(I) complex is connected by 
self-complementary amide···amide hydrogen bonds, Figure 1.32.49          
  
  
Figure 1.32 Three-dimensional architecture formed from trigonal Ag(I) ions and 
isonicotinamide ligands through coordination and hydrogen bonds. 
 
1.5 Goals 
 
     Bearing the principles of crystal engineering in mind, the subsequent chapters will 
focus on the fundamental aspects of the discipline.  These goals include the: 1) study of 
reliabilities of intermolecular interactions, 2) construction of inorganic-organic 
supramolecular architectures, and 3) systematic study of the hierarchy of supramolecular 
synthons using supramolecular reagents (SR’s). 
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1.5.1 Study of reliabilities of intermolecular interactions 
 
     The reliability of an intermolecular interaction is typically reflected by its frequency 
or occurrence in a given number of crystal structures.  In the same way that organic 
chemists determine molecular yields through a ratio of product to starting material, 
suparmolecular yields can be determined from the ratio of the frequency of that 
interaction to the total number of crystal structures.  In particular, the reliability of 
heteromeric synthons containing O−H···N and C−H···O hydrogen bonds will be studied in 
organic co-crystals (Chapters 2 and 3).  As a result, we can conclude whether they can be 
employed as tools for the construction of more elaborate supramolecular architectures. 
     Another critical aspect of this study is to establish whether the C−H···O interactions 
arise from the most acidic hydrogen on C−H moieties.  One of the Etter rules states that 
the most acidic hydrogen will form a hydrogen bond to the best hydrogen-bond acceptor, 
the second most acidic hydrogen will form a hydrogen bond to the second best hydrogen-
bond acceptor, and so on.  A systematic study of organic co-crystals in Chapter 3 will 
enable us to determine if this rule is consistent.   
 
1.5.2 Construction of inorganic-organic supramolecular architectures 
 
     Inorganic-organic supramolecular architectures will also be built from a combination 
of metal ions and organic ligands through coordination and hydrogen bonds (Chapters 5 
and 6).  While taking advantage of the versatility of hydrogen bonds in coordination 
chemistry, we will also focus on longer and more structurally flexible ligands.  We will 
attempt to construct one-dimensional supramolecular architectures by employing these 
ligands and metal ions with inherent linear coordination geometries. 
 
1.5.3  Systematic study of the hierarchy of supramolecular synthons 
 
     The Etter rules will be used as guidelines in the systematic study of the hierarchy of 
supramolecular synthons.  The primary rule states that the best hydrogen-bond donor will 
form a hydrogen bond with the best hydrogen-bond acceptor, the second best hydrogen-
bond donor will form a hydrogen bond with the second best hydrogen-bond acceptor, and 
so on.  In order to realize this study, organic co-crystals of two or more molecules and an 
SR, containing different hydrogen-bond moieties, will be analyzed to determine which 
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synthons are preferred over others under certain reaction conditions (Chapters 4, 7, 8, and 
9).  In other words, the hydrogen-bond moieties compete to form preferred 
supramolecular synthons.  Based on a balance between, and awareness of these 
interactions in ternary, quaternary, and higher-order co-crystals, we can begin to establish 
a hierarchy of supramolecular synthons using a systematic, modular, and transferable 
non-covalent synthetic protocol. 
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Chapter 2 
 
Is conformational flexibility in a supramolecular reagent advantageous for high-
yielding co-crystallization reactions? 
 
2.1 Introduction 
 
     An integral part of organic supramolecular chemistry is the design of discrete building 
blocks with intermolecular preferences that can be utilized for the directed assembly of 
homomeric1 or heteromeric2 solid-state architectures with predictable and desirable 
connectivities.  These building blocks, or supramolecular reagents (SR’s), frequently 
operate with hydrogen-bond based supramolecular synthons as their organizational 
tools.1a,3  The carboxylic acid···pyridine heteromeric synthon, Scheme 2.1, has been used 
extensively as a synthetic tool for the construction of co-crystals not only because of its 
strength and directionality, but also because it is relatively tolerant of the presence of 
other potentially competing or disruptive hydrogen-bonding moieties.4 
R
O
O H N
H
 
Scheme 2.1 The carboxylic acid···pyridine synthon. 
 
     An important attribute of every SR is its latent supramolecular dimensionality, i.e. a 
molecule with a single hydrogen-bond acceptor site can only act as a terminating or 
capping reagent in a hydrogen-bonded network, whereas a molecule with two self-
complementary sites is designed to produce extended 1-D motifs.  Suitable combinations 
of relatively simple molecular building blocks can then lead to 3-D architectures of 
considerable complexity.  For example, in the 1:1 co-crystal of 1,4-
naphthalenedicarboxylic acid and 4,4’-bipyridine (bipy),5 neighboring components 
interact through heteromeric O−H···N hydrogen bonds resulting in an infinite 1-D chain.  
The primary extended structural element in this co-crystal is readily predictable since 
both components are inherently supramolecularly linear.  Infinite one-dimensional chains 
can also be generated from more structurally flexible dicarboxylic acid-based SR’s and 
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bipy and its homologues, which illustrates the generality of reliable non-covalent 
synthesis.6   
     If, instead, 1,3,5-tricarboxylic acid benzene (trimesic acid, a 2-D builder) is allowed to 
react with bipy, an elegant two-dimensional “chicken-wire” framework is afforded via 
heteromeric O−H···N interactions,7 Scheme 2.2. 
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Scheme 2.2 Representation of a two-dimensional hexagonal motif formed from a three-
fold symmetric SR and a ditopic base through hydrogen bonds.  D = hydrogen-bond 
donor, A = hydrogen-bond acceptor. 
 
     In this case, trimesic acid is a suitable SR for two-dimensional architectures since it 
contains three carboxyl groups that are “locked” into a conformation with three-fold 
symmetry.  The highly symmetric nature of trimesic acid has thus become a source of 
inspiration for deliberate strategies and subsequent formulation of aesthetically pleasing 
host-guest complexes8 and co-crystals.8a,9  At the same time, however, researchers have 
been compelled to employ relatively unconventional and/or harsher crystal growing 
techniques such as hydrothermal synthesis,8a CS2 as a solvent system,8b as well as vapor 
condensation on cold surfaces8d in order to obtain these architectures.  Although the 
structural rigidity in trimesic acid is advantageous for preparing the intended 
supramolecular frameworks, the poor solubility that accompanies this highly symmetric 
molecule is a distinct drawback.  This is arguably the reason for why there is not an 
abundance of molecular co-crystals in the Cambridge Structural Database (CSD)10 
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involving trimesic acid; instead, only a relatively small collection of solvates,11 co-
crystals,9 and organic salts12 with trimesic acid have been crystallographically 
characterized.    
     To compensate for poor solubility, the structural rigidity of a three-fold symmetric SR 
can be tempered by introducing a more flexible backbone.  For example, 1,3,5-
cyclohexanetricarboxylic acid (CTA) contains a cyclohexane framework, which 
organizes the C−C bonds involving the carboxyl groups in a non-planar manner whereas 
those of trimesic acid are co-planar with the phenyl ring.  In co-crystals of CTA and 
bipy13 and its ditopic homologues,14 it is clear that this SR at times is capable of directing 
the formation of two-dimensional hexagonal frameworks through O−H···N hydrogen 
bonds.5,15    
     What would happen then if even more conformational flexibility was added to a 
supramolecular reagent with, in principle, three-fold symmetry?  Would such a SR be 
able to yield predictable two-dimensional hexagonal motifs in combination with bipy and 
its homologues as is the case with trimesic acid?  Will improved solubility facilitate the 
formation of co-crystals?  To try to answer these questions we have carried out a 
structural study of some co-crystals based around 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-
triazine (TCPT), Scheme 2.3. 
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Scheme 2.3 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine (TCPT). 
 
     TCPT possesses three carboxyl groups that can rotate about the C−C bonds and are 
also located at the end of molecular “arms” that can rotate about the ether C−O−C bonds.  
This degree of conformational flexibility is not present in trimesic acid and, as a result, 
TCPT would be expected to be soluble in a wider range of solvents.   
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     In this chapter, we present six crystal structures involving TCPT with bipy and some 
of its homologues in order to examine the balance between conformational flexibility and   
supramolecular efficiency.  The latter will be assessed based upon the reproducibility of 
the desired intermolecular motif as well as the ease with which co-crystals can be 
prepared.  The following crystal structures are reported; TCPT bipy1.5, 1; TCPT bipy1.5 
(H2O)0.3, 2; TCPT trans-1,2-bis-(4-pyridyl)-ethylene (bipye)1.5, 3; TCPT bis-(4-pyridyl)-
ethane (bipya)1.5, 4; TCPT- 4,4’-trimethylenedipyridinium (tmdipyH+), 5; and TCPT 
bipya0.5 DMF, 6. 
 
2.2 Experimental 
 
2.2.1 Synthesis 
 
All starting materials were purchased from Aldrich and used without further purification.  
Melting points were determined on a Fisher-Johns melting point apparatus and are 
uncorrected. 
 
2.2.1.1 Synthesis of 2,4,6-tris-4-(bromophenoxy)-1,3,5-triazine16 
 
4-Bromophenol (6.06 g, 35.0 mmol) and cyanuric chloride (1.84 g, 10.0 mmol) were 
added to a 50-mL round-bottomed flask.  A reflux condenser was attached, and the two 
solids were heated and stirred under reflux in a sand bath at 210˚C for 8 h.  Once the 
brown-white solid crude product was formed at the bottom of the flask, the reaction was 
stopped and set to cool.  The solid was then washed with 30 mL of hot ethanol by heating 
and stirring the mixture under reflux for 30 min.  An off-white solid was obtained after 
filtration of the ethanolic mixture and then recrystallized from 300 mL of chloroform by 
heating and stirring the solution under reflux for 30 min., which upon cooling gave white 
needles.  The pure product was obtained via vacuum filtration and collected.  Yield 4.85 
g (82.0 %); m.p. 235-238˚C; IR (KBr) ν 1567, 1095, 1067 cm-1; 1H NMR (CDCl3, 400 
MHz) δ 6.98 (d, 6H, J = 8 Hz), 7.45 (d, 6H, J = 8 Hz); MS (MALDI) m/e = 591.851 (M + 
H)+. 
 
2.2.1.2 Synthesis of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine (TCPT)17 
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2,4,6-tris-4-(bromophenoxy)-1,3,5-triazine (4.00 g, 6.77 mmol) was dissolved in 400 mL 
of dry THF with stirring.  The reaction mixture was cooled to -110˚C with liquid 
nitrogen/ethanol slush.  20 mL of 1.6M butyllithium cooled to -110˚C was added to the 
stirring solution under nitrogen, and the mixture was stirred for 10 min. at that 
temperature.  The pale yellow solution was poured onto solid carbon dioxide covered 
with diethyl ether.  The mixture was then allowed to warm to room temperature.  30 mL 
of water was added to the mixture, and the ether phase was extracted 7 times with 30 mL 
portions of water and then with 20 mL of 1M NaOH.  6M HCl was added to the 
combined aqueous solutions until a white flaky precipitate came out and the pH of 2-3 
was attained.  The crude product was obtained via vacuum filtration and then 
recrystallized from 500 mL THF to give the pure product.  Yield 2.22 g (67.0 %); m.p. 
>300˚C; IR (KBr) ν 3430, 1696, 1572, 1127, 1087 cm-1; 1H NMR (DMSO-d6, 400 MHz) 
δ 7.37 (d, 6H, J = 7.4 Hz), 7.99 (d, 6H, J = 6.6 Hz), 13.00 (s, 3H, broad); MS (MALDI) 
m/e = 490 (M + H)+. 
 
2.2.2 Syntheses of co-crystals and salts 
 
2.2.2.1 Synthesis of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine 4,4’-bipyridine1.5, 1 
 
TCPT (0.05 g, 0.10 mmol) was dissolved in 25 mL of THF.  To this solution was added a 
solution of bipy (0.03 g, 0.20 mmol) in 5 mL of absolute ethanol.  Yellow plates were 
obtained after a few days upon slow evaporation of the solvent.  M.p. >300˚C. 
 
2.2.2.2 Synthesis of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine 4,4’-bipyridine1.5 
(H2O)0.3, 2 
 
To a solution of TCPT (0.05 g, 0.10 mmol) in THF (25 mL) was added a solution of bipy 
(0.02 g, 0.15 mmol) in absolute ethanol (5 mL).  The resulting clear solution was left to 
evaporate slowly in ambient air.  Colorless plates crystallized after a few days.  M.p. 
>300˚C. 
 
2.2.2.3 Synthesis of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine trans-1,2-bis-(4-
pyridyl)-ethylene1.5, 3 
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To a solution of TCPT (0.05 g, 0.10 mmol) in THF (25 mL) was added a solution of 
bipye (0.03 g, 0.15 mmol) in absolute ethanol (5 mL).  The resulting clear solution was 
allowed to evaporate slowly in ambient air.  Colorless prisms were obtained after a few 
days.  M.p. 228-230˚C (decomp.). 
 
2.2.2.4 Synthesis of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine bis-(4-pyridyl)-
ethane1.5, 4 
 
To a solution of TCPT (0.05 g, 0.10 mmol) in DMF (5 mL) was added a solution of bipya 
(0.03 g, 0.15 mmol) in DMF (5 mL).  The resulting yellow solution was allowed to 
evaporate slowly in ambient air.  Colorless plates were obtained after two days.  M.p. 
>300˚C (decomp.). 
 
2.2.2.5 Synthesis of 4,4’-trimethylenedipyridinium 2,4-bis-(4-carboxyphenoxy)-6-(4-
carboxylatephenoxy)-1,3,5-triazine, 5 
 
To a solution of TCPT (0.05 g, 0.10 mmol) in 5 mL of DMF was added a DMF solution 
(5 mL) containing 4,4’-trimethylenedipyridine (tmdipy) (0.03 g, 0.15 mmol).  Slow 
evaporation of the solvent produced colorless prisms after two days.  M.p. 218-221˚C 
(decomp.). 
 
2.2.2.6 Synthesis of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine bis-(4-pyridyl)-ethane0.5 
DMF, 6 
 
TCPT (0.05 g, 0.10 mmol) was dissolved in 5 mL of DMF.  To this solution was added a 
DMF solution (5 mL) containing bipya (0.02 g, 0.10 mmol).  Slow evaporation of the 
solvent yielded yellow prisms after two weeks.  M.p. 190-195˚C (decomp.). 
 
2.2.3 X-ray crystallography 
 
     X-ray data were collected on a Bruker SMART 1000 four-circle CCD diffractometer 
using a fine-focus molybdenum Kα tube.  Data were collected using SMART.18  Initial 
cell constants were found by small widely separated “matrix” runs.  Preliminary Laué 
symmetry was determined from axial images.  Generally, an entire hemisphere of 
reciprocal space was collected regardless of Laué symmetry. Scan speed and scan width 
were chosen based on scattering power and peak rocking curves. Unless otherwise noted, 
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0.3 ° scans were used.  Unit cell constants and orientation matrix were improved by least-
squares refinement of reflections “thresholded” from the entire dataset. Integration was 
performed with SAINT,19 using this improved unit cell as a starting point. Precise unit 
cell constants were calculated in SAINT from the final merged dataset. Lorenz and 
polarization corrections were applied, but data were not corrected for absorption. Laué 
symmetry, space group, and unit cell contents were found with XPREP.  Data were 
reduced with SHELXTL.20 The structures were solved in all cases by direct methods 
without incident.  In general, hydrogen atoms were assigned to idealized positions and 
were allowed to ride.  Unless otherwise noted, the coordinates of hydrogen-bonding 
hydrogen atoms were allowed to refine. 
 
2.2.4 Powder X-ray diffraction 
 
     Powder XRD data were collected on a Bruker/Nonius D8 ADVANCE diffractometer 
with Bragg-Brentano geometry.  For a sample containing a 1:1 ratio between TCPT and 
bipya, a step size of 0.04˚ and a step time of 45.7 sec per step were used.  A step size of 
0.04˚ and a step time of 24 sec per step were used for a sample containing a 1:2 ratio 
between TCPT and bipya.  Data for 6 were obtained over a 5-50˚ 2-θ range in both cases.  
Data were then processed using EVA v8.0.21 
 
2.3 Results 
 
     Crystallographic data are given in Tables A1-A6.  Hydrogen-bond geometries for 1-6 
are provided in Table 2.1.  Thermal ellipsoid plots showing numbering schemes and 
molecular geometries are displayed in Figure 2.1.   
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Table 2.1 Hydrogen-bond geometries for 1-6. 
 
 
Compound D-H A D-H/Å H…A/Å D…A/Å <(DHA)/° generator for A 
1 O27 H27 N51 
O37 H37 N71 
O47 H47 N61 
0.85(3) 
1.04(3) 
1.08(2) 
1.86(3) 
1.55(3) 
1.54(3) 
2.714(2) 
2.578(2) 
2.602(2) 
175(3) 
172(2) 
168(2) 
-1+x, y, z 
1+x, y, z 
-1-x, 1-y, 1-z 
2 O29 H29 N71 
O39 H39 N51 
O49 H49 N61 
0.92(3) 
0.98(3) 
1.10(3) 
1.80(3) 
1.61(3) 
1.52(3) 
2.717(2) 
2.589(2) 
2.617(2) 
178(2) 
172(2) 
170(2) 
1+x, y, z 
-1+x, y, z 
2-x, 1-y, -z 
3 O27 H27 N51 
O37 H37 N71 
O47 H47 N61 
1.09(4) 
1.04(4) 
0.85(5) 
1.49(4) 
1.63(4) 
1.88(5) 
2.575(3) 
2.654(4) 
2.657(4) 
172(3) 
167(4) 
151(5) 
2-x, 1-y, 1-z 
x, y, -1+z 
1+x, -1+y, z 
4 
 
O27 H27 N61 
O37 H37 N51 
O47 H47 N71 
1.07(3) 
0.98(4) 
1.09(4) 
1.51(3) 
1.66(4) 
1.59(4) 
2.573(3) 
2.623(3) 
2.663(3) 
175(3) 
166(3) 
167(3) 
1+x, y, 1+z 
2-x, 1-y, 1-z 
-x, 1-y, 1-z 
5 N51 H51 O27 
O37 H37 O28 
O47 H47 N61 
1.12(4) 
1.10(5) 
1.00(5) 
1.52(4) 
1.46(5) 
1.66(5) 
2.625(5) 
2.538(4) 
2.654(5) 
170(4) 
165(4) 
171(5) 
-1+x, y, z 
2-x, 1-y, 1-z 
-1+x, 1+y, 1+z 
6 O27 H27 O1S 
O37 H37 N51 
O47 H47 O48 
1.01(2) 
1.04(2) 
0.926(18) 
1.58(2) 
1.55(2) 
1.686(19) 
2.5963(15) 
2.5778(17) 
2.6061(13) 
176(2) 
169(2) 
172.3(19) 
-1+x, 1-y, z 
1+x, y, z 
2-x, -y, -z 
 
                             
                                                                    (a) 
                    
                                                                    (b) 
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                                                                    (c) 
 
 
                    
                                                                    (d) 
 
 
 
    
                                        (e) 
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                                                                    (f) 
 
Figure 2.1a-f Thermal ellipsoid plots (50% probabilities) and labeling schemes for 1-6. 
 
2.3.1 Crystal structure of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine 4,4’-bipyridine1.5, 
1 
 
     The crystal structure of 1 consists of one molecule of TCPT and one and a half 
molecules of bipy in the asymmetric unit, Figure 2.1a.  These molecules interact through 
three crystallographically unique O−H···N hydrogen bonds involving the O−H protons on 
the carboxylic acid moieties in TCPT and the pyridine nitrogen atoms on bipy 
(O27···N51, 2.714(2) Å; O37···N71, 2.578(2) Å; O47···N61, 2.602(2) Å).  Two of the 
“arms” in TCPT are oriented in one direction while the third “arm” is situated in another 
direction together to adopt a φ- conformation, Scheme 2.4. 
N
N
N
O
OO
COOH
COOH
HOOC
                               
N N
NO O
O
COOHCOOH
COOH  
   a      b 
Scheme 2.4 Two different possible conformations of TCPT: (a) the high-symmetry ∆-
conformation and (b) the low-symmetry φ-conformation. 
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One of the three carboxyphenoxy moieties is oriented almost perpendicular to the plane 
of the triazine core (C15-O15-C44-C43, -98.7(2)˚).  The three intermolecular O−H···N 
interactions produce an infinite 1-D assembly, Figure 2.2. 
 
Figure 2.2 Infinite one-dimensional motif in 1. 
 
Two C−H···O bonds are also observed in the crystal structure of 1 between ortho- C−H 
moieties on bipy and carbonyl oxygen atoms on the carboxy groups in TCPT 
(C56−H56···O28, 3.14 Å; C72−H72···O38, 3.34 Å).  These interactions augment two of 
the three primary carboxylic acid···pyridine hydrogen bonds. 
 
2.3.2 Crystal structure of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine 4,4’-bipyridine1.5 
(H2O)0.3, 2 
     
     The asymmetric unit of 2 contains one molecule of TCPT, one and a half molecules of 
bipy, and one molecule of water of 30 % occupancy, Figure 2.1b.  Three 
crystallographically distinct O−H···N hydrogen bonds occur between the O−H groups on 
the carboxylic acid moieties in TCPT and the pyridine nitrogen atoms on bipy 
(O29···N71, 2.717(2) Å; O39···N51, 2.589(2) Å; O49···N61, 2.617(2) Å).  The TCPT 
molecule displays a φ-conformation similar to the one observed for TCPT in the crystal 
structure of 1.  One of the three carboxyphenoxy moieties is almost perpendicular to the 
plane of the triazine core (C16-O40-C41-C46, -98.4(2)˚).  A water molecule is located 
between the two arms on the acid that are pointing in the same direction; however, since 
the hydrogen atoms could not be located, no hydrogen bonds were assigned within this 
structural unit.  The asymmetric unit is propagated through an inversion center into an 
infinite one-dimensional chain, Figure 2.3, where two water molecules are located in 
each loop of the chain. 
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Figure 2.3 Extended one-dimensional chain in 2 showing water molecules inside the 
loops. 
 
Two C−H···O hydrogen bonds are present in the crystal structure of 2 between the ortho- 
C−H moieties on bipy and the carbonyl oxygen atoms on carboxyl groups in TCPT 
(C52−H52···O38, 3.35 Å; C76−H76···O28, 3.14 Å).  There are no significant interchain 
interactions in this crystal structure. 
 
2.3.3 Crystal structure of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine trans-1,2-bis-(4-
pyridyl)-ethylene1.5, 3 
 
     The asymmetric unit of 3 consists of one molecule of TCPT and one and a half 
molecules of bipye, Figure 2.1c.  These molecules interact through three 
crystallographically inequivalent O−H···N hydrogen bonds formed by the O−H groups on 
the carboxyl moieties in TCPT and the pyridine nitrogen atoms on bipye (O27···N51, 
2.574(3) Å; O37···N71, 2.654(4) Å; O47···N61, 2.654(4) Å).  Two of the carboxyphenoxy 
groups in TCPT are located in one direction while the third carboxyphenoxy moiety is 
oriented in the opposite direction with respect to the first two groups resulting in a φ-
conformation.  The intermolecular O−H···N hydrogen bonds organize TCPT and the 
ditopic hydrogen-bond acceptors into an extended one-dimensional chain, Figure 2.4. 
 
 
Figure 2.4 Infinite one-dimensional chain in the crystal structure of 3. 
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The bipye molecules that form part of a loop are aligned in a parallel manner with respect 
to each other separated by ca. 7 Å.  No C−H···O interactions are present in the crystal 
structure, as the ortho- C−H moieties on bipye and the carbonyl oxygen atoms on the 
carboxyl groups in TCPT are not co-planar.  There are no significant directional 
interactions exist between neighboring chains. 
 
2.3.4 Crystal structure of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine bis-(4-pyridyl)-
ethane1.5, 4 
  
     The asymmetric unit in 4 contains one molecule of TCPT and one and a half 
molecules of bipya, Figure 2.1d.  These molecules are interconnected through three 
crystallographically unique O−H···N hydrogen bonds involving the O−H groups of 
carboxyl groups in TCPT and pyridine nitrogen atoms in bipya (O27···N61, 2.571(3) Å; 
O37···N51, 2.621(3) Å; O47···N71, 2.661(3) Å).  Two of the carboxyphenoxy moieties 
are pointing in one vector whereas the third carboxyphenoxy group is located in the 
opposite direction to generate a φ-conformation.  The asymmetric units are assembled 
into infinite one-dimensional hydrogen-bonded chains, Figure 2.5. 
 
Figure 2.5 Infinite one-dimensional hydrogen-bonded chain in the crystal structure of 4. 
 
The two bipya molecules in each loop of the chain are aligned in a parallel fashion with 
respect to each other, separated by approximately 7 Å.  There are no short C−H···O 
contacts present in the crystal structure, as the ortho- C−H protons on bipya and carbonyl 
oxygen atoms on carboxyl groups in TCPT are not co-planar.  There are no readily 
identifiable directional interactions between adjacent chains. 
 
2.3.5 Crystal structure of 4,4’-trimethylenedipyridinium 2,4-bis-(4-carboxyphenoxy)-6-
(4-carboxylatephenoxy)-1,3,5-triazine, 5 
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     The crystal structure of 5 consists of one anion of TCPT- and one cation of tmdipyH+ 
in the asymmetric unit, Figure 2.1e.  A charge-assisted N−H···O interaction forms as a 
consequence of proton transfer between one of the carboxyl moieties in TCPT and a 
pyridine nitrogen atom in tmdipy (N51···O27, 2.625(5) Å). The anion in the crystal 
structure of 5 displays the φ-conformation which is similar to that presented by TCPT in 
1-4.  One of the carboxyphenoxy groups and the carboxylatephenoxy moiety in TCPT- 
are oriented in one direction while the other carboxyphenoxy group is pointing in the 
opposite direction.  The asymmetric units are in turn connected into an infinite undulating 
1-D ladder, Figure 2.6, by O−H···N hydrogen bonds between the O−H groups on 
carboxyl moieties in TCPT- and the pyridine nitrogen atoms in tmdipyH+ (O47···N61, 
2.654(5) Å) as well as O−H···O hydrogen bonds between carboxylate units in TCPT- and 
neighboring TCPT- carboxyl groups (O37···O28, 2.538(4) Å). 
 
Figure 2.6 Infinite one-dimensional ladder motif in 5. 
 
The O−H···N hydrogen bonds are accompanied by C−H···O interactions formed between 
the ortho- C−H pmoieties on tmdipyH+ and carbonyl oxygen atoms of carboxyl groups 
on TCPT- (C66−H66···O48, 3.19 Å).  No significant directional interactions occur 
between adjacent ladders in 5. 
 
2.3.6 Crystal structure of 2,4,6-tris-(4-carboxyphenoxy)-1,3,5-triazine bis-(4-pyridyl)-
ethane0.5 DMF, 6 
  
     The crystal structure of 6 contains one molecule of TCPT, half a molecule of bipya, 
and one molecule of DMF in the asymmetric unit, Figure 2.1f.  These components 
interact through an O−H···N hydrogen bond between a carboxyl O−H group on TCPT 
and a pyridine nitrogen atom in bipya (O37···N51, 2.5780(17) Å) and an O−H···O 
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hydrogen bond between another carboxyl O−H moiety on TCPT and the oxygen atom in 
DMF (O27···O1S, 2.5972(14) Å).  Once again, two of the carboxyphenoxy moieties in 
TCPT are located in one direction while the third carboxyphenoxy group is oriented in 
the opposite direction, resulting in a φ-conformation.  The primary supramolecular motif 
is an undulating one-dimensional chain assembled by means of additional O−H···O 
hydrogen bonds between carboxyl groups in adjacent TCPT molecules (O47···O48, 
2.6061(13) Å), Figure 2.7. 
      
Figure 2.7 Infinite undulating 1-D motif in the crystal structure of 6 obtained through 
capping of outer carboxyphenoxy moieties with DMF molecules. 
 
C−H···O interactions between ortho- C−H moieties of bipya and carbonyl oxygen atoms 
of carboxyl units in TCPT accompany the primary O−H···N hydrogen bonds 
(C52−H52···O38, 3.47 Å).  No other noteworthy interactions occur in the crystal structure 
of 6. 
 
2.4 Discussion 
 
     Compounds 1-6 were all obtained upon crystallization of TCPT with bipy or its 
homologues in polar solvents.  In each case, the solubility of TCPT was compatible with 
that of the ditopic base, which assisted the formation of binary co-crystals.  The improved 
solubility of TCPT, compared with that of trimesic acid, has allowed for the facile 
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preparation of co-crystals, all of which contain the expected heteromeric O−H···N 
interaction.  To date, there are only two crystallographically characterized molecular co-
crystals of trimesic acid with bipy and its homologues7 which, undoubtedly, is largely 
due to its poor solubility compared to that of the bipy counterparts.  Consequently, simply 
in terms of generating a larger number of co-crystals, the SR examined herein possesses 
an advantage over trimesic acid.  At the same time however, crystal structures 1-6 do not 
display the intended two-dimensional hexagonal frameworks as shown in Figure 2.2; 
instead, they all yield infinite one-dimensional architectures. 
     Structures 1-4 contain identical primary supramolecular chain-like motifs where 
interconnected loops are obtained as a result of O−H···N hydrogen bonding between the 
carboxyphenoxy moieties (in a φ-conformation) and the bipyridine homologues.  The 
graph–set notations22 for the loops are R 44 (54) (for 1 and 2), and R
4
4 (58) (for 3 and 4), 
which reflects the fact that a slightly longer ditopic hydrogen-bond acceptor is used for 
the latter structures; the number of hydrogen-bonds, however, stays the same.  No proton 
transfer from acid to base takes place in any of these four structures.  Furthermore, water 
molecules have been incorporated into the crystal structure of 2, and the solvent 
molecules are located within the loops of the extended chains without disrupting the 
primary O−H···N hydrogen-bonded motif.  The parallel alignment of the double bonds of 
bipye molecules in 3 resembles that obtained from resorcinol-directed assembly of bipye 
molecules;2c however, the distance between adjacent double bonds in 3 is too great (ca. 7 
Å), to make it a suitable candidate for successful photoinduced 2+2 cycloaddition. 
     The crystal structure of 5 reveals a different connectivity than 1-4 since an ionic 
compound had formed as a consequence of proton transfer between one of the 
carboxyphenoxy moieties in TCPT and one of the pyridine nitrogen atoms in tmdipy.  In 
addition to this primary N−H+···O- interaction, complementary carboxylic 
acid···carboxylate hydrogen bonds occur between adjacent TCPT units.  Thus, only one 
of the carboxyphenoxy groups interacts with a pyridine nitrogen atom in tmdipy to form a 
neutral O−H···N hydrogen bond.  The same structural conformation of TCPT in 1-4 was 
also observed in 5. 
     The crystal structure of 6 contains DMF solvent molecules, which is not observed in 
4.  In 4, the supramolecular reaction was set up in a 1:1.5 ratio whereas in 6 the reaction 
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was carried out in a 1:1 stoichiometry.  The solvated structure, 6, was also obtained from 
a reaction between TCPT and bipya in a 1:2 molar ratio.  The central SR once again 
adopts the φ-conformation. 
     The structural homogeneities of bulk samples of co-crystals consisting of TCPT and 
bipya in both 1:1 and 1:2 molar ratios were examined using powder XRD.  When TCPT 
and bipya were set up in a 1:1 stoichiometry, the DMF-solvated structure was obtained 
(6) but the experimental powder pattern of the bulk, Figure 2.8b, also contain peaks that 
originate from the crystal structure of 4, as demonstrated by the simulated powder pattern 
for this structure, Figure 2.8a.  Consequently, the supramolecular reaction yielded a 
mixture of the two products.  When the reaction between TCPT and bipya was carried out 
in a 1:2 molar ratio, diffraction peaks derived from both crystalline compounds 4 and 6 
were observed, Figure 2.8c.   The powder diffraction work indicates that the structural 
outcome cannot be fully controlled by controlling stoichiometries of the two reactants, 
and the reactions do not proceed completely to a single new crystalline phase under the 
different conditions that we have examined. 
 
                
                                       (a)                                                           (b) 
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                                  (c) 
Figure 2.8 Powder XRD patterns for (a) 4 (simulated); (b) TCPT:bipya 1:1 
(experimental); and (c) TCPT:bipya 1:2 (experimental). 
 
     There are two different possible conformations for TCPT, ∆ and φ, Scheme 2.4.  In 
every structure, 1-6, TCPT appears in the low-symmetry φ-conformation.  For each 
possible conformation, the primary robust O−H···N hydrogen bonds in co-crystals of 
TCPT and ditopic bases could, in principle, be the same.  The energetically more “stable” 
high-symmetry conformation is, however, abandoned each time in favor of the φ-
conformation.  This is probably because the low-symmetry φ-conformation results in a 
supramolecular motif (an infinite chain) that can produce a closer packed structure 
compared to the much more open hexagonal extended framework that would result if 
TCPT had adopted the ∆-conformation.  In 1-6, the carboxyphenoxy groups in the φ-
conformation of TCPT are frequently coplanar with the triazine ring.  Such a 
conformation is similar to that observed in other structurally flexible tritopic SR’s 
containing bridging methylene groups in the “arms” such as 1,3,5-tris-(imidazol-1-
ylmethyl)-2,4,6-trimethylbenzene;23 in this SR, however, the imidazol-1-ylmethyl 
moieties are not coplanar with respect to the benzene core. 
     We furthermore noted in the CSD that in the absence of any hydrogen-bond 
functionalities, similar 2,4,6-tris-phenoxy-1,3,5-triazine compounds adopt the ∆-
conformation and are mainly stabilized by weaker intermolecular interactions.16a,24  
     In an attempt to induce three-fold symmetry in our SR (in order to construct infinite 2-
D networks) we proceeded to set up co-crystallizations employing highly symmetric 
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guests and/or co-solvents such as hexachlorobenzene, hexamethylbenzene, and 
tribromobenzene that can act as templates for a three-fold symmetric framework.25   
However, even in the presence of a variety of rigid tritopic guests or co-solvents we were 
unable to produce co-crystals that contained TCPT in the high-symmetry ∆-
conformation.   
 
2.5 Conclusions 
 
     The structurally flexible TCPT does provide an advantage over the rigid trimesic acid 
in that it is more soluble and thus creates more opportunity for co-crystal formation.  At 
the same time, however, such flexibility also changes the supramolecular product to a 1-
D motif, instead of the desired 2-D hexagonal network.  On one hand, if the goal is to 
maintain high symmetry, then a more structurally rigid SR such as trimesic acid can be 
employed as long as the inherent problems with solvent compatibility between the two or 
more reactants can be overcome.  One the other hand, if the goal is to facilitate co-
crystallization formation with heterocyclic hydrogen-bond acceptors then a more 
structurally flexible SR such as TCPT is a better choice for a co-crystallizing agent.   The 
latter option is often desired in the pharmaceutical industry, since co-crystal formation 
may provide improvement in the physical properties of a pharmaceutical product, thereby 
acquiring a higher priority than supramolecular predictability.26,27 
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Chapter 3 
 
Directed assembly of ditopic imidazoles/benzimidazoles and dicarboxylic acids into 
co-crystals via selective O−H…N hydrogen bonds 
         
3.1 Introduction 
 
     Understanding the nature of intermolecular interactions is a crucial aspect of crystal 
engineering,1,2,3 and the hydrogen bond has been established as the most effective tool for 
constructing sophisticated assemblies from discrete ionic or molecular building blocks 
due to its strength and directionality.1,3 A key requirement in the development of 
strategies for non-covalent synthesis is the availability of reliable supramolecular 
synthons.4,5  The usefulness of supramolecular synthons is related to the frequency of 
occurrence of desired intermolecular interactions between molecules under certain 
reaction conditions.  Such reliability can be paralleled to named reactions in organic 
chemistry where molecular transformations or specific bond-making/breaking events take 
place under particular reaction conditions with high degrees of certainty.  Typically, 
reliable supramolecular synthons need to be insensitive to subtle changes in molecular 
shape, substituent groups, as well as to competition from other intermolecular 
interactions such as π···π interactions and interactions with solvent molecules.   
     In Chapter 2 we examined a supramolecular synthon that has been employed 
frequently in the construction of extended architectures in the solid state − the carboxylic 
acid···pyridine (COOH···Py) synthon, Scheme 3.1. 
 
R
O
O H N
H
 
 
Scheme 3.1 The carboxylic acid···pyridine synthon. 
 
The COOH···Py synthon consists of the primary O−H···N hydrogen bond and the 
auxiliary C−H···O interaction (although the latter may not always be present).  It has been 
instrumental in the design of one- and two-dimensional supramolecular architectures, 
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such as infinite chains,6 honeycomb layers,7 and sheets,8 utilizing 4,4’-bipyridine and its 
derivatives as the hydrogen-bond acceptor.  
     Since crystal engineering also seeks to mimic sophisticated and delicate systems 
observed in Nature, it is necessary to identify synthons built upon chemical moieties 
compatible with or encountered in biology and biochemistry.  As a result, we will focus 
on the carboxylic acid···imidazole (COOH···Im) and carboxylic acid···benzimidazole 
(COOH···Bzim) interactions, which have more biological relevance than the COOH···Py 
synthon. 
     Imidazole (Im), benzimidazole (Bzim), and their derivatives are ubiquitous in 
biological and biochemical structure and function, such as the roles of histidine as a metal 
ion binding site in metalloenzymes9 and in the catalytic mechanisms of ribonucleases and 
other phosphoesterases.10  Histidine also plays a part in cytochrome c peroxidase11 as 
well as in copper transport in humans.12  Im and Bzim derivatives have also found 
applications in drug design in the forms of antitumor13 and anticancer14 agents. In fact, 
these derivatives are known to treat a variety of physiological disorders.15  Consequently, 
the importance of imidazoles and benzimidazoles in biology and biochemistry cannot be 
overstated. 
     We are interested in exploring the reliability of the COOH···Im and COOH···Bzim 
synthons in the presence of potentially disruptive intermolecular interactions such as π···π 
interactions and interactions with solvent molecules.  In addition, we will study the effect 
of molecular shape, molecular isomerism, and substituent groups on these synthons by 
altering the geometry involved in the constituent intermolecular interactions (i.e. 
switching from imidazole to benzimidazole, varying the positions of these heterocyclic 
moieties in molecules, and by replacing the H2 hydrogen atom on the benzimidazol-1-yl 
moiety with a methyl group).  By understanding these scenarios we can develop a library 
of reliable supramolecular synthons that can, in principle, find applications in more 
sophisticated biological systems e.g. cytochrome c peroxidase11 and CGS 14796C17 in 
order to better understand the nature and roles of relevant intermolecular interactions.  
     When carboxylic acids interact with Im and Bzim the solid state outcome is often an 
organic salt, not a co-crystal, as a result of proton transfer.16  A co-crystal can form, 
however, if a carboxylic acid interacts with an imidazol-1-yl or benzimidazol-1-yl moiety 
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as noted in the crystal structure of 1,4-bis-[(imidazol-1-yl)methyl]-cyclohexane succinic 
acid, a 1:1 co-crystal (CGS 14796C, an active non-steroidal aromatase inhibitor).17  An 
O−H···N hydrogen bond is formed between the carboxylic acid group on succinic acid 
and the imidazol-1-yl nitrogen atom. 
     In this chapter, we present the syntheses of six closely related symmetric ditopic bis-
imidazol-1-yl/bis-benzimidazol-1-yl compounds, and the crystal structures of three of 
them, 7-9. We will subsequently test the limits and limitations of 
COOH···Im/COOH···Bzim interactions through a systematic structural study of eleven 
molecular co-crystals composed of dicarboxylic acids and these ditopic N-heterocyclic 
compounds; 1,4-bis-[(imidazol-1-yl)methyl]-benzene trans-3-hexenedioic acid (10), 1,4-
bis-[(imidazol-1-yl)methyl]-benzene fumaric acid (11), 1,4-bis-[(imidazol-1-yl)methyl]-
benzene succinic acid (12), 1,4-bis-[(imidazol-1-yl)methyl]-benzene isophthalic acid 
(13), 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene fumaric acid (14), 1,4-bis-
[(benzimidazol-1-yl)methyl]-benzene malonic acid (15), 1,4-bis-[(benzimidazol-1-
yl)methyl]-benzene isophthalic acid EtOH0.5 (16), 1,4-bis-[(benzimidazol-1-yl)methyl]-
benzene 5-aminoisophthalic acid EtOH0.5 (17), 1,3-bis-[(benzimidazol-1-yl)methyl]-
benzene malonic acid (18), 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene trans-
3-hexenedioic acid (19), and 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene 
adipic acid (20).   
     N-substituted symmetric ditopic imidazoles and benzimidazoles can be prepared by 
substituting the N1 atom on the Im and Bzim moieties with an alkyl group, Scheme 3.2. 
 
N3 N1 R N3 N1 R
 
Scheme 3.2 N-substituted imidazoles and benzimidazoles denoting labeled nitrogen 
atoms. 
 
      We will also investigate the nature of the C−H···O interaction that can arise from the 
COOH···Im and COOH···Bzim synthons.  Since an O−H···N hydrogen bond would 
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involve the best hydrogen-bond donor (the acidic OH group of the carboxylic acid) and 
the best hydrogen-bond acceptor (the heterocyclic nitrogen atom), we can, therefore, 
expect this hydrogen bond to be the primary intermolecular force.  In co-crystals of 
carboxylic acids and 4,4’-bipyridine, a secondary C−H···O interaction arises from the 
C−H group on the C2 carbon of 4,4’-bipyridine and the carbonyl oxygen atom of the 
carboxylic acid.  However, since 4,4’-bipyridine is symmetric about the nitrogen atoms, 
the ortho- C−H groups are equivalent.  This is not the case in the COOH···Im and 
COOH···Bzim synthons because the ortho- C−H groups possess different acidities.  Thus, 
our study will allow us to establish if the carbonyl oxygen atom on the acid shows a 
preference for the more acidic of the two C−H options,18 Scheme 3.3.  
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Scheme 3.3 The (a) COOH···Im and (b) COOH···Bzim synthons indicating the best and 
second-best hydrogen-bond donor/acceptor couples. 
 
3.2 Experimental  
 
3.2.1 Synthesis 
 
All starting materials were purchased from Aldrich and used without further purification.  
Melting points were determined on a Fisher-Johns melting point apparatus and are 
uncorrected. 
 
3.2.1.1 Synthesis of 1,4-bis-[(imidazol-1-yl)methyl]-benzene dihydrate19 
 
α,α′-Dichloro-p-xylene (3.90 g, 22.3 mmol) and imidazole (15.8 g, 232 mmol) were 
dissolved in 250 mL of methanol with stirring in a 500-mL round-bottomed flask.  A 
reflux condenser was attached, and the clear, colorless solution was heated and stirred 
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under reflux.  The reaction was followed by TLC.  After 17 h, the mixture was cooled 
and concentrated via rotary evaporation to afford a yellow syrup.  A K2CO3 solution 
(31.2 g in 300 mL of distilled water) was then added to the flask containing the yellow 
syrup immediately producing white microcrystals, which were collected by vacuum 
filtration.  The microcrystalline solid was recrystallized from 600 mL of hot distilled 
water to yield long, white needles, which was filtered via vacuum filtration, collected, 
and dried.  Yield 4.17 g (68%); m.p. 128-131˚C; 1H NMR (DMSO-d6, 400 MHz) δ 5.16 
(s, 4H), 6.88 (s, 2H), 7.15 (s, 2H), 7.23 (s, 4H), 7.72 (s, 2H). 
 
3.2.1.2 Synthesis of 1,3-bis-[(imidazol-1-yl)methyl]-benzene 
 
α,α′-Dichloro-m-xylene (2.00 g, 11.0 mmol) and imidazole (7.76 g, 114 mmol) were 
dissolved in 100 mL of methanol with stirring in a 250-mL round-bottomed flask.  A 
reflux condenser was attached, and the clear, colorless solution was heated and stirred 
under reflux.  The reaction progress was followed by TLC.  After 42 h, the mixture was 
cooled and concentrated via rotary evaporation to produce a yellow syrup.  A K2CO3 
solution (15.4 g in 100 mL of distilled water) was added to form a clear, pale yellow 
solution.  A fine and white solid precipitated within 30 min, and was filtered via vacuum 
filtration, collected, and dried.  Yield 2.06 g (78.8%); m.p. 45-48˚C; 1H NMR (DMSO-d6, 
400 MHz) δ 5.17 (s, 4H), 6.90 (s, 2H), 7.14 (d, 4H, J = 6.4 Hz), 7.20 (s, 1H), 7.34 (t, 1H, 
J = 7.6 Hz), 7.72 (s, 2H). 
 
3.2.1.3 Synthesis of 1,4-bis-[(2-methylimidazol-1-yl)methyl]-benzene 
 
α,α′-Dichloro-p-xylene (2.00 g, 11.0 mmol) and 2-methylimidazole (9.77 g, 119 mmol) 
were dissolved in 100 mL of methanol with stirring in a 250-mL round-bottomed flask.  
A reflux condenser was attached, and the clear, colorless solution was heated and stirred 
under reflux.  The reaction progress was monitored by TLC.  After 24 h, the mixture was 
cooled and concentrated via rotary evaporation to afford a white microcrystalline solid.  
A K2CO3 solution (15.4 g in 125 mL of distilled water) was added to produce a clear, 
colorless solution.  Within 2 h, a white microcrystalline solid formed, which was filtered 
via vacuum filtration, collected, and dried.  Yield 2.18 g (74.6%); m.p. 150-153˚C; 1H 
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NMR (DMSO-d6, 400 MHz) δ 2.20 (s, 6H), 5.11 (s, 4H), 6.74 (d, 2H, J = 1.2 Hz), 7.09 
(d, 2H, J = 1.2 Hz), 7.11 (s, 4H). 
  
3.2.1.4 Synthesis of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene, 7 
 
α,α′-Dichloro-p-xylene (1.00 g, 5.70 mmol) and benzimidazole (7.03 g, 59.5 mmol) were 
dissolved in 60 mL of methanol with stirring in a 250-mL round-bottomed flask.  A 
reflux condenser was attached, and the clear, dark brown mixture was heated and stirred 
under reflux.  The reaction progress was monitored by TLC.  After 22 h, the mixture was 
cooled and concentrated via rotary evaporation to obtain a dark brown syrup that soon 
solidified.  The solid was then washed with 100 mL of acetone and filtered by vacuum 
filtration.  The remaining solid was further washed with 75 mL of distilled water by 
heating and stirring the suspension under reflux for 1 h.  The resulting pale brown solid, 
was filtered via vacuum filtration, collected, and dried.  Slow evaporation of the product 
from absolute ethanol produced orange plates, 7.  Yield 1.31 g (67.8%); m.p. 187-191˚C; 
1H NMR (DMSO-d6, 400 MHz) δ 5.45 (s, 4H), 7.17 (m, 4H), 7.26 (s, 4H), 7.46 (m, 2H), 
7.64 (m, 2H), 8.36 (s, 2H). 
 
3.2.1.5 Synthesis of 1,3-bis-[(benzimidazol-1-yl)methyl]-benzene 
 
α,α′-Dichloro-m-xylene (2.00 g, 11.0 mmol) and benzimidazole (13.6 g, 115 mmol) were 
dissolved in 100 mL of methanol with stirring in a 250-mL round-bottomed flask.  A 
reflux condenser was attached, and the clear, dark brown solution was heated and stirred 
under reflux.  The reaction progress was monitored via TLC.  The reaction was cooled 
after 24 h and concentrated by rotary evaporation to produce a dark brown solid.  The 
solid was then washed with 150 mL of acetone and filtered via vacuum filtration.  The 
clear, brown filtrate was concentrated by rotary evaporation to obtain a brown solid.  This 
solid was washed with 150 mL of distilled water by heating and stirring the suspension 
under reflux for 1.5 h.  The remaining brown solid was filtered via vacuum filtration, 
collected, and dried.  Slow evaporation of the product from absolute ethanol produced 
amber prisms, 8.  Yield 2.09 g (56.1%); m.p. 70-75˚C; 1H NMR (DMSO-d6, 400 MHz) δ 
5.46 (s, 4H), 7.17 (m, 5H), 7.28 (t, 1H, J = 8 Hz), 7.43 (m, 4H), 7.65 (dd, 2H, J1 = 6.4 
Hz, J2 = 1.6 Hz), 8.38 (s, 2H). 
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3.2.1.6 Synthesis of 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene, 9 
 
α,α′-Dichloro-p-xylene (0.50 g, 2.86 mmol) and 2-methylbenzimidazole (3.93 g, 29.8 
mmol) were dissolved in 30 mL of methanol with stirring in a 100-mL round-bottomed 
flask.  A reflux condenser was attached, and the clear, yellow solution was heated and 
stirred under reflux.  The reaction progress was followed by TLC.  After 24 h, the 
mixture was cooled and concentrated by rotary evaporation to obtain an off-white solid.  
The solid was washed with 40 mL of distilled water by heating and stirring the 
suspension under reflux for 1 h.  The remaining off-white solid was filtered via vacuum 
filtration.  The solid was then washed with 10 mL of cold acetone, and a fine, white solid 
was obtained upon vacuum filtration.  The white solid was further washed with 150 mL 
of distilled water by heating and stirring the suspension under reflux for 1 h.  The 
resulting white solid was immediately filtered by vacuum filtration, washed with small 
amounts of distilled water, collected, and dried.  Colorless plates of 9 were obtained upon 
recrystallization from absolute ethanol.  Yield 0.32 g (30.7%); m.p. 255-258˚C; 1H NMR 
(DMSO-d6, 400 MHz) δ 2.48 (s, 6H), 5.41 (s, 4H), 7.08 (s, 4H), 7.12 (m, 4H), 7.41 (m, 
2H), 7.52 (m, 2H). 
 
3.2.2 Syntheses of co-crystals20 
 
3.2.2.1 Synthesis of 1,4-bis-[(imidazol-1-yl)methyl]-benzene trans-3-hexenedioic acid, 
10 
 
1,4-bis-[(imidazol-1-yl)methyl]-benzene (0.05 g, 0.18 mmol) was dissolved in 1 mL of 
methanol.  To this solution was added an ethanolic solution containing trans-3-
hexenedioic acid (0.03 g, 0.18 mmol).  Colorless prisms were obtained after one week of 
slow evaporation of the solvent.  M.p. 171-176˚C; IR (KBr pellet) ν 2450 cm-1, 1928 cm-1 
(O−H···N, br), 1700 cm-1 (C=O, s). 
 
3.2.2.2 Synthesis of 1,4-bis-[(imidazol-1-yl)methyl]-benzene fumaric acid, 11 
 
1,4-bis-[(imidazol-1-yl)methyl]-benzene (0.05 g, 0.18 mmol) was dissolved in 1 mL of 
methanol.  To this solution was added fumaric acid (0.02 g, 0.18 mmol) in ethanol.  
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Colorless prisms were afforded after one week of slow evaporation of the solvent.  M.p. 
175-178˚C; IR (KBr pellet) ν 2472 cm-1, 1931 cm-1 (O−H···N, br), 1695 cm-1 (C=O, s). 
 
3.2.2.3 Synthesis of 1,4-bis-[(imidazol-1-yl)methyl]-benzene succinic acid, 12 
 
1,4-bis-[(imidazol-1-yl)methyl]-benzene (0.05 g, 0.18 mmol) was dissolved in 1 mL of 
methanol.  An ethanolic solution of succinic acid (0.02 g, 0.18 mmol) was added to this 
solution.  Colorless prisms were obtained after one week upon evaporation of the solvent. 
M.p. 159-161˚C; IR (KBr pellet) ν 2423 cm-1, 1952 cm-1 (O−H···N, br), 1700 cm-1 (C=O, 
s). 
 
3.2.2.4 Synthesis of 1,4-bis-[(imidazol-1-yl)methyl]-benzene isophthalic acid, 13 
 
1,4-bis-[(imidazol-1-yl)methyl]-benzene (0.05 g, 0.18 mmol) was dissolved in 1 mL of 
methanol.  To this solution was added isophthalic acid (0.03 g, 0.18 mmol) in ethanol.  
Colorless prisms were afforded after one week of slow evaporation of the solvent.  M.p. 
174-178˚C; IR (KBr pellet) ν 2448 cm-1, 1927 cm-1 (O−H···N, br), 1691 cm-1 (C=O, s). 
 
3.2.2.5 Synthesis of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene fumaric acid, 14 
 
1,4-bis-[(benzimidazol-1-yl)methyl]-benzene (0.05 g, 0.15 mmol) was dissolved in 1 mL 
of ethanol.  To this solution was added an ethanolic solution containing fumaric acid 
(0.020 g, 0.15 mmol).  Orange plates were afforded after 24 h of slow evaporation of the 
solvent.  M.p. 234-238˚C (decomp.); IR (KBr pellet) ν 2450 cm-1, 1917 cm-1 (O−H···N, 
br), 1700 cm-1 (C=O, s). 
 
3.2.2.6 Synthesis of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene malonic acid, 15 
 
1,4-bis-[(benzimidazol-1-yl)methyl]-benzene (0.05 g, 0.15 mmol) was dissolved in 1 mL 
of ethanol.  To this solution was added malonic acid (0.02 g, 0.15 mmol) in ethanol.  
Orange prisms were obtained after six days of slow evaporation of the solvent.  M.p. 175-
180˚C; IR (KBr pellet) ν 2500 cm-1, 1942 cm-1 (O−H···N, br), 1700 cm-1 (C=O, s). 
 
3.2.2.7 Synthesis of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene isophthalic acid 
EtOH0.5, 16 
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1,4-bis-[(benzimidazol-1-yl)methyl]-benzene (0.05 g, 0.15 mmol) was dissolved in 1 mL 
of ethanol.  To this solution was added an ethanolic solution containing isophthalic acid 
(0.03 g, 0.15 mmol).  Orange prisms were obtained after two weeks of slow evaporation 
of the solvent.  M.p. 177-180˚C; IR (KBr pellet) ν 2494 cm-1, 1918 cm-1 (O−H···N, br), 
1696 cm-1 (C=O, s). 
 
3.2.2.8 Synthesis of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene 5-aminoisophthalic 
acid EtOH0.5, 17 
 
1,4-bis-[(benzimidazol-1-yl)methyl]-benzene (0.05 g, 0.15 mmol) was dissolved in 1 mL 
of ethanol.  To this solution was added a solution containing 5-aminoisophthalic acid 
(0.03 g, 0.15 mmol) in ethanol.  Orange plates were afforded after two weeks of slow 
evaporation of the solvent.  M.p. 230-234˚C; IR (KBr pellet) ν 2438 cm-1, 1917 cm-1 
(O−H···N, br), 1700 cm-1 (C=O, s). 
 
3.2.2.9 Synthesis of 1,3-bis-[(benzimidazol-1-yl)methyl]-benzene malonic acid, 18 
 
1,3-bis-[(benzimidazol-1-yl)methyl]-benzene (0.02 g, 0.06 mmol) was dissolved in 1 mL 
of ethanol.  To this solution was added a solution of malonic acid (0.01 g, 0.06 mmol) in 
ethanol.  Colorless plates were obtained after two weeks of slow evaporation of the 
solvent.  M.p. 175-179˚C; IR (KBr pellet) ν 2515 cm-1, 1918 cm-1 (O−H···N, br), 1700 
cm-1 (C=O, s). 
 
3.2.2.10 Synthesis of 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene trans-3-
hexenedioic acid, 19 
 
1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene (0.02 g, 0.05 mmol) was dissolved 
in 1 mL of ethanol.  To this solution was added trans-3-hexenedioic acid (0.01 g, 0.05 
mmol) in ethanol.  Colorless plates were obtained after two days of slow evaporation of 
the solvent.  M.p. 215-220˚C; IR (KBr pellet) ν 2525 cm-1, 1918 cm-1 (O−H···N, br), 1700 
cm-1 (C=O, s). 
 
3.2.2.11 Synthesis of 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene adipic acid, 
20 
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1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene (0.02 g, 0.05 mmol) was dissolved 
in 1 mL of ethanol.  To this solution was added an ethanolic solution containing adipic 
acid (0.01 g, 0.05 mmol).  Colorless plates were afforded after one week of slow 
evaporation of the solvent.  M.p. 184-187˚C; IR (KBr pellet) ν 2514 cm-1, 1946 cm-1 
(O−H···N, br), 1696 cm-1 (C=O, s). 
 
3.2.3 X-ray crystallography 
 
     X-ray data were collected on a Bruker SMART 1000 four-circle CCD diffractometer 
using a fine-focus molybdenum Kα tube.  Data were collected using SMART.21  Initial 
cell constants were found by small widely separated “matrix” runs.  Preliminary Laué 
symmetry was determined from axial images.  Generally, an entire hemisphere of 
reciprocal space was collected regardless of Laué symmetry.  Scan speed and scan width 
were chosen based on scattering power and peak rocking curves. 
     Unit cell constants and orientation matrix were improved by least-squares refinement 
of reflections thresholded from the entire dataset.  Integration was performed with 
SAINT,22 using this improved unit cell as a starting point.  Precise unit cell constants 
were calculated in SAINT from the final merged dataset.  Lorenz and polarization 
corrections were applied, but data were generally not corrected for absorption.  Laué 
symmetry, space group, and unit cell contents were found with XPREP. 
     Data were reduced with SHELXTL.23  The structures were solved in all cases by 
direct methods without incident.  In general, hydrogens were assigned to idealized 
positions and were allowed to ride.  Where possible, the coordinates of hydrogen-bonding 
hydrogens were allowed to refine.  Heavy atoms, other than those of the guests, were 
refined with anisotropic thermal parameters.  Additional experimental details: 10 The 
carboxylic acid hydrogen and the imidazole C-2 hydrogen were allowed to refine; all 
other hydrogens were located at calculated positions; 11 The carboxylic acid hydrogens 
and the imidazole C-5 hydrogen were allowed to refine; all other hydrogens were located 
at calculated positions; 12 The carboxylic acid hydrogens and the imidazole C-5 
hydrogen were allowed to refine; all other hydrogens were located at calculated positions; 
13 The carboxylic acid hydrogens and the imidazole C-2 hydrogen were allowed to 
refine; all other hydrogens were located at calculated positions; 14 The carboxylic acid 
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hydrogens and the imidazole C-2 hydrogen were allowed to refine; all other hydrogens 
were located at calculated positions; 16 A disordered solvent ethanol was located in the 
difference Fourier map.  The molecule was located on an inversion center, the two 
occupancies were constrained so that their sum equalled 0.50, and the two species were 
each assigned a free variable for their thermal motion.  The geometry of the two ethanol 
species was constrained with 'DFIX' distance constraints.  For neither of these species 
was the hydroxyl hydrogen located.  The carboxylic acid hydrogens were allowed to 
refine; 17 A disordered solvent ethanol was located in the difference Fourier map.  The 
molecule was located on an inversion center, the two occupancies were constrained so 
that their sum equalled 0.50, and the geometry of the two ethanol species was constrained 
with 'DFIX' distance constraints; 19 Highly anisotropic thermal parameters for the two 
carboxylate oxygens suggested the presence of disorder.  Two −COOH moieties were 
introduced into the structural model, representing a small “wobble” about the C−COOH 
bond.  The two species refined to approximately a 3:1 ratio.  Because of this disorder, the 
carboxylate hydrogens were included in calculated positions. 
 
3.2.4 Powder X-ray diffraction 
 
     Powder XRD data for 13 and 14 were collected on a Bruker/Nonius D8 ADVANCE 
diffractometer with Bragg-Brentano geometry.  A step size of 0.04˚ and step time of 60 
sec per step were used.  Data were processed using EVA v8.0.24 
 
3.3 Results 
 
     Relevant crystallographic data for 7-20 are given in Tables A7-A20, hydrogen-bond 
parameters for 10-20 are provided in Table 3.1, and thermal ellipsoids and labeling 
schemes for 7-20 are shown in Figure 3.1.   
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Table 3.1 Hydrogen-bond geometries for 10-20. 
 
Compound D-H A D-H/Å H...A/Å D...A/Å <(DHA)/° generator for A 
10 O31 H31 N13 1.03(2) 1.60(2) 2.6245(16) 175.2(16) − 
11 O31 H31 N13 1.042(18) 1.523(19) 2.5624(15) 174.3(15) − 
12 O31 H31 N13 0.962(17) 1.648(18) 2.6077(14) 174.5(15) − 
13 O37 H37 N13 0.985(17) 1.633(17) 2.6126(15) 173.1(16) − 
14 O31 H31 N13 1.125(17) 1.487(17) 2.6096(14) 174.9(13) − 
15 O51 H51A N33 
O53 H53 N13 
1.10(7) 
1.01(3) 
1.52(7) 
1.59(3) 
2.615(3) 
2.597(3) 
178(6) 
178(3) 
− 
− 
16 O57 H57 N33 
O59 H59 N13 
1.07(2) 
0.92(2) 
1.54(2) 
1.74(2) 
2.6080(18) 
2.6463(16) 
171.2(18) 
166(2) 
− 
− 
17 O51 H51 N43 
O53 H53 N23 
N55 H55B O53 
1.03(2) 
1.020(18) 
0.97(2) 
1.57(2) 
1.592(18) 
2.25(2) 
2.5852(17) 
2.6041(15) 
3.189(2) 
171.2(15) 
170.8(17) 
163.9(16) 
− 
− 
x-1, y, z 
18 O41 H41 N33 
O43 H43 N23 
0.952(17) 
0.907(18) 
1.690(17) 
1.747(18) 
2.6407(15) 
2.6508(15) 
176.0(15) 
174.6(15) 
− 
x, y+1, z-1 
19 O31 H31 N13 1.07(2) 1.59(2) 2.644(2) 168.3(18) − 
20 O31 H31 N13 1.05(2) 1.61(2) 2.652(2) 171.4(19) − 
 
 
                                     
                                                                 (a) 
 
                                 
                                                                 (b) 
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                                                                 (c) 
   
    (d)     (e)    
 
 
    (f)          (g)        
 
                                      
                                                                      (h) 
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                                                                       (i) 
 
                          
                                                                       (j) 
 
                          
                                                                       (k) 
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                                                                       (l) 
 
                                  
                                                                       (m) 
 
                                 
                                                                       (n) 
 
Figure 3.1 Thermal ellipsoid plots (50% probabilities) and labeling schemes for 7-20 (a-
n).   
 
3.3.1 Crystal structure of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene, 7 
 
     No significant intermolecular interactions are present in the crystal structure of 7, 
Figure 3.1a; molecules pack mainly via π···π interactions. 
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3.3.2 Crystal structure of 1,3-bis-[(benzimidazol-1-yl)methyl]-benzene hydrate ethanol, 8 
 
     Water and disordered ethanol solvent molecules are present in the crystal structure of 
8, Figure 3.1b, and hydrogen bonds between 1,3-bis-[(benzimidazol-1-yl)methyl]-
benzene molecules and these solvent molecules could not be identified. 
 
3.3.3 Crystal structure of 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene, 9 
 
     Similarly to 7, there are no noteworthy intermolecular interactions in the crystal 
structure of 9, Figure 3.1c, and 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene 
molecules are mainly stabilized by π···π interactions. 
 
3.3.4 Crystal structure of 1,4-bis-[(imidazol-1-yl)methyl]-benzene trans-3-hexenedioic 
acid, 10 
 
     The asymmetric unit of 10 consists of half a molecule each of 1,4-bis-[(imidazol-1-
yl)methyl]-benzene and trans-3-hexenedioic acid, Figure 3.1d.  The desired O−H···N 
hydrogen bond is formed by the O−H group on the dicarboxylic acid and the imidazol-1-
yl nitrogen atom, (O31···N13, 2.6245(16) Å), and no proton transfer has occurred 
between the acid and the base.  This hydrogen bond is accompanied by a C−H···O contact 
involving H14 on Im and O32 on the COOH carbonyl oxygen atom (C14···O32, 3.34 Å) 
in which the imidazole-carboxylic acid moieties are co-planar.  This heteromeric synthon 
further propagates the acid and the base into an infinite one-dimensional zig-zag chain, 
Figure 3.2.   
   
Figure 3.2 Extended 1-D chain in 10. 
 
Neighboring one-dimensional chains are stacked in an antiparallel fashion through 
C−H···O contacts between H12 on Im and O32 on carbonyl oxygen atoms of adjacent 
dicarboxylic acids (C12···O32, 3.12 Å). 
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3.3.5 Crystal structure of 1,4-bis-[(imidazol-1-yl)methyl]-benzene fumaric acid, 11  
 
     The principal O−H···N hydrogen bond in 11 is formed between the acid and the base, 
and therefore a co-crystal is produced (O31···N13, 2.5624(15) Å), Figure 3.1e.  A 
C−H···O contact also accompanies the O−H···N hydrogen bond, this time utilizing H12 
on Im and O32 on the COOH carbonyl oxygen atom (C12···O32, 3.40 Å).  The extended 
supramolecular architecture is an infinite one-dimensional undulating chain, Figure 3.3.   
      
Figure 3.3 Extended 1-D supramolecular chain in 11. 
 
Adjacent one-dimensional chains are further held together by C−H···O contacts between 
H15 on Im and O32 on carbonyl oxygen atoms of neighboring fumaric acid molecules 
(C15···O32, 3.20 Å). 
 
3.3.6 Crystal structure of 1,4-bis-[(imidazol-1-yl)methyl]-benzene succinic acid, 12 
   
     The expected O−H···N interaction was afforded in 12 through the O−H group on the 
dicarboxylic acid and the imidazol-1-yl nitrogen atom (O31···N13, 2.6077(14) Å) and no 
proton transfer from the acid to the base took place, Figure 3.1f.  The O−H···N hydrogen 
bond is accompanied by a C−H···O contact involving H12 on Im and O32 on the COOH 
carbonyl oxygen atom (C12···O32, 3.40 Å).  This heteromeric synthon in turn connects 
the molecular components into an infinite one-dimensional undulating chain, Figure 3.4.   
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Figure 3.4 Infinite hydrogen-bonded 1-D chain in 12. 
  
Neighboring chains are further held together by C−H···O contacts between H15 on Im 
and O32 on carbonyl oxygen atoms of adjacent succinic acid molecules (C15···O32, 3.26 
Å). 
 
3.3.7 Crystal structure of 1,4-bis-[(imidazol-1-yl)methyl]-benzene isophthalic acid, 13 
    
     The intended infinite one-dimensional chain was produced in 13 via COOH···Im 
hydrogen bonds (O37···N13, 2.6126(15) Å, Figures 3.1g and 3.5. 
 
 
Figure 3.5 Infinite hydrogen-bonded chain in 13. 
 
The COOH···Im hydrogen bond is accompanied by a C−H···O contact utilizing H14 on 
Im and O38 on the COOH carbonyl oxygen atom (C14···O38, 3.32 Å).  Adjacent chains 
are organized in a parallel manner through C−H···O contacts between H12 on Im and 
O38 on carbonyl oxygen atoms of neighboring isophthalic acid molecules (C12···O38, 
3.15 Å). 
 
3.3.8 Crystal structure of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene fumaric acid, 14 
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     The expected O−H···N hydrogen bond is produced in 14 from the interaction between 
the COOH-Bzim moieties (O31···N13, 2.6096(14) Å), Figure 3.1h.  This hydrogen bond 
co-exists with a C−H···O contact arising from H15 on Bzim and O32 on the COOH 
carbonyl oxygen atom (C15···O32, 3.32 Å).  The resulting O−H···N/C−H···O heteromeric 
synthon propagates the acid and the base into an infinite one-dimensional chain, Figure 
3.6.   
       
Figure 3.6 1-D hydrogen-bonded chain in 14. 
 
Neighboring chains are stacked in an alternating parallel/antiparallel fashion via C−H···O 
contacts between H12 and H16 respectively on Bzim and O32 on carbonyl oxygen atoms 
of adjacent fumaric acid molecules (C12···O32, 3.17 Å; C16···O32, 3.45 Å).  Proximal 
chains are further stabilized by π···π interactions between the benzene core of the ditopic 
base of one layer and the Bzim aromatic ring of the ditopic base of another layer. 
 
3.3.9 Crystal structure of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene malonic acid, 15 
 
     The asymmetric unit of 15 shows the presence of two crystallographically unique 
molecules of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene and one molecule of malonic 
acid, Figure 3.1i.  These components interact through two different O−H···N hydrogen 
bonds (O51···N33, 2.615(3) Å; O53···N13, 2.597(3) Å).  One of these heteromeric 
interactions is accompanied by a C−H···O contact (C35···O52, 3.48 Å).  The primary 
COOH···Bzim hydrogen bonds combine to produce an undulating 1-D chain, Figure 3.7.  
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Figure 3.7 1-D chain in 15. 
 
Adjacent chains are stabilized by C−H···O interactions between a C−H proton on the 
benzene ring of the ditopic base and the carbonyl oxygen atom of proximal malonic acid 
molecules (C42···O54, 3.36 Å), as well as between H12 on Bzim and phenolic oxygen 
atoms on COOH moieties (C12···O51, 3.33 Å). 
   
3.3.10 Crystal structure of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene isophthalic acid 
EtOH0.5, 16 
   
     The asymmetric unit of 16 contains two crystallographically unique halves of 1,4-bis-
[(benzimidazol-1-yl)methyl]-benzene, one isophthalic acid molecule, and half a 
disordered ethanol molecule, Fig. 3.1j.  Two O−H···N hydrogen bonds are produced as a 
result of the interaction between the COOH-Bzim moieties (O57···N33, 2.6080(18) Å; 
O59···N13, 2.6463(16) Å).  No C−H···O contacts accompany the primary O−H···N 
hydrogen bonds, and as a consequence, the COOH···Bzim hydrogen bonds interconnect 
the acid and the base into an infinite one-dimensional undulating chain, Figure 3.8.   
 
 
Figure 3.8 Primary hydrogen-bonded motif in 16. 
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Adjacent chains are arranged in a parallel fashion by C−H···O contacts involving H32 and 
H12 on Bzim and O58 and O60 respectively on carbonyl oxygen atoms of neighboring 
isophthalic acid molecules (C32···O58, 3.20 Å; C12···O60, 3.20 Å). 
 
3.3.11 Crystal structure of 1,4-bis-[(benzimidazol-1-yl)methyl]-benzene 5-
aminoisophthalic acid EtOH0.5, 17 
    
     The asymmetric unit of 17 consists of two crystallographically distinct halves of 1,4-
bis-[(benzimidazol-1-yl)methyl]-benzene, one 5-aminoisophthalic acid molecule, and 
half of a disordered ethanol solvent molecule, Figure 3.1k.  Two inequivalent O−H···N 
hydrogen bonds result from the interactions between the COOH···Bzim moieties 
(O51···N43, 2.5852(17) Å; O53···N23, 2.6041(15) Å).  No C−H···O contacts accompany 
the primary O−H···N hydrogen bonds.  As a result, the COOH···Bzim hydrogen bonds 
connect the acid and the base into an infinite one-dimensional undulating chain.  
Proximal chains are further stabilized in a parallel fashion by N−H···O hydrogen bonds 
(N55···O53, 3.189(2) Å) to afford a two-dimensional sheet, Figure 3.9. 
 
         
Figure 3.9 Infinite two-dimensional sheet in 17 resulting from N−H···O hydrogen bonds 
between 5-aminoisophthalic acid molecules in adjacent one-dimensional chains. 
 
3.3.12 Crystal structure of 1,3-bis-[(benzimidazol-1-yl)methyl]-benzene malonic acid, 18 
 
     There is one molecule each of 1,3-bis-[(benzimidazol-1-yl)methyl]-benzene and 
malonic acid in the asymmetric unit of 18, Figure 3.1l, that together display two distinct 
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heteromeric O−H···N hydrogen bonds (O41···N33, 2.6407(15) Å; O43···N23, 2.6508(15) 
Å).  No C−H···O interactions co-exist with these primary hydrogen bonds and, thus, the 
principal supramolecular motif is an infinite 1-D chain, Figure 3.10.  
 
                                 
 
Figure 3.10 Extended chain in the crystal structure of 18. 
 
These chains are stacked in an antiparallel manner via C−H···O contacts involving the 
phenylic C−H protons on the ditopic base and O42 of neighboring diacids (C12···O42, 
3.32 Å) and π···π interactions between adjacent Bzim moieties (about 3.3 Å).      
  
3.3.13 Crystal structure of 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene trans-3-
hexenedioic acid, 19 
 
     The dominant O−H···N hydrogen bond in 19 is produced via the interaction of 
COOH···Bzim moieties (O31···N13, 2.644(2) Å), Figure 3.1m.  A C−H···O contact co-
exists with the primary O−H···N hydrogen bond, which uses H20C on Bzim and O32 on 
the COOH carbonyl oxygen atom (C20···O32, 3.44 Å).  The resulting heteromeric 
synthon connects the acid and the base into an infinite one-dimensional zig-zag chain, 
Figure 3.11.   
    
Figure 3.11 Extended supramolecular chain in 19. 
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Adjacent chains are stabilized in a parallel manner through C−H···O contacts between 
H22 from the benzene core on the ditopic base and O32 on carbonyl oxygen atoms of 
neighboring trans-3-hexenedioic acid molecules (C22···O32, 3.31 Å). 
 
3.3.14 Crystal structure of 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene adipic 
acid, 20 
 
     The acid and the base in 20 interact through O−H···N hydrogen bonds (O31···N13, 
2.652(2) Å), Figure 3.1n, and no C−H···O interactions are present in the primary motif, an 
infinite undulating 1-D chain, Figure 3.12.  
 
                              
Figure 3.12 1-D supramolecular assembly in 20. 
 
Two types of C−H···O contacts are identified between neighboring chains, involving 
phenylic and Bzim C−H protons and carbonyl oxygen atoms of COOH moieties 
(C18···O32, 3.39 Å; C22···O32, 3.30 Å).   
 
3.4 Discussion 
 
     Crystal structures of 10-20 all display the primary O−H···N hydrogen-bond interaction 
between COOH-Im/Bzim moieties in which no protons have been transferred from the 
acid to the base.  This observation is unambiguously supported by the C−O bond lengths 
as determined by single crystal X-ray crystallography.  Furthermore, IR information of 
these compounds suggests that co-crystals were afforded and not salts, since the C=O 
stretches in 10-20 correspond to the carboxylic acid instead of the carboxylate (see 
Experimental section).  Characteristic broad O−H···N bands at around 2500 cm-1 and 
1900 cm-1 also reinforce the presence of extensive strong O−H···N hydrogen bonds in the 
IR spectra of co-crystals 10-20.16a  Co-crystals were obtained for all eleven structures 
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despite the fact that experimental pKb values for the Im/Bzim N-methylated analogs and 
Im/Bzim are almost identical.25,26  Based upon information extracted from the Cambridge 
Structural Database (CSD),27 there is a strong bias towards co-crystal formation, in 
preference to organic salts, when a carboxylic acid is allowed to react with a symmetric 
ditopic base such as 4,4’-bipyridine.  Out of the 43 total crystal structures retrieved from 
the CSD containing 4,4’-bipyridine and a carboxylic acid, 34 are co-crystals (79%).28  Of 
these co-crystals, there are 13 monocarboxylic acids, 17 dicarboxylic acids, and 4 
tricarboxylic acids.  Therefore, co-crystal formation involving symmetric ditopic bases 
does not seem to require a symmetric carboxylic acid.  
     The thermal stabilities of co-crystals 10-20 were modulated by increasing the 
molecular mass of the heterocyclic base from imidazole to benzimidazole.  The melting 
points of the co-crystals corresponding to the imidazol-1-yl base were below 200˚C while 
employing the benzimidazol-1-yl base in general imparted a greater thermal stability in 
the resulting co-crystals, since their melting points were above 200˚C; co-crystals 15, 16, 
18, and 20 had melting points lower than 200˚C.     
     We also examined the structural homogeneity of bulk samples of 13 and 14 through a 
comparison of experimental and simulated powder X-ray diffraction (XRD) patterns.  
The experimental patterns correlate favorably with the simulated ones generated from 
single crystal X-ray diffraction data, Figure 3.13. 
                       
                                            (a)                                             (b) 
 
 
Figure 3.13 Representative powder XRD patterns of co-crystals in (a) 13 and (b) 14.  
The top and bottom patterns in each case correspond to simulated and experimental 
respectively.29 
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     All these supramolecular reactions were carried out in the presence of potentially 
disruptive solvent molecules such as water and ethanol.  In addition, hydrogen-bond 
interactions also faced potential competition from the requirements of a variety of π···π 
interactions between bis-Bzim moieties.  We also induced changes in molecular shape by 
switching from Im to Bzim, and by introducing substituent groups in the case of 19 and 
20 in order to put the COOH···Im and COOH···Bzim synthons to the test.  The results 
clearly indicate that these synthons are very robust, and the primary intermolecular 
interactions, the O−H···N hydrogen bonds, remain intact even in the presence of an –NH2 
moiety (as in 17).  Consequently, the best donor/acceptor guideline is clearly evident in 
this case since the O−H···N hydrogen bond is the best donor/acceptor couple while the 
secondary N−H···O interaction involves the second-best donor and second-best acceptor. 
The infinite one-dimensional motif was the same in all crystal structures, propagated by 
the heteromeric COOH···Im and COOH···Bzim synthons.  We have furthermore 
demonstrated that the COOH···Bzim synthon is invariant to changes in molecular 
isomerism in 15 and 18 (1,3- vs. 1,4-substituted bis-benzimidazol-1-yl supramolecular 
reagents).30  In all, the success of transforming the dicarboxylic acids and the ditopic 
bases into co-crystals with predictable connectivities can be equated to a high 
supramolecular yield (100%) of the COOH···Im and COOH···Bzim synthons.   
     While the O−H···N hydrogen bond involves the best donor and best acceptor we also 
observed that the C−H···O interaction does not necessarily utilize the most acidic C−H 
proton.  A statistical analysis of crystal structures 10-20 reveals that out of the eleven 
structures ten of them employ C−H···O interactions while one does not.  Of the ten 
structures that involve C−H···O contacts seven of them contain intrachain interactions, 
which utilize either H2 or other protons on the Im/Bzim moieties.  Thus we can formulate 
alternative heteromeric O−H···N/C−H···O patterns compared to the suggestions shown in 
Scheme 3.3 for the COOH···Im and COOH···Bzim interactions, Scheme 3.4. 
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Scheme 3.4 Alternative heteromeric O−H···N/C−H···O motifs in the (a) COOH···Im and 
(b) COOH···Bzim intrachain interactions. 
 
     We furthermore noted that C−H···O interactions between adjacent 1-D chains also 
occurred in most of our crystal structures, Scheme 3.5. 
   
  
 
Scheme 3.5 Intrachain (horizontal) and interchain (vertical) C−H···O contacts represented 
by dashed lines. 
  
     How important are these interchain C−H···O interactions?  To establish if these 
contacts were merely the result of  “close packing” or if they displayed directionalities 
that could be readily rationalized, we examined the geometries of both intrachain and 
interchain C−H···O interactions by studying the relationship between the C=O···H angles 
and C···O distances, Figure 3.14.   
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Figure 3.14 Relationship between intrachain and interchain C=O···H angles versus C···O 
distances in crystal structures 10-20.  Inset: The angular dependence of intrachain and 
interchain C−H···O interactions as defined by φ and θ respectively.   
 
     Figure 3.14 shows two highly localized regions corresponding to intrachain and 
interchain C−H···O interactions.  The data points describing intrachain C−H···O 
interactions range from 120 to 131˚ and 3.3 to 3.5 Å, whereas the corresponding data 
points for the interchain C−H···O contacts range from -160 to -116˚ and 3.1-3.5 Å.  The 
tight clustering of both sets of data and the fact that φ and θ are centered around 120˚ and 
-120˚ respectively (coinciding with regions of maximum electron density around the 
oxygen atom), indicate that intra- and interchain C−H···O hydrogen bonds are of equal 
importance and principally driven by electrostatic considerations.31  Crystal structures 11, 
12, and 15 also contain interchain C−H···O interactions in which the phenolic O−H 
oxygen atom on the COOH moiety acts as the hydrogen-bond acceptor (C−O···H angle 
ca. -120˚), and were therefore also incorporated into this study. 
     Interchain C−H···O interactions are responsible for the assembly of secondary 
structures in co-crystals 10-16 and 18-20 while the principal O−H···N hydrogen bond 
directs the assembly of ditopic base and dicarboxylic acid molecules into the primary 
one-dimensional motifs.  In the case of 17, no significant C−H···O interactions are present 
because the N−H···N hydrogen bond acts as the secondary intermolecular force.  Figure 
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3.14 also indicates that there is no selectivity towards one particular C−H proton in 
C−H···O interactions in this set because there are cases when these interactions involve a 
phenylic C−H proton on the ditopic base.  This behavior can be rationalized based on the 
electrostatics of the C−H···O interaction.  The carbonyl oxygen atom, which acts as the 
hydrogen-bond acceptor, has a greater electrostatic charge density than any of the C−H 
protons; consequently, even if C−H protons possess varying acidities, the product of the 
charges between the proton and the carbonyl oxygen atom would not vary significantly.  
 
3.5 Conclusions 
 
     This systematic structural study has demonstrated that the O−H···N hydrogen bond is 
the primary intermolecular force in a family of structures containing the COOH···Im and 
COOH···Bzim synthons.  These interactions are responsible for the high-yielding 
supramolecular assembly of ditopic imidazoles/benzimidazoles and dicarboxylic acids 
into co-crystals, not salts, with desired connectivities.  The O−H···N hydrogen bond 
remains intact in every case despite competition from π···π interactions and the presence 
of solvent molecules while the auxiliary C−H···O interaction is less robust and can be 
replaced by a suitable hydrogen-bond donor such as an amino moiety.  Two types of 
C−H···O hydrogen bonds were observed, intra- and interchain interactions, and based 
upon their geometric preferences they seem to be of equal structural importance.   
     The results presented in this chapter indicate that the strength and directionality of the 
O−H···N hydrogen bond between carboxylic acids and ditopic imidazoles/benzimidazoles 
are sufficient to bring about the formation of binary co-crystals despite the proclivity for 
solid-state selfishness displayed by the vast majority of molecular species.  It is very 
likely that the primary intermolecular interactions observed in 10-20 can be employed in 
practical and transferable supramolecular synthetic strategies in co-crystal formation 
involving a range of biologically relevant residues. 
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Chapter 4 
 
[(Benzimidazol-1-yl)methyl]-benzamides as supramolecular reagents for binary and 
ternary co-crystals 
                                                                         
4.1 Introduction 
 
     A central part of crystal engineering employs molecular recognition events for the 
directed assembly of discrete or extended supramolecular architectures.1,2,3  This type of 
supramolecular synthesis is frequently based upon a library of hydrogen-bond based 
synthons, Scheme 4.1, and can offer rational and versatile strategies for the directed 
assembly of molecular co-crystals.   
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Scheme 4.1 A few examples of hydrogen-bond based synthons employed in crystal 
engineering. 
 
Co-crystallization reactions provide helpful means for probing the importance of, and 
balance between, different intermolecular interactions and, thus, offer invaluable 
information for developing new methodologies in supramolecular synthesis.  However, 
the synthesis of new co-crystals can also be an important goal in and of itself, especially 
within the pharmaceutical industry, since co-crystal formation may provide a tool for 
fine-tuning a variety of relevant physical properties like solubility, hygroscopicity, 
thermal stability, and processability.4   
     Even though synthesis that relies on reversible and relatively weak intermolecular 
interactions provide many unusual challenges, previous efforts have shown that it is 
possible to prepare a variety of binary co-crystals through a judicious choice of molecular 
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building blocks;5 more complex systems (ternary, quaternary, etc), however, are very 
rare. 
     We are particularly interested in formulating reliable supramolecular synthetic 
strategies as well as in identifying suitable supramolecular reagents that will allow for the 
directed assembly of ternary and higher-order supermolecules or co-crystals with 
predetermined intermolecular connectivities.  This study is derived from results that were 
obtained with isonicotinamide, a relatively simple molecule that contains two distinctly 
different “binding sites”, Scheme 4.2a, which allows it to act as a central hub for the 
assembly of ternary supermolecules.  The synthetic protocol for these reactions relies on 
a best donor-acceptor/second-best donor-acceptor approach,2(b),6 which, in the case of 
isonicotinamide, consistently directs a stronger carboxylic acid towards the pyridyl 
nitrogen atom whereas a weaker carboxylic acid is left to complete the ternary 
supermolecule through a heteromeric carboxylic acid···carboxamide synthon, Scheme 
4.2b.7,8 
(a)
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isonicotinamide       
                                                       (b) 
Scheme 4.2 (a) Isonicotinamide, a supramolecular reagent.  (b) Ternary supermolecules 
formed from a “strong” carboxylic acid, isonicotinamide, and a “weak” carboxylic acid 
through carboxylic acid···pyridine and carboxamide···carboxylic acid hydrogen bonds. 
 
     We have employed a similar approach in the design of a family of new structurally 
versatile supramolecular reagents for the assembly of ternary co-crystals.  These reagents, 
[(benzimidazol-1-yl)methyl]-benzamides, possess several attractive features when 
compared to isonicotinamide, Scheme 4.3. 
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R = H (4.2.1.7), CH3 (4.2.1.9), Cl (4.2.1.11)             R = H (4.2.1.8), CH3 (4.2.1.10), Cl (4.2.1.12)                                
                                                         
                                      (a)                                                                  (b) 
 
Scheme 4.3 New supramolecular reagents based on (a) 3- and (b) 4-substituted 
[(benzimidazol-1-yl)methyl]-benzamides. 
 
First, the two different binding sites are uncoupled, which allows us to fine-tune the 
electronic nature of the benzimidazol-1-ylmethyl nitrogen atoms without affecting the 
electronic environment of the carboxamide moiety by varying the substituent group (H, 
CH3, Cl) in the 2-position of the benzimidazol-1-yl ring.  Second, the inclusion of a 
bridging methylene group expands the solubility of these reagents, which is of 
considerable concern in co-crystal synthesis.  Third, the commercial availability of 
different isomers (3- and 4-substituted starting materials) provides the opportunity to 
synthesize a family of closely related compounds and thus to explore their ability to act 
as suitable supramolecular reagents in a systematic fashion. 
     In this chapter we present the syntheses of six [(benzimidazol-1-yl)methyl]-benzamide 
molecules that can, in principle, act as supramolecular reagents for ternary 
supermolecules.  We also present crystal structures for five of these molecules, as well as 
crystal structures of two binary co-crystals, and a 1:1:1 ternary supermolecule in order to 
begin understanding how these reagents respond to the presence of one or more 
carboxylic acids.     
 
4.2 Experimental 
 
 
N N
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 83
4.2.1 Synthesis 
 
All starting materials were purchased from Aldrich and used without further purification.  
Melting points were determined on a Fisher-Johns melting point apparatus and are 
uncorrected. 
 
4.2.1.1 Synthesis of 3-[(benzimidazol-1-yl)methyl]-benzonitrile 
 
Benzimidazole (0.60 g, 5.10 mmol) was dissolved in 100 mL of dry THF with stirring in 
a 250-mL round-bottomed flask.  To the clear and colorless solution was added NaOH 
(2.13 g, 53.3 mmol), and the resulting mixture was stirred for 2 h at room temperature 
under a N2 atmosphere.  To this mixture was added a 40-mL dry THF solution containing 
α-bromo-m-tolunitrile (1.00 g, 5.10 mmol), which immediately turned the mixture into an 
off-white and cloudy suspension.  Stirring was continued at room temperature for 12 h 
under a N2 atmosphere.  50 mL of distilled water was added to the reaction mixture to 
dissolve the NaOH pellets and NaBr that had formed upon reaction of the two starting 
materials, and two layers formed.  The two layers were separated using a separatory 
funnel, and the THF layer was dried over anhydrous Na2SO4 overnight.  The Na2SO4 was 
filtered by vacuum filtration, and the filtrate was concentrated via rotary evaporation to 
produce a pale brown, microcrystalline solid.  Recrystallization of the solid from hot 
acetonitrile afforded large, pale brown plates.  Yield 1.02 g (85.4%); m.p. 93-96˚C; 1H 
NMR (DMSO-d6, 400 MHz) δ 5.57 (s, 2H), 7.21 (m, 2H), 7.55 (m, 2H), 7.61 (d, 1H, J = 
6.4 Hz), 7.66 (dd, 1H, J1 = 7.6 Hz, J2 = 2.4 Hz), 7.77 (d, 1H, J = 7.6 Hz), 7.86 (s, 1H), 
8.44 (s, 1H); IR (KBr pellet) ν 2234 cm-1 (C≡N). 
 
4.2.1.2 Synthesis of 4-[(benzimidazol-1-yl)methyl]-benzonitrile 
 
Benzimidazole (0.60 g, 5.10 mmol) was dissolved in 100 mL of dry THF with stirring in 
a 250-mL round-bottomed flask.  To this solution was added NaOH (2.13 g, 53.3 mmol) 
and allowed to stir for 2 h at room temperature under a N2 atmosphere.  Then, α-bromo-
p-tolunitrile (1.00 g, 5.10 mmol) in 40 mL of dry THF was added to the stirring reaction 
mixture, which immediately turned into an off-white and cloudy suspension.  This 
mixture was allowed to stir for 12 h at room temperature under a N2 atmosphere.  50 mL 
of distilled water was added to the clear, yellow heterogeneous reaction mixture, and 
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stirred to dissolve the NaOH pellets and NaBr that had formed during the reaction to 
form a biphasic system.  The two phases were separated using a separatory funnel, and 
the THF layer was dried over anhydrous Na2SO4 overnight.  The Na2SO4 was filtered via 
vacuum filtration, and the filtrate was concentrated by rotary evaporation to obtain a pale 
brown solid.  Recrystallization of the solid from hot ethyl acetate produced colorless 
plates.  Yield 1.13 g (95.0%); m.p. 81-85˚C; 1H NMR (DMSO-d6, 400 MHz) δ 5.63 (s, 
2H), 7.21 (m, 2H), 7.44 (d, 2H, J = 8.4 Hz), 7.48 (m, 1H), 7.67 (m, 1H), 7.81 (d, 2H, J = 
8.4 Hz), 8.43 (s, 1H); IR (KBr pellet) ν 2227 cm-1 (C≡N). 
 
4.2.1.3 Synthesis of 3-[(2-methylbenzimidazol-1-yl)methyl]-benzonitrile 
 
2-Methylbenzimidazole (0.67 g, 5.10 mmol) was dissolved in 100 mL of dry THF with 
stirring in a 250-mL round-bottomed flask.  To this clear and colorless solution was 
added NaOH (2.13 g, 53.3 mmol) and continued to stir for 2 h at room temperature under 
a N2 atmosphere.  Then, α-bromo-m-tolunitrile (1.00 g, 5.10 mmol) in 40 mL of dry THF 
was added to the reaction mixture, which immediately formed an off-white, cloudy 
suspension.  The mixture was consequently allowed to stir for 12 h at room temperature 
under a N2 atmosphere.  50 mL of distilled water was added to the clear, yellow 
heterogeneous reaction mixture to dissolve the NaOH pellets and NaBr that had 
precipitated during the reaction, and two layers were obtained.  The two layers were 
separated by using a separatory funnel, and the THF layer was dried over anhydrous 
Na2SO4 overnight.  Upon vacuum filtration of Na2SO4, the filtrate was concentrated via 
rotary evaporation to give a white powder.  The white powder was recrystallized from hot 
acetonitrile to produce a white, microcrystalline solid.  Yield 1.17 g (93.1%); m.p. 110-
115˚C; 1H NMR (CD3CN, 400 MHz) δ 2.51 (s, 3H), 5.42 (s, 2H), 7.18 (m, 2H), 7.27 (dd, 
1H, J1 = 7.2 Hz, J2 = 2.4 Hz), 7.34 (d, 1H, J = 9.2 Hz), 7.45 (s, 1H), 7.48 (t, 1H, J = 5.2 
Hz), 7.60 (dd, 1H, J1 = 8.4 Hz, J2 = 2 Hz), 7.64 (d, 1H, J = 8 Hz); IR (KBr pellet) ν 2232 
cm-1 (C≡N). 
 
4.2.1.4 Synthesis of 4-[(2-methylbenzimidazol-1-yl)methyl]-benzonitrile 
 
2-Methylbenzimidazole (0.67 g, 5.10 mmol) was dissolved in 100 mL of dry THF with 
stirring in a 250-mL round-bottomed flask.  To this clear and colorless solution was 
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added NaOH (2.13 g, 53.3 mmol), and the resulting mixture was allowed to stir for 2 h at 
room temperature under a N2 atmosphere.  Then, α-bromo-p-tolunitrile (1.00 g, 5.10 
mmol) in 40 mL of dry THF was added to the stirring mixture, and a cloudy, pale yellow 
suspension was immediately formed.  This mixture was stirred for 12 h at room 
temperature under a N2 atmosphere.  50 mL of distilled water was then added to the clear, 
yellow heterogeneous reaction mixture, and stirred to dissolve the NaOH pellets and 
NaBr that had formed during the reaction.  Two layers formed, which were separated by 
means of a separatory funnel, and the THF layer was dried over anhydrous Na2SO4 
overnight.  The Na2SO4 was filtered by vacuum filtration, and the filtrate was 
concentrated via rotary evaporation to produce a yellow, microcrystalline solid.  The 
solid was recrystallized from hot acetonitrile to afford off-white, fine needles.  Yield 0.85 
g (67.1%); m.p. 120-122˚C; 1H NMR (CD3CN, 400 MHz) δ 2.49 (s, 3H), 5.45 (s, 2H), 
7.19 (d, m, 4H, J = 7.2 Hz), 7.25 (dd, 1H, J1 = 6 Hz, J2 = 2.4 Hz), 7.59 (dd, 1H, J1 = 8 
Hz, J2 = 2 Hz), 7.66 (d, 2H, J = 8.4 Hz); IR (KBr pellet) ν 2222 cm-1 (C≡N). 
 
4.2.1.5 Synthesis of 3-[(2-chlorobenzimidazol-1-yl)methyl]-benzonitrile 
 
2-Chlorobenzimidazole (0.78 g, 5.10 mmol) was dissolved in 75 mL of dry THF with 
stirring in a 250-mL round-bottomed flask.  To the clear and colorless solution was added 
NaOH (2.13 g, 53.3 mmol), and stirring was continued for 2 h at room temperature under 
a N2 atmosphere.  α-Bromo-m-tolunitrile (1.00 g, 5.10 mmol) dissolved in 75 mL of dry 
THF was then added to the reaction mixture, which immediately produced a white and 
cloudy suspension.  This mixture was consequently allowed to stir for 12 h at room 
temperature under a N2 atmosphere.  60 mL of distilled water was added to the reaction 
mixture to dissolve the NaOH pellets and NaBr that had formed from the reaction, and a 
biphasic system was attained.  The two layers were separated using a separatory funnel, 
and the THF layer was dried over anhydrous Na2SO4 overnight.  The Na2SO4 was then 
filtered by vacuum filtration, and the filtrate was concentrated via rotary evaporation to 
obtain a fluffy white solid.  Recrystallization of the white powder from hot ethyl acetate 
afforded colorless plates.  Yield 1.06 g (77.6%); m.p. 146-148˚C; 1H NMR (DMSO-d6, 
400 MHz) δ 5.61 (s, 2 H), 7.29 (m, 2H), 7.46 (d, 1H, J = 8 Hz), 7.56 (t, 1H, J = 8 Hz), 
7.64 (m, 2H), 7.79 (s, d, 2 H, J = 8.8 Hz); IR (KBr pellet) ν 2233 cm-1(C≡N). 
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4.2.1.6 Synthesis of 4-[(2-chlorobenzimidazol-1-yl)methyl]-benzonitrile 
 
2-Chlorobenzimidazole (0.78 g, 5.10 mmol) was dissolved in 100 mL of dry THF with 
stirring in a 250-mL round-bottomed flask.  To the clear and colorless solution was added 
NaOH (2.13 g, 53.3 mmol) and continued to stir for 2 h at room temperature under a N2 
atmosphere.  Then, a 40-mL dry THF solution containing α-bromo-p-tolunitrile (1.00 g, 
5.10 mmol) was added to the reaction mixture, which immediately produced a white and 
cloudy suspension.  This mixture was allowed to stir for 12 h at room temperature under 
a N2 atmosphere.  50 mL of distilled water was then added to the clear, yellow 
heterogeneous mixture, and stirred to dissolve the NaOH pellets and NaBr that had 
formed upon reaction of the two starting materials, to form two layers.  The two layers 
were separated by means of a separatory funnel, and the THF layer was dried over 
anhydrous Na2SO4 overnight.  The Na2SO4 was then filtered via vacuum filtration, and 
the filtrate was concentrated by rotary evaporation to produce a yellow solid.  The solid 
was recrystallized from hot ethyl acetate to give pale yellow plates.  Yield 1.07 g 
(78.4%); m.p. 138-141˚C; 1H NMR (DMSO-d6, 400 MHz) δ 5.66 (s, 2H), 7.29 (m, 2H), 
7.34 (d, 2H, J = 8.8 Hz), 7.60 (dd, 1H, J1 = 7.2 Hz, J2 = 2 Hz), 7.65 (dd, 1H, J1 = 7.6 Hz, 
J2 = 2.4 Hz), 7.83 (d, 2H, J = 8.4 Hz); IR (KBr pellet) ν 2233 cm-1 (C≡N). 
 
4.2.1.7 Synthesis of 3-[(benzimidazol-1-yl)methyl]-benzamide, 21 
 
3-[(Benzimidazol-1-yl)methyl]-benzonitrile (1.00 g, 4.29 mmol) was dissolved in 4 mL 
of DMSO with stirring in a 100-mL three-necked flask under a N2 atmosphere.  The 
reaction flask was then cooled in an ice-water bath, and anhydrous K2CO3 (0.090 g, 0.62 
mmol) was added to the reaction mixture.  9 mL of 30 wt % H2O2 solution was syringed 
dropwise into the reaction mixture, and an off-white, fine solid formed almost 
immediately.  The reaction was consequently allowed to warm to room temperature with 
continued stirring for 1 h while wrapped in aluminum foil.  5 mL of distilled water was 
added to the reaction mixture, and cooling in an ice-water bath was applied to result in an 
off-white, cloudy suspension.  An off-white solid was obtained upon vacuum filtration, 
which was washed with small portions of distilled water and dried.  Recrystallization of 
the solid from hot acetonitrile gave colorless plates.  Yield 0.85 g (79.2%); m.p. 181-
184˚C; 1H NMR (DMSO-d6, 400 MHz) δ 5.54 (s, 2H), 7.20 (m, 2H), 7.41 (m, 3H), 7.50 
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(m, 1H), 7.66 (m, 1H), 7.78 (d, 1H, J = 7.2 Hz), 7.85 (s, 1H), 7.99 (s, 1H), 8.43 (s, 1H); 
IR (KBr pellet) ν 1679 cm-1 (C=O, s), 3142 cm-1 (N-H, broad), 3284 cm-1 (N-H, broad). 
 
4.2.1.8 Synthesis of 4-[(benzimidazol-1-yl)methyl]-benzamide 
 
4-[(Benzimidazol-1-yl)methyl]-benzonitrile (0.50 g, 2.15 mmol) was dissolved in 2 mL 
of DMSO with stirring in a 100-mL three-necked flask under a N2 atmosphere.  The 
reaction flask was then placed in an ice-water bath, and anhydrous K2CO3 (0.04 g, 0.31 
mmol) was added to the reaction mixture.  5 mL of 30 wt % H2O2 solution was syringed 
dropwise into the reaction mixture, and a white, chalky solid precipitated almost 
immediately.  The reaction was then allowed to warm to room temperature with 
continued stirring for 1 h while covered in aluminum foil.  2.5 mL of distilled water was 
added to the reaction mixture, cooling in an ice-water bath was applied, and the solid was 
filtered by vacuum filtration.  The solid was then washed with small amounts of distilled 
water and dried.  The solid was recrystallized from hot acetonitrile to afford colorless 
needles.  Yield 0.34 g (63.5%); m.p. 203-206˚C; 1H NMR (DMSO-d6, 400 MHz) δ 5.56 
(s, 2H), 7.19 (m, 2H), 7.35 (s, d, 3H, J = 8.4 Hz), 7.49 (m, 1H), 7.66 (m, 1H), 7.82 (d, 
2H, J = 8.4 Hz), 7.92 (s, 1H), 8.42 (s, 1H); IR (KBr pellet) ν 1690 cm-1 (C=O, s), 3148 
cm-1 (N-H, broad), 3293 cm –1 (N-H, broad). 
 
4.2.1.9 Synthesis of 3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide, 22 
 
3-[(2-Methylbenzimidazol-1-yl)methyl]-benzonitrile (1.00 g, 4.05 mmol) was dissolved 
in 5 mL of DMSO with stirring in a 100-mL three-necked flask under a N2 atmosphere.  
The reaction flask was then placed in an ice-water bath, and anhydrous K2CO3 (0.080 g, 
0.59 mmol) was added to the reaction mixture.  8 mL of 30 wt % H2O2 solution was 
syringed dropwise into the reaction mixture, and an off-white solid formed almost 
immediately.  The mixture was then warmed to room temperature with continued stirring 
for 1 h while covered in aluminum foil.  5mL of distilled water was added to the reaction 
mixture, cooling in an ice-water bath was applied, and the solid was filtered via vacuum 
filtration.  The solid was then washed with small amounts of distilled water and dried.  
The solid was recrystallized from hot acetonitrile/ethyl acetate (95:5) to afford colorless 
plates.  Yield 0.68 g (63.6%); m.p. 236-239˚C; 1H NMR (DMSO-d6, 400 MHz) δ 2.52 (s, 
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3H), 5.51 (s, 2H), 7.14 (m, 2H), 7.23 (d, 1H, J = 7.6 Hz), 7.42 (m, 3H), 7.55 (dd, 1H, J1 = 
6 Hz, J2 = 3.2 Hz), 7.68 (s, 1H), 7.77 (d, 1H, J = 8 Hz), 7.99 (s, 1H); IR (KBr pellet) ν 
1682 cm-1 (C=O, s), 3144 cm-1 (N-H, broad), 3300 cm-1 (N-H, broad). 
 
4.2.1.10 Synthesis of 4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide, 23 
 
4-[(2-Methylbenzimidazol-1-yl)methyl]-benzonitrile (0.82 g, 3.32 mmol) was dissolved 
in 5 mL of DMSO with stirring in a 100-mL three-necked flask under a N2 atmosphere.  
The reaction flask was then cooled in an ice-water bath, and anhydrous K2CO3 (0.070 g, 
0.48 mmol) was added to the reaction mixture.  8 mL of 30 wt % H2O2 solution was 
syringed dropwise into the reaction mixture, and an off-white, chalky solid formed almost 
immediately.  The mixture was then allowed to warm to room temperature with 
continued stirring for 1 h while wrapped in aluminum foil.  5 mL of distilled water was 
added to the reaction mixture, cooling in an ice-water bath was applied, and the solid was 
filtered via vacuum filtration.  The solid was then washed with small portions of distilled 
water and dried.  Recrystallization from hot acetonitrile afforded colorless needles.  Yield 
0.63 g (71.1%); m.p. 224-227˚C; 1H NMR (DMSO-d6, 400 MHz) δ 2.51 (s, 3H), 5.53 (s, 
2H), 7.16 (m, 4H), 7.34 (s, 1H), 7.44 (dd, 1H, J1 = 6 Hz, J2 = 3.2 Hz), 7.55 (dd, 1H, J1 = 
6Hz, J2 = 3.2 Hz), 7.81 (d, 2H, J = 8.8 Hz), 7.92 (s, 1H); IR (KBr pellet) ν 1685 cm-1 
(C=O, s), 3148 cm-1 (N-H, broad), 3322 cm-1 (N-H, broad). 
 
4.2.1.11 Synthesis of 3-[(2-chlorobenzimidazol-1-yl)methyl]-benzamide, 24 
 
3-[(2-Chlorobenzimidazol-1-yl)methyl]-benzonitrile (0.85 g, 3.18 mmol) was dissolved 
in 8 mL of DMSO with stirring in a 100-mL three-necked flask under a N2 atmosphere.  
The reaction flask was then placed in an ice-water bath, and anhydrous K2CO3 (0.06 g, 
0.46 mmol) was added to the reaction mixture.  7 mL of 30 wt % H2O2 solution was 
syringed dropwise into the stirring reaction mixture, and a white solid formed almost 
immediately.  The reaction was then allowed to warm to room temperature for 1 h while 
covered in aluminum foil.  5 mL of distilled water was added to the mixture, cooling in 
an ice-water bath was applied, and the solid was filtered via vacuum filtration.  The solid 
was then washed with small amounts of distilled water and dried.  Recrystallization of the 
solid from hot acetonitrile afforded the pure product.  Colorless prisms were obtained 
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upon crystallization from methanol.  Yield 0.67 g (73.6%); m.p. 222-224˚C; 1H NMR 
(DMSO-d6, 400 MHz) δ 5.58 (s, 2H), 7.28 (m, 2H), 7.42 (s, t, 2H, J = 7.6 Hz), 7.60 (dd, 
1H, J1 = 6.6 Hz, J2 = 2 Hz), 7.64 (dd, 1H, J1 = 6.2 Hz, J2 = 2.4 Hz), 7.75 (s, 1H), 7.79 (d, 
1H, J = 7.6 Hz), 8.00 (s, 1H); IR (KBr pellet) ν 1680 cm-1 (C=O, s), 3161 cm-1 (N-H, 
broad), 3351 cm-1 (N-H, broad). 
 
4.2.1.12 Syntheses of 4-[(2-chlorobenzimidazol-1-yl)methyl]-benzamide, and 4-[2-
chlorobenzimidazol-1-yl)methyl]-benzamide monohydrate, 25 
 
4-[(2-Chlorobenzimidazol-1-yl)methyl]-benzonitrile (0.70 g, 2.61 mmol) was dissolved 
in 7 mL of DMSO with stirring in a 100-mL three-necked flask under a N2 atmosphere.  
The reaction flask was then placed in an ice-water bath, and anhydrous K2CO3 (0.05 g, 
0.38 mmol) was added to the reaction mixture.  7 mL of 30 wt % H2O2 solution was 
syringed dropwise into the reaction mixture, and an off-white, chalky solid formed almost 
immediately.  The reaction was then allowed to warm to room temperature for 1 h while 
wrapped in aluminum foil.  5 mL of distilled water was added to the reaction mixture, 
cooling in an ice-water bath was applied, and the solid was filtered via vacuum filtration.  
The solid was then washed with small portions of distilled water and dried.  
Recrystallization of the solid from hot acetonitrile gave a first crop as white 
microcrystals, which formed almost immediately, and harvested. Yield of microcrystals 
0.60 g (80.8%); m.p. 185-190˚C; 1H NMR of microcrystals (DMSO-d6, 400 MHz) δ 5.59 
(s, 2H), 7.25 (d, 2H, J = 8.8 Hz), 7.28 (m, 2H), 7.36 (s, 1H), 7.61 (dd, 1H, J1 = 6.6 Hz, J2 
= 2.8 Hz), 7.64 (dd, 1H, J1 = 6.6 Hz, J2 = 2.4 Hz), 7.82 (d, 2H, J = 8.4 Hz), 7.93 (s, 1H); 
IR (KBr pellet) ν 1684 cm-1 (C=O, s), 3176 cm-1 (N-H, broad), 3336 cm-1 (N-H, broad).  
Slow evaporation of the mother liquor afforded colorless prisms as the second crop, 25.  
Yield of prisms 0.16 g (19.8%); m.p. 124-127˚C; IR (KBr pellet) ν 1671 cm-1 (C=O, s), 
3195 cm-1 (N-H, broad), 3350 cm-1 (N-H, broad), 3100-3500 cm-1 (O-H, very broad). 
 
4.2.2 Syntheses of binary co-crystals 
 
4.2.2.1 Synthesis of 3-[(benzimidazol-1-yl)methyl]-benzamide 4-nitrobenzoic acid, 26 
 
3-[(Benzimidazol-1-yl)methyl]-benzamide (0.020 g, 0.080 mmol) was dissolved in 2 mL 
of ethanol.  To this solution was added an ethanolic solution containing 4-nitrobenzoic 
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acid (0.013 g, 0.080 mmol).  The resulting solution was allowed to evaporate slowly 
under ambient conditions for six days whereupon colorless prisms were obtained.  M.p. 
219-222˚C.9 
 
4.2.2.2 Synthesis of 3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide 4-nitrobenzoic 
acid, 27 
 
3-[(2-Methylbenzimidazol-1-yl)methyl]-benzamide (0.020 g, 0.075 mmol) was dissolved 
in 3 mL of ethanol.  A solution of 4-nitrobenzoic acid (0.013 g, 0.075 mmol) in ethanol 
was added to this solution.  Colorless plates formed after six days of slow evaporation of 
the solvent under ambient conditions.  M.p. 223-227˚C.9 
 
4.2.3 Syntheses of ternary co-crystals 
 
4.2.3.1 Synthesis of 4-[(2-methylbenzimidazolium-1-yl)methyl]-benzamide 2,6-
dichlorobenzoate 4-nitrobenzoic acid, 28 
 
4-[(2-Methylbenzimidazol-1-yl)methyl]-benzamide (0.020 g, 0.075 mmol) was dissolved 
in 2 mL of ethanol, which was added to a 3 mL ethanolic solution containing 2,6-
dichlorobenzoic acid (0.014 g, 0.075 mmol) and 4-nitrobenzoic acid (0.013 g, 0.075 
mmol).  The resulting solution was slowly evaporated under ambient conditions for one 
month until colorless prisms formed.  M.p. 176-178˚C. 
   
4.2.4 X-ray crystallography 
 
     X-ray data were collected on a Bruker SMART 1000 four-circle CCD diffractometer 
using a fine-focus molybdenum Kα tube.  Data were collected using SMART.10  Initial 
cell constants were found by small widely separated “matrix” runs.  Preliminary Laué 
symmetry was determined from axial images.  Generally, an entire hemisphere of 
reciprocal space was collected regardless of Laué symmetry. Scan speed and scan width 
were chosen based on scattering power and peak rocking curves. Unless otherwise noted, 
data were collected at -70 °C, using 0.2° scan width. 
     Unit cell constants and orientation matrix were improved by least-squares refinement 
of reflections “thresholded” from the entire dataset.  Integration was performed with 
SAINT,11 using this improved unit cell as a starting point. Precise unit cell constants were 
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calculated in SAINT from the final merged dataset. Lorenz and polarization corrections 
were applied, but data were generally not corrected for absorption. Laué symmetry, space 
group, and unit cell contents were found with XPREP. 
     Data were reduced with SHELXTL.12  The structures were solved in all cases by 
direct methods without incident.  In general, hydrogen atoms were assigned to idealized 
positions and were allowed to ride.  Where possible, the coordinates of hydrogen-bonding 
hydrogen atoms were allowed to refine. Heavy atoms, other than those of the guests, 
were refined with anisotropic thermal parameters. None of the datasets were corrected for 
absorption. Linear absorption coefficients for the strongest absorbers, 24 and 25, were 
0.294 mm-1 and 0.273 mm-1, respectively. Merging R for these two datasets were 4.9% 
and 5.2%, respectively.  24: Coordinates for the amide hydrogen atoms were allowed to 
refine. 25: This compound crystallizes in the noncentrosymmetric space group P212121, 
with the asymmetric unit containing one molecule of the benzimidazole compound and 
one molecule of water.  Coordinates for the amide hydrogen atoms and water hydrogen 
atoms were allowed to refine. The structure was refined as a racemic twin and converged 
to an approximately 28:72 ratio of the two enantiomorphs.  21: This compound 
crystallizes with two formula units per asymmetric unit. A scan width of 0.3 °C was 
chosen for data collection. Coordinates for the amide hydrogen atoms were allowed to 
refine.  23: Coordinates for the amide hydrogen atoms were allowed to refine. 26: 
Coordinates for the amide hydrogens and carboxylic acid hydrogens were allowed to 
refine.  27: Data were collected at -100 °C. Coordinates for the amide and carboxylic acid 
hydrogen atoms were allowed to refine.   
 
4.2.5 Powder X-ray diffraction 
 
     Powder XRD data were collected on a Bruker/Nonius D8 ADVANCE diffractometer 
with Bragg-Brentano geometry.  A step size of 0.04˚ and step time of 5 sec per step were 
used.  Data for 26 and 27 were obtained over 5-50˚ and 2-50˚ 2-θ ranges respectively.  
Data were then processed using EVA v8.0.13 
  
4.3 Results 
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     A summary of the crystallographic information for each compound is displayed in 
Tables A21-A28, all hydrogen-bond geometries are listed in Table 4.1, and the relevant 
labeling schemes and thermal ellipsoids are shown in Figure 4.1. 
 
Table 4.1 Hydrogen-bond geometries for 21-28. 
 
Compound D-H A D-H/Å H…A/
Å 
D…A/Å <(DHA)/° generator for A 
21 N27 H27A N33 
N27 H27B O47 
N47 H47A O27 
N47 H47B N13 
0.91(2) 
0.90(2) 
0.91(2) 
0.84(2) 
2.07(2) 
2.04(2) 
2.00(2) 
2.21(2) 
2.962(2) 
2.926(2) 
2.898(2) 
3.030(2) 
166.3(17) 
168.7(19) 
170.3(19) 
163.1(18) 
− 
− 
− 
− 
22 N27 H27A O47 
N47 H47A O27 
N27 H27B N33 
N47 H47B N13 
0.95(3) 
0.99(3) 
0.95(3) 
0.92(3) 
1.99(3) 
1.90(3) 
2.12(3) 
2.14(3) 
2.929(4) 
2.889(3) 
2.996(3) 
3.009(3) 
171(3) 
174(3) 
153(3) 
156(3) 
− 
− 
x, y-1, z 
x, y+1, z 
23 N27 H27A N13 
N27 H27B O27 
0.88(3) 
0.97(3) 
2.17(3) 
1.93(3) 
3.014(3) 
2.888(3) 
162(2) 
168(2) 
x, -y-1/2, z-1/2 
x, -y-1/2, z-1/2 
24 
 
N27 H27A O47 
N47 H47A O27 
N27 H27B N33 
N47 H47B N13 
0.90(2) 
0.89(2) 
0.95(2) 
0.90(2) 
1.97(2) 
2.02(2) 
2.12(2) 
2.20(2) 
2.869(2) 
2.909(2) 
3.022(2) 
3.060(2) 
174(2) 
174(2) 
158(2) 
159.7(19) 
− 
− 
− 
− 
25 N27 H27A O1S 
N27 H27B O1S 
O1S H1B N13 
O1S H1A O27 
0.86(2) 
0.92(2) 
0.85(2) 
0.82(3) 
2.07(2) 
2.01(2) 
1.98(3) 
1.95(3) 
2.885(3) 
2.858(3) 
2.803(3) 
2.750(2) 
158(2) 
153(2) 
162(2) 
163(2) 
-x+1/2, -y, z+1/2 
-x, y+1/2, z+1/2 
− 
-x, y+1/2, z+1/2 
26 O47 H47 N13 
N27 H27A O27 
N27 H27B O48 
1.11(2) 
1.00(2) 
1.09(2) 
1.49(2) 
1.95(2) 
1.94(2) 
2.5808(18) 
2.944(2) 
2.989(2) 
165.2(16) 
174(2) 
161.1(17) 
− 
-x, -y, -z 
-x, -y, -z 
27 O31 H31 O27 
O41 H41 N13 
N27 H27A O32 
N27 H27B O41 
0.94(2) 
1.07(2) 
0.96(2) 
0.86(2) 
1.64(2) 
1.53(2) 
1.92(3) 
2.57(2) 
2.571(2) 
2.591(2) 
2.873(3) 
3.342(3) 
172(2) 
170.8(19) 
169(2) 
149(2) 
− 
− 
− 
-x, -y, -z 
28 N13 H13 O31 
O41 H41 O27 
N27 H27A O42 
N27 H27B O32 
1.24(2) 
0.82(2) 
0.90(3) 
0.90(3) 
1.31(2) 
1.75(2) 
2.01(3) 
2.09(3) 
2.533(2) 
2.562(2) 
2.875(2) 
2.918(2) 
169.5(18) 
169(2) 
160(2) 
152(2) 
− 
− 
− 
-x+1, y-1/2, -z+1/2 
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                                                          (e)                        
       
                                                                      (f) 
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                                                           (g) 
 
                          
                                                                       (h) 
Figure 4.1a-h Thermal ellipsoid plots (50% probabilities) and labeling schemes for 21-
28.   
 
4.3.1 Crystal structure of 3-[(benzimidazol-1-yl)methyl]-benzamide, 21 
 
     The crystal structure of 21 contains two molecules of 3-[(benzimidazol-1-yl)methyl]-
benzamide in the asymmetric unit, Figure 4.1a.  These molecules interact through two 
different N−H···O hydrogen bonds in which the syn- N−H protons of carboxamide 
moieties interact with carbonyl oxygen atoms of carboxamide moieties on adjacent 
molecules (N27···O47, 2.926(2) Å; N47···O27, 2.898(2) Å), Figure 4.2.  The dimeric 
units are propagated into an infinite 1-D ribbon through two crystallographically 
 96
inequivalent N−H···N hydrogen bonds between the anti- N−H proton of a carboxamide 
moiety and the benzimidazol-1-yl nitrogen atom of another molecule (N27···N33, 
2.962(2) Å; N47···N13, 3.030(2) Å.                        
 
Figure 4.2 Infinite 1-D ribbon in the crystal structure of 21. 
 
4.3.2 Crystal structure of 3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide, 22 
 
     Similarly to 21, the crystal structure determination of 22 revealed the presence of two 
molecules of 3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide in the asymmetric unit, 
Figure 4.1b, that interact via head-to-head R 22 (8) carboxamide···carboxamide hydrogen 
bonds (N27···O47, 2.929(4) Å; N47···O27, 2.889(3) Å), Figure 4.3.  This dimeric unit is 
further extended into an infinite 1-D ribbon through N−H···N interactions involving the 
anti- N−H proton of one carboxamide moiety and the 2-methylbenzimidazol-1-yl moiety 
of an adjacent molecule (N27···N33, 2.996(3) Å; N47···N13, 3.009(3) Å).   
 
        
 
Figure 4.3 Extended 1-D motif in the crystal structure of 22. 
 97
4.3.3 Crystal structure of 4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide, 23 
 
     The asymmetric unit of 23 contains one 4-[(2-methylbenzimidazol-1-yl)methyl]-
benzamide molecule, Figure 4.1c, which extends into an infinite two-dimensional 
puckered sheet through N−H···O and N−H···N hydrogen bonds, Figure 4.4. 
               
Figure 4.4 Extended 2-D sheet in the crystal structure of 23. 
 
The N−H···O hydrogen bonds arise from catemeric C(4) carboxamide···carboxamide 
interactions between the anti- N−H proton of a carboxamide moiety on one molecule and 
the carbonyl oxygen atom of a neighboring molecule (N27···O27, 2.888(3) Å).  The 
second component of the sheet is the “head-to-tail” N−H···N hydrogen bond between the 
syn- N−H proton of a carboxamide moiety and the 2-methylbenzimidazol-1-yl nitrogen 
atom of an adjacent molecule (N27···N13, 3.014(3) Å). 
 
4.3.4 Crystal structure of 3-[(2-chlorobenzimidazol-1-yl)methyl]-benzamide, 24 
 
     The crystal structure of 24 contains two molecules of 3-[(2-chlorobenzimidazol-1-
yl)methyl]-benzamide in the asymmetric unit, Figure 4.1d.  These molecules interact 
through two crystallographically inequivalent N−H···O hydrogen bonds involving the 
syn- N−H proton of one carboxamide moiety and the carbonyl oxygen atom of another 
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carboxamide moiety (N27···O47, 2.869(2) Å; N47···O27, 2.909(2) Å).  These dimeric 
units are then propagated into the expected infinite 1-D undulating ribbons through 
hydrogen bonds between the anti- N−H protons and the 2-chlorobenzimidazol-1-yl 
nitrogen atoms of adjacent molecules (N27···N33, 3.022(2) Å; N47···N13, 3.060(2) Å), 
Figure 4.5. 
           
Figure 4.5 Extended 1-D ribbon in 24. 
 
4.3.5 Crystal structure of 4-[2-chlorobenzimidazol-1-yl)methyl]-benzamide monohydrate, 
25  
 
     The asymmetric unit in the crystal structure of 25 consists of one molecule of 4-[(2-
chlorobenzimidazol-1-yl)methyl]-benzamide and one water molecule, Figure 1e.  These 
interact via an O−H···N hydrogen bond involving the 2-chlorobenzimidazol-1-yl nitrogen 
atom (O1S···N13, 2.803(3) Å).  Expansion of the asymmetric unit reveals the presence of 
an aggregate that can be described as a water-bridged hydrogen-bonded R 34 (10) 
hexameric unit, Figure 4.6.   
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Figure 4.6 Local environment around a water-bridged R 34 (10) hexameric unit in the 
crystal structure of 25 generated by hydrogen bonds between 4-[(2-chlorobenzimidazol-
1-yl)methyl]-benzamide and water molecules. 
 
The water-bridged R 34 (10) motif arises from a combination of N−H···O and O−H···O 
hydrogen bonds.  The first N−H···O interaction involves the syn- N−H proton of a 
carboxamide moiety on one 4-[(2-chlorobenzimidazol-1-yl)methyl]-benzamide molecule 
and the oxygen atom of a water molecule (N27···O1S, 2.885(3) Å) whereas the second 
N−H···O hydrogen bond takes place between the anti- N−H proton of the same 
carboxamide and the oxygen atom of another water molecule (N27···O1S, 2.858(3) Å).  
The O−H···O hydrogen bond is formed between H1A of a water molecule and the 
carbonyl oxygen atom of an adjacent carboxamide moiety (O1S···O27, 2.750(2) Å).  This 
local environment, when extended further, results in an extended 2-D corrugated sheet, 
Figure 4.7, which is formed from ladders of interconnected R 34 (10) hydrogen-bond units.  
Adjacent sheets are interconnected in a parallel fashion through O−H···O hydrogen bonds 
involving O−H donors of water molecules on one layer and carbonyl oxygen atoms of 
carboxamide moieties in another layer (O1S···O27, 2.750(2) Å) to afford a three-
dimensional network.         
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Figure 4.7 Extended view of the crystal structure of 25 showing the interconnections of 
R 34 (10) motifs. 
 
4.3.6 Crystal structure of 3-[(benzimidazol-1-yl)methyl]-benzamide 4-nitrobenzoic acid, 
26  
         
     The crystal structure of 26 contains one molecule each of 4-nitrobenzoic acid and 3-
[(benzimidazol-1-yl)methyl]-benzamide in the asymmetric unit, Figure 4.1f.  The two 
molecules interact via an O−H···N hydrogen bond between the carboxylic acid O−H 
moiety of 4-nitrobenzoic acid and the benzimidazol-1-yl nitrogen atom of 3-
[(benzimidazol-1-yl)methyl]-benzamide (O47···N13, 2.5808(18) Å).  The two molecules 
are extended into a four-component supermolecule consisting of two molecules each of 
4-nitrobenzoic acid and 3-[(benzimidazol-1-yl)methyl]-benzamide related by an 
inversion center through self-complementary “head-to-head” R 22 (8) N−H···O hydrogen 
bonds involving syn- N−H protons and carbonyl oxygen atoms (N27···O27, 2.944(2) Å), 
Figure 4.8. 
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Figure 4.8 Hydrogen-bond driven assembly of a four-component supermolecule in the 
crystal structure of 26. 
  
Adjacent supermolecules are connected into an infinite 1-D ladder motif through 
N−H···O hydrogen bonds between the anti- N−H proton of a carboxamide moiety and a 
carbonyl oxygen atom of a 4-nitrobenzoic acid molecule on a neighboring layer 
(N27···O48, 2.989(2) Å), Figure 4.9.   
          
Figure 4.9 Infinite 1-D ladder motif in the crystal structure of 26 showing interactions 
between neighboring supermolecules. 
 
4.3.7 Crystal structure of 3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide 4-
nitrobenzoic acid, 27 
 
     In contrast to the crystal structure of 26, the asymmetric unit of 27 consists of two 4-
nitrobenzoic acid molecules and one 3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide 
molecule.  The latter is therefore a 2:1 molecular co-crystal Figure 4.1g.  The molecules 
interact through an O−H···N hydrogen bond between the carboxylic acid O−H moiety of 
the first 4-nitrobenzoic acid molecule and the 2-methylbenzimidazol-1-yl nitrogen atom 
of 3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide (O41···N13, 2.591(2) Å) and a 
“head-to-head” carboxylic acid···carboxamide interaction consisting of O−H···O and 
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N−H···O hydrogen bonds, (O31···O27, 2.571(2) Å; N27···O32, 2.873(3) Å), Figure 4.10.  
Adjacent supermolecules are interconnected in an antiparallel fashion through N−H···O 
hydrogen bonds involving the anti- N−H proton of a carboxamide moiety in one layer 
and a 4-nitrobenzoic acid molecule in a neighboring layer (N27···O41, 3.342(3) Å).   
             
Figure 4.10 Trimeric supermolecule in the crystal structure of 27. 
 
4.3.8 Crystal structure of 4-[(2-methylbenzimidazolium-1-yl)methyl]-benzamide 2,6-
dichlorobenzoate 4-nitrobenzoic acid, 28 
 
     In the crystal structure of 28, a 1:1:1 ternary compound had formed between the 
stronger carboxylic acid (as determined by pKa values),14 2,6-dichlorobenzoic acid, 4-[(2-
methylbenzimidazol-1-yl)methyl]-benzamide, and the weaker acid, 4-nitrobenzoic acid, 
Figure 4.1h.  The stronger acid seeks out the best acceptor, the 2-methylbenzimidazol-1-
yl nitrogen atom, to form an ionic N+−H···O- hydrogen bond (N13···O31, 2.533(2) Å), 
while the weaker carboxylic acid forms a heteromeric acid···amide synthon with the 
second-best acceptor, the carboxamide moiety (O41···O27, 2.562(2) Å; N27···O42, 
2.875(2) Å), Figure 4.11. 
                        
 
Figure 4.11 Ternary compound in the crystal structure of 28. 
 
Neighboring compounds are interconnected into an infinite undulating 1-D chain through 
N−H···O hydrogen bonds involving the anti- N−H protons on carboxamide moieties and 
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carbonyl oxygen atoms of 2,6-dichlorobenzoic acid molecules on adjacent compounds 
(N27···O32, 2.918(2) Å), Figure 4.12. 
 
              
Figure 4.12 1-D chain in 28 resulting from interactions between adjacent ternary 
compounds. 
 
4.4 Discussion 
 
     All (benzimidazol-1-yl)methylbenzonitrile precursors 4.2.1.1-4.2.1.6 were synthesized 
in good yields by allowing the appropriate α-bromotolunitrile and benzimidazole to react 
under alkaline conditions15 employing a slightly modified procedure.  Their formation is 
supported by 1H NMR spectroscopy in which the chemical shifts corresponding to the 
methylene protons on the α-bromotolunitrile compared to those of the coupled products 
are significantly different.  IR spectra of these precursors also indicate the presence of 
C≡N stretches demonstrating that the nitrile groups remain intact upon reaction of the 
two starting materials.  Hydrolysis of 4.2.1.1-4.2.1.6 with 30 wt % H2O2 in DMSO16 
afforded the desired benzamides 4.2.1.7-4.2.1.12 in good yields.  The chemical shifts, 
splitting patterns, and integration in the 1H NMR spectra correlate well with the 
molecular structures of the desired products, and there were no traces of starting material 
in the spectra.  Furthermore, characteristic C=O and N-H stretches as a result of 
carboxamide formation were observed in the IR spectra of the products. 
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     Recrystallization of benzamides 4.2.1.7-4.2.1.12 from either hot acetonitrile, ethyl 
acetate, or methanol afforded crystals suitable for X-ray crystallography except for 
4.2.1.8.  In the case of 4.2.1.12, recrystallization from hot acetonitrile yielded 
microcrystals that were too small for X-ray crystallography.  Slow evaporation of the 
mother liquor, however, produced colorless prisms suitable for X-ray crystallography, 25.  
IR spectroscopy of these prisms shows a characteristic broad O−H stretch at 3100-3500 
cm-1, which is due to the presence of water.  This broad stretch is not observed in the IR 
spectrum of 4.2.1.12.  Structural analysis of these prisms subsequently confirms the 
presence of water molecules in the crystal structure of 25.  The crystal structures of the 
other benzamide compounds do not incorporate solvent molecules.  The non-hydrated 
compounds 4.2.1.7-4.2.1.12 are thermally stable from 181-239˚C.  The melting point of 
25, however, is much lower (124-127˚C) than that of the non-hydrated form in 4.2.1.12 
(185-190˚C).  The workup and purification/recrystallization of 4.2.1.7-4.2.1.12 show that 
these compounds have overall very good solubility, which is a desirable attribute for 
effective and versatile co-crystal formation. 
     An examination of the crystal structures of 21-24 reveals two well-known hydrogen-
bond motifs.  In 21, 22, and 24, the same infinite 1-D motif, constructed from N−H···N 
and N−H···O hydrogen bonds, is observed.  The self-complementary 
carboxamide···carboxamide interactions create a dimeric arrangement, Scheme 4.4a.   
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Scheme 4.4 Possible hydrogen-bond motifs between carboxamide moieties, (a) dimer 
and (b) catemer. 
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     The crystal structure of 23 contains a different hydrogen-bond motif, however, as the 
self-complementary carboxamide···carboxamide interactions generate a catemeric 
structure, Scheme 4.4b.  Both the dimer and the catemer motif can be expected in these 
molecules, since they are common hydrogen-bond patterns encountered in carboxamide 
moieties, and are robust enough to be employed as supramolecular tools in the solid state.  
     The hydrogen-bond patterns in the crystal structure of 25 are very different due to the 
presence of a water molecule.  The appearance of hydrated structures tends to be highly 
unpredictable, and it is clear that even the reasonably robust carboxamide···carboxamide 
interactions can be disrupted by a suitable solvent molecule, resulting in an unexpected 
structural outcome. 
     As mentioned previously, these supramolecular reagents (SR’s) were prepared with 
the ultimate goal of generating ternary co-crystals by taking advantage of the best 
donor/best acceptor concept in a series of reactions between suitable SR's and two 
different carboxylic acids.  However, unless a binary solid can be obtained in some 
rational manner there would be little point in pursuing ternary co-crystals.  Therefore we 
prepared two binary co-crystals, 26 and 27, by allowing 4-nitrobenzoic acid to react with 
4.2.1.7 and 4.2.1.9, respectively.  Although co-crystallization attempts employing 
4.2.1.12 with 4-nitrobenzoic acid and 3,5-dinitrobenzoic acid in each case did not yield 
single crystals of sufficient quality, the IR spectra of both powdery materials displayed 
broad O−H···N stretches typical of co-crystal formation between carboxylic acids and 
nitrogen-containing heterocycles via hydrogen bonding.17,18  Both 26 and 27 are 
molecular co-crystals and not salts since no proton transfer between carboxylic acid and 
the benzimidazol-1-yl moiety has taken place.  This conclusion is based upon the 
observed C−O bond lengths as determined by single crystal X-ray crystallography.  The 
formation of molecular solids in reactions between N-substituted benzimidazole and 
carboxylic acids is also consistent with previous results gathered from a systematic 
structural study of symmetric ditopic N-substituted imidazoles/benzimidazoles and 
dicarboxylic acids.19  
     The crystal structure of 26 is typical of binary co-crystals between heterocyclic-based 
carboxamides such as isonicotinamide and carboxylic acids6 in that the carboxylic acid 
(the best donor) interacts with the heterocyclic nitrogen atom (the best acceptor), thus 
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leaving the carboxamide moiety to form self-complementary hydrogen bonds.  The 
crystal structure of 27, however, exhibits a somewhat different scenario in that the self-
complementary carboxamide···carboxamide interaction present in 26 is disrupted by a 
second 4-nitrobenzoic acid molecule in favor of a heteromeric carboxylic 
acid···carboxamide hydrogen-bond interaction.  This disruption is, in fact, welcome as it 
indicates that this particular supramolecular reagent can simultaneously form hydrogen 
bonds with carboxylic acids at both its binding sites; the next phase will involve 
exploring the selectivity of these supramolecular reagents when confronted with two 
different carboxylic acids. 
     We also examined the structural homogeneity of the products that were obtained in the 
syntheses of 26 and 27 through an analysis of bulk samples using powder X-ray 
diffraction (XRD) data.  Bulk samples were collected and analyzed in two stages and 
were obtained from reactions between [benzimidazol-1-yl)methyl]-benzamides and 4-
nitrobenzoic acid that were set up in 1:1 and 1:2 stoichiometric ratios.  The first crop of 
crystals was harvested immediately upon precipitation, and the second crop was obtained 
upon complete evaporation of the solvent.   
     The powder XRD patterns of both the first and second crop resulting from the 1:1 
reaction between 3-[(benzimidazol-1-yl)methyl]-benzamide and 4-nitrobenzoic acid are 
essentially the same and correspond very well to the X-ray powder pattern simulated 
from the single-crystal data of the crystal structure of 26, Figure 4.13a.  When the same 
reaction is carried out in a 1:2 ratio, the first crop still has a powder pattern that 
corresponds to the crystal structure of the 1:1 co-crystal, 26.  The experimental powder 
pattern of the second crop only shows the presence of unreacted 4-nitrobenzoic acid,20 
Figure 4.13b.  Both crops are homogeneous and show the presence of only one phase in 
each case.  The only new compound that is formed in the reaction between 3-
[(benzimidazol-1-yl)methyl]-benzamide and 4-nitrobenzoic acid, regardless of initial 
ratio, is the 1:1 molecular co-crystal.  Furthermore, the reaction is quantitative and none 
of the limiting reactant is left behind. 
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     (a)                                                              (b) 
Figure 4.13 Simulated (top) and experimental (bottom) powder XRD patterns for (a) 26 
(first crop) and (b) 26 (second crop).  The reaction was carried out in a 1:2 stoichiometry, 
and the only material left over is unreacted 4-nitrobenzoic acid. 
 
     In the 1:1 reaction between 3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide and 4-
nitrobenzoic acid, the powder pattern of the first crop of crystals corresponds exclusively 
to that simulated from the single-crystal data of 27, a molecular co-crystal with a 1:2 
composition.  The second crop from this reaction corresponds exclusively to the pattern 
simulated from that of the crystal structure of the SR by itself (which is expected as 4-
nitrobenzoic acid is now the limiting reactant).   When a starting ratio of 1:2 is employed, 
only the 1:2 supramolecular product, 27, is attained (100 % conversion) in both first and 
second crops as demonstrated by the experimental powder patterns, Figures 4.14a and 
4.14b, respectively. 
                     
            (c)                                                      (d) 
Figure 4.14 Simulated (top) and experimental (bottom) powder XRD patterns for (a) 27 
(first crop) and (b) 27 (second crop). 
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     When 4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide was allowed to react with 
two different carboxylic acids, 2,6-dichlorobenzoic acid and 4-nitrobenzoic acid, it 
effectively produced a 1:1:1 ternary supermolecule, 28, with predetermined connectivity.  
The stronger carboxylic acid, 2,6-dichlorobenzoic acid, interacted with the best 
hydrogen-bond acceptor while the weaker acid, 4-nitrobenzoic acid, formed a 
carboxamide···carboxylic acid synthon.  Although the heterocyclic moiety on the SR was 
protonated, the structural selectivity in 28 still followed the best donor−best 
acceptor/second-best donor−second-best acceptor concept. 
                    
4.5 Conclusions 
 
     A family of closely related [(benzimidazol-1-yl)methyl]-benzamide compounds was 
synthesized in good yields through a two-step procedure.  These molecules were 
characterized by 1H NMR and IR spectroscopy, and the crystal structures of 21-25 were 
obtained via single-crystal X-ray crystallography.  Analyses of these crystal structures 
revealed self-complementary dimeric R 22 (8) and catemeric C(4) hydrogen-bond motifs 
between carboxamide moieties in combination with the expected amide···heterocycle N-
H···N hydrogen bond.  These compounds have two independent binding sites suitable for 
two different intermolecular interactions, and they are also soluble in a range of polar 
solvents.  Two of them, 3-[(benzimidazol-1-yl)methyl]-benzamide and 3-[(2-
methylbenzimidazol-1-yl)methyl]-benzamide, have already been shown to be capable of 
co-crystal formation with a carboxylic acid.  The co-crystallization reactions proceed in a 
quantitative manner, as evidenced by powder XRD.  The potential effectiveness of these 
compounds as reliable and versatile supramolecular reagents for the assembly of ternary 
supermolecules was also shown in 28, employing 4-[(2-methylbenzimidazol-1-
yl)methyl]-benzamide and two different carboxylic acids.  The structural and electronic 
aspects in this family of SR’s are readily tunable (1,3- and 1,4- isomers and different 
substituents), which provide opportunities for the formation of more ternary co-crystals.  
These examples would then serve to gain a better command over the competition and 
balance of intermolecular forces as a result of a transferable and modular non-covalent 
synthetic approach.  
 
 109
References 
                                                 
1 (a) Desiraju, G. R. Crystal Engineering: The Design of Organic Solids; Elsevier Science Publishers B. V.: 
Amsterdam, 1989. (b) Steed, J. W.; Atwood, J. L. Supramolecular Chemistry; John Wiley & Sons, Ltd.: 
Chichester, 2000. (c) Desiraju, G. R. The Crystal as a Supramolecular Entity; John Wiley & Sons, Ltd.: 
1996. (d) Desiraju, G. R. Angew. Chem. Int. Ed. Engl. 1995, 34, 2311. (e) Etter, M. C. Acc. Chem. Res. 
1990, 23, 120. (f) Sharma, C. V. K.; Panneerselvam, K.; Pilati, T.; Desiraju, G. R. J. Chem. Soc., Perkin 
Trans. 2 1993, 2209. (g) Aakeröy, C. B.; Desper, J.; Elisabeth, E.; Helfrich, B. A.; Levin, B.; Urbina, J. F. 
Zeit. Kristallogr. 2005, 220, 325. 
 
2 (a) Aakeröy, C. B. Acta Crystallogr. 1997, B53, 569. (b) Etter, M. C. J. Phys. Chem. 1991, 95, 4601. 
 
3 (a) Shan, N.; Bond, A. D.; Jones, W. Cryst. Eng. 2002, 5, 9. (b) Shan, N.; Bond, A. D.; Jones, W. New J. 
Chem. 2003, 2, 365. (c) Shan, N.; Batchelor, E.; Jones, W. Tetrahedron Lett. 2002, 43, 8721. (d) Liu, R.; 
Valiyaveettil, S.; Mok, K.-F.; Vittal, J. J.; Hoong, A. K. M. CrystEngComm. 2002, 4, 574. (e) Sharma, C. 
V. K.; Zaworotko, M. J. Chem. Commun. 1996, 2655. (f) Bhogala, B. R.; Vishweshwar, P.; Nangia, A. 
Cryst. Growth Des. 2002, 2, 325. (g) Bhogala, B. R.; Nangia, A. Cryst. Growth Des. 2003, 3, 547. (h) 
Arora, K. K.; Pedireddi, V. R. J. Org. Chem. 2003, 68, 9177. (i) Vishweshwar, P.; Nangia, A.; Lynch, V. 
M. J. Org. Chem. 2002, 67, 556. 
 
4 Almarsson, Ö.; Zaworotko, M. J. Chem. Commun. 2004, 1889. 
 
5 (a) Bailey Walsh, R. D.; Bradner, M. W.; Fleischman, S.; Morales, L. A.; Moulton, B.; Rodriguez-
Hornedo, N.; Zaworotko, M. J. Chem. Commun. 2003, 186. (b) MacGillivray, L. R.; Reid, J. L.; 
Ripmeester, J. A. J. Am. Chem. Soc. 2000, 122, 7817. (c) Vishweshwar, P.; Thaimattam, R.; Jaskolski, M.; 
Desiraju, G. R. Chem. Commun. 2002, 1830. (d) Zerkowski, J. A.; MacDonald, J. C.; Whitesides, G. M. 
Chem. Mater. 1997, 9, 1933. (e) Kane, J. J.; Liao, R.-F.; Lauher, J. W.; Fowler, F. W. J. Am. Chem. Soc. 
1995, 117, 12003. (f) Lehn, J.-M.; Mascal, M.; DeCian, A.; Fischer, J. J. Chem. Soc., Chem. Commun. 
1990, 479. (g) Vishweshwar, P.; Nangia, A.; Lynch, V. M. CrystEngComm, 2003, 5, 164. (h) Aakeröy, C. 
B.; Desper, J.; Helfrich, B. A. CrystEngComm 2004, 6, 19. (i) Dale, S. H.; Elsegood, M. R. J.; Hemmings, 
M.; Wilkinson, A. L. CrystEngComm 2004, 6, 207. (j) Pedireddi, V. R.; PrakashaReddy, J.; Arora, K. K.  
Tetrahedron Lett  2003,  44, 4857. 
  
6 Aakeröy, C. B.; Beatty, A. M.; Helfrich, B. A. J. Am. Chem. Soc. 2002, 124, 14425. 
 
7 Aakeröy, C. B.; Beatty, A. M.; Helfrich, B. A. Angew. Chem. Int. Ed. Engl. 2001, 40, 3240. 
 
8 Other examples of heteromeric carboxylic acid···carboxamide interactions include: (a) Leiserowitz, L.; 
Nader, F. Acta Crystallogr. 1977, B33, 2719. (b) Leiserowitz, L. Acta Crystallogr. 1976, B32, 775. 
 
9 Almost quantitative yields for 13 and 14 were determined by powder X-ray diffraction. 
 
10 SMART v5.060; Bruker Analytical X-ray Systems: Madison, WI, 1997 – 1999. 
  
11 SAINT v6.02; Bruker Analytical X-ray Systems: Madison, WI, 1997 – 1999. 
 
12 SHELXTL v5.10; Bruker Analytical X-ray Systems: Madison, WI, 1997. 
 
13 EVA v8.0; Bruker AXS Gmbh: Karlsruhe, West Germany, 1997 – 2002.  
 
14 (a) pKa values were calculated using Advanced Chemistry Development (ACD/Labs) Software Solaris 
v4.76; ACD/Labs, 1994-2005. (b) pKa of 2,6-dichlorobenzoic acid: 1.69 ± 0.20; pKa of 4-nitrobenzoic acid: 
3.42 ± 0.20. 
 
  
 110
                                                                                                                                                 
15 (a) Zhou, C. H.; Guo, S. J.; Xie, R. G.; Zhao, H. M. Chin. Chem. Lett. 1996, 7, 321. (b) Liu, H. K.; Sun, 
W. Y.; Zhu, H. L.; Yu, K. B.; Tang, W. X. Inorg. Chim. Acta 1999, 295, 129. 
 
16 Katritzky, A. R.; Pilarski, B.; Urogdi, L. Synthesis 1989, 949. 
 
17 The observed O−H···N stretches in the IR spectra for these materials correspond to (a) 4.2.1.12/4-
nitrobenzoic acid (2512 and 1918 cm-1) and (b) 4.2.1.12/3,5-dinitrobenzoic acid (2466 and 1869 cm-1). 
  
18 Trivedi, D. R.; Ballabh, A.; Dastidar, P. CrystEngComm 2003, 5, 358. 
 
19 Aakeröy, C. B.; Desper, J.; Leonard, B.; Urbina, J. F. Cryst. Growth Des. 2005, DOI: 
10.1021/cg049682i. 
 
20 Groth, P. Acta Chem. Scand. A 1980, 34, 229. 
 
 
 
 
 
 
 
 111
Chapter 5 
 
[(Benzimidazol-1-yl)methyl]-benzamides as ligands for high-yielding inorganic-
organic supramolecular synthesis 
 
5.1 Introduction 
 
     The supramolecular synthesis of extended metal-ligand frameworks with 
predetermined metrics and connectivities is a rapidly expanding area of crystal 
engineering.1  Many of these architectures are constructed from rigid linkers (multi-topic 
ligands) and can possess a high degree of structural integrity even though they may 
display open structures with pores and channels.  Some of the most popular building 
blocks in the synthesis of coordination polymers are ditopic ligands such as 4,4’-
bipyridine that can be combined in different stoichiometries with metal ions of different 
coordination modes.2  Recently, a number of coordination polymers built from flexible 
ditopic3 and tritopic4 N-substituted imidazole/benzimidazole ligands, Scheme 5.1, have 
also been reported which demonstrates that such N-heterocycles are also useful building 
blocks of extended metal-containing networks. 
 
 
      
 
 
 
 
 
 
 
Scheme 5.1 Ditopic and tritopic imidazol-1-yl/benzimidazol-1-yl ligands used in the 
construction of coordination polymers. 
 
     Imidazol-1-yl and benzimidazol-1-yl-containing ligands may turn out to be more 
versatile that their pyridyl counterparts mainly due to their smaller C−N−C angles (108˚ 
vs 120˚ respectively) which alleviate steric crowding at the metal center upon 
R
R
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coordination.  Consequently, five-membered N-heterocycles can readily be 
accommodated in an octahedral geometry around a suitable metal ion, an arrangement 
that is extremely rare for pyridyl-based ligands, Scheme 5.2.  Better access to symmetric 
octahedral building blocks provides opportunities for the construction of porous networks 
in a more controlled manner; the geometry of the metal node can be propagated 
simultaneously in 3-D with only one type of ligand, which reduces potential structural 
interference. 
 
     
                                           
                          
 
 
 
 
 
 
 
(a) C−N−C angle = 108˚          (b) C−N−C angle = 120˚ 
 
Scheme 5.2 Comparison of C−N−C angles in (a) benzimidazol-1-yl- and (b) pyridyl-
containing ligands. 
            
     Another supramolecular synthetic strategy for the construction of extended metal-
containing networks combines a suitable ligand moiety (for metal coordination) with an 
appropriate self-complementary hydrogen-bond functionality (for the supramolecular 
chemistry).5  An example of such a coordinating/hydrogen-bonding ligand is 
isonicotinamide,6,7 which typically binds to a metal ion via the pyridyl moiety and also 
employs an R 22 (8) carboxamide···carboxamide hydrogen bond to propagate the inherent 
geometry of the complex ion into extended networks.  The self-complementarity of the 
amide moiety essentially produces a supramolecular dimer that is topologically 
equivalent to the ditopic 4,4'-(1,4-phenylene)bis-pyridine,8 Scheme 5.3. 
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Scheme 5.3 (a) Hydrogen-bond linked and (b) covalently-linked extended ligands.    
 
     At times, supramolecular ligands may provide some advantages compared to their 
covalent counterparts.  Representatives from the latter group may require significant 
synthetic efforts, and extended rigid aromatic ligands frequently suffer from poor 
solubility, which can be a drawback during the synthesis of the extended metal-
containing network.  It is frequently necessary to employ harsher and (at times) more 
unpredictable reaction conditions such as solvothermal methods, whereas hydrogen-
bonded ligands are typically more soluble in a range of solvents.                                                                 
     The choice of hydrogen-bonding moiety is typically governed by its ability to form 
consistent and predictable supramolecular motifs but it is also important that it does not 
compete with the N-heterocycle for the metal ion itself.  The carboxamide moiety 
frequently forms either dimeric or catemeric hydrogen-bonded patterns in the presence of 
potentially disruptive species (counterions, solvent molecules, etc.), and it is less likely to 
coordinate directly to the metal ion than are pyridyl- or imidazol-1-yl moieties.  These 
attributes combine to make the carboxamide functionality a useful connector in 
inorganic-organic supramolecular synthesis.  Even though flexible [(imidazol-1-
yl)methyl]-benzoic acid ligands have been employed in coordination chemistry,9 the 
carboxylic acid moiety is less reliable than the carboxamide moiety.  This is due to the 
propensity of the carboxylate moiety to bind directly to the metal ion via one of many 
possible coordination modes in which case the outcome is most likely a coordination 
polymer. 
     Based on the versatility of five-membered N-heterocycles as coordination sites in 
inorganic supramolecular synthesis, coupled with the robust self-complementarity of the 
carboxamide functionality, we have previously synthesized (in Chapter 4) a new family 
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of ligands for the directed assembly of extended metal-containing networks, 
[(benzimidazol-1-yl)methyl]-benzamides,10 Scheme 5.4. 
 
 
                                                                                              
   
                                          
 
                                     
                                    
 
 
 
(a)                                                                      (b) 
 
Scheme 5.4 Comparison of (a) [(benzimidazol-1-yl)methyl]-benzamide ligands and (b) 
nicotinamide. 
 
     In comparison with previously utilized nicotinamide and isonicotinamide, these 
ligands would provide greater space between the nodes (metal ions) in the structure, 
which can increase porosity.  Furthermore, the conformational flexibility resulting from 
the methylene bridge imparts an expanded solubility in a wide range of solvents without 
compromising the intended supramolecular assembly process.  In addition, these ligands 
can be readily prepared through common synthetic procedures to generate a family of 
closely related ligands, which allows us to examine solid-state assembly and structure in 
a systematic manner. 
     In this chapter, we will begin to explore the inorganic-organic supramolecular 
chemistry of [(benzimidazol-1-yl)methyl]-benzamide ligands by allowing them to react 
with a variety of Ag(I) salts.  Silver(I) provides a good starting point thanks to its 
propensity for simple linear coordination.  The intention is, therefore, to establish how 
reliably we can propagate the inherent linear geometry of the complex ion into infinite 1-
D chains with the aid of self-complementary ligand-ligand based hydrogen-bond 
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interactions.  The necessary presence of various counterions also allows for an 
examination of the structural complications that these counterions may present vis-a-vi 
the desired supramolecular assembly process.  In this way, we will be able to assess the 
supramolecular yield, the capacity of this family of ligands to form specific and 
reproducible architectures through the use of self-complementary intermolecular 
interactions. 
   
5.2 Experimental 
 
5.2.1 Syntheses of Ag(I) complexes 
 
The syntheses of [(2-methylbenzimidazol-1-yl)methyl]-benzamide ligands are reported 
elsewhere.10 Silver(I) tetrafluoroborate, silver(I) hexafluoroarsenate, and silver(I) 
hexafluoroantimonate were purchased from Aldrich and used without further purification.  
Melting points were determined on a Fisher-Johns melting point apparatus and are 
uncorrected. 
 
5.2.1.1 Synthesis of bis-[4-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
tetrafluoroborate hydrate methanol, 29 
 
4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide (0.020 g, 0.075 mmol) was dissolved 
in 3 mL of methanol with heat in a small beaker and cooled to room temperature.  To this 
solution was added a methanolic solution containing silver(I) tetrafluoroborate (0.007 g, 
0.038 mmol) and the beaker with the resulting solution covered in Al foil and stored in 
the dark.  Pale-yellow needles were obtained after 5 days.  M.p. 172˚C (decomp.). 
 
5.2.1.2 Synthesis of bis-[3-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
tetrafluoroborate, 30 
 
3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide (0.020 g, 0.075 mmol) was dissolved 
in 3 mL of methanol with heat in a small beaker and cooled to room temperature.  To this 
solution was added silver(I) tetrafluoroborate (0.007 g, 0.038 mmol) in methanol and the 
beaker containing the resulting solution covered in Al foil and stored in the dark.  
Colorless plates were afforded after 5 days.  M.p. 264-266˚C (decomp.). 
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5.2.1.3 Synthesis of bis-[4-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
hexafluoroarsenate methanol, 31 
 
4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide (0.030 g, 0.113 mmol) was dissolved 
in 5 mL of methanol with heat in a small beaker and cooled to room temperature.  To this 
solution was added a methanolic solution containing silver(I) hexafluoroarsenate (0.017 
g, 0.057 mmol) and the beaker with the resulting solution covered in Al foil and stored in 
the dark.  Colorless needles appeared after 2 days.  M.p. 195-197˚C. 
 
5.2.1.4 Synthesis of bis-[3-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
hexafluoroarsenate methanol0.5, 32 
 
3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide (0.030 g, 0.113 mmol) was dissolved 
in 5 mL of methanol with heat in a small beaker and cooled to room temperature.  To this 
solution was added silver(I) hexafluoroarsenate (0.017 g, 0.057 mmol) in methanol and 
the beaker containing the resulting solution covered in Al foil and stored in the dark.  
Colorless microcrystals formed after 1 day, which were too small for X-ray 
crystallography.  The experiment was repeated, this time adding a few microcrystals from 
the previous experiment to the reaction mixture as seed crystals.  Colorless plates were 
obtained after 1 day.  M.p. 248-250˚C (decomp.). 
 
5.2.1.5 Synthesis of bis-[4-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
hexafluoroantimonate, 33 
 
4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide (0.030 g, 0.113 mmol) was dissolved 
in 5 mL of methanol with heat in a small beaker and cooled to room temperature.  To this 
solution was added a methanolic solution containing silver(I) hexafluoroantimonate 
(0.019 g, 0.057 mmol) and the beaker with the resulting solution covered in Al foil and 
stored in the dark.  Colorless plates formed after 2 days.  M.p. 238-241˚C. 
 
5.2.1.6 Synthesis of bis-[3-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
hexafluoroantimonate, 34 
 
3-[(2-methylbenzimidazol-1-yl)methyl]-benzamide (0.030 g, 0.113 mmol) was dissolved 
in 5 mL of methanol with heat in a small beaker and cooled to room temperature.  To this 
solution was added silver(I) hexafluoroantimonate (0.019 g, 0.057 mmol) in methanol 
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and the beaker containing the resulting solution covered in Al foil and stored in the dark.  
Colorless plates were afforded after 2 days.  M.p. 235-238˚C (decomp.). 
 
5.2.2 X-ray crystallography 
 
     X-ray data were collected on a Bruker SMART 1000 four-circle CCD diffractometer 
(29, 30, and 32) or SMART APEX CCD diffractometer (31, 33, and 34) using a fine-
focus molybdenum Kα tube.  Data were collected using SMART.11  Initial cell constants 
were found by small widely separated “matrix” runs.  Generally, an entire hemisphere of 
reciprocal space was collected regardless of Laué symmetry. Scan speed and scan width 
were chosen based on scattering power and peak rocking curves. Datasets were collected 
under an N2 stream at the temperature indicated in Tables A29-A34. 
     Unit cell constants and orientation matrix were improved by least-squares refinement 
of reflections thresholded from the entire dataset. Integration was performed with 
SAINT,12 using this improved unit cell as a starting point. Precise unit cell constants were 
calculated in SAINT from the final merged dataset. Lorenz and polarization corrections 
were applied. Laué symmetry, space group, and unit cell contents were found with 
XPREP. 
     Data were reduced with SHELXTL.13  The structures were solved in all cases by 
direct methods without incident.  In general, hydrogen atoms were assigned to idealized 
positions and were allowed to ride.  Where possible, the coordinates of the amide 
hydrogens were allowed to refine. Heavy atoms were refined with anisotropic thermal 
parameters. Unless otherwise noted, data were corrected for absorption. 
29 Amide hydrogen atoms were inserted in calculated positions and were allowed to ride. 
Three peaks in the difference Fourier were assigned as water oxygen atoms; hydrogen 
atoms for these molecules could not be located. Occupancies for these oxygen atoms 
were allowed to refine during initial least-squares cycles and were fixed during the last 
cycle. Two [BF4] anions were located in the difference Fourier map. The fluorine atoms 
for the major species were refined using anisotropic thermal parameters; isotropic 
thermal motion for the remaining five atoms was modeled with an overall free variable. 
The geometry of the major species was restrained using DFIX commands. The geometry 
of the minor species was linked to that of the major species with the SAME command. 
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30 Two [BF4] anions were refined using DFIX commands to restrain their geometries. 
The two boron atoms shared anisotropic thermal parameters (using the EADP command). 
The fluorine atoms for the major species were allowed anisotropic thermal parameters; 
those on the minor species were given isotropic thermal parameters. Data were not 
corrected for absorption. 
31 Amide hydrogen atoms were inserted in calculated positions and were allowed to ride. 
Peaks in the difference Fourier map were assigned to four closely-spaced methanol 
molecules. Occupancies for these four species were allowed to refine during early least-
squares cycles and were fixed for final refinement. Carbon and oxygen atoms for the four 
molecules were refined using isotropic thermal parameters and restrained geometry 
(using the DFIX command). Two closely located [AsF6] anions were refined using 
pairwise linked thermal parameters (using the EADP command). The arsenic atom and 
five of the six fluorine atoms were given anisotropic thermal parameters. The geometry 
of the minor species was linked to that of the major species with the SAME command. 
32 Amide hydrogen atoms were inserted in calculated positions and were allowed to ride. 
One of the two amide groups was best treated as two closely located “wobble” 
conformers differing in C(aryl)-C(carbonyl) torsion angle. Peaks in the difference Fourier 
map were assigned to a single well-behaved methanol molecule. A single AsF6 counter-
ion was included in the structural model. 
33 Amide hydrogen atoms were inserted in calculated positions and were allowed to ride. 
Three peaks in the difference Fourier were assigned to water molecules; the hydrogen 
atoms could not be located. The three water oxygen atoms were allowed full occupancy 
and refined successfully with anistropic thermal parameters. Two closely located SbF6 
anions were refined using restrained geometry. Atoms in the major species were allowed 
anisotropic thermal parameters. Thermal parameters for the minor antimony atom were 
linked (using EADP) to those of the major antimony atom; the remaining atoms were 
given isotropic thermal parameters. The geometry of the minor species was linked to that 
of the major species with the SAME command. 
34 A single well-behaved [SbF6] was included in the structural model. 
 
5.3 Results 
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     Crystallographic data are given in Tables A29-A34, selected bond distances and 
angles in Table 5.1, hydrogen-bond geometries in Table 5.2, and thermal ellipsoids and 
labeling schemes are shown in Figure 5.1. 
 
Table 5.1 Selected bond distances and angles for 29-34. 
 
Compound Ag−N (Å) < N−Ag−N (˚) 
29 Ag1−N13, 2.070(3) N13−Ag1−N13, 180.00(10) 
30 Ag1−N13, 2.085(2) 
Ag1−N33, 2.086(2) 
N13−Ag1−N33, 173.38(9) 
31 Ag1−N13, 2.073(2) 
Ag1−N33, 2.070(2) 
N13−Ag1−N33, 173.67(7) 
32 Ag1−N13, 2.102(3) 
Ag1−N33, 2.103(3) 
N13−Ag1−N33, 171.38(13) 
33 Ag1−N13, 2.066(4) 
Ag1−N33, 2.086(4) 
N13−Ag1−N33, 173.97(13) 
34 Ag1−N13, 2.1025(17) 
Ag1−N33, 2.0995(18) 
N13−Ag1−N33, 174.06(7) 
 
 
Table 5.2 Hydrogen-bond geometries for 29-34. 
 
Compound D-H A H…A/Å D…A/Å <(DHA)/° generator for A 
29 N27 H27A O27 
N27 H27B O1S 
2.03 
2.28 
2.911(5) 
2.96(3) 
173.9 
133.1 
-x+1, -y-1, -z+1 
− 
30 N27 H27A F12 
N27 H27A F16 
N27 H27B F11 
N27 H27B F15 
N47 H47A O47 
N47 H47B O27 
2.02(4) 
2.08(4) 
2.26(3) 
2.03(4) 
2.10(3) 
2.14(3) 
2.918(4) 
2.982(18) 
3.090(4) 
2.834(12) 
2.881(3) 
2.866(3) 
166(3) 
167(3) 
160(3) 
152(3) 
177(3) 
149(3) 
-x, -y+1, -z-1 
-x, -y+1, -z-1 
− 
− 
-x, -y, -z+2 
x, y-1, z+1 
31 N27 H27A F3A 
N47 H47A F2B 
N27 H27B O47 
N47 H47B O27 
O1S H1S O27 
2.29 
2.22 
2.12 
2.11 
2.17 
3.124(3) 
3.027(18) 
2.962(3) 
2.977(3) 
2.818(8) 
158.3 
152.7 
159.4 
166.2 
134.1 
x+1, y+1, z 
x+1, y, z 
-x+2, y+1/2, -z+1/2 
x, y-1, z 
− 
32 N27A H27A O27A 
N27B H27C O27B 
N47 H47A F1 
N47 H47B F3 
O1S H1S O47 
2.07 
2.05 
2.15 
2.36 
2.22 
2.930(6) 
2.88(2) 
2.898(5) 
3.181(6) 
3.021(9) 
172.0 
159.2 
143.6 
157.9 
162.3 
-x+1, -y+1, -z+2 
-x+1, -y+1, -z+2 
-x+1, -y, -z 
x, y, z-1 
− 
33 N27 H27B O47 
N47 H47B O27 
2.16 
2.13 
3.023(4) 
2.969(4) 
165.6 
158.9 
x, y-1, z 
-x+2, y+1/2, -z+1/2 
34 N27 H27A O27 
N47 H47A F1 
2.04(3) 
2.15(4) 
2.907(3) 
2.959(3) 
171(3) 
165(3) 
-x-1, -y+2, -z+2 
− 
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                                                                  (a)  
 
 
                          
                                                                  (b) 
                       
                            
                                                                  (c) 
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                                                                  (d) 
  
                                       
                                                                 (e) 
 
                                           
                                                                 (f) 
                   
 Figure 5.1 Thermal ellipsoid plots (50% probabilities) and labeling scheme for 29-34 (a-
f). 
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5.3.1 Crystal structure of bis-[4-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
tetrafluoroborate hydrate methanol, 29 
 
     The crystal structure determination of 29 revealed that water and methanol had been 
incorporated into the lattice.  The silver ion is coordinated to two 4-[(2-
methylbenzimidazol-1-yl)methyl]-benzamide ligands in a linear fashion, Figure 5.1a, and 
this geometry is propagated through symmetry-related head-to-head R 22 (8) 
carboxamide···carboxamide hydrogen bonds (N27···O27, 2.911(5) Å) to produce an 
infinite undulating one-dimensional chain, Figure 5.2. 
 
 
Figure 5.2 Linear cationic assembly in 29.  Tetrafluoroborate anions and solvent 
molecules are omitted for clarity. 
 
Anti-N−H protons of carboxamide groups form N−H···O hydrogen bonds with disordered 
methanol molecules (N27···O1S, 2.96(3) Å) while the tetrafluoroborate anions do not 
form any significant interactions with the cationic chains.  The shortest through space 
intra-chain distance between Ag(I) ions is approximately 23.6 Å. 
 
5.3.2 Crystal structure of bis-[3-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
tetrafluoroborate, 30  
  
     The asymmetric unit of 30 contains a disordered anion in addition to two 
crystallographically unique molecules of 3-[(2-methylbenzimidazol-1-yl)methyl]-
benzamide coordinated to a central silver(I) cation in a near-linear fashion through their 
benzimidazol-1-yl nitrogen atoms, Figure 5.1b.  Neighboring complexes are 
interconnected through self-complementary head-to-head R 22 (8) motifs (N47···O47, 
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2.881(3) Å) as well as through catemeric C(4) N−H···O motifs (N47···O27, 2.866(3) Å) to 
produce an infinite one-dimensional ladder, Figure 5.3. 
 
 
Figure 5.3 Extended one-dimensional ladder motif in 30.  [BF4]- anions removed for 
clarity. 
 
N−H protons of the carboxamide moieties also display short contacts to adjacent anions, 
thereby providing a bridge between cationic ribbons (N27···F11, 3.090(4) Å; N27···F15, 
2.834(12) Å; N27···F12, 2.918(4) Å; N27···F16, 2.982(18) Å), Figure 5.4. The shortest 
through space intra-chain distance between Ag(I) ions is approximately 21.5 Å. 
 
 
Figure 5.4 Interconnection of adjacent one-dimensional ladders in 30 through disordered 
tetrafluoroborate anions. 
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 5.3.3 Crystal structure of bis-[4-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
hexafluoroarsenate methanol, 31 
 
     The crystal structure of 31 contains linear complex ions composed of silver ions and 
two crystallographically unique 4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide 
ligands.  The counterions are disordered, and there is also a disordered methanol 
molecule in the lattice, Figure 5.1c.  Neighboring complex ions are connected through 
catemeric C(4) N−H···O hydrogen bonds (N27···O47, 2.962(3) Å; N47···O27, 2.977(3) Å) 
to afford infinite undulating chains.  Pairs of chains are then linked through additional 
C(4) N-H···O hydrogen bonds to produce one-dimensional ribbons.  Neighboring ribbons 
are held together by  π···π interactions (3.4 Å) to generate a two-dimensional sheet, 
Figure 5.5. 
   
        
Figure 5.5 Infinite two-dimensional sheet in 31 formed from catemeric 
carboxamide···carboxamide hydrogen bonds and  π···π interactions. 
 
     Hexafluoroarsenate anions are positioned inside the pores of the sheet via interactions 
between syn- N−H protons of carboxamide moieties and fluorine atoms (N27···F3A, 
3.124(3) Å; N47···F2B, 3.027(18) Å).  Methanol molecules also interact with carbonyl 
oxygen atoms of the carboxamide groups in the two-dimensional sheet (O1S···O27, 
2.818(8) Å). 
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5.3.4 Crystal structure of bis-[3-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
hexafluoroarsenate methanol0.5, 32 
  
     The crystal structure of 32 contains two crystallographically unique molecules of 3-
[(2-methylbenzimidazol-1-yl)methyl]-benzamide coordinated in a linear geometry to a 
central silver(I) cation through their benzimidazol-1-yl nitrogen atoms.  One of the 
carboxamide moieties is disordered and there is also disordered methanol in the lattice, 
Figure 5.1d.  The geometry of the complex ion is propagated into an infinite one-
dimensional chain by dimeric head-to-head R 22 (8) N−H···O hydrogen bonds between 
neighboring carboxamide moieties on one side of the metal complex (N27A···O27A, 
2.930(6) Å; N27B···O27B, 2.88(2) Å).  In addition, there are O−H···O hydrogen bonds 
between the O−H groups of methanol and carbonyl oxygen atoms of carboxamide 
moieties (O1S···O47, 3.021(9) Å) to produce an alternating N−H···O/O−H···O hydrogen-
bonded pattern, Figure 5.6. 
 
 
Figure 5.6 Infinite 1-D chain in 32 formed from N−H···O/O−H···O hydrogen bonds. 
 
Syn- and anti- N−H protons of carboxamide groups on the methanol side of the complex 
ion interact with anions (N47···F1, 2.898(5) Å and N47···F3, 3.181(6) Å respectively). 
 
5.3.5 Crystal structure of bis-[4-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
hexafluoroantimonate, 33 
  
     The crystal structure determination of 33 reveals the presence of two 
crystallographically unique 4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide ligands 
coordinated to a silver(I) cation in a near-linear geometry via their benzimidazol-1-yl 
nitrogen atoms, as well as a disordered hexafluoroantimonate anion, Figure 5.1e.  
 126
Adjacent units are held together by catemeric N−H···O hydrogen bonds (N27···O47, 
3.023(4) Å; N47···O27, 2.969(4) Å) to produce an infinite undulating one-dimensional 
chain.  Neighboring chains are connected by catemeric N−H···O hydrogen bonds to 
generate an infinite ribbon.  Adjacent ribbons interact via  π···π interactions (3.3 Å) 
between benzimidazol-1-yl moieties to generate a two-dimensional sheet, Figure 5.7, 
similar to the extended structure in 31.  The anions reside within the pores of the sheet. 
 
       
Figure 5.7 2-D sheet in 33 formed from N-H···O hydrogen bonds and π···π interactions.  
 
5.3.6 Crystal structure of bis-[3-(2-methylbenzimidazol-1-yl)methylbenzamide]silver(I) 
hexafluoroantimonate, 34 
  
     The crystal structure of 34 contains two crystallographically distinct 3-[(2-
methylbenzimidazol-1-yl)methyl]-benzamide ligands molecules coordinated to a silver(I) 
ion in a near-linear manner, Figure 5.1f.  Adjacent ions are interconnected through 
dimeric head-to-head R 22 (8) N−H···O hydrogen bonds on one side of the metal complex 
(N27···O27, 2.907(3) Å) whereas the carboxamide moieties on the other side are capped 
by interactions with hexafluoroantimonate anions (N47···F1, 2.959(3) Å).  Neighboring 
dimeric units interact through π···π interactions (3.6 Å) between benzimidazol-1-yl 
moieties resulting in a one-dimensional assembly, Figure 5.8. 
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Figure 5.8 Extended 1-D assembly in 34 held together by dimeric 
carboxamide···carboxamide hydrogen bonds and π···π interactions.   
 
5.4 Discussion 
     Six inorganic-organic coordination complexes with Ag(I) ions and [(benzimidazol-1-
yl)methyl]-benzamide ligands were characterized using single-crystal X-ray diffraction in 
order to establish if this family of ligands is capable of facilitating high-yielding 
supramolecular synthesis. 
     In each structure, 29-34, the Ag(I) ion is coordinated in a linear manner by two ligands 
and the ligand-metal interaction invariably takes place through the accessible nitrogen 
atom of the benzimidazol-1-yl moiety.  The amide moiety does not bind directly to the 
metal ion in any case which leaves it open to engage in the supramolecular assembly 
process.  With six linear complexes there are twelve amide moieties that need to be 
classified according to the type of hydrogen-bond interactions that they participate in.  
Ligand-ligand based hydrogen bonds (either R 22 (8) or C(4) motifs) will lead to extended 
assemblies, whereas hydrogen bonding to counterions and/or solvent molecules 
represents loss of control and directionality and is considered a failed assembly event.  In 
this family of compounds, adjacent amides produced five R 22 (8) motifs and five C(4) 
motifs.  Only on two occasions were the intended supramolecular ligand···ligand 
interactions disrupted, once by an [SbF6]- anion (in 34) and once by a methanol molecule 
(in 32).  The ligands are therefore capable of propagating the inherent linear geometry of 
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the metal complex in four of the six structures – a supramolecular yield of 67%.  Since 
each structure necessarily contains potentially disruptive counterions and, on three 
occasions, included solvent molecules, a supramolecular assembly strategy of extended 
metal-containing architectures using this family of ligands is likely to be quite successful.  
The fact that ligand-based amide···amide hydrogen bonds are capable of maneuvering 
complex ions of substantial size, also bodes well for the transferability and versatility of 
these ligands.   
     Since there was only one occasion when an anion disrupted an intended recognition 
event it is not possible to rank the potential structural interference from the anions used in 
this structural study: [BF4]-, [AsF6]-, and [SbF6]-.  Based upon charge-size ratio one might 
expect the tetrafluoroborate anion to be most likely to cause problems by competing as an 
alternative hydrogen-bond acceptor, but that was not the case in 29-34.  It should be 
noted that these six compounds represent most of the complexes in this family of 
compounds that have been crystallographically characterized to date.14  With an increased 
number of structural data points we do not expect to find any marked deviations from the 
supramolecular yield that we have found so far.  
     Secondary intermolecular interactions are responsible for organizing 1-D assemblies 
with respect to each other, and these forces can principally be classified as π···π contacts.  
The asymmetric charge distribution in heterocyclic compounds can strengthen such 
interactions, and there were several examples of short π···π distances (3.3-3.6 Å) in these 
structures, indicative of attractive forces that further stabilized the extended structures. 
 
5.5 Conclusions 
      
     At this stage, it is clear that ligands, such as those described herein, can be used 
effectively for the directed assembly of complex ions into desired extended motifs even 
in the presence of a variety of structurally disruptive counterions and solvent molecules. 
We are currently synthesizing 2-D and 3-D inorganic-organic hybrid systems employing 
[(benzimidazol-1-yl)methyl]-benzamide ligands and metal ions with preferences for 
higher coordination numbers in order to take advantage of the coordinating versatility of 
five-membered N-substituted heterocyclic moieties for the construction of open 
architectures.  Furthermore, we are also synthesizing even longer ligands, with the same 
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coordinating and hydrogen-bonding sites, to determine how the supramolecular yield is 
affected by an increase in molecular weight of the constituent building blocks in the 
assembly process. 
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Chapter 6 
 
Organizing M(II)(acac)2 complexes into infinite 1-D chains using ditopic 
imidazole/benzimidazole ligands and hydrogen-bond analogues 
   
6.1 Introduction 
 
     Synthetic inorganic supramolecular chemistry frequently begins with metal ions with 
predictable (or at least preferential) coordination geometries, followed by the application 
of a reliable method for propagating the shape or dimensionality of the complex ion into 
an extended architecture.  An example of such a strategy is the combination of metal ions 
that tend to adopt a linear geometry (e.g. Ag(I)), with rigid ditopic ligands, such as 4,4’-
bipyridine – the inherent symmetry of the metal center is readily extrapolated into an 
infinite 1-D chain.1  Challenges to such approaches are frequently encountered when the 
metal ion can adopt a multitude of geometries and coordination numbers, or when 
potentially disruptive species such as coordinating counterions are present in order to 
maintain charge neutrality. 
     One way of gaining better control over the coordination geometry of a metal ion is to 
employ chelating ligands, which tend to yield more predictable results due to relatively 
limited binding modes of a rigid multitopic ligand compared to most of their 
monodentate counterparts.  The potential supramolecular problems that arise due to 
competition from counterions can also be eliminated by ensuring that the complex ion 
itself is electrically neutral. 
     We are interested in developing robust and versatile methods for practical inorganic 
supramolecular synthesis, and a helpful starting point for testing the reliability and 
supramolecular effectiveness of new ligands is a discrete, low-dimensional and charge-
neutral coordination complex.   
     For example, linear building blocks are readily obtained by preparing metal 
complexes derived from acetylacetonato (acac) ligands,2 where two of these “capping” 
ligands coordinate to octahedral M(II) centers in the equatorial positions, thus leaving the 
axial sites accessible for additional ligands that can form a bridge between adjacent 
complex ions, Scheme 6.1. 
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                                                       R = CH3, CF3, phenyl 
                                                        M = Cu(II), Co(II), Ni(II) 
 
 
 
Scheme 6.1 M(II)(acac)2 complexes showing accessible axial coordination sites. 
 
Not only do the two acac ligands create opportunities for the assembly of infinite chains, 
but they also produce an overall neutral metal complex, thus eliminating possible 
structural interference from counterions.  Consequently, we will employ various 
M(II)(acac)2 complexes (M = Cu, Co, and Ni) as starting points in our supramolecular 
assembly.  Both Co(II) and Ni(II) adopt octahedral geometries whereas in Cu(II) the 
coordination mode is usually less predictable.  In addition to acac, the chelating ligands 
will include hexafluoroacetylacetonato (hfacac) and dibenzoylmethanato (DBM).     
     Interlinking of discrete metal complexes into extended networks is typically achieved 
either with only coordinate-covalent bonds,3 or through a combination of metal-ligand 
coordination and intermolecular ligand···ligand hydrogen-bond interactions.4  We intend 
to explore both strategies in this study.  First, we will use symmetric ditopic bridging 
ligands based upon N-substituted imidazoles/benzimidazoles,5 Scheme 6.2, since they are 
capable of coordinating to metal ions without significant steric hindrance due to their 
smaller C−N−C angles (108˚) compared to their bipyridyl counterparts (120˚). 
  
 
 
 
 
  
      
 
Scheme 6.2 Ditopic imidazol-1-yl/benzimidazol-1-yl ligands used in coordination 
chemistry. 
 
R
R
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R
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Specifically, we will utilize a previously synthesized ditopic bis-imidazole ligand, 1,4-
bis-[(imidazol-1-yl)methyl]-benzene (bix), 5m,6 and imidazol-1-yl/benzimidazol-1-yl 
analogues thereof in an attempt to  produce infinite 1-D chains  of M(II)(acac)2 
complexes using only coordinate covalent bonds as our supramolecular tools. 
     Second, in order to vary the metrics in these metal-containing 1-D chains, it is 
necessary to alter the distance between metal centers, a task that can be achieved by 
changing the length of the bridging ligand.  This can be accomplished by covalently 
adding rigid spacers between heterocycles but this frequently requires significant 
synthetic efforts and the resulting extended ditopic ligand may be considerably less 
soluble than its shorter analogue, which may prove to be an obstacle for the 
supramolecular assembly.  Alternatively, an extended ligand can be obtained through 
self-complementary hydrogen-bond interactions, and such species may also have the 
added benefit of better solubility compared to their covalent analogues.  We have 
previously shown in Chapter 5 that [(benzimidazol-1-yl)methyl]-benzamide ligands can 
be employed in the assembly of linear Ag(I) complexes into infinite chains through self-
complementary ligand···ligand hydrogen bonds.7  In this chapter we intend to compare 
the metrics and supramolecular reliability of assembly processes that are driven by (a) 
coordinate covalent bonds (symmetric ditopic imidazole/benzimidazole), and (b) 
hydrogen bonds (4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide), Scheme 6.3. 
 
 
 
 
      
 
 
 
 
 
Scheme 6.3 A comparison between (a) a ditopic benzimidazol-1-yl ligand and (b) a 
hydrogen bond-linked analogue based upon a 4-[(2-methylbenzimidazol-1-yl)methyl]-
benzamide supramolecular dimer.  
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     Herein we present the crystal structures of five M(II)(acac)2(L)x (L = ditopic imidazol-
1-yl/benzimidazol-1-yl ligand) structures, 35-39, that we obtained in our attempts at 
organizing different M(II)(acac)2 blocks into infinite 1-D chains.  
 
6.2 Experimental 
 
6.2.1 Synthesis 
 
All starting materials were purchased from Aldrich and used without further purification.  
Bis-(dibenzoylmethanato)cobalt(II) (Co(II)(DBM)2) and bis-
(dibenzoylmethanato)nickel(II) (Ni(II)(DBM)2) were prepared according to the 
literature.8  The syntheses of bis-imidazol-1-yl/benzimidazol-1-yl ligands are described in 
Chapter 3.  The synthesis of 4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide is 
presented in Chapter 4.9  Melting points were determined on a Fisher-Johns melting point 
apparatus and are uncorrected. 
 
6.2.2 Syntheses of M(II)(acac)2 complexes 
 
6.2.2.1 Synthesis of [1,4-bis-(2-methylbenzimidazol-1-yl)methylbenzene]0.5bis-
(acetylacetonato)copper(II) hydrate, 35 
 
1,4-Bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene (0.110 g, 0.300 mmol) was 
dissolved in 20 mL of methanol in a small beaker.  Bis-(acetylacetonato)copper(II) (0.026 
g, 0.100 mmol) dissolved in 5 mL of chloroform was then added to the ligand solution 
and the resulting solution heated for 15 min, and the solvent allowed to evaporate to 
dryness.  After three days, blue-green plates formed that correspond to 35, as well as 
crystals of excess ligand and unreacted Cu(II)(acac)2.  M.p. of blue-green plates 212-
216˚C (decomp.).  
 
6.2.2.2 Synthesis of [1,4-bis-(imidazol-1-yl)methylbenzene]bis-
(hexafluoroacetylacetonato)copper(II), 36  
 
1,4-Bis-[(imidazol-1-yl)methyl]-benzene dihydrate (0.082 g, 0.300 mmol) was dissolved 
in 4 mL of absolute ethanol in a small beaker.  To this solution was added a solution 
containing bis-(hexafluoroacetylacetonato)copper(II) (0.048 g, 0.100 mmol) in 5 mL of 
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chloroform.  The combined solutions were subsequently heated for 15 min and the 
solvent evaporated to dryness.  Blue-green rods, 36, formed after six days, along with 
crystals of excess ligand and unreacted Cu(II)(hfacac)2.  M.p. of blue-green rods 205-
209˚C (decomp.). 
 
6.2.2.3 Synthesis of [1,4-bis-(2-methylbenzimidazol-1-yl)methylbenzene]bis-
(dibenzoylmethanato)copper(II), 37 
 
1,4-Bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene (0.030 g, 0.082 mmol) and bis-
(dibenzoylmethanato)copper(II) (0.014 g, 0.027 mmol) were dissolved in 6 mL of DMF 
with heat in a small beaker.  The solvent was then allowed to evaporate for twelve days 
under ambient conditions, upon which green prisms, 37, formed.  M.p. 243-245˚C 
(decomp.).   
 
6.2.2.4 Synthesis of [4-(2-methylbenzimidazol-1-yl)methylbenzamide]bis-
(dibenzoylmethanato)cobalt(II) THF, 38 
 
4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide (0.040 g, 0.153 mmol) was dissolved 
in 7 mL of dry tetrahydrofuran with heat in a small vial and cooled to room temperature.  
To this solution was added a solution (3 mL) containing bis-
(dibenzoylmethanato)cobalt(II) (0.039 g, 0.076 mmol) in dry acetonitrile with the 
resulting solution covered and allowed to stand under ambient conditions.  Orange plates, 
38, were grown after four days.  M.p. >300˚C. 
 
6.2.2.5 Synthesis of [4-(2-methylbenzimidazol-1-yl)methylbenzamide]bis-
(dibenzoylmethanato)nickel(II) THF, 39 
 
4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide (0.040 g, 0.153 mmol) was dissolved 
in 7 mL of dry tetrahydrofuran with heat in a small vial and cooled to room temperature.  
To this solution was added bis-(dibenzoylmethanato)nickel(II) (0.039 g, 0.076 mmol) 
dissolved in 3 mL of dry acetonitrile.  The resulting solution was covered and allowed to 
stand under ambient conditions.  Green plates corresponding to 39 were obtained after 
two weeks.  M.p. 283-287˚C (decomp.). 
 
6.2.3 X-ray crystallography 
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     X-ray data were collected on a Bruker SMART 1000 four-circle CCD diffractometer 
using a fine-focus molybdenum Kα tube.  Data were collected using SMART.10  Initial 
cell constants were found by small widely separated “matrix” runs.  Preliminary Laué 
symmetry was determined from axial images.  Generally, an entire hemisphere of 
reciprocal space was collected regardless of Laué symmetry. Scan speed and scan width 
were chosen based on scattering power and peak rocking curves. Unless otherwise noted, 
data were collected at low temperatures, using a scan width appropriate for the crystal’s 
mosaic spread. 
     Unit cell constants and orientation matrix were improved by least-squares refinement 
of reflections thresholded from the entire dataset. Integration was performed with 
SAINT,11 using this improved unit cell as a starting point. Precise unit cell constants were 
calculated in SAINT from the final merged dataset. Lorenz and polarization corrections 
were applied. Laué symmetry, space group, and unit cell contents were found with 
XPREP. 
     Data were reduced with SHELXTL.12  The structures were solved in all cases by 
direct methods without incident.  In general, hydrogens were assigned to idealized 
positions and were allowed to ride.  Where possible, the coordinates of hydrogen-bonding 
hydrogens were allowed to refine. Heavy atoms were refined with anisotropic thermal 
parameters.  Strongly absorbing atoms such as transition metals were corrected for 
absorption. 
 
6.3 Results 
 
     A summary of the crystallographic information for 35-39 is displayed in Tables A35-
A39.  Bond distances and angles for these compounds are given in Table 6.1, hydrogen-
bond geometries for 38 and 39 are listed in Table 6.2, and thermal ellipsoid plots and 
labeling schemes are provided in Figure. 6.1.   
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Table 6.1 Selected bond distances and angles for 35-39. 
 
 
Compound M(II)−N (Å) < N−M(II)−N (˚) 
35 Cu1−N13, 2.280(2) − 
36 Cu1−N23, 1.991(2) N13−Cu1−N23, 180.00(10) 
37 Cu1−N13, 2.535(2) N13−Cu1−N13, 180.00 
38 Co1−N13, 2.175(2) N13−Co1−N13, 179.999(2) 
39 Ni1−N13, 2.114(4) N13−Ni1−N13, 180.000(1) 
 
 
Table 6.2 Hydrogen-bond geometries for 38 and 39. 
 
 
Compound D-H A D-H/Å H…A/Å D…A/Å <(DHA)/° generator for A 
38 N27 H27A O27 
N27 H27B O1A 
0.87 
0.87 
2.09 
2.11 
2.954(4) 
2.932(7) 
171.4 
156.8 
-x+2, -y, -z 
-x+2, -y+1, -z 
39 N27 H27A O27 
N27 H27B O1A 
0.87 
0.87 
2.06 
2.17 
2.922(6) 
2.975(8) 
171.9 
153.9 
-x+2, -y, -z 
-x+2, -y+1, -z 
 
 
                      
                                                                       (a) 
                       
                                                                       (b) 
 138
                                  
                                                                       (c) 
 
                            
                                                                        (d) 
                           
                                                                       (e) 
Figure 6.1 Thermal ellipsoid plots (50% probabilities) and labeling scheme for 35-39 (a-
e).  Whenever appropriate, hydrogen atoms were removed for clarity. 
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6.3.1 Crystal structure of [1,4-bis-(2-methylbenzimidazol-1-yl)methylbenzene]0.5bis-
(acetylacetonato)copper(II) hydrate, 35 
  
     The geometry around the copper(II) center in 35 is five-coordinate square pyramidal 
and thus only one of the two available axial sites (Cu1−N13, 2.280(2) Å)  is occupied, 
Figure 6.1a.  The result is a 0-D structure consisting of two Cu(II)(acac)2 complexes 
bridged by one ditopic ligand, Figure 6.2. 
 
                         
                        Figure 6.2 0-D structure in 35 formed by two Cu(II)(acac)2 complexes bridged by 
one 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene ligand. 
 
The through-space intrachain Cu(II) distance is about 14.2 Å. Acetylacetonato oxygen 
atoms on adjacent metal complexes are connected by hydrogen bonds involving water 
molecules (hydrogen atoms could not be located), to form an infinite 1-D ladder, Figure 
6.3.    
                              
Figure 6.3 Infinite 1-D ladder in 35 obtained through interactions between 
acetylacetonato oxygen atoms and bridging water molecules. 
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6.3.2 Crystal structure of [1,4-bis-(imidazol-1-yl)methylbenzene]bis-
(hexafluoroacetylacetonato)copper(II), 36  
 
     The crystal structure of 36 reveals an infinite undulating 1-D coordination polymer 
where bridging 1,4-bis-[(imidazol-1-yl)methyl]-benzene ligands coordinate to the 
copper(II) ions through their imidazol-1-yl nitrogen atoms in a linear fashion (Cu1−N23, 
1.991(2) Å; < N23−Cu1−N23, 180.00(10)˚), Figures 6.1b and 6.4.  Each metal ion 
possesses an octahedral geometry, and both axial sites are engaged in coordination to the 
bridging ligands.  Through-space intrachain Cu(II)-Cu(II) distances are approximately 
13.1 Å.   
 
    
                        Figure 6.4 Infinite 1-D coordination polymer in 36 formed through coordination of 
bridging ligands and Cu(II)(hfacac)2 centers. 
 
6.3.3 Crystal structure of [1,4-bis-(2-methylbenzimidazol-1-yl)methylbenzene]bis-
(dibenzoylmethanato)copper(II), 37 
 
     In the crystal structure of 37, an infinite zig-zag 1-D coordination polymer is 
generated where bridging 1,4-bis-[(2-methylbenzimidazol-1-yl)methyl]-benzene ligands 
coordinate through the accessible axial sites of octahedral copper(II) ions in a linear 
manner (Cu1−N13, 2.535(2) Å; < N13−Cu1−N13, 180.00˚), Figures 6.1c and 6.5.  
Through-space intrachain Cu−Cu distances are about 15.3 Å. 
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Figure 6.5 Extended 1-D coordination polymer in 37 afforded through coordination 
of bridging ligands to the axial sites of Cu(II)(DBM)2 centers. 
 
     Adjacent 1-D chains interact via π···π stacking involving the aromatic rings of 2-
methylbenzimidazol-1-yl moieties, Figure 6.6, with distances averaging about 3.5 Å.   
   
                        Figure 6.6 Extended view of 37 showing π···π interactions between the aromatic rings 
of 2-methylbenzimidazol-1-yl moieties of adjacent 1-D chains. 
 
6.3.4 Crystal structure of [4-(2-methylbenzimidazol-1-yl)methylbenzamide]bis-
(dibenzoylmethanato)cobalt(II) THF, 38  
 
     The crystal structure of 38 contains dibenzoylmethanato (DBM) ligands coordinated 
to a cobalt(II) ion while the axial coordination sites on the metal ion are occupied by two 
4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide ligands through their heterocyclic 
nitrogen atoms (Co1−N13, 2.175(2) Å; < N13−Co1−N13, 179.999(2)˚) resulting in an 
octahedral metal complex, Figure 6.1d.  Neighboring complexes are interconnected 
through dimeric head-to-head R 22 (8) N−H···O hydrogen bonds between carboxamide 
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moieties using their syn- N−H protons and carbonyl oxygen atoms (N27···O27, 2.954(4) 
Å) to generate an infinite l-D chain, Figure 6.7. 
 
  
Figure 6.7 1-D chain in 38 formed by dimeric carboxamide···carboxamide hydrogen 
bonds.  THF molecules interact with anti- N−H protons of carboxamide moieties. 
 
Additionally, the anti- N−H protons of carboxamide moieties interact with oxygen atoms 
of THF molecules (N27···O1A, 2.932(7) Å).  Cobalt(II) ions within the chain are 
separated by approximately 21.0 Å. 
 
6.3.5 Crystal structure of [4-(2-methylbenzimidazol-1-yl)methylbenzamide]bis-
(dibenzoylmethanato)nickel(II) THF, 39 
   
     The crystal structure of 39 comprises DBM ligands coordinated to a central nickel(II) 
ion with the axial sites of the metal ion coordinated by the benzimidazol-1-yl nitrogen 
atoms of two 4-[(2-methylbenzimidazol-1-yl)methyl]-benzamide ligands (Ni1−N13, 
2.114(4) Å; < N13−Ni1−N13, 180.0(1)˚) resulting in an octahedral metal complex, 
Figure 6.1e.  The extended structure is isostructural with that of 38 − neighboring metal 
complexes are linked by dimeric head-to-head R 22 (8) N−H···O hydrogen bonds utilizing 
the syn- N−H protons and carbonyl oxygen atoms of carboxamide moieties (N27···O27, 
2.922(6) Å) to produce an infinite one-dimensional chain, Figure 6.8, while the anti- 
N−H protons are capped through interactions with oxygen atoms of tetrahydrofuran 
solvent molecules also present in the crystal structure (N27···O1A, 2.975(8) Å).  
Intrachain Ni−Ni distances are about 21.0 Å. 
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                        Figure 6.8 One-dimensional supramolecular chain in 39 showing interactions with 
THF solvent molecules. 
 
6.4 Discussion 
 
     Compounds 35-39 were obtained as a result of coordination from either ditopic 
imidazol-1-yl/benzimidazol-1-yl ligands or their hydrogen bond-linked analogues, with 
various M(II)(acac)2 complexes.  The intended supramolecular strategy, seeking different 
means of propagating M(II)(acac)2 complexes through ditopic imidazol-1-
yl/benzimidazol-1-yl or hydrogen bond-linked ligands into infinite 1-D chains, turned out 
to be highly effective, as four of the five structures displayed the desired motif – an 80% 
supramolecular yield.  In the case of 35, however, a 0-D motif was obtained, due to the 
square pyramidal geometry adopted by the Cu ion which serves to illustrate the 
unpredictability of the coordination chemistry of Cu(II).  The remaining two Cu(II) 
complexes, 36 and 37, are however extended 1-D chains built upon octahedral Cu(II) 
centers. 
     The infinite chains observed in 38 and 39 were generated through the combination of 
metal-ligand coordination (involving the 2-methylbenzimidazol-1-yl moiety) and a head-
to-head amide-amide hydrogen-bonded dimer.  The use of this ligand allowed for the 
separation of metal centers to increase to approx. 21.0 Å, compared to Cu(II)-Cu(II) 
separations of 13.1-15.3 Å in the structures of 35-37. 
     The lack of counterions may certainly have contributed in a positive way to the high 
supramolecular yield that was observed in this study.  Neither the coordinate covalent 
bonds nor the primary hydrogen bonds were disrupted by the presence of solvent 
molecules (THF in the case of 38 and 39), and despite opportunities for extensive π···π 
interactions in these systems, no discernable patterns involving ligand-ligand stacking 
were observed. 
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     A similar supramolecular strategy as the one employed here was previously reported 
in the directed assembly of Co(II) and Ni(II)(DBM)2 complexes into infinite chains.4a 
The supramolecular chemistry was then performed by isonicotinamide as a bridging 
ligand and it also produced the primary 1-D motifs observed in 38 and 39.  In these 
complexes, the metal-metal separation, bridged by isonicotinamide ligands via 
amide···amide hydrogen bonds, is about 17 Å, which is comparable with those using the 
[(benzimidazol-1-yl)methyl]-benzamide dimer.  A possible reason for this similarity is 
that the [(benzimidazol-1-yl)methyl-benzamide ligands are “bent” due to the bridging 
methylene groups, thereby shortening the through-space intrachain distances between 
metal centers. 
     The propensity of Cu(II)(acac)2 complexes to form five-coordinate or octahedral 
geometries using nitrogen-containing ligands was further examined through a CSD 
search,13,14 Table 6.3. 
 
Acac ligand Five-coordinate Six-coordinate 
            
O
Cu
OO
O
CH3
CH3
H3C
H3C  
(a) axial nitrogen-containing ligands 
(b) axial imidazole/benzimidazole-    
containing ligands 
 
 
 
 
7 
0 
 
 
 
 
1 
0 
           
O
Cu
OO
O
CF3
CF3
F3C
F3C  
(a) axial nitrogen-containing ligands 
(b) axial imidazole/benzimidazole-containing 
ligands 
 
 
 
 
21 
15 
 
 
 
 
88 
4 
         
O
Cu
OO
O
 
(a) axial nitrogen-containing ligands 
(b) axial imidazole/benzimidazole-containing 
ligands 
 
 
 
 
 
 
 
0 
0 
 
 
 
 
 
 
 
1 
0 
      
Table 6.3 Five-coordinate versus six-coordinate Cu(acac)2 complexes in the CSD with 
axial nitrogen-containing ligands. 
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     There are only seven five-coordinate and one six-coordinate Cu(acac)2 structures with 
nitrogen donors in the axial positions.  Of the five-coordinate structures, three of them 
utilize monotopic N-ligands (e.g. cyano and quinoline) while the remaining four 
structures involve ditopic N-ligands (piperazine, pyrazine, and 4,4’-bipyridine).  No 
examples in either five- or six-coordinate Cu(acac)2 complexes contain imidazoles as N-
ligands; compound 35, therefore, is the first example of a five-coordinate Cu(acac)2 
complex that consists of a bis-imidazol-1-yl ligand.  Based on these search results, it also 
seems that there is a greater tendency of acac to produce a five-coordinate complex when 
it is employed as the “capping” ligand. 
     In the case of Cu(II)(hfacac)2 complexes, the odds are stacked favorably towards an 
octahedral geometry (88 octahedral structures over 21 five-coordinate structures) when a 
nitrogen-containing ligand is used.  Of the 88 structures, only four structures involve 
imidazole ligands and their derivatives (one chelating bis-imidazole, two bridging 
imidazoles, and one non-bridging imidazole).  On the other hand, fifteen of the 21 five-
coordinate structures contain imidazole and their derivatives as bridging ligands (ten 
imidazoles, three ditopic imidazole/pyrazole ligands, and two ditopic imidazole/pyridine 
ligands).  We were also able to generate the first octahedral bis-imidazol-1-yl-containing 
Cu(II)(hfacac)2 complex in  36 that extends into an infinite 1-D architecture. 
     Only one octahedral Cu(II)(DBM)2 structure exists in the CSD, which involves a N-
ligand (the DBM ligands in this structure contain an acetonitrile functionality), whereas 
there are no five-coordinate examples.  Compound 37, thus, is the first example of an 
octahedral Cu(II)(DBM)2 complex consisting of a bis-N-heterocyclic ligand.             
 
6.5 Conclusions 
 
     In this chapter we have employed a cooperative supramolecular strategy combining 
imidazol-1-yl/benzimidazol-1-yl bridging ligands and various M(II)(acac)2 complexes 
into infinite 1-D chains resulting in a high supramolecular yield.  The use of acac ligands 
with octahedral metal ions led to the formation of well-defined building blocks whose 
resulting linear geometry consists of readily accessible axial coordination sites.  At the 
same time, possible competition from counterions is avoided.  Additionally, the metrics 
of the ditopic ligand was deliberately increased with a hydrogen bond-linked ligand, 
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which also proved to be essential in further separating M(II)(acac)2 units.  We are 
currently employing this approach to form more elaborate supramolecular architectures in 
conjunction with metal ions containing higher accessible coordination sites (square 
planar, octahedral, etc.) with the goal of producing highly porous extended frameworks.               
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Chapter 7 
 
Asymmetric supramolecular reagents for binary and ternary co-crystals 
 
7.1 Introduction 
 
     Many elegant studies have shown that extended supramolecular architectures can be 
synthesized with the aid of complementary intermolecular interactions.1  When such 
assemblies are constructed from neutral molecular building blocks they are typically 
homomeric, which is consistent with the observation that “most crystals are built from 
identical (or enantiomeric) copies of the same molecule”.2  Despite an abundance of 
papers dealing with design and assembly of organic extended networks with desirable 
connectivities and shapes, it remains exceedingly difficult to bring more than two 
different molecular species into one crystalline lattice in a predictable manner, without 
making or breaking covalent bonds.3,4,5  In fact, recent work with isonicotinamide 
remains the only reported successful strategy for the reliable construction of ternary 
supermolecules.6,7,8,9,10,11  In a typical reaction, isonicotinamide is allowed to react with 
two carboxylic acids resulting in ternary supermolecules with two primary 
supramolecular synthons;12 (1) the heteromeric carboxylic acid···pyridine hydrogen bond 
and (2) the heteromeric amide···acid hydrogen bond.  In Chapter 4 it was also shown that 
[(benzimidazol-1-yl)methyl]-benzamides can act as supramolecular reagents for the 
directed assembly of ternary supermolecules.  The supramolecular targets are assembled 
using a synthetic strategy based upon a hierarchical view of intermolecular forces -- the 
stronger acid (as determined by pKa values) interacts preferentially with the best 
hydrogen-bond acceptor (the pyridyl or benzimidazol-1-yl nitrogen atom), and the 
weaker acid binds to the amide moiety.13   
     Despite its success, isonicotinamide is not an ideal supramolecular reagent.  First, it is 
capable of forming self-complementary amide···amide and amide···pyridine hydrogen 
bonds, which makes it inherently difficult to combine it with molecules that lack moieties 
that can compete successfully with the hydrogen-bonding capabilities of the amide 
functionality.  Second, since the two binding sites on isonicotinamide are attached to the 
same delocalized backbone, it is not possible to tune the electronics of the two sites 
independently, which reduces versatility. 
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     In order to bring supramolecular synthesis in the solid state (crystal engineering) to a 
new level of complexity we are now developing supramolecular reagents (SR’s) that can 
be refined in such a way that they offer more opportunities for structural selectivity and 
specificity.  
     This chapter describes the rationale behind, and synthesis of, a family of 
pyridyl/benzimidazol-1-yl and pyrimidyl/benzimidazol-1-yl-based SR’s, Scheme 7.1, and 
the subsequent modular assembly of ternary co-crystals (1:1:1). 
   
                                
N N
N pKa 4.71 ± 0.10
pKa 5.72 ± 0.30
pKa 5.85 ± 0.18
pKa 4.72 ± 0.10
N N
N
CH3
pKa 4.05 ± 0.30
pKa 4.82 ± 0.10
N N
N
Cl
pKa 4.85 ± 0.18 pKa -0.74 ± 0.10N N N
N
(a)
(b)
(c)
(d)  
Scheme 7.1 Proposed strategy for ternary supermolecules based upon asymmetric (a)-(c) 
pyridyl-benzimidazol-1-yl and (d) pyrimidyl-benzimidazol-1-yl supramolecular reagents 
(SR’s). 
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Our approach is based upon hydrogen-bond interactions in the context of the best-
donor/best-acceptor, second-best donor/second-best acceptor concept. 6,14,15  The SR’s in 
this study are built around asymmetric bis-heterocycles where two binding sites 
(hydrogen-bond acceptor sites) are linked by a methylene bridge (in the case of 
pyridyl/benzimidazol-1-yl SR’s) in order to provide increased solubility in a range of 
solvents. The binding sites have significantly different basicities,16 which means that their 
abilities to accept hydrogen bonds vary.  They also lack strong hydrogen-bond donors 
and, consequently, any self-complementary intermolecular interaction will be weak and 
less likely to disrupt the desired heteromeric interactions. 
     Even though pKa/pKb values do not provide direct measures of hydrogen-bond 
strength, hydrogen bond abilities and free energies of complexation have been correlated 
with pKa values, and within closely related classes of compounds, such comparisons 
frequently yield correct qualitative results.17  Finally, the basicity of each heterocycle can 
be independently altered through suitable covalent substituents on each ring, which 
thereby provides an effective handle for fine-tuning differences in intermolecular 
reactivity between the two binding sites.  The latter is highly significant as it creates a 
supramolecular reagent with the potential for a high degree of versatility and 
transferability.  Ditopic bis-imidazoles/bis-benzimidazoles are also known to form binary 
co-crystals with a variety of dicarboxylic acids as presented earlier in Chapter 2.18    
     The ability of these supramolecular reagents to form binary co-crystals with 
monocarboxylic acids was first investigated, as these results provide valuable information 
about the selectivity and specificity of these SR’s.  Subsequently, our strategy for the 
directed assembly of ternary supermolecules with predictable connectivity employing 
these SR’s was put to the test by allowing each SR to react with pairs of carboxylic acids 
with different pKa values19 in a 1:1:1 ratio. 
 
7.2 Experimental 
 
7.2.1 Synthesis 
 
Starting materials were obtained from Aldrich and used without further purification.  
Melting points were determined on a Fisher-Johns melting point apparatus and are 
uncorrected. 
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7.2.1.1 Synthesis of 3-(benzimidazol-1-yl)methylpyridine and synthesis of 3-
(benzimidazol-1-yl)methylpyridine hydrate, 40 
 
Benzimidazole (4.25 g, 36.0 mmol) was dissolved in 18 mL of anhydrous DMF with 
stirring under a N2 atmosphere.  To the clear, light-brown solution was added NaH (0.86 
g, 36.0 mmol) inside a glove bag under a N2 atmosphere.  Effervescence was 
immediately observed, and once fizzing had subsided, the mixture was heated and stirred 
under reflux for 1 h under a N2 atmosphere.  After 1 h, the mixture was cooled to room 
temperature.  To this solution was added dropwise a solution of 3-picolyl chloride 
hydrochloride (2.95 g, 18.0 mmol) in 36 mL of anhydrous DMF.  The resulting mixture 
was heated and stirred under reflux under a N2 atmosphere and monitored by TLC.  After 
48 h, the brown mixture was cooled to room temperature.  NaCl that had formed during 
the reaction was filtered via vacuum filtration, and the clear, brown filtrate was 
concentrated by rotary evaporation to obtain a brown syrup.  The syrup was purified by 
column chromatography using silica gel (200-425 mesh), and ethyl acetate : hexanes 1:1, 
ethyl acetate, followed by methanol as eluents.  Concentration of the appropriate fractions 
via rotary evaporation afforded the pure product as a pale yellow crystalline solid.  The 
monohydrate, 40, was obtained as colorless plates suitable for X-ray crystallography 
upon slow evaporation of the pure product in ethyl acetate after 24 h.  Yield 1.99 g 
(52.9%); m.p. 48-51˚C; 1H NMR (DMSO-d6, 400 MHz) δ 5.56 (s, 2H), 7.21 (m, 2 H), 
7.35 (dd, 1H, J1 = 7.6 Hz, J2 = 4.8 Hz), 7.57 (m, 1H), 7.68 (m, 2H), 8.45 (s, 1H), 8.49 
(dd, 1H, J1 = 5 Hz, J2 = 1.6 Hz), 8.64 (s, 1H). 
 
7.2.1.2 Synthesis of 3-(2-methylbenzimidazol-1-yl)methylpyridine 
 
2-Methylbenzimidazole (8.06 g, 61.0 mmol) was dissolved in 61 mL of anhydrous DMF 
with stirring under a N2 atmosphere.  To the clear, light-brown solution was added NaH 
(1.46 g, 61.0 mmol) inside a glove bag under a N2 atmosphere.  Effervescence was 
immediately observed, and once fizzing had subsided, the mixture was heated and stirred 
under reflux for 1 h under a N2 atmosphere.  After 1 h, the mixture was cooled to room 
temperature.  To this solution was added dropwise a solution of 3-picolyl chloride 
hydrochloride (5.00 g, 30.5 mmol) in 61 mL of anhydrous DMF.  The resulting mixture 
was heated and stirred under reflux under a N2 atmosphere and monitored by TLC.  After 
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96 h, the brown mixture was cooled to room temperature.  NaCl that had formed during 
the reaction was filtered via vacuum filtration, and the clear, brown filtrate was 
concentrated by rotary evaporation to obtain a brown syrup.  The syrup was purified by 
column chromatography using silica gel (200-425 mesh), and ethyl acetate : hexanes 1:2 
followed by ethyl acetate as eluents.  Concentration of the appropriate fractions via rotary 
evaporation afforded the pure product as a pale brown microcrystalline solid.  Yield 1.43 
g (21.0%); m.p. 91-93˚C; 1H NMR (CD3OD, 400 MHz) δ 2.60 (s, 3H), 5.55 (s, 2H), 7.25 
(m, 2H), 7.39 (m, 2H), 7.52 (d, 1H, J = 8.8 Hz), 7.61 (m, 1H), 8.42 (s, 1H), 8.47 (dd, 1H, 
J1 = 4.8 Hz, J2 = 1.6 Hz). 
 
7.2.1.3 Synthesis of 3-(2-chlorobenzimidazol-1-yl)methylpyridine and synthesis of 3-(2-
chlorobenzimidazol-1-yl)methylpyridine hydrate, 41 
 
2-Chlorobenzimidazole (3.00 g, 19.7 mmol) was dissolved in 300 mL of dry THF with 
stirring in a 1000 mL round-bottomed flask under a N2 atmosphere.  To the pale brown 
solution was added NaOH pellets (8.24 g, 205.9 mmol) and the resulting suspension 
stirred at room temperature under a N2 atmosphere for 2 h whereupon the suspension 
turned yellowish-green.  After 2 h, a suspension of 3-picolyl chloride hydrochloride (3.23 
g, 19.7 mmol) in 400 mL of dry THF was added all at once to the stirring reaction 
mixture, and the resulting pale yellow-brown suspension was heated and stirred under 
reflux under a N2 atmosphere and monitored by TLC.  After one week, the dark red-
brown mixture was cooled to room temperature.  Distilled water (100 mL) was then 
added to the suspension to dissolve the NaOH pellets and NaCl that had formed during 
the reaction to obtain two layers.  The THF layer was separated and dried over anhydrous 
Na2SO4, the suspension filtered, and the filtrate concentrated by rotary evaporation to 
afford the crude product as a brown syrup.  The syrup was purified by column 
chromatography using silica gel (200-425 mesh), and hexanes : ethyl acetate 10:1 as the 
eluent.  Concentration of the appropriate fractions via rotary evaporation afforded the 
pure product as an off-white solid.  Colorless prisms of the hydrate, 41, were afforded 
after 24 h upon slow evaporation of the pure product in ethyl acetate.  Yield 3.16 g 
(65.8%); m.p. 95-97˚C; 1H NMR (DMSO-d6, 400 MHz) δ 5.60 (s, 2H), 7.29 (m, 2 H), 
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7.37 (dd, 1H, J1 = 8 Hz, J2 = 4.8 Hz), 7.58 (d, 1H, J = 8 Hz), 7.64 (d, 1H, J = 7.2 Hz), 
7.69 (d, 1H, J = 6.8 Hz), 8.51 (d, 1H, J = 4.8 Hz), 8.57 (s, 1H). 
 
7.2.1.4 Synthesis of 5-(benzimidazol-1-yl)-pyrimidine 
 
Benzimidazole (1.06 g, 9.00 mmol) was dissolved in 9 mL of anhydrous DMF with 
stirring under a N2 atmosphere.  To the clear, light brown solution was added NaH (0.25 
g, 10.5 mmol) inside a glove bag under a N2 atmosphere.  Effervescence was 
immediately observed, and once the fizzing had subsided, the cloudy, dark brown 
mixture was heated and stirred under reflux for 1 h.  The clear, brown mixture was then 
cooled to room temperature, and to it was added dropwise a solution of 5-
bromopyrimidine (1.43 g, 9.00 mmol) in 9 mL of anhydrous DMF.  The resulting mixture 
was allowed to heat and stir under reflux under a N2 atmosphere, and its progress 
monitored by TLC.  After 48 h, the red-orange mixture was cooled to room temperature, 
and the NaBr that had formed during the reaction was filtered via vacuum filtration and 
the clear, red-orange filtrate was concentrated by rotary evaporation to afford the crude 
product as a pale brown solid.  The crude product was purified upon recrystallization 
from 30 mL of hot water, and an off-white solid formed upon cooling, which was filtered 
via vacuum filtration, dried, and collected.  Yield 1.13 g (64.2%); m.p. 137-138˚C; 1H 
NMR (DMSO-d6, 400 MHz) δ 7.37 (m, 2H), 7.74 (m, 1H), 7.81 (m, 1H), 8.70 (s, 1H), 
9.27 (s, 2H), 9.32 (s, 1H). 
 
7.2.2 Syntheses of binary co-crystals and salts 
 
7.2.2.1 Synthesis of 4-nitrobenzoic acid 3-(benzimidazol-1-yl)methylpyridine, 42 
 
To an ethanolic solution (4 mL) of 4-nitrobenzoic acid (0.032 g, 0.191 mmol) was added 
a solution containing 3-(benzimidazol-1-yl)methylpyridine (0.020 g, 0.096 mmol) in 1 
mL of absolute ethanol.  Colorless blocks resulted from slow evaporation of the solvent 
after 5 days.  M.p. 178-181˚C. 
 
7.2.2.2 Synthesis of 2,3-dimethylbenzoic acid 3-(benzimidazol-1-yl)methylpyridine, 43 
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2,3-Dimethylbenzoic acid (0.014 g, 0.096 mmol) was dissolved in 2 mL of absolute 
ethanol.  To this solution was added 3-(benzimidazol-1-yl)methylpyridine (0.020 g, 0.096 
mmol) dissolved in 1 mL of absolute ethanol.  The solvent was evaporated slowly upon 
which colorless blocks formed after 3 weeks.  M.p. 100-103˚C. 
 
7.2.2.3 Synthesis of 3-N,N-dimethylaminobenzoic acid 3-(2-methylbenzimidazol-1-
yl)methylpyridine, 44 
 
3-N,N-dimethylaminobenzoic acid (0.012 g, 0.072 mmol) was dissolved in 1 mL of 
absolute ethanol.  To this solution were added 4-nitrobenzoic acid (0.012 g, 0.072 mmol) 
in 2 mL of absolute ethanol and 3-(2-methylbenzimidazol-1-yl)methylpyridine (0.016 g, 
0.072 mmol) in 1 mL of absolute ethanol.  The resulting solution was evaporated slowly 
for one month until amber prisms of 44 formed.  M.p. 162-165˚C. 
 
7.2.2.4 Synthesis of 3-(2-methylbenzimidazolium-1-yl)methylpyridine 3,5-dinitrobenzoate 
3,5-dinitrobenzoic acid, 45 
        
3,5-Dinitrobenzoic acid (0.030 g, 0.144 mmol) was dissolved in 2 mL of absolute 
ethanol.  An ethanolic solution (1 mL) containing 3-(2-methylbenzimidazol-1-
yl)methylpyridine (0.016 g, 0.072 mmol) was then added to the first solution.  Slow 
evaporation of the solvent yielded colorless plates after 10 days.  M.p. 170-173˚C. 
 
7.2.2.5 Synthesis of 3-(benzimidazolium-1-yl)methylpyridine pentamethylbenzoate 
pentamethylbenzoic acid, 46 
 
An ethanolic solution (1 mL) of 3-(benzimidazol-1-yl)methylpyridine (0.020 g, 0.096 
mmol) was added to a 2 mL ethanolic solution containing pentamethylbenzoic acid 
(0.036 g, 0.191 mmol).  The resulting solution was evaporated slowly for 3 weeks until 
colorless blocks of 46 formed.  M.p. 152-155˚C. 
 
7.2.2.6 Synthesis of 3-(benzimidazolium-1-yl)methylpyridine 3,5-dinitrobenzoate 3,5-
dinitrobenzoic acid, 47 
 
3,5-Dinitrobenzoic acid (0.040 g, 0.191 mmol) was dissolved in 2 mL of absolute 
ethanol.  To this solution was added 3-(benzimidazol-1-yl)methylpyridine (0.020 g, 0.096 
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mmol) in 1 mL of absolute ethanol.  The combined solution was evaporated slowly for 6 
days until colorless prisms formed.  M.p. 158-161˚C. 
 
7.2.2.7 Synthesis of 3-(2-methylbenzimidazolium-1-yl)methylpyridine 4-nitrobenzoate 4-
nitrobenzoic acid hydrate, 48 
 
4-Nitrobenzoic acid (0.024 g, 0.144 mmol) was dissolved in 4 mL of absolute ethanol.  
An ethanolic solution (1 mL) containing 3-(2-methylbenzimidazol-1-yl)methylpyridine 
(0.016 g, 0.072 mmol) was then added to the first solution.  Colorless plates formed upon 
slow evaporation of the solvent after 1 week.  M.p. 163-166˚C. 
 
7.2.2.8 Synthesis of 3,5-dinitrobenzoic acid 5-(benzimidazol-1-yl)-pyrimidine, 49  
 
To an ethanolic solution (2 mL) containing 3,5-dinitrobenzoic acid (0.032 g, 0.153 mmol) 
was added 5-(benzimidazol-1-yl)-pyrimidine (0.015 g, 0.077 mmol) in 2 mL of absolute 
ethanol.  Amber rods of 49 were obtained after 24 h upon slow evaporation of the 
solvent.  M.p. 172-174˚C. 
 
7.2.2.9 Synthesis of 4-nitrobenzoic acid 5-(benzimidazol-1-yl)-pyrimidine, 50  
 
4-Nitrobenzoic acid (0.026 g, 0.153 mmol) was dissolved in 4 mL of absolute ethanol.  
To this solution was added 5-(benzimidazol-1-yl)-pyrimidine (0.015 g, 0.077 mmol) in 2 
mL of absolute ethanol.  Slow evaporation of the solvent yielded yellow prisms of 50 
after 3 weeks.  M.p. 168-170˚C. 
 
7.2.3 Syntheses of ternary co-crystals 
 
7.2.3.1 Synthesis of 3,5-dinitrobenzoic acid 3-(benzimidazol-1-yl)methylpyridine 4-
nitrobenzoic acid, 51 
   
3,5-Dinitrobenzoic acid (0.020 g, 0.10 mmol) was dissolved in 1 mL of absolute ethanol 
and added to a 2 mL ethanolic solution containing 4-nitrobenzoic acid (0.016 g, 0.10 
mmol).  To the resulting solution was added 3-(benzimidazol-1-yl)methylpyridine (0.020 
g, 0.10 mmol) in 1 mL of absolute ethanol.  Slow evaporation of the solvent after two 
weeks yielded colorless plates.  TLC of individual crystals showed spots corresponding 
to all three components.  M.p. 133-136˚C.20 
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 7.2.3.2 Synthesis of 3,5-dinitrobenzoic acid 3-(benzimidazol-1-yl)methylpyridine 3-N,N-
dimethylaminobenzoic acid, 52 
   
3,5-Dinitrobenzoic acid (0.020 g, 0.10 mmol) was dissolved in 1 mL of absolute ethanol 
and added to a 1 mL ethanolic solution containing 3-N,N-dimethylaminobenzoic acid 
(0.016 g, 0.10 mmol).  To the resulting solution was added 3-(benzimidazol-1-
yl)methylpyridine (0.020 g, 0.10 mmol) in 1 mL of ethanol.  Slow evaporation of the 
solvent yielded a crop of yellow prisms after two weeks.21  A few days later, a second 
crop consisting of red prisms formed. TLC of individual red crystals showed spots 
corresponding to all three components.  M.p. 110-113˚C. 
 
7.2.3.3 Synthesis of 3,5-dinitrobenzoic acid 3-(benzimidazol-1-yl)methylpyridine 4-
cyanobenzoic acid, 53 
 
3,5-Dinitrobenzoic acid (0.02 g, 0.10 mmol) was dissolved in 1 mL of absolute ethanol 
and added to a 1 mL ethanolic solution containing 4-cyanobenzoic acid (0.02 g, 0.10 
mmol).  To the resulting solution was added 3-(benzimidazol-1-yl)methylpyridine (0.02 
g, 0.10 mmol) in 1 mL of ethanol.  Slow evaporation of the solvent after two weeks 
yielded colorless plates.  TLC of the crystals showed spots corresponding to all three 
components.  M.p. 145-150˚C. 
 
7.2.3.4 Synthesis of 3,5-dinitrobenzoic acid 3-(2-methylbenzimidazol-1-yl)methylpyridine 
4-nitrobenzoic acid, 54 
    
3,5-Dinitrobenzoic acid (0.015 g, 0.070 mmol) was dissolved in 1 mL of absolute ethanol 
and added to a 2 mL ethanolic solution containing 4-nitrobenzoic acid (0.012 g, 0.070 
mmol).  To the resulting solution was added 3-(2-methylbenzimidazol-1-
yl)methylpyridine (0.016 g, 0.070 mmol) in 1 mL of ethanol.  Slow evaporation of the 
solvent after two weeks yielded colorless plates.  TLC of individual crystals showed spots 
corresponding to all three components.  M.p. 158-161˚C.22 
 
7.2.3.5 Synthesis of 4-nitrobenzoic acid 3-(2-chlorobenzimidazol-1-yl)methylpyridine 4-
cyanobenzoic acid, 55 
 
4-Nitrobenzoic acid (0.014 g, 0.082 mmol) and 4-cyanobenzoic acid (0.012 g, 0.082 
mmol) were dissolved in 2 mL of absolute ethanol.  To this solution was added an 
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ethanolic solution (1 mL) containing 3-(2-chlorobenzimidazol-1-yl)methylpyridine 
(0.020 g, 0.082 mmol), and the resulting solution evaporated slowly under ambient 
conditions upon which colorless blocks formed after 12 days.  M.p. 150-153˚C.23 
 
7.2.4 X-ray crystallography 
 
     X-ray data were collected on a Bruker SMART 1000 four-circle CCD diffractometer 
using a fine-focus molybdenum Kα tube.  Data were collected using SMART.24  Initial 
cell constants were found by small widely separated “matrix” runs.  Preliminary Laué 
symmetry was determined from axial images.  Generally, an entire hemisphere of 
reciprocal space was collected regardless of Laué symmetry. Scan speed and scan width 
were chosen based on scattering power and peak rocking curves. Unless otherwise noted, 
data were collected at low temperatures, using a scan width appropriate for the crystal’s 
mosaic spread. 
     Unit cell constants and orientation matrix were improved by least-squares refinement 
of reflections thresholded from the entire dataset. Integration was performed with 
SAINT,25 using this improved unit cell as a starting point. Precise unit cell constants were 
calculated in SAINT from the final merged dataset. Lorenz and polarization corrections 
were applied. Laué symmetry, space group, and unit cell contents were found with 
XPREP. 
     Data were reduced with SHELXTL.26  The structures were solved in all cases by 
direct methods without incident.  In general, hydrogens were assigned to idealized 
positions and were allowed to ride.  Where possible, the coordinates of hydrogen-bonding 
hydrogens were allowed to refine. Heavy atoms were refined with anisotropic thermal 
parameters. 
 
7.3 Results 
 
     Crystallographic data for 40-55 are given in Tables A40-A55.  Hydrogen-bond 
geometries for 40-55 are presented in Table 7.1.  Thermal ellipsoid plots, showing 
numbering schemes, hydrogen bonds, and molecular geometries, are displayed in Figures 
7.1-7.18. 
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Table 7.1 Hydrogen-bond geometries for 40-55. 
 
 
Compound D-H A D-H/Å H…A/Å D…A/Å <(DHA)/° generator for A 
40 O1S H1A N13 
O1S H1B O1S 
O1S H1C O1S 
0.87(2) 
1.00(5) 
0.93(4) 
1.98(2) 
1.98(5) 
2.09(4) 
2.8486(14) 
2.976(3) 
2.999(3) 
174(2) 
171(4) 
167(3) 
− 
-x+1, -y, -z+2 
-x+1, y, -z+3/2 
41 O1S H1A N13 
O1S H1B N21 
0.85(2) 
0.85(2) 
2.13(2) 
2.02(2) 
2.9837(18) 
2.8667(19)   
175(2) 
172(2) 
− 
-x+1, -y+1, -z 
42 O31 H31 N13 
O41 H41 N21 
1.078(16) 
1.031(15) 
1.500(16) 
1.550(15) 
2.5717(11) 
2.5747(12)   
172.2(14) 
171.8(14) 
− 
− 
43 O31 H31 N13 0.972(16) 1.657(16) 2.6263(12) 174.5(15) − 
44 O31 H31 N13 0.92(3) 1.71(3) 2.622(2)       169(2) − 
45 O41 H41 N21 
N13 H13 O31 
0.99(2) 
1.197(19) 
1.57(2) 
1.340(19) 
2.5551(19) 
2.5337(19) 
173(2) 
174.2(16) 
− 
− 
46 N13 H13 O41 
O61 H61 O41 
1.019(15) 
0.942(19) 
1.557(15) 
1.65(2) 
2.5750(12) 
2.5823(12) 
176.9(15) 
171.6(18) 
− 
− 
47 O31 H31 O41 
N13 H13 N21 
1.13(2) 
1.14(2) 
1.32(2) 
1.50(2) 
2.4501(17) 
2.6287(18) 
176(2) 
171.5(19) 
− 
x, -y+3/2, z+1/2 
48 N13 H13 O31 
O41 H41 O1S 
O1S H1A N21 
O1S H1B O32 
1.08(3) 
0.89(3) 
0.95(3) 
0.74(3) 
1.49(3) 
1.68(3) 
1.84(3) 
2.10(3) 
2.560(2) 
2.559(2) 
2.779(3) 
2.842(3) 
173(2) 
169(3) 
169(3) 
173(3) 
− 
− 
− 
x-1,y+1,z 
49 O31 H31 N13 0.926(19) 1.719(19) 2.6398(15) 172.5(18) − 
50 O31 H31 N21 
O41 H41 N13 
0.901(15) 
0.945(15) 
1.801(15) 
1.719(15) 
2.7007(11) 
2.6569(11) 
176.1(14) 
171.4(14) 
− 
− 
51 O31 H31 N13 
O71 H71 N53 
O41 H41 N21 
O81 H81 N61 
1.024(18) 
1.044(19) 
1.018(18) 
1.06(2) 
1.559(18) 
1.502(19) 
1.594(19) 
1.55(2) 
2.5762(17) 
2.5455(18) 
2.6081(18) 
2.6057(19) 
171.0(16) 
177.4(15) 
173.6(16) 
174.2(16) 
− 
− 
− 
− 
52 O47 H47 N13 
O37 H37 N21 
0.94(3) 
0.90(3) 
1.71(3) 
1.78(3) 
2.652(3) 
2.665(3) 
175(3) 
166(3) 
− 
− 
53 O37 H37 N21 
O47 H47 N13 
O77 H77 N61 
O87 H87 N53 
1.09(3) 
1.10(3) 
0.96(3) 
1.02(3) 
1.53(3) 
1.44(3) 
1.61(3) 
1.55(3) 
2.611(3) 
2.544(3) 
2.568(3) 
2.571(3) 
172(2) 
175(2) 
176(3) 
179(3) 
− 
− 
− 
− 
54 O47 H47 N13 
O37 H37 N21 
1.01(3) 
1.08(3) 
1.55(3) 
1.56(3) 
2.553(3) 
2.641(3) 
170(2) 
179(2) 
x+1, y+1, z 
− 
55 O31 H31 N13 
O41 H41 N21 
0.84 
0.84 
1.84 
1.82 
2.6764(14) 
2.6551(14) 
175.3 
174.4 
− 
− 
 
 
7.3.1 Crystal structure of 3-(benzimidazol-1-yl)methylpyridine hydrate, 40 
  
     The crystal structure of 40 displays a hydrated molecule of 3-(benzimidazol-1-
yl)methylpyridine, with one disordered water molecule hydrogen-bonded to the 
benzimidazol-1-yl nitrogen atom of the SR through O−H···N interactions (O1S···N13, 
2.8486(14) Å), Figure 7.1.  The other protons on the water molecule interact with the 
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oxygen atoms of neighboring water molecules.  No significant intermolecular interactions 
involve the pyridyl nitrogen atom of the SR.   
 
                               
Figure 7.1 Hydrogen bonding between the disordered water molecule and 3-
(benzimidazol-1-yl)methylpyridine in 40. 
 
7.3.2 Crystal structure of 3-(2-chlorobenzimidazol-1-yl)methylpyridine hydrate, 41 
      
     The crystal structure determination of 41 reveals a hydrate of 3-(2-
chlorobenzimidazol-1-yl)methylpyridine in which a proton of the water molecule 
interacts with the 2-chlorobenzimidazol-1-yl nitrogen site via O−H···N hydrogen bonds 
(O1S···N13, 2.9837(18) Å), Figure 7.2. 
                                            
Figure 7.2 Hydrogen-bonded unit in 41. 
 
The pyridyl nitrogen atom also partakes in hydrogen bonding with the second proton of 
the water molecule (O1S···N21, 2.8667(19) Å).   The combined interactions produce a 
R 44 (20) hydrogen-bond motif composed of alternating molecules of 3-(2-
chlorobenzimidazol-1-yl)methylpyridine and water molecules, Figure 7.3. 
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Figure 7.3 Four membered ring formed in 41. 
 
7.3.3 Crystal structure of 3-(benzimidazol-1-yl)methylpyridine 4-nitrobenzoic acid, 42 
  
     A 2:1 molecular co-crystal is formed in 42 where the two 4-nitrobenzoic acid 
molecules interact at both heterocyclic nitrogen sites of 3-(benzimidazol-1-
yl)methylpyridine through two different O−H···N hydrogen bonds (O31···N13, 
2.5717(11) Å; O41···N21, 2.5747(12) Å), Figure 7.4; no proton transfer is observed.  
There are also no significant C−H···O interactions accompanying these primary hydrogen 
bonds as the carboxylic acid moieties are not co-planar with respect to the two 
heterocycles. 
 
                       
Figure 7.4 Three-component hydrogen-bonded motif in 42. 
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7.3.4 Crystal structure of 3-(benzimidazol-1-yl)methylpyridine 2,3-dimethylbenzoic acid, 
43 
 
     A 1:1 co-crystal is evidenced in the crystal structure of 43 involving 3-(benzimidazol-
1-yl)methylpyridine and 2,3-dimethylbenzoic acid, Figure 7.5.  The primary O−H···N 
hydrogen bond (O31···N13, 2.6263(12) Å) involves the carboxylic acid and the more 
basic benzimidazol-1-yl nitrogen site while no interactions occur at the less basic pyridyl 
nitrogen atom.  As in 42, there is no C−H···O interaction that accompanies this hydrogen 
bond, nor is there any proton transfer. 
 
                      
Figure 7.5 1:1 Binary co-crystal in 43. 
 
7.3.5 Crystal structure of 3-(2-methylbenzimidazol-1-yl)methylpyridine 3-N,N-
dimethylaminobenzoic acid, 44 
 
     A 1:1 co-crystal between 3-(2-methylbenzimidazol-1-yl)methylpyridine and 3-N,N-
dimethylaminobenzoic acid is formed in 44, with the same connectivity as that in 43, 
Figure 7.6.  A single O−H···N hydrogen bond is formed between the carboxylic acid and 
the more basic 2-methylbenzimidazol-1-yl nitrogen atom (O31···N13, 2.622(2) Å).  
Again, the pyridyl nitrogen atom of the SR does not engage in any noteworthy 
intermolecular interactions, and no C−H···O contacts were identified as the carboxylic 
acid and 2-methylbenzimidazol-1-yl moieties are not coplanar. 
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Figure 7.6 Primary motif in the crystal structure of 44. 
 
7.3.6 Crystal structure of 3-(2-methylbenzimidazolium-1-yl)methylpyridine 3,5-
dinitrobenzoate 3,5-dinitrobenzoic acid, 45 
  
     The crystal structure of 45 consists of a 3,5-dinitrobenzoic acid molecule, 3-(2-
methylbenzimidazolium-1-yl)methylpyridine, and a 3,5-dinitrobenzoate anion, Figure 
7.7.  The SR is protonated at the more basic 2-methylbenzimidazol-1-yl nitrogen atom 
resulting in an N+−H···O- hydrogen bond (N13···O31, 2.5337(19) Å) whereas the pyridyl 
site forms a neutral O−H···N hydrogen bond with the second 3,5-dinitrobenzoic acid 
molecule (O41···N21, 2.5551(19) Å).  No C−H···O interactions augment these primary 
hydrogen bonds. 
 
                         
Figure 7.7 Hydrogen-bond motif in 45. 
 
7.3.7 Crystal structure of 3-(benzimidazolium-1-yl)methylpyridine pentamethylbenzoate 
pentamethylbenzoic acid, 46 
 
     An ionic compound is also produced in 46, Figure 7.8, comprising a 
pentamethylbenzoate anion, a pentamethylbenzoic acid molecule, and 3-
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(benzimidazolium-1-yl)methylpyridine.  Proton transfer occurs to the more basic site of 
the SR (the benzimidazol-1-yl moiety) (N13···O41, 2.5750(12) Å). A C−H···O contact 
also accompanies the N−H···O hydrogen bond involving the most acidic C−H proton of 
the benzimidazol-1-yl moiety in the SR and the carboxylate oxygen group of the 
pentamethylbenzoate anion (C12−H12···O42, 3.48 Å).  The pentamethylbenzoic acid 
molecule forms an O−H···O hydrogen bond with the carboxylate functionality of the 
pentamethylbenzoate anion (O61···O41, 2.5823(12) Å).  The pyridyl nitrogen atom does 
not participate in any principal intermolecular interactions.  
 
                                
Figure 7.8 Ionic compound in the crystal structure of 46. 
 
7.3.8 Crystal structure of 3,5-dinitrobenzoic acid 3-(benzimidazolium-1-
yl)methylpyridine 3,5-dinitrobenzoate, 47 
  
     In the crystal structure of 47, a molecule of 3,5-dinitrobenzoic acid, a 3,5-
dinitrobenzoate anion, and 3-(benzimidazol-1-yl)methylpyridine form an ionic compound 
with a different connectivity pattern to that of 46, Figure 7.9.  Although the more basic 
site of the SR is protonated (the benzimidazol-1-yl nitrogen atom), it forms an N+−H···N 
hydrogen bond with the pyridyl nitrogen atom of a neighboring SR (N13···N21, 
2.6287(18) Å) resulting in an infinite 1-D chain.  The anion interacts with the neutral 
carboxylic acid through an O−H···O hydrogen bond (O31···O41, 2.4501(17) Å).  The 3,5-
dinitrobenzoic acid molecule furthermore interacts through π···π stacking interactions 
(~3.5 Å) with the benzimidazol-1-yl moiety of the SR. 
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Figure 7.9 Charged-assisted hydrogen bonds and π···π interactions in the crystal structure 
of 47. 
 
7.3.9 Crystal structure of 3-(2-methylbenzimidazolium-1-yl)methylpyridine 4-
nitrobenzoate  4-nitrobenzoic acid hydrate, 48  
 
     The crystal structure determination of 48 reveals a hydrogen-bonded motif involving 
4-nitrobenzoic acid, 4-nitrobenzoate, 3-(2-methylbenzimidazolium-1-yl)methylpyridine, 
and a water molecule, Figure 7.10.  The carboxylate moiety formed due to proton transfer 
to the 2-methylbenzimidazol-1-yl nitrogen atom to produce a charge-assisted N+−H···O- 
hydrogen bond (N13···O31, 2.560(2) Å).  The carboxylic acid is bridged by the water 
molecule through an O−H···O hydrogen bond (O41···O1S, 2.559(2) Å).  An additional 
O−H···N hydrogen bond between the water molecule and the pyridyl nitrogen atom of the 
SR also forms part of the crystal structure of 48 (O1S···N21, 2.779(3) Å). 
    
                           
 Figure 7.10 Hydrogen-bonded pattern in 48.  A water molecule provides a hydrogen-
bond bridge between one carboxylic acid moiety and the pyridyl nitrogen atom of the SR. 
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The resulting extended structure of 48, an infinite 1-D chain, is afforded through O−H···O 
hydrogen bonds between the bridging water molecule and the carboxylate moiety of a 
neighboring anion (O1S···O32, 2.842(3) Å), Figure 7.11. 
 
            
 
Figure 7.11 1-D chain in the crystal structure of 48. 
 
7.3.10 Crystal structure of 3,5-dinitrobenzoic acid 5-(benzimidazol-1-yl)-pyrimidine, 49 
  
     A 1:1 co-crystal, 49, is afforded between 5-(benzimidazol-1-yl)-pyrimidine and 3,5-
dinitrobenzoic acid, Figure 7.12.  As in the previous 1:1 co-crystals, the carboxylic acid 
forms an O−H···N hydrogen bond with the benzimidazol-1-yl nitrogen site (the stronger 
base) (O31···N13, 2.6398(15) Å).  In addition, a C−H···O interaction accompanies this 
hydrogen bond utilizing the most acidic C−H proton of the benzimidazol-1-yl moiety and 
the carbonyl oxygen atom of the carboxylic acid (C12−H12···O32, 3.02 Å).  The 
pyrimidyl nitrogen sites, however, are not involved in any primary intermolecular 
interactions. 
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Figure 7.12 1:1 Motif in the crystal structure of 49. 
 
7.3.11 Crystal structure of 4-nitrobenzoic acid 5-(benzimidazol-1-yl)-pyrimidine, 50 
  
     The crystal structure of 50 displays a 2:1 stoichiometry between 4-nitrobenzoic acid 
and 5-(benzimidazol-1-yl)-pyrimidine, Figure 7.13.  Consequently, two unique O−H···N 
hydrogen bonds are formed, involving both benzimidazol-1-yl (O41···N13, 2.6569(11) Å) 
and pyrimidyl (O31···N21, 2.7007(11) Å) sites.  The O−H···N hydrogen bond that 
incorporates the benzimidazol-1-yl site is further accompanied by a C−H···O interaction 
(C12−H12···O42, 3.68 Å). 
 
                          
Figure 7.13 2:1 Co-crystal in 50. 
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7.3.12 Crystal structure of 3,5-dinitrobenzoic acid 3-(benzimidazol-1-yl)methylpyridine 
4-nitrobenzoic acid, 51 
 
     The crystal structure of 51 consists of two crystallographically inequivalent sets of 
ternary supermolecules with identical connectivity, Figure 7.14. 
 
Figure 7.14 One of two ternary supermolecules in the crystal structure of 51 (both have 
the same connectivity).  The best hydrogen-bond donor binds to the best hydrogen-bond 
acceptor and the second-best donor binds to the second-best acceptor. 
 
The primary synthons in this structure are (a) the O−H···N hydrogen bonds from the 
stronger acid (3,5-dinitrobenzoic acid) to the most  basic nitrogen atom located on the 
benzimidazol-1-yl ring (O31···N13, 2.5762(17) Å and O71···N53, 2.5455(18) Å), and (b) 
the O−H···N hydrogen bonds from the weaker acid (4-nitrobenzoic acid) to the less basic 
nitrogen atom located on the pyridyl moiety (O41···N21, 2.6081(18) Å and O81···N61, 
2.6057(19) Å). 
 
7.3.13 Crystal structure of 3,5-dinitrobenzoic acid 3-(benzimidazol-1-yl)methylpyridine 
3-N,N-dimethylaminobenzoic acid, 52 
   
     The crystal structure determination of 52 also reveals a ternary 1:1:1 supermolecule 
with the same connectivity as found in 51, Figure 7.15. 
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Figure 7.15 The ternary supermolecule in the crystal structure of 52. The best hydrogen-
bond donor binds to the best hydrogen-bond acceptor and the second-best donor binds to 
the second-best acceptor. 
 
The primary synthons comprise (a) an O−H···N hydrogen bond between the stronger acid, 
3,5-dinitrobenzoic acid, and the most basic heterocyclic moiety (O47···N13, 2.652(3) Å), 
and (b) another O−H···N interaction between the weaker acid, 3-N,N-
dimethylaminobenzoic acid, and the second-best hydrogen-bond acceptor, the pyridyl 
moiety (O37···N21, 2.665(3) Å). 
 
7.3.14 Crystal structure of 3,5-dinitrobenzoic acid 3-(benzimidazol-1-yl)methylpyridine 
4-cyanobenzoic acid, 53 
 
     A 1:1:1 ternary co-crystal is also observed in the crystal structure of 53, which 
contains two inequivalent sets of supermolecules with the intended connectivity, Figure 
7.16. 
 
                              
 
Figure 7.16 One of the two sets of ternary supermolecule in 53, which contains the 
expected hydrogen-bond connectivities. 
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Once again the two principal O−H···N hydrogen bonds involve (a) an interaction between 
the stronger carboxylic acid (3,5-dinitrobenzoic acid) and the more basic benzimidazol-1-
yl nitrogen atom (O47···N13, 2.544(3) Å and O87···N53, 2.571(3) Å), and (b) the weaker 
acid, 4-cyanobenzoic acid, interacting with the less basic pyridyl site (O37···N21, 
2.611(3) Å and O77···N61, 2.568(3) Å).   
 
7.3.15 Crystal structure of 3,5-dinitrobenzoic acid 3-(2-methylbenzimidazol-1-
yl)methylpyridine 4-nitrobenzoic acid, 54 
  
     The crystal structure of 54 contains the desired 1:1:1 supermolecule with the expected 
connectivity, Figure 7.17. 
Figure 7.17 The ternary supermolecule in the crystal structure of 54. The best hydrogen-
bond donor binds to the best hydrogen-bond acceptor and the second-best donor binds to 
the second-best acceptor. 
 
The best acceptor, the 2-methylbenzimidazol-1-yl moiety, forms an O−H···N hydrogen 
bond with the best donor, the stronger acid, 3,5-dinitrobenzoic acid (O47···N13, 2.553(3) 
Å).  The second-best acceptor, the pyridyl moiety, binds to the weaker acid (4-
nitrobenzoic acid) via an O−H···N hydrogen bond (O37···N21, 2.641(3) Å). 
 
7.3.16 Crystal structure of 4-nitrobenzoic acid 3-(2-chlorobenzimidazol-1-
yl)methylpyridine 4-cyanobenzoic acid, 55 
 
     The crystal structure determination of 55 reveals a disordered 1:1:1 ternary co-crystal, 
Figure 7.18, where the 4-cyanobenzoic acid molecule is 60% occupied.  The remaining 
40% occupancy is completed by 4-nitrobenzoic acid.  
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Figure 7.18 Ternary co-crystal in 55. 
 
The stronger acid, 4-nitrobenzoic acid, hydrogen-bonds to the 2-chlorobenzimidazol-1-yl 
nitrogen site (O31···N13, 2.6764(14) Å), thereby leaving the weaker acid (4-
cyanobenzoic acid) to interact with the pyridyl nitrogen atom (O41···N21, 2.6551(14) Å).   
 
7.4 Discussion 
   
     Asymmetric pyridyl-benzimidazol-1-yl and pyrimidyl-benzimidazol-1-yl SR’s readily 
formed several binary co-crystals/hydrates and salts, 42-50, with carboxylic acids and 
water molecules, Scheme 7.2. 
 
                                               
 
 
 
 
 
Scheme 7.2 Classification of binary structures resulting from supramolecular reactions 
between carboxylic acids and asymmetric pyridyl-benzimidazol-1-yl and pyrimidyl-
benzimidazol-1-yl SR’s.  The values in parentheses indicate the number of structures 
obtained in each case. 
 
Acid + Base (11 structures)
co-crystals/hydrates (7) salts (4)
2:1 (3) 1:1 (4)
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The presence of only one co-crystallizing agent determined either a 1:1 (four structures) 
or 2:1 (three structures) co-crystal/hydrate, or salt (four structures).  Formation of salts 
led to unpredictable motifs, as the carboxylate moieties possess more diffuse electrostatic 
regions, thereby becoming a strong hydrogen-bond acceptor. Both 1:1 and 2:1 
compositions are obtained for co-crystals and hydrates.  When a 1:1 co-crystal/hydrate is 
formed, the correct selectivity is displayed in all four structures, with preference for the 
benzimidazol-1-yl nitrogen atom of the SR (a 100% supramolecular yield).    
     Since these SR’s were specifically designed for the construction of ternary 
supermolecules, structures 51-55 were obtained through the deliberate use of directional 
intermolecular synthetic operations.  Each SR has two binding sites that differ primarily 
in their basicity but neither site is otherwise biased or predisposed towards interacting 
preferentially with either of the two competing carboxylic acids.  The differences in 
basicity are translated into supramolecular reactivity and selectivity that subsequently 
carry over into the solid state, which demonstrates that supramolecular assembly can be 
controlled by fine-tuning individual binding sites.  It seems, therefore, that when the 
basicities of the two heterocycles are significantly different, as in 3-(benzimidazol-1-
yl)methylpyridine and 3-(2-methylbenzimidazol-1-yl)methylpyridine (by about one pKa 
unit), the desired selectivity is witnessed.  This raises the possibility that a solution to the 
problem of making non-covalent one-pot synthesis “sequential” may be to devise 
modular assembly processes based upon a hierarchy of intermolecular interactions 
derived from molecular properties and structural trends. 
     It should be emphasized that ternary co-crystals are extremely rare and that the 
supramolecular reagents presented in this chapter contribute to high-yielding reactions -- 
in a supramolecular sense, this translates to high frequency of occurrence of a particular 
intermolecular binding pattern in the presence of potentially disruptive intermolecular 
interactions.  All four ternary co-crystals obtained in this study display the intended 
selectivity (51-54), a 100% supramolecular yield. 
     The only SR possessing moieties of similar basicities is 3-(2-chlorobenzimidazol-1-
yl)methylpyridine (Scheme 7.1c), with the pyridyl moiety in this case displaying a 
slightly greater basicity than the 2-chlorobenzimidazol-1-yl nitrogen acceptor.  This 
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situation, in principle, may lead to a lack of selectivity in this SR and, consequently, to a 
mixture of supramolecular products in the presence of two different carboxylic acids.20  
The structural selectivity in 55 cannot be ascertained due to disorder about the 4-
cyanobenzoic acid molecule. 
 
7.5 Conclusions  
     The SR’s presented in this chapter were able to form ternary co-crystals with a high 
degree of selectivity and specificity using a “hierarchical” concept of non-covalent 
interactions.  These SR’s will at some point undoubtedly generate results that do not 
acquiesce to the proposed assembly principles.  However, through covalent synthesis we 
have unlimited opportunities for modulating the electronic and geometric details of each 
binding site on a supramolecular reagent such that a variety of chemical functionalities 
can be targeted for binding.  In this way we can build a team of SR’s where each member 
is capable of affecting the assembly of new supermolecules with a high degree of 
specificity and reliability, thereby clearing a path towards practical and transferable 
guidelines for versatile supramolecular synthesis.   We are currently probing the limits 
and limitations of this hierarchical approach to non-covalent synthesis by examining the 
structural reactivity of libraries of supramolecular reagents containing multiple binding 
sites with easily adjustable differences in hydrogen-bonding donating/accepting 
capabilities.  We will therefore continue to investigate this hierarchical strategy in 
Chapters 8 and 9. 
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Chapter 8 
 
A continued study of binary and ternary co-crystals using asymmetric 
supramolecular reagents 
 
 
8.1 Introduction 
 
     As shown in Chapter 7, asymmetric pyridyl/benzimidazol-1-yl supramolecular 
reagents (SR’s) can guide the supramolecular assembly of ternary co-crystals when 
introduced to two carboxylic acids with different pKa values according to the best 
donor/best acceptor, second-best donor/second-best acceptor concept.1  Furthermore, 
imidazol-1-yl- and benzimidazol-1-yl-based SR’s are each capable of forming co-crystals 
with a variety of hydrogen-bond donors (Chapters 3, 5, and 7).  Thus, we reasoned that 
SR’s with both heterocyclic moieties attached to the same backbone could, in principle, 
give rise to ternary supermolecules in the presence of two different carboxylic acids.  In 
this chapter, we will explore the structural selectivity and specificity of asymmetric SR’s 
4-[(benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene, Scheme 8.1a, and 4-[(2-
methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene, Scheme 8.1b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 8.1 Asymmetric SR’s, (a) 4-[(benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene, 
and (b) 4-[(2-methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene. 
NN
N
N
NN
N
N
CH3
pKa 5.72 ± 0.30
pKa 5.94 ± 0.10
pKa 5.94 ± 0.10
pKa 5.82 ± 0.10
(a)
(b)
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As in pyridyl/benzimidazol-1-yl SR’s, the two acceptor sites are uncoupled, which 
provides the opportunity to independently fine-tune their basicities through electron-
donating and electron-withdrawing substituents.  The pKa values of each SR were also 
calculated in the same manner as in Chapter 7,2 but they now in each case indicate a 
much smaller difference in basicity between the two heterocyclic nitrogen sites.  It is still 
useful, however, to determine whether these SR’s can facilitate the formation of ternary 
co-crystals.  Similarly to pyridyl/benzimidazol-1-yl SR’s, the benzimidazol-1-yl moieties 
in each case are linked to a central phenyl ring through a methylene bridge in order to 
enhance solubility. 
     As shown in Chapter 3, a useful indication of co-crystal formation can be obtained 
through IR spectroscopy, particularly the presence of heteromeric O−H···N hydrogen 
bonds between O−H donors and N-heterocyclic moieties.  These relevant interactions 
have been studied in carboxylic acid-pyridine,3 carboxylic acid-benzimidazole,4 and 
carboxylic acid-imidazol-1-yl/benzimidazol-1-yl5 systems, all of which show two 
characteristic broad O−H···N stretches, one between 2600-2500 cm-1, and the other at 
about 1900 cm-1.  Strictly speaking, co-crystal formation could also be driven by other 
intermolecular interactions,6 e.g. π···π stacking, even though the molecular components 
are intended to form heteromeric interactions, and as such the expected IR stretches 
would not be observed.   
     We will carry out IR analyses of binary and ternary co-crystallization experiments 
using 4-[(benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene and 4-[(2-
methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene each with various co-
crystallizing agents to detect the presence of these “marker” bands.  Through these 
analyses we will determine the supramolecular yields (the frequency or occurrence of 
O−H···N hydrogen-bond formation in each set of experiments) of the two SR’s and, thus, 
attempt to establish their supramolecular efficiencies. 
 
8.2 Experimental 
 
8.2.1 Synthesis 
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All starting materials were obtained from Aldrich and used without further purification. 
Melting points were determined on a Fisher-Johns melting point apparatus and are 
uncorrected.   
 
8.2.1.1 Synthesis of 4-[(benzimidazol-1-yl)methyl]-bromobenzene 
 
Benzimidazole (1.42 g, 12.0 mmol) was dissolved in 100 mL of dry THF with stirring at 
room temperature in a 250 mL round-bottomed flask.  To this solution was added NaOH 
pellets (6.40 g, 160 mmol), and the reaction mixture was stirred for 2 h under a N2 
atmosphere.  4-Bromobenzyl bromide (3.00 g, 12.0 mmol) was then added all at once to 
the reaction mixture to immediately produce a white suspension.  This mixture was 
stirred for 12 h at room temperature under a N2 atmosphere.  Distilled water (100 mL) 
was then added to it to dissolve excess NaOH pellets and NaBr that had formed during 
the reaction, and formed two layers, which were separated by using a separatory funnel.  
The THF layer was dried over anhydrous Na2SO4 overnight, the Na2SO4 filtered by 
vacuum filtration, and the filtrate concentrated via rotary evaporation to give the crude 
product as an off-white solid.  The crude product was then washed with cold distilled 
water and dried to afford the pure product as a pale yellow solid.  Yield 2.97 g (86.2%); 
m.p. 83-85˚C; 1H NMR (DMSO-d6, 400 MHz) δ 5.49 (s, 2H), 7.20 (m, 2H), 7.26 (d, 2H, 
J = 8.4 Hz), 7.49 (m, 1H), 7.53 (d, 2H, J = 8.4 Hz), 7.66 (m, 1H), 8.40 (s, 1H).    
 
8.2.1.2 Synthesis of 4-[(2-methylbenzimidazol-1-yl)methyl]-bromobenzene 
 
2-Methylbenzimidazole (1.59 g, 12.0 mmol) was dissolved in 100 mL of dry THF with 
stirring at room temperature in a 250 mL round-bottomed flask.  To this solution was 
added NaOH pellets (6.40 g, 160 mmol) and the resulting mixture stirred for 2 h under a 
N2 atmosphere.  4-Bromobenzyl bromide (3.00 g, 12.0 mmol) was then added all at once 
to the reaction mixture upon which a pale yellow suspension formed immediately.  
Stirring was continued for 12 h at room temperature under a N2 atmosphere.  Distilled 
water (100 mL) was then added to the mixture to dissolve the excess NaOH pellets, as 
well as NaBr that had formed during the reaction, to produce two layers.  These layers 
were separated using a separatory funnel and the THF layer dried over anhydrous Na2SO4 
overnight.  The Na2SO4 was filtered by vacuum filtration and the pale yellow filtrate was 
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concentrated via rotary evaporation to afford the pure product as a pale yellow-brown 
syrup, which turned into a microcrystalline pale yellow-brown solid.  Yield 2.81 g 
(78.1%); m.p. 66-70˚C; 1H NMR (DMSO-d6, 400 MHz) δ 2.50 (s, 3H), 5.44 (s, 2H), 7.07 
(d, 2H, J = 8.8 Hz), 7.15 (m, 2H), 7.43 (m, 1H), 7.52 (d, 2H, J = 8.4 Hz), 7.55 (m, 1H). 
 
8.2.1.3 Synthesis of 4-[(benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene7 
 
4-[(Benzimidazol-1-yl)methyl]-bromobenzene (5.00 g, 17.4 mmol) was dissolved in 25 
mL of anhydrous 1,4-dioxane with stirring in a 100 mL three-necked flask under a N2 
atmosphere.  Imidazole (1.42 g, 20.9 mmol), anhydrous K2CO3 (5.06 g, 36.6 mmol), 
trans-1,2-cyclohexanediamine (0.40 g, 3.49 mmol), and CuI (0.33 g, 1.74 mmol) were 
then added to the reaction mixture, which immediately formed a bright blue suspension.  
This mixture was heated and stirred at 110˚C under a N2 atmosphere and continuously 
monitored by TLC.  After 5 days, the reaction mixture was cooled to room temperature 
and purified by column chromatography using silica gel (200-425 mesh), and ethyl 
acetate : hexanes 1:3, 1:2, and ethyl acetate as eluents.  Rotary evaporation of the ethyl 
acetate fractions yielded the pure product as a dark brown solid.  Yield 1.03 g (21.6%); 
m.p. 125-130˚C; 1H NMR (DMSO-d6, 400 MHz) δ 5.55 (s, 2H), 7.08 (s, 1H), 7.20 (m, 
2H), 7.46 (d, 2H, J = 8.8 Hz), 7.56 (m, 1H), 7.62 (d, 2H, J = 8.4 Hz), 7.66 (m, 1H), 7.70 
(s, 1H), 8.21 (s, 1H), 8.45 (s, 1H).    
 
8.2.1.4 Synthesis of 4-[(2-methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene7 
 
4-[(2-Methylbenzimidazol-1-yl)methyl]-bromobenzene (1.00 g, 3.32 mmol) was 
dissolved in 3.4 mL of anhydrous 1,4-dioxane with stirring in a 100 mL three-necked 
flask under a N2 atmosphere.  To this solution was added imidazole (0.27 g, 3.99 mmol), 
anhydrous K2CO3 (0.96 g, 6.98 mmol), trans-1,2-cyclohexanediamine (0.08 g, 0.66 
mmol), and CuI (0.03 g, 0.17 mmol).  The suspension turned bright blue and was heated 
and stirred at 110˚C under a N2 atmosphere.  Monitoring by TLC indicated that the 
reaction was complete after 72 h, and at this point the dark brown reaction mixture was 
cooled to room temperature.  The mixture was then diluted with 3 mL of ethyl acetate 
and filtered through a plug of silica gel with continuous amounts of ethyl acetate until the 
filtrate turned colorless.  The filtrate was then concentrated by rotary evaporation to give 
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the crude product.  Purification of the crude product by column chromatography using 
silica gel (200-425 mesh) and ethyl acetate : hexanes 1:1, 3:1, and ethyl acetate, followed 
by concentration of the ethyl acetate fractions by rotary evaporation gave the pure 
product as a pale brown solid.  Yield 0.22 g (22.5%); m.p. 95-98˚C; 1H NMR (DMSO-d6, 
400 MHz) δ 2.54 (s, 3H), 5.52 (s, 2H), 7.08 (s, 1H), 7.16 (m, 2H), 7.25 (d, 2H, J = 8.4 
Hz), 7.49 (m, 1H), 7.56 (m, 1H), 7.60 (d, 2H, J = 8.8 Hz), 7.69 (s, 1H), 8.20 (s, 1H). 
 
8.2.2 General procedure for syntheses of binary co-crystals 
 
4-[(Benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene and either a carboxylic acid, 
oxime, carboxamide, or bis-phenol were combined in a 1:1 molar ratio and dissolved in a 
minimum amount of absolute ethanol.  Amorphous solids were obtained after about two 
weeks of slow evaporation of the solvent, and examined by IR spectroscopy. 
 
8.2.3 General procedure for syntheses of ternary co-crystals 
 
4-[(2-Methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene was added to ethanolic 
solutions each containing two different carboxylic acids in 1:1:1 stoichiometries, and the 
resulting solutions allowed to evaporate under ambient conditions.  Amorphous solids 
were afforded after about two weeks, and characterized by IR spectroscopy. 
 
8.2.4 Infrared spectroscopy of binary and ternary co-crystals 
 
All samples were prepared for IR analysis as KBr discs.  IR spectroscopy of co-crystals 
was performed using a Protégé™ 460 E.S.P.™ FT-IR spectrometer,8 and the data 
analyzed with the Nicolet OMNIC® software8 between 4000 and 400 cm-1.  
 
8.3 Results 
 
     Table 8.1 summarizes the O−H···N hydrogen-bond IR bands of binary and ternary co-
crystallization experiments carried out using 4-[(benzimidazol-1-yl)methyl]-imidazol-1-
ylbenzene and various co-crystallizing agents.  Table 8.2 incorporates the O−H···N 
hydrogen-bond IR frequencies of ternary co-crystallization experiments with 4-[(2-
methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene and two different co-
crystallizing agents. 
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Table 8.1 IR data for binary and ternary co-crystallization experiments carried out using 
4-[(benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene and several co-crystallizing agents. 
 
 
Experiment Compound A Compound B ν O−H···N (cm-1) 
1 3,5-dinitrobenzoic acid9 − − 
2 4-nitrobenzoic acid − 2578, 1942 
3 2,3-dimethylbenzoic acid − 2511, 1942 
4 succinic acid − 2589, 1918 
5 4-bromophenyl-acetyloxime − − 
6 3,5-dinitrobenzamide10 − − 
7 resorcinol − − 
8 3,5-dinitrobenzoic acid 4-nitrobenzoic acid 2444, 1918 
9 3,5-dinitrobenzoic acid 3-N,N-
dimethylamino-
benzoic acid 
2499, 1918 
10 3-nitrobenzoic acid 4-cyanobenzoic acid 2509, 1918 
 
 
Table 8.2 IR data for ternary co-crystallization experiments with 4-[(2-
methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene and various co-crystallizing 
agents. 
 
 
Experiment Compound A Compound B ν O−H···N (cm-1) 
11 3,5-dinitrobenzoic acid 4-cyanobenzoic acid 2427, 1918  
12 4-nitrobenzoic acid 4-cyanobenzoic acid 2444, 1942 
13 4-nitrobenzoic acid 3-N,N-
dimethylaminobenzoic 
acid 
2443, 1918 
14 4-nitrobenzoic acid 3-hydroxycinnamic acid 2441, 1902 
15 4-cyanobenzoic acid 3-N,N-
dimethylaminobenzoic 
acid 
2450, 1932 
16 4-cyanobenzoic acid 3,5-dimethylbenzoic acid 2443, 1918 
17 4-cyanobenzoic acid 4-chlorobenzoic acid 2473, 1932 
18 2-fluorobenzoic acid 4-hydroxy-3-
methoxycinnamic acid 
2583, 1918 
19 2-fluorobenzoic acid 3-N,N-
dimethylaminobenzoic 
acid 
2484, 1918 
20 3-N,N-
dimethylaminobenzoic acid
4-bromophenyl-
acetyloxime 
− 
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Table 8.2 (continued) IR data for ternary co-crystallization experiments with 4-[(2-
methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene and various co-crystallizing 
agents. 
 
Experiment Compound A Compound B ν O−H···N (cm-1) 
21 3,5-dinitrobenzoic acid 4-chlorobenzoic acid − 
22 3,5-dinitrobenzoic acid 4-nitrobenzoic acid 2491, 1918 
23 3,5-dinitrobenzoic acid 3-N,N-
dimethylaminobenzoic 
acid 
2613, 1918 
24 3,5-dinitrobenzoic acid 4-N,N-
dimethylaminobenzoic 
acid 
− 
25 4-nitrobenzoic acid 4-N,N-
dimethylaminobenzoic 
acid 
− 
26 4-cyanobenzoic acid 4-N,N-
dimethylaminobenzoic 
acid 
2560, 1918 
27 3,5-dinitrobenzoic acid 3-iodobenzoic acid 2591, 1918 
28 3,5-dinitrobenzoic acid 3-cyanobenzoic acid 2527, 1918 
29 4-iodobenzoic acid pentamethylbenzoic 
acid 
2492, 1942 
30 3,5-dinitrobenzoic acid pentamethylbenzoic 
acid 
2530, 1918 
31 4-nitrobenzoic acid pentamethylbenzoic 
acid 
2478, 1942 
32 4-cyanobenzoic acid pentamethylbenzoic 
acid 
2474, 1942 
33 3,5-dinitrobenzoic acid 2,3-dimethylbenzoic 
acid 
− 
34 4-nitrobenzoic acid 2,3-dimethylbenzoic 
acid 
2512, 1900 
35 4-cyanobenzoic acid 2,3-dimethylbenzoic 
acid 
2468, 1942 
36 3-nitrobenzoic acid 4-cyanobenzoic acid 2498, 1942 
37 2-nitrobenzoic acid 4-cyanobenzoic acid 2490, 1942 
38 3,5-dinitrobenzoic acid 3-nitrobenzoic acid 2499, 1918 
 
8.4 Discussion 
 
     IR analyses of both binary and ternary co-crystallization experiments involving both 
SR’s and various co-crystallizing agents did provide an indication of co-crystal formation  
via the presence of characteristic broad O−H···N stretches between 2613-2427 cm-1 and 
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1942-1900 cm-1.  These bands fall within the range of typical values addressed in 
previous studies (2600-2500 cm-1 and ca. 1900 cm-1).3,4,5  These bands do not allow us to 
distinguish between binary and ternary co-crystals, since the differences in stretching 
frequencies of the two distinct heteromeric O−H···N interactions are not expected to be 
significant.  We can state, however, that in IR spectra of ternary co-crystallization 
experiments displaying these bands, at least a binary co-crystal had formed.  In the case 
of binary co-crystallization experiments, the presence of O−H···N stretches in their IR 
spectra directly points to the formation of the desired co-crystal. 
     The IR spectrum of ternary co-crystallization experiment 29 (also see Table 8.2), 
comprising 4-[(2-methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene, 4-iodobenzoic 
acid, and pentamethylbenzoic acid, is a typical example of an IR spectrum containing the 
two O−H···N stretches indicative of co-crystal formation, Figure 8.1. 
 
 
 
Figure 8.1 IR spectrum of a ternary co-crystallization attempt indicative of co-crystal 
formation involving 4-[(2-methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene, 4-
iodobenzoic acid, and pentamethylbenzoic acid, 29, pointing out to the two broad 
O−H···N bands at 2492 cm-1 and 1942 cm-1. 
 
     Having established co-crystal formation by IR spectroscopy, the supramolecular yield 
of 4-[(benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene was determined.  IR spectra 
containing the SR 4-[(benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene (Table 8.1) 
shows successful co-crystal formation in six out of the total ten attempts, equating to a 
2492
1942
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60% supramolecular yield.  This yield includes attempts with 4-
bromophenylacetyloxime, 5; 3,5-dinitrobenzamide, 6; and resorcinol, 7.  None of these 
compounds formed co-crystals, which may be the reason why they are not popular 
choices as hydrogen-bond donors for N-heterocycles.  On the other hand, the use of 
carboxylic acids gave rise to all six co-crystals, which emphasizes why such 
supramolecular synthons have become successful in organic crystal engineering.  Similar 
results were obtained in Chapter 3, whereby bis-imidazol-1-yl/benzimidazol-1-yl SR’s, 
given a choice for co-crystal formation with carboxylic acids, oximes, or carboxamides, 
showed a clear preference for binary co-crystal formation with carboxylic acids. 
     Attempts at forming binary and ternary crystalline samples suitable for X-ray 
crystallography with 4-[(benzimidazol-1-yl)methyl]-imidazol-1-ylbenzene and 4-[(2-
methylbenzimidazol-1-yl)methyl]-imidazol-1-ylbenzene, each with several co-
crystallizing agents, proved futile.  It is not likely that the failure to produce single 
crystals is due to the solubility of the SR’s, since they are comparatively soluble to the 
pyridyl/benzimidazol-1-yl SR’s.  However, the pKa differences of the heterocyclic 
moieties in each SR may not be sufficient for them to display the intended selectivity (see 
Schemes 8.1a and 8.1b).  It is possible, therefore, that a mixture of products for both 
binary and ternary (three and eight possible combinations respectively) co-
crystallizations was obtained, Schemes 8.2 and 8.3 respectively. 
 
 
 
 
 
  
 
 
 
 
Scheme 8.2 Possible combinations in binary experiments involving imidazol-1-yl-
benzimidazol-1-yl SR’s and co-crystallizing agents. 
 
= SR
= co-crystallizing agent
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Scheme 8.3 Possible combinations in ternary experiments involving imidazol-1-yl-
benzimidazol-1-yl SR’s and co-crystallizing agents. 
 
The possible presence of these impurities could prevent the formation of suitable crystals 
and, as a result, the structural selectivity and specificity of each SR for the co-
crystallizing partner(s) remains unknown. 
     We attempted to employ other means of characterization such as TLC and powder 
XRD in order to obtain useful information about the compositions of the co-
crystallization experiments, but they could not be used due to the amorphous and/or oily 
nature of these products.  TLC could not provide accurate information about the number 
of components present in these solids, while powder XRD analysis could not distinguish 
between the formations of binary or ternary compounds.       
      
8.5 Conclusions 
 
     The supramolecular reactions between two asymmetric imidazol-1-yl/benzimidazol-1-
yl-based SR’s and a variety of hydrogen-bond donors were determined by IR 
spectroscopy.  This study provides an alternative yet useful approach to understanding 
the solid-state behavior of the various components, and may become a reliable screening 
= SR
= co-crystallizing agent A
= co-crystallizing agent B
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method for determining co-crystal formation when presented with a multitude of 
individual supramolecular reactions.   
     Although the two SR’s employed in this study did not produce crystalline samples, 
and did not allow us to explore their structural selectivities and specificities for the donor 
compounds involved, they can still be fine-tuned such that a greater difference between 
the two acceptor sites is achieved.  
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Chapter 9 
 
The quest for quaternary co-crystals 
 
9.1 Introduction 
 
     In Chapter 7 it was demonstrated that SR’s containing two distinct heterocyclic 
moieties can give rise to ternary co-crystals with predictable connectivities when 
combined with two different monocarboxylic acids.1  The stronger carboxylic acid 
interacts with the more basic site while the weaker acid engages in hydrogen bonding 
with the less basic hydrogen-bond acceptor and, thus, follows the best donor-best 
acceptor, second best donor-second best acceptor guidelines.  With this success, we 
reasoned that our hierarchical approach could result in a even higher level of complexity 
by designing a SR containing three different hydrogen-bond acceptor sites with the goal 
of making quaternary co-crystals, through a combination of heterocycles utilized in 
Chapters 7 and 8 (pyridine, benzimidazole, and imidazole), Scheme 9.1. 
 
                                     
N
N
N
N
N
H3C
pKa 3.52 ± 0.30
pKa 5.59 ± 0.69
pKa 4.87 ± 0.10  
 
Scheme 9.1 Proposed strategy for quaternary supermolecules based upon an asymmetric 
SR, 3-[2-(2-methylimidazol-1-yl)benzimidazol-1-yl]-methylpyridine. 
 
     The basicities of these binding sites are in the order 2-methylimidazol-1-yl > pyridyl > 
benzimidazol-1-yl.2  This SR is capable of forming co-crystals, since the binding sites 
possess reasonably different basicities, and the basicity of each heterocycle can be 
independently tuned through various substituents.   
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     It was shown in previous chapters (i.e. Chapters 3, 4, and 7) that each heterocyclic 
moiety present in this SR is readily able to form co-crystals with carboxylic acids through 
reliable and robust heteromeric O−H···N hydrogen bonds.1,3  This SR may also have the 
added benefit of good solubility in an array of polar solvents through a bridging 
methylene group, and this attribute is an important requirement for possible co-crystal 
formation. 
     A helpful starting point in understanding the hierarchical nature of intermolecular 
forces possible in this SR is to form binary co-crystals, since in Chapter 7 it was observed 
in 1:1 co-crystals that a single carboxylic acid, when given the choice of two different 
binding sites, preferentially hydrogen-bonds to the best acceptor.  In this chapter, 
therefore, we will first attempt to generate binary co-crystals in order to begin exploring 
the structural selectivity and specificity of this SR, and consequently carry out co-
crystallization experiments involving the SR and three different carboxylic acids with the 
ultimate goal of producing quaternary co-crystals with predictable connectivities.    
 
9.2 Experimental 
 
9.2.1 Synthesis 
 
All starting materials were obtained from Aldrich and used without further purification.  
The synthesis of 3-(2-chlorobenzimidazol-1-yl)methylpyridine is reported in Chapter 7.  
Melting points were determined on a Fisher-Johns melting point apparatus and are 
uncorrected.   
 
9.2.1.1 Synthesis of 3-[2-(2-methylimidazol-1-yl)benzimidazol-1-yl]-methylpyridine 
 
2-Methylimidazole (2.02 g, 24.6 mmol) was dissolved in 60 mL of anhydrous DMF with 
stirring in a 500 mL three-necked flask under a N2 atmosphere.  To the clear, colorless 
solution was added NaH (1.18 g, 49.2 mmol) inside a glove bag under a N2 atmosphere 
whereupon effervescence was observed.  Once fizzing had subsided, the white cloudy 
suspension was heated and stirred under reflux for 1 h under a N2 atmosphere.  A solution 
containing 3-(2-chlorobenzimidazol-1-yl)methylpyridine (6.00 g, 24.6 mmol) in 120 mL 
of anhydrous DMF was added dropwise to the dark brown mixture using a dropping 
funnel, and the resulting mixture turned dark yellow-brown.  This mixture was then 
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heated and stirred under reflux under a N2 atmosphere, and the reaction progress followed 
by TLC.  After 48 h, the deep brown reaction mixture was cooled to room temperature, 
the NaCl that formed during the reaction filtered via vacuum filtration, and the clear dark 
brown filtrate concentrated by rotary evaporation to obtain the crude product as a thick 
brown syrup.  The crude product was purified by column chromatography using silica gel 
(200-425 mesh) and hexanes : ethyl acetate 5:1, 3:1, and 1:1, followed by ethyl acetate as 
eluents.  Rotary evaporation of the ethyl acetate fractions afforded the desired product as 
a pale yellow microcrystalline solid.  This solid was then washed with hexanes : ethyl 
acetate 3:2 (75 mL : 50 mL) with heat and the off-white solid isolated via vacuum 
filtration.  The off-white solid was further washed with small portions of hexanes, dried, 
and collected to give the pure product.  Slow evaporation of a 1 mL ethyl acetate solution 
containing 0.03 g of the pure product yielded colorless blocks after 2 days.  Yield 4.84 g 
(68.1%); m.p. 115-117˚C; 1H NMR (DMSO-d6, 400 MHz) δ 2.00 (s, 3H), 5.41 (s, 2H), 
7.04 (d, 1H, J = 1.6 Hz), 7.28 (dd, 2H, J1 = 3.4 Hz, J2 = 1.6 Hz), 7.38 (m, 2H), 7.59 (d, 
1H, J = 1.2 Hz), 7.76 (d, 1H, J = 7.6 Hz), 7.81 (d, 1H, J = 8 Hz), 8.18 (s, 1H), 8.46 (t, 1H, 
J = 3 Hz). 
 
9.2.2 Syntheses of co-crystals 
 
9.2.2.1 Synthesis of 3-[2-(2-methylimidazol-1-yl)benzimidazol-1-yl]-methylpyridine 4-
nitrobenzoic acid, 56 
 
4-Nitrobenzoic acid (0.012 g, 0.069 mmol) was dissolved in 2 mL of absolute ethanol.  
To this solution was added an ethanolic solution (1 mL) containing 3-[2-(2-
methylimidazol-1-yl)benzimidazol-1-yl]-methylpyridine (0.020 g, 0.069 mmol), and the 
resulting mixture allowed to stand under ambient conditions.  Slow evaporation of the 
solvent produced colorless plates, 56, after 12 days.  M.p. 163-166˚C.  
 
9.2.3 Infrared spectroscopy of co-crystals 
 
     All samples were prepared for IR analysis as KBr discs.  IR spectroscopy of co-
crystals was performed using a Protégé™ 460 E.S.P.™ FT-IR spectrometer,4 and the data 
analyzed with the Nicolet OMNIC® software4 between 4000 and 400 cm-1. 
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9.2.4 X-ray crystallography 
 
     X-ray data were collected on a Bruker SMART 1000 four-circle CCD diffractometer 
using a fine-focus molybdenum Kα tube.  Data were collected using SMART.5  Initial 
cell constants were found by small widely separated “matrix” runs.  Preliminary Laué 
symmetry was determined from axial images.  Generally, an entire hemisphere of 
reciprocal space was collected regardless of Laué symmetry. Scan speed and scan width 
were chosen based on scattering power and peak rocking curves. Unless otherwise noted, 
data were collected at low temperatures, using a scan width appropriate for the crystal’s 
mosaic spread. 
     Unit cell constants and orientation matrix were improved by least-squares refinement 
of reflections thresholded from the entire dataset. Integration was performed with 
SAINT,6 using this improved unit cell as a starting point. Precise unit cell constants were 
calculated in SAINT from the final merged dataset. Lorenz and polarization corrections 
were applied. Laué symmetry, space group, and unit cell contents were found with 
XPREP. 
     Data were reduced with SHELXTL.7  The structure was solved by direct methods 
without incident.  In general, hydrogens were assigned to idealized positions and were 
allowed to ride.  Where possible, the coordinates of hydrogen-bonding hydrogens were 
allowed to refine. Heavy atoms were refined with anisotropic thermal parameters. 
 
9.3 Results 
 
     Crystallographic data for 56 are given in Table A56, the hydrogen-bond geometries in 
Table 9.1, and the thermal ellipsoid plot (50% probability level) and labeling scheme 
shown in Figure 9.1.  IR data for 56 and a few quaternary co-crystallization reactions are 
displayed in Table 9.2. 
 
Table 9.1 Hydrogen-bond geometries for 56. 
 
 
Compound D-H A D-H/Å H...A/Å D...A/Å <(DHA)/° generator for A 
56 O41 H41 N31 
O51 H51 N23 
0.95(3) 
0.98(3) 
1.66(4) 
1.74(3) 
2.606(3) 
2.709(3) 
176(3) 
170(3) 
− 
− 
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Table 9.2 IR data for products from quaternary co-crystallization reactions involving 3-
[2-(2-methylimidazol-1-yl)benzimidazol-1-yl]-methylpyridine and carboxylic acids. 
 
 
Compound Acid A Acid B Acid C ν O−H···N (cm-1) 
56 4-nitrobenzoic acid − − 2456, 1889 
− 3,5-dinitrobenzoic acid 4-nitrobenzoic acid 4-cyanobenzoic acid 2460, 1904 
− 4-nitrobenzoic acid 4-cyanobenzoic acid 3-hydroxybenzoic 
acid 
2453, 1905 
 
 
9.3.1 Crystal structure of 3-[2-(2-methylimidazol-1-yl)benzimidazol-1-yl]-methylpyridine 
4-nitrobenzoic acid, 56 
 
     The crystal structure of 56 shows a 1:2 co-crystal consisting of 3-[2-(2-
methylimidazol-1-yl)benzimidazol-1-yl]-methylpyridine and 4-nitrobenzoic acid 
respectively, Figure 9.1.  One 4-nitrobenzoic acid molecule interacts with the most basic 
site, the 2-methylimidazol-1-yl nitrogen atom, via an O−H···N hydrogen bond 
(O51···N23, 2.709(3) Å), while a second carboxylic acid forms an O−H···N hydrogen 
bond with the second-best acceptor, the pyridyl moiety (O41···N31, 2.606(3) Å).  The 
benzimidazol-1-yl nitrogen atom, however, is not involved in any significant interactions.  
The two carboxylic acids are arranged in a parallel manner, and are separated by about 
3.6 Å. 
 
            
 
Figure 9.1 Binary co-crystal in 56. 
 
9.4 Discussion 
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     The SR 3-[2-(2-methylimidazol-1-yl)benzimidazol-1-yl]-methylpyridine was prepared 
according to a two-step procedure in good yield, and displays good solubility in a range 
of polar solvents.  Its solubility was compatible with those of most aromatic carboxylic 
acids used in binary and quaternary co-crystallization experiments, and as such provided 
an opportunity for co-crystal formation. 
     A 1:2 co-crystal was obtained in 56 when 1:1 molar equivalents of the SR and 4-
nitrobenzoic acid, respectively, were combined.  Even though there is only one data point 
available to date, the crystal structure of 56, however, provides an encouraging result in 
that the two carboxylic acids showed preference for the best and second-best hydrogen-
bond acceptors (the 2-methylimidazol-1-yl and pyridyl moieties respectively) over the 
other two possible binding options (a 33% probability).  A hierarchy of hydrogen bonds 
is therefore observed in the crystal structure. 
     Co-crystallization reactions were subsequently carried out with the aim of producing 
quaternary supermolecules.  In each case, three carboxylic acids and the SR were 
combined in a 1:1:1:1 ratio.  Although no structural information has been obtained yet 
from the crystals produced (in most cases), TLC8 and IR analyses were performed on 
individual crystallites of a few reactions in an attempt to determine the number of 
components present as well as possible co-crystal formation.  The IR data for the two 
quaternary co-crystallization reactions in Table 9.2 shows the two broad O−H···N bands 
at around 2460 and 1900 cm-1, but this information does not indicate whether a binary, 
ternary or quaternary co-crystal had formed. 
 
9.5 Conclusions and future work 
 
     We have shown that an asymmetric tritopic SR, 3-[2-(2-methylimidazol-1-
yl)benzimidazol-1-yl]-methylpyridine, is capable of forming a 1:2 binary co-crystal with 
4-nitrobenzoic acid, and also that the two acids in this crystal structure form hydrogen 
bonds according to the proposed supramolecular assembly guidelines.  It is therefore 
possible that this SR can act as a central hub for the formation of quaternary co-crystals 
with structural selectivity and specificity. 
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     A few possible candidates as SR’s for quaternary supermolecules may be prepared 
through the use of a combination of heterocycles possessing independently tunable 
binding sites, Scheme 9.2 and Table 9.3. 
 
 
 
 
 
 
 
 
 
Scheme 9.2 A few possible SR’s for the directed assembly of quaternary supermolecules. 
 
Table 9.3 Calculated pKa values2 of a few possible SR’s for quaternary supermolecules. 
 
SR pKa of R1 pKa of R2 pKa of R3 
1  
 
 
 
imidazol-1-yl, 6.77 ± 0.12 
 
 
 
 
pyrazol-1-yl, 1.78 ± 0.19 
 
 
 
 
benzimidazol-1-yl, 5.53 ± 0.12 
2  
 
 
 
imidazol-1-yl, 6.76 ± 0.12 
 
 
 
 
pyrazol-1-yl, 1.75 ± 0.19 
 
 
 
 
 
2-chlorobenzimidazol-1-yl, 3.86 ± 
0.34 
3  
 
 
 
imidazol-1-yl, 6.77 ± 0.12  
 
 
 
 
3-methylpyrazol-1-yl, 2.29 
± 0.50 
 
 
 
 
 
benzimidazol-1-yl, 5.54 ± 0.30 
4  
 
 
 
4-nitroimidazol-1-yl, 0.02 ± 
0.61 
 
 
 
 
 
indazol-1-yl, 1.10 ± 0.40 
 
 
 
 
 
2-chlorobenzimidazol-1-yl, 3.87 ± 
0.34 
5  
 
 
 
imidazol-1-yl, 6.72 ± 0.12  
 
 
 
 
 
7-azaindol-1-yl, 5.10 ± 
0.30 
 
 
 
 
 
2-chlorobenzimidazol-1-yl, 3.83 ± 
0.34 
CH3
CH3
H3C
R1
R2
R3
N N
N N
N N
N N
N N
NO2
N N
N N
N N
H3C
N N
N N
NN
NN
NN
Cl
NN
Cl
NN
Cl
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     Much work lies ahead in the quest for quaternary and higher-order supermolecules, 
which can only be achieved through a modular, systematic, and transferable non-covalent 
synthetic approach.  We are currently exploring the limits and limitations of our 
supramolecular strategy by designing and preparing a library of SR’s that contain 
different binding sites. 
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ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Jun 22 2002  dfrq       399.842
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju0621i~ dm             nnn
midazoleligandpure~ dmm              c
              .fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.842  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  lb            0.30
sw          6000.6  wtfile            
fb            3400  proc            ft
bs               4  fn           32768
tpwr            55  math             f
pw             7.0
d1           2.000  werr              
tof              0  wexp              
nt              16  wbs               
ct              16  wnt               
alock            n
gain      not used
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -992.9
wp          6000.6
vs             157
sc               0
wc             250
hzmm         24.00
is          106.94
rfl         1992.5
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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N
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N
 
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Sep 18 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju09180~ dm             nnn
   3-13bixpure.fid  dmm              c
   ACQUISITION      dmf            200
sfrq       399.822  dseq              
tn              H1  dres           1.0
at           3.701  homo             n
np           44416      PROCESSING
sw          6000.6  wtfile            
fb            3400  proc            ft
bs               4  fn           32768
tpwr            55  math             f
pw            19.8
d1           1.000  werr              
tof              0  wexp              
nt               4  wbs               
ct               4  wnt               
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -981.6
wp          6000.6
vs             160
sc               0
wc             250
hzmm         24.00
is         2358.04
rfl         1981.2
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Sep 19 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju09190~ dm             nnn
  3-2Mebixpure.fid  dmm              c
   ACQUISITION      dmf            200
sfrq       399.822  dseq              
tn              H1  dres           1.0
at           3.701  homo             n
np           44416      PROCESSING
sw          6000.6  wtfile            
fb            3400  proc            ft
bs               4  fn           32768
tpwr            55  math             f
pw            19.8
d1           1.000  werr              
tof              0  wexp              
nt               4  wbs               
ct               4  wnt               
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -981.6
wp          6000.6
vs             117
sc               0
wc             250
hzmm         24.00
is         2026.96
rfl         1981.2
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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N
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ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Aug 27 2002  dfrq       199.980
solvent       DMSO  dn              H1
file /export/home/~ dof              0
chemnmr/Gemini Dat~ dm             nnn
a/Aakeroy/ju0827-b~ dmm              c
is-benzimidazolepu~ dmf            200
            re.fid      PROCESSING
   ACQUISITION      wtfile            
sfrq       199.980  proc            ft
tn              H1  fn        not used
at           1.994
np           11968  werr              
sw          3000.3  wexp              
fb            1500  wbs               
bs              16  wnt               
pw             7.0
d1           2.000
tof              0
nt              16
ct              16
alock            n
gain      not used
      FLAGS
il               n
in               n
dp               y
     DISPLAY
sp          -496.0
wp          3000.3
vs             142
sc               0
wc             250
hzmm         12.00
is         3503.72
rfl          995.9
rfp          499.9
th              20
ins        100.000
nm  cdc  ph  
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ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Sep 29 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju09290~ dm             nnn
3-3CNbenzylbenzimi~ dmm              c
         dpure.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -980.1
wp          6000.6
vs             718
sc               0
wc             250
hzmm         24.00
is         5087.92
rfl         1979.7
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Sep  8 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju09080~ dm             nnn
3-4CN1Hbenzylbenzi~ dmm              c
           mid.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -981.6
wp          6000.6
vs             693
sc               0
wc             250
hzmm         24.00
is         3673.37
rfl         1981.2
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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NC
N N
CH3
 
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Sep 29 2003  dfrq       399.823
solvent      CD3CN  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju09290~ dm             nnn
3-3CNbenzyl2Mebenz~ dmm              c
     imidcrude.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.823  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -996.7
wp          6000.6
vs             232
sc               0
wc             250
hzmm         24.00
is         2307.28
rfl         1772.4
rfp          775.7
th              20
ins        100.000
nm  cdc  ph  
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CN
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ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Sep  8 2003  dfrq       399.823
solvent      CD3CN  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju09080~ dm             nnn
3-4CN2Mebenzylbenz~ dmm              c
          imid.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.823  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -997.5
wp          6000.6
vs             226
sc               0
wc             250
hzmm         24.00
is         3935.69
rfl         1773.1
rfp          775.7
th              20
ins        100.000
nm  cdc  ph  
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ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   May 27 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            45
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju05270~ dm             nnn
3-3CNbenzyl2Clbenz~ dmm              c
      imidpure.fid  dmf           6100
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            20.0  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain      not used
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -982.3
wp          6000.6
vs             155
sc               0
wc             250
hzmm         24.00
is          149.86
rfl         1981.9
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Sep 11 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju09110~ dm             nnn
3-4CNbenzyl2Clbenz~ dmm              c
      imidpure.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -982.0
wp          6000.6
vs             389
sc               0
wc             250
hzmm         24.00
is         4192.52
rfl         1981.5
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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H2N OC
N N
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   May  5 2005  dfrq       399.796
solvent       DMSO  dn              H1
file           exp  dpwr            30
   ACQUISITION      dof              0
sfrq       399.796  dm             nnn
tn              H1  dmm              c
at           3.701  dmf            200
np           44416  dseq              
sw          6000.6  dres           1.0
fb            3400  homo             n
bs               4      PROCESSING
tpwr            55  wtfile            
pw             6.0  proc            ft
d1           1.000  fn           32768
tof              0  math             f
nt               4
ct               4  werr              
alock            n  wexp              
gain      not used  wbs               
      FLAGS         wnt               
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -992.7
wp          6000.6
vs             153
sc               0
wc             250
hzmm         24.00
is          168.92
rfl         1992.1
rfp          999.5
th              20
ins        100.000
nm  cdc  ph  
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N N
CONH2
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Oct  8 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju10080~ dm             nnn
3-4amidebenzylbenz~ dmm              c
      imidpure.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -980.1
wp          6000.6
vs             769
sc               0
wc             250
hzmm         24.00
is         4172.91
rfl         1979.7
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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H2N OC
N N
CH3
 
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Oct  8 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju10080~ dm             nnn
3-3amidebenzyl2Meb~ dmm              c
   enzimidpure.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -980.1
wp          6000.6
vs             253
sc               0
wc             250
hzmm         24.00
is         5044.96
rfl         1979.7
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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CONH2
N N
CH3
 
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Oct  6 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju10060~ dm             nnn
3-4amidebenzyl2Meb~ dmm              c
   enzimidpure.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -980.1
wp          6000.6
vs             394
sc               0
wc             250
hzmm         24.00
is         4723.57
rfl         1979.7
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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H2N OC
N N
Cl
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Oct  6 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju10060~ dm             nnn
3-3amidebenzyl2Clb~ dmm              c
   enzimidpure.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -980.5
wp          6000.6
vs             733
sc               0
wc             250
hzmm         24.00
is         6664.45
rfl         1980.1
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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N N
Cl
CONH2
 
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Oct  5 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju10050~ dm             nnn
3-4amidebenzyl2Clb~ dmm              c
   enzimidpure.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -980.5
wp          6000.6
vs             845
sc               0
wc             250
hzmm         24.00
is         3633.90
rfl         1980.1
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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N
N
N
 
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Mar  8 2004  dfrq       399.816
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2004/ju03080~ dm             nnn
4-3benzimidazol1yl~ dmm              c
methylpyridinepure~ dmf            200
              .fid  dseq              
   ACQUISITION      dres           1.0
sfrq       399.816  homo             n
tn              H1      PROCESSING
at           3.701  wtfile            
np           44416  proc            ft
sw          6000.6  fn           32768
fb            3400  math             f
bs               4
tpwr            55  werr              
pw            19.8  wexp              
d1           1.000  wbs               
tof              0  wnt               
nt               4
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -987.1
wp          6000.6
vs             148
sc               0
wc             250
hzmm         24.00
is         6261.62
rfl         1986.6
rfp          999.5
th              20
ins        100.000
nm  cdc  ph  
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N
N
N
CH3
 
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Aug 17 2004  dfrq       399.809
solvent      cd3od  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2004/joaquin~ dm             nnn
      _17Aug04.fid  dmm              c
   ACQUISITION      dmf            200
sfrq       399.809  dseq              
tn              H1  dres           1.0
at           3.701  homo             n
np           44416      PROCESSING
sw          6000.6  wtfile            
fb            3400  proc            ft
bs               4  fn           32768
tpwr            55  math             f
pw             6.0
d1           1.000  werr              
tof              0  wexp              
nt             256  wbs               
ct             256  wnt               
alock            n
gain            40
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp         -1000.9
wp          6000.6
vs             418
sc               0
wc             250
hzmm         24.00
is          364.41
rfl         1000.9
rfp              0
th              20
ins        100.000
nm  cdc  ph  
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N
N
N
Cl
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Oct 27 2004  dfrq       399.809
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2004/ju10270~ dm             nnn
4-32Clbenzimidazol~ dmm              c
1ylmethylpyridinep~ dmf            200
           ure.fid  dseq              
   ACQUISITION      dres           1.0
sfrq       399.809  homo             n
tn              H1      PROCESSING
at           3.701  wtfile            
np           44416  proc            ft
sw          6000.6  fn           32768
fb            3400  math             f
bs               4
tpwr            55  werr              
pw            19.8  wexp              
d1           1.000  wbs               
tof              0  wnt               
nt               4
ct               4
alock            n
gain      not used
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -980.9
wp          6000.6
vs             186
sc               0
wc             250
hzmm         24.00
is          358.90
rfl         1980.4
rfp          999.5
th              20
ins        100.000
nm  cdc  ph  
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N
N
N N
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Jan 19 2004  dfrq       399.816
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2004/ju01190~ dm             nnn
4-5benzimidazol1yl~ dmm              c
pyrimidinepure.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.816  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -987.8
wp          6000.6
vs              80
sc               0
wc             250
hzmm         24.00
is        10360.78
rfl         1987.4
rfp          999.5
th              20
ins        100.000
nm  cdc  ph  
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N
Br
N
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Mar  4 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            45
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju0304-~ dm             nnn
  4br-benzimid.fid  dmm              c
   ACQUISITION      dmf           6100
sfrq       399.822  dseq              
tn              H1  dres           1.0
at           3.701  homo             n
np           44416      PROCESSING
sw          6000.6  wtfile            
fb            3400  proc            ft
bs               4  fn           32768
tpwr            55  math             f
pw            20.0
d1           1.000  werr              
tof              0  wexp              
nt               4  wbs               
ct               4  wnt               
alock            n
gain            48
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -980.5
wp          6000.6
vs             166
sc               0
wc             250
hzmm         24.00
is         1340.24
rfl         1980.1
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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N
Br
N
CH3
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Apr  2 2003  dfrq       399.822
solvent       DMSO  dn              H1
file /export/home/~ dpwr            45
chemnmr/aakeroy/Jo~ dof              0
aquin/2003/ju04020~ dm             nnn
3-4Br2Mebenzimid.f~ dmm              c
                id  dmf           6100
   ACQUISITION      dseq              
sfrq       399.822  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            20.0  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain      not used
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -983.4
wp          6000.6
vs             178
sc               0
wc             250
hzmm         24.00
is          332.50
rfl         1983.0
rfp          999.6
th              20
ins        100.000
nm  cdc  ph  
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N
N
N
N
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Mar 20 2004  dfrq       399.816
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2004/ju04010~ dm             nnn
5-imidbenzylbenzim~ dmm              c
           id2.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.816  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  lb            0.50
sw          6000.6  wtfile            
fb            3400  proc            ft
bs               4  fn           32768
tpwr            55  math             f
pw            19.8
d1           1.000  werr              
tof              0  wexp              
nt               4  wbs               
ct               4  wnt               
alock            n
gain            30
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -987.5
wp          6000.6
vs             106
sc               0
wc             250
hzmm         24.00
is         3817.24
rfl         1987.0
rfp          999.5
th              20
ins        100.000
nm  cdc  ph  
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N
N
N
N
CH3
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Apr  1 2005  dfrq       399.803
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2005/ju04010~ dm             nnn
5-imidbenzyl2Meben~ dmm              c
         zimid.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.803  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw            19.8  werr              
d1           1.000  wexp              
tof              0  wbs               
nt              32  wnt               
ct              32
alock            n
gain      not used
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -986.8
wp          6000.6
vs             162
sc               0
wc             250
hzmm         24.00
is          333.60
rfl         1986.3
rfp          999.5
th              20
ins        100.000
nm  cdc  ph  
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N
N
N
N
N
H3C
 
ppm-1-0123456789101112
STANDARD 1H OBSERVE
exp1  std1h
      SAMPLE            DEC. & VT
date   Mar 16 2005  dfrq       399.803
solvent       DMSO  dn              H1
file /export/home/~ dpwr            30
chemnmr/aakeroy/Jo~ dof              0
aquin/2005/ju03160~ dm             nnn
5-quaternary2Meimi~ dmm              c
  dpurelargesc.fid  dmf            200
   ACQUISITION      dseq              
sfrq       399.803  dres           1.0
tn              H1  homo             n
at           3.701      PROCESSING
np           44416  wtfile            
sw          6000.6  proc            ft
fb            3400  fn           32768
bs               4  math             f
tpwr            55
pw             6.0  werr              
d1           1.000  wexp              
tof              0  wbs               
nt               4  wnt               
ct               4
alock            n
gain      not used
      FLAGS
il               n
in               n
dp               y
hs              nn
     DISPLAY
sp          -986.4
wp          6000.6
vs             151
sc               0
wc             250
hzmm         24.00
is          214.44
rfl         1985.9
rfp          999.5
th              20
ins        100.000
nm  cdc  ph  
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Table A1.  Crystal data and structure refinement for 1. 
 
Empirical formula  C78 H54 N12 O18 
Formula weight  1447.33 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.1053(3) Å α= 93.474(3)°. 
 b = 10.2214(4) Å β= 91.530(2)°. 
 c = 19.8293(7) Å γ = 115.155(2)°. 
Volume 1664.58(10) Å3 
Z 1 
Density (calculated) 1.444 g/cm3 
Absorption coefficient 0.105 mm-1 
F(000) 750 
Crystal size 0.40 x 0.30 x 0.05 mm3 
Theta range for data collection 2.06 to 28.27°. 
Index ranges -11<=h<=11, -13<=k<=13, -24<=l<=26 
Reflections collected 12493 
Independent reflections 7441 [R(int) = 0.0412] 
Completeness to theta = 28.27° 90.1 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7441 / 0 / 497 
Goodness-of-fit on F2 0.883 
Final R indices [I>2sigma(I)] R1 = 0.0522, wR2 = 0.1152 
R indices (all data) R1 = 0.1087, wR2 = 0.1352 
Extinction coefficient 0.0194(15) 
Largest diff. peak and hole 0.360 and -0.293 e.Å-3 
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Table A2.  Crystal data and structure refinement for 2. 
 
Empirical formula  C78 H54 N12 O18.30 
Formula weight  1452.13 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.1469(18) Å α= 93.606(4)°. 
 b = 10.239(2) Å β= 91.498(4)°. 
 c = 19.880(4) Å γ = 115.046(4)°. 
Volume 1680.6(6) Å3 
Z 1 
Density (calculated) 1.435 g/cm3 
Absorption coefficient 0.105 mm-1 
F(000) 752 
Crystal size 0.5 x 0.4 x 0.05 mm3 
Theta range for data collection 1.03 to 27.48°. 
Index ranges -11<=h<=11, -13<=k<=13, -25<=l<=25 
Reflections collected 11565 
Independent reflections 7336 [R(int) = 0.0209] 
Completeness to theta = 27.48° 95.1 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7336 / 0 / 500 
Goodness-of-fit on F2 0.918 
Final R indices [I>2sigma(I)] R1 = 0.0472, wR2 = 0.1098 
R indices (all data) R1 = 0.0991, wR2 = 0.1373 
Largest diff. peak and hole 0.240 and -0.238 e.Å-3 
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Table A3.  Crystal data and structure refinement for 3. 
 
Empirical formula  C84 H60 N12 O18 
Formula weight  1525.44 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.5039(15) Å α= 107.274(3)°. 
 b = 14.003(3) Å β= 94.192(4)°. 
 c = 18.931(4) Å γ = 101.419(4)°. 
Volume 1843.3(7) Å3 
Z 1 
Density (calculated) 1.374 g/cm3 
Absorption coefficient 0.099 mm-1 
F(000) 792 
Crystal size 0.30 x 0.20 x 0.20 mm3 
Theta range for data collection 1.57 to 23.85°. 
Index ranges -8<=h<=7, -15<=k<=15, -21<=l<=21 
Reflections collected 8307 
Independent reflections 5593 [R(int) = 0.0254] 
Completeness to theta = 23.85° 98.1 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5593 / 0 / 523 
Goodness-of-fit on F2 0.870 
Final R indices [I>2sigma(I)] R1 = 0.0502, wR2 = 0.1131 
R indices (all data) R1 = 0.1119, wR2 = 0.1354 
Largest diff. peak and hole 0.556 and -0.340 e.Å-3 
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Table A4.  Crystal data and structure refinement for 4. 
 
Empirical formula  C84 H66 N12 O18 
Formula weight  1531.49 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.5699(16) Å α= 106.044(4)°. 
 b = 13.952(3) Å β= 94.194(6)°. 
 c = 19.020(4) Å γ = 101.069(5)°. 
Volume 1877.5(7) Å3 
Z 1 
Density (calculated) 1.354 g/cm3 
Absorption coefficient 0.097 mm-1 
F(000) 798 
Crystal size 0.05 x 0.20 x 0.40 mm3 
Theta range for data collection 1.56 to 27.48°. 
Index ranges -9<=h<=9, -18<=k<=17, -24<=l<=24 
Reflections collected 14505 
Independent reflections 8216 [R(int) = 0.0622] 
Completeness to theta = 27.48° 95.5 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8216 / 0 / 524 
Goodness-of-fit on F2 0.860 
Final R indices [I>2sigma(I)] R1 = 0.0592, wR2 = 0.1391 
R indices (all data) R1 = 0.1321, wR2 = 0.1678 
Extinction coefficient 0.036(2) 
Largest diff. peak and hole 0.389 and -0.340 e.Å-3 
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Table A5.  Crystal data and structure refinement for 5. 
 
Empirical formula  C74 H58 N10 O18 
Formula weight  1375.30 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.5781(17) Å α= 92.884(4)°. 
 b = 9.419(2) Å β= 92.293(6)°. 
 c = 23.145(5) Å γ = 105.501(4)°. 
Volume 1587.4(6) Å3 
Z 1 
Density (calculated) 1.439 g/cm3 
Absorption coefficient 0.105 mm-1 
F(000) 716 
Crystal size 0.28 x 0.12 x 0.08 mm3 
Theta range for data collection 1.76 to 27.47°. 
Index ranges -9<=h<=9, -12<=k<=11, -26<=l<=29 
Reflections collected 10469 
Independent reflections 6717 [R(int) = 0.0775] 
Completeness to theta = 27.47° 92.5 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6717 / 0 / 470 
Goodness-of-fit on F2 1.000 
Final R indices [I>2sigma(I)] R1 = 0.0810, wR2 = 0.1628 
R indices (all data) R1 = 0.1922, wR2 = 0.1838 
Extinction coefficient 0.0171(15) 
Largest diff. peak and hole 0.292 and -0.315 e.Å-3 
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Table A6.  Crystal data and structure refinement for 6. 
 
Empirical formula  C66 H56 N10 O20 
Formula weight  1309.21 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.2958(6) Å α= 85.884(2)°. 
 b = 9.3808(7) Å β= 86.036(2)°. 
 c = 22.8854(17) Å γ = 77.521(2)°. 
Volume 1523.0(2) Å3 
Z 1 
Density (calculated) 1.427 g/cm3 
Absorption coefficient 0.108 mm-1 
F(000) 682 
Crystal size 0.40 x 0.40 x 0.25 mm3 
Theta range for data collection 1.79 to 27.48°. 
Index ranges -8<=h<=9, -11<=k<=10, -29<=l<=29 
Reflections collected 11376 
Independent reflections 6701 [R(int) = 0.0322] 
Completeness to theta = 27.48° 95.6 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6701 / 0 / 443 
Goodness-of-fit on F2 1.084 
Final R indices [I>2sigma(I)] R1 = 0.0445, wR2 = 0.1300 
R indices (all data) R1 = 0.0577, wR2 = 0.1391 
Extinction coefficient 0.047(3) 
Largest diff. peak and hole 0.359 and -0.243 e.Å-3 
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Table A7.  Crystal data and structure refinement for 7. 
 
Empirical formula  C22 H18 N4 
Formula weight  338.40 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 14.7435(5) Å α= 90°. 
 b = 18.5337(5) Å β= 101.685(2)°. 
 c = 12.6624(4) Å γ = 90°. 
Volume 3388.31(18) Å3 
Z 8 
Density (calculated) 1.327 Mg/m3 
Absorption coefficient 0.081 mm-1 
F(000) 1424 
Crystal size 0.35 x 0.30 x 0.20 mm3 
Theta range for data collection 1.79 to 28.29°. 
Index ranges -18<=h<=17, -23<=k<=23, -16<=l<=15 
Reflections collected 12807 
Independent reflections 3982 [R(int) = 0.0543] 
Completeness to theta = 28.29° 94.4 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3982 / 0 / 236 
Goodness-of-fit on F2 0.969 
Final R indices [I>2sigma(I)] R1 = 0.0423, wR2 = 0.1013 
R indices (all data) R1 = 0.0688, wR2 = 0.1152 
Extinction coefficient 0.0141(9) 
Largest diff. peak and hole 0.224 and -0.228 e.Å-3 
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Table A8.  Crystal data and structure refinement for 8. 
 
Empirical formula  C22.80 H22 N4 O1.40 
Formula weight  374.44 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 21.0283(12) Å α= 90°. 
 b = 10.3074(6) Å β= 113.199(4)°. 
 c = 18.9978(11) Å γ = 90°. 
Volume 3784.8(4) Å3 
Z 8 
Density (calculated) 1.314 g/cm3 
Absorption coefficient 0.085 mm-1 
F(000) 1584 
Crystal size 0.35 x 0.30 x 0.25 mm3 
Theta range for data collection 2.11 to 28.30°. 
Index ranges -27<=h<=27, -13<=k<=13, -25<=l<=25 
Reflections collected 13677 
Independent reflections 4412 [R(int) = 0.0651] 
Completeness to theta = 28.30° 93.5 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4412 / 6 / 279 
Goodness-of-fit on F2 0.955 
Final R indices [I>2sigma(I)] R1 = 0.0576, wR2 = 0.1488 
R indices (all data) R1 = 0.1032, wR2 = 0.1708 
Extinction coefficient 0.0106(9) 
Largest diff. peak and hole 0.522 and -0.217 e.Å-3 
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Table A9.  Crystal data and structure refinement for 9. 
 
Empirical formula  C24 H22 N4 
Formula weight  366.46 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 29.5856(12) Å α= 90°. 
 b = 5.3536(2) Å β= 113.442(2)°. 
 c = 12.7407(6) Å γ = 90°. 
Volume 1851.43(13) Å3 
Z 4 
Density (calculated) 1.315 g/cm3 
Absorption coefficient 0.080 mm-1 
F(000) 776 
Crystal size 0.45 x 0.45 x 0.10 mm3 
Theta range for data collection 1.50 to 28.27°. 
Index ranges -37<=h<=38, -7<=k<=7, -16<=l<=16 
Reflections collected 6700 
Independent reflections 2158 [R(int) = 0.0605] 
Completeness to theta = 28.27° 94.3 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2158 / 0 / 128 
Goodness-of-fit on F2 1.043 
Final R indices [I>2sigma(I)] R1 = 0.0430, wR2 = 0.1112 
R indices (all data) R1 = 0.0578, wR2 = 0.1218 
Extinction coefficient 0.032(3) 
Largest diff. peak and hole 0.216 and -0.167 e.Å-3 
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Table A10.  Crystal data and structure refinement for 10. 
 
Empirical formula  C20 H22 N4 O4 
Formula weight  382.42 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 6.3599(9) Å α= 90°. 
 b = 9.7320(14) Å β= 94.874(3)°. 
 c = 15.357(2) Å γ = 90°. 
Volume 947.1(2) Å3 
Z 2 
Density (calculated) 1.341 g/cm3 
Absorption coefficient 0.095 mm-1 
F(000) 404 
Crystal size 0.40 x 0.30 x 0.20 mm3 
Theta range for data collection 2.48 to 28.23°. 
Index ranges -8<=h<=8, -12<=k<=12, -20<=l<=20 
Reflections collected 6970 
Independent reflections 2200 [R(int) = 0.0431] 
Completeness to theta = 28.23° 93.7 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2200 / 0 / 133 
Goodness-of-fit on F2 1.073 
Final R indices [I>2sigma(I)] R1 = 0.0534, wR2 = 0.1219 
R indices (all data) R1 = 0.0709, wR2 = 0.1332 
Largest diff. peak and hole 0.259 and -0.510 e.Å-3 
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Table A11.  Crystal data and structure refinement for 11. 
 
Empirical formula  C18 H18 N4 O4 
Formula weight  354.36 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 5.2226(6) Å α= 90°. 
 b = 13.2875(15) Å β= 93.256(2)°. 
 c = 12.1453(15) Å γ = 90°. 
Volume 841.47(17) Å3 
Z 2 
Density (calculated) 1.399 g/cm3 
Absorption coefficient 0.101 mm-1 
F(000) 372 
Crystal size 0.45 x 0.40 x 0.30 mm3 
Theta range for data collection 2.27 to 28.26°. 
Index ranges -6<=h<=6, -17<=k<=17, -16<=l<=15 
Reflections collected 6268 
Independent reflections 1954 [R(int) = 0.0367] 
Completeness to theta = 28.26° 94.6 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1954 / 0 / 124 
Goodness-of-fit on F2 1.102 
Final R indices [I>2sigma(I)] R1 = 0.0484, wR2 = 0.1153 
R indices (all data) R1 = 0.0575, wR2 = 0.1228 
Largest diff. peak and hole 0.243 and -0.437 e.Å-3 
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Table A12.  Crystal data and structure refinement for 12. 
 
Empirical formula  C18 H20 N4 O4 
Formula weight  356.38 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 5.0725(7) Å α= 90°. 
 b = 13.7671(18) Å β= 91.248(3)°. 
 c = 12.1951(17) Å γ = 90°. 
Volume 851.4(2) Å3 
Z 2 
Density (calculated) 1.390 Mg/m3 
Absorption coefficient 0.101 mm-1 
F(000) 376 
Crystal size 0.40 x 0.40 x 0.25 mm3 
Theta range for data collection 2.23 to 28.19°. 
Index ranges -6<=h<=6, -17<=k<=17, -15<=l<=15 
Reflections collected 6042 
Independent reflections 1917 [R(int) = 0.0370] 
Completeness to theta = 28.19° 91.4 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1917 / 0 / 125 
Goodness-of-fit on F2 1.093 
Final R indices [I>2sigma(I)] R1 = 0.0397, wR2 = 0.1037 
R indices (all data) R1 = 0.0468, wR2 = 0.1083 
Extinction coefficient 0.089(8) 
Largest diff. peak and hole 0.305 and -0.187 e.Å-3 
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Table A13.  Crystal data and structure refinement for 13. 
 
Empirical formula  C22 H20 N4 O4 
Formula weight  404.42 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 28.229(4) Å α= 90°. 
 b = 6.9743(10) Å β= 111.248(3)°. 
 c = 10.8784(15) Å γ = 90°. 
Volume 1996.1(5) Å3 
Z 4 
Density (calculated) 1.346 g/cm3 
Absorption coefficient 0.095 mm-1 
F(000) 848 
Crystal size 0.40 x 0.40 x 0.40 mm3 
Theta range for data collection 1.55 to 28.28°. 
Index ranges -35<=h<=37, -8<=k<=8, -14<=l<=14 
Reflections collected 7250 
Independent reflections 2307 [R(int) = 0.0656] 
Completeness to theta = 28.28° 92.8 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2307 / 0 / 144 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0479, wR2 = 0.1100 
R indices (all data) R1 = 0.0722, wR2 = 0.1237 
Extinction coefficient 0.0343(16) 
Largest diff. peak and hole 0.213 and -0.213 e.Å-3 
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Table A14.  Crystal data and structure refinement for 14. 
 
Empirical formula  C26 H22 N4 O4 
Formula weight  454.48 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 19.6454(17) Å α= 90°. 
 b = 11.7257(11) Å β= 108.704(2)°. 
 c = 10.0116(8) Å γ = 90°. 
Volume 2184.4(3) Å3 
Z 4 
Density (calculated) 1.382 g/cm3 
Absorption coefficient 0.095 mm-1 
F(000) 952 
Crystal size 0.40 x 0.20 x 0.05 mm3 
Theta range for data collection 2.05 to 28.18°. 
Index ranges -23<=h<=25, -15<=k<=14, -13<=l<=13 
Reflections collected 7892 
Independent reflections 2515 [R(int) = 0.0423] 
Completeness to theta = 28.18° 93.4 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2515 / 0 / 161 
Goodness-of-fit on F2 1.023 
Final R indices [I>2sigma(I)] R1 = 0.0439, wR2 = 0.1158 
R indices (all data) R1 = 0.0592, wR2 = 0.1265 
Extinction coefficient 0.0107(16) 
Largest diff. peak and hole 0.275 and -0.210 e.Å-3 
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Table A15.  Crystal data and structure refinement for 15. 
 
Empirical formula  C25 H22 N4 O4 
Formula weight  442.47 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.9999(12) Å α= 75.050(3)°. 
 b = 12.0030(17) Å β= 73.567(3)°. 
 c = 12.1462(17) Å γ = 75.081(3)°. 
Volume 1059.2(3) Å3 
Z 2 
Density (calculated) 1.387 g/cm3 
Absorption coefficient 0.096 mm-1 
F(000) 464 
Crystal size 0.50 x 0.45 x 0.45 mm3 
Theta range for data collection 1.78 to 27.87°. 
Index ranges -10<=h<=10, -15<=k<=15, -15<=l<=15 
Reflections collected 7558 
Independent reflections 4633 [R(int) = 0.0309] 
Completeness to theta = 27.87° 91.6 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4633 / 0 / 318 
Goodness-of-fit on F2 1.094 
Final R indices [I>2sigma(I)] R1 = 0.0559, wR2 = 0.1645 
R indices (all data) R1 = 0.0671, wR2 = 0.1705 
Extinction coefficient 0.086(7) 
Largest diff. peak and hole 0.446 and -0.258 e.Å-3 
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Table A16.  Crystal data and structure refinement for 16. 
 
Empirical formula  C31 H26.50 N4 O4.50 
Formula weight  527.06 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.2994(5) Å α= 81.721(2)°. 
 b = 12.8648(10) Å β= 89.530(2)°. 
 c = 14.6528(11) Å γ = 74.090(2)°. 
Volume 1308.77(17) Å3 
Z 2 
Density (calculated) 1.337 g/cm3 
Absorption coefficient 0.091 mm-1 
F(000) 553 
Crystal size 0.50 x 0.45 x 0.45 mm3 
Theta range for data collection 1.41 to 27.10°. 
Index ranges -8<=h<=9, -16<=k<=15, -17<=l<=18 
Reflections collected 8877 
Independent reflections 5333 [R(int) = 0.0330] 
Completeness to theta = 27.10° 92.3 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5333 / 6 / 372 
Goodness-of-fit on F2 1.056 
Final R indices [I>2sigma(I)] R1 = 0.0487, wR2 = 0.1334 
R indices (all data) R1 = 0.0594, wR2 = 0.1425 
Extinction coefficient 0.107(7) 
Largest diff. peak and hole 0.380 and -0.511 e.Å-3 
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Table A17.  Crystal data and structure refinement for 17. 
 
Empirical formula  C31 H27.50 N5 O4.50 
Formula weight  542.08 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.5488(4) Å α= 97.729(3)°. 
 b = 12.6754(6) Å β= 91.058(4)°. 
 c = 14.4453(8) Å γ = 105.310(3)°. 
Volume 1318.91(12) Å3 
Z 2 
Density (calculated) 1.365 g/cm3 
Absorption coefficient 0.094 mm-1 
F(000) 569 
Crystal size 0.45 x 0.45 x 0.15 mm3 
Theta range for data collection 1.42 to 28.31°. 
Index ranges -10<=h<=10, -16<=k<=16, -18<=l<=18 
Reflections collected 10106 
Independent reflections 5914 [R(int) = 0.0450] 
Completeness to theta = 28.31° 90.3 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5914 / 6 / 390 
Goodness-of-fit on F2 1.030 
Final R indices [I>2sigma(I)] R1 = 0.0460, wR2 = 0.1143 
R indices (all data) R1 = 0.0657, wR2 = 0.1264 
Extinction coefficient 0.072(5) 
 
Largest diff. peak and hole               0.320 and -0.233 e.Å-3 
 
 
 
 
 
 
 
 242
Table A18.  Crystal data and structure refinement for 18. 
 
Empirical formula  C25 H22 N4 O4 
Formula weight  442.47 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 14.7902(15) Å α= 90°. 
 b = 8.5534(7) Å β= 95.463(6)°. 
 c = 17.1781(15) Å γ = 90°. 
Volume 2163.3(3) Å3 
Z 4 
Density (calculated) 1.359 g/cm3 
Absorption coefficient 0.094 mm-1 
F(000) 928 
Crystal size 0.40 x 0.30 x 0.20 mm3 
Theta range for data collection 1.74 to 28.31°. 
Index ranges -19<=h<=19, -11<=k<=10, -21<=l<=22 
Reflections collected 15583 
Independent reflections 5039 [R(int) = 0.0377] 
Completeness to theta = 28.31° 93.5 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5039 / 0 / 305 
Goodness-of-fit on F2 1.017 
Final R indices [I>2sigma(I)] R1 = 0.0428, wR2 = 0.1086 
R indices (all data) R1 = 0.0629, wR2 = 0.1179 
Extinction coefficient 0.0208(17) 
 
Largest diff. peak and hole               0.281 and -0.223 e.Å-3 
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Table A19.  Crystal data and structure refinement for 19. 
 
Empirical formula  C30 H30 N4 O4 
Formula weight  510.58 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.3455(19) Å α= 77.825(14)°. 
 b = 9.0921(19) Å β= 75.061(15)°. 
 c = 9.858(2) Å γ = 66.352(9)°. 
Volume 657.1(3) Å3 
Z 1 
Density (calculated) 1.290 g/cm3 
Absorption coefficient 0.087 mm-1 
F(000) 270 
Crystal size 0.40 x 0.20 x 0.10 mm3 
Theta range for data collection 2.15 to 28.23°. 
Index ranges -9<=h<=10, -10<=k<=11, -13<=l<=12 
Reflections collected 4931 
Independent reflections 2969 [R(int) = 0.0393] 
Completeness to theta = 28.23° 91.5 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2969 / 3 / 183 
Goodness-of-fit on F2 0.891 
Final R indices [I>2sigma(I)] R1 = 0.0467, wR2 = 0.0956 
R indices (all data) R1 = 0.0990, wR2 = 0.1132 
Extinction coefficient 0.076(6) 
Largest diff. peak and hole 0.209 and -0.291 e.Å-3 
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Table A20.  Crystal data and structure refinement for 20. 
 
Empirical formula  C30 H32 N4 O4 
Formula weight  512.60 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.4774(18) Å α= 78.057(14)°. 
 b = 9.306(2) Å β= 67.175(12)°. 
 c = 9.4594(18) Å γ = 74.613(15)°. 
Volume 658.6(2) Å3 
Z 1 
Density (calculated) 1.292 g/cm3 
Absorption coefficient 0.087 mm-1 
F(000) 272 
Crystal size 0.40 x 0.40 x 0.10 mm3 
Theta range for data collection 2.29 to 27.48°. 
Index ranges -10<=h<=10, -12<=k<=11, -11<=l<=12 
Reflections collected 4637 
Independent reflections 2856 [R(int) = 0.0442] 
Completeness to theta = 27.48° 95.1 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2856 / 0 / 175 
Goodness-of-fit on F2 0.939 
Final R indices [I>2sigma(I)] R1 = 0.0529, wR2 = 0.1176 
R indices (all data) R1 = 0.0836, wR2 = 0.1296 
Largest diff. peak and hole 0.221 and -0.428 e.Å-3 
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Table A21.  Crystal data and structure refinement for 21. 
 
Empirical formula  C15 H13 N3 O 
Formula weight  251.28 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.2133(11) Å α= 104.058(9)°. 
 b = 11.6848(13) Å β= 98.623(8)°. 
 c = 12.1071(15) Å γ = 94.900(7)°. 
Volume 1239.9(3) Å3 
Z 4 
Density (calculated) 1.346 g/cm3 
Absorption coefficient 0.088 mm-1 
F(000) 528 
Crystal size 0.40 x 0.35 x 0.10 mm3 
Theta range for data collection 2.25 to 27.87°. 
Index ranges -11<=h<=12, -15<=k<=15, -15<=l<=15 
Reflections collected 8487 
Independent reflections 5341 [R(int) = 0.0514] 
Completeness to theta = 27.87° 90.4 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5341 / 0 / 356 
Goodness-of-fit on F2 0.988 
Final R indices [I>2sigma(I)] R1 = 0.0510, wR2 = 0.1208 
R indices (all data) R1 = 0.0894, wR2 = 0.1409 
Extinction coefficient 0.015(2) 
Largest diff. peak and hole 0.286 and -0.247 e.Å-3 
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Table A22.  Crystal data and structure refinement for 22. 
 
Empirical formula  C16 H15 N3 O 
Formula weight  265.31 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.7022(19) Å α= 93.162(17)°. 
 b = 12.118(3) Å β= 106.515(12)°. 
 c = 13.920(3) Å γ = 110.538(15)°. 
Volume 1298.1(5) Å3 
Z 4 
Density (calculated) 1.358 g/cm3 
Absorption coefficient 0.088 mm-1 
F(000) 560 
Crystal size 0.40 x 0.35 x 0.10 mm3 
Theta range for data collection 2.18 to 27.47°. 
Index ranges -10<=h<=9, -15<=k<=15, -16<=l<=17 
Reflections collected 7988 
Independent reflections 5294 [R(int) = 0.0483] 
Completeness to theta = 27.47° 88.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5294 / 0 / 373 
Goodness-of-fit on F2 0.899 
Final R indices [I>2sigma(I)] R1 = 0.0660, wR2 = 0.1607 
R indices (all data) R1 = 0.1232, wR2 = 0.1845 
Largest diff. peak and hole 0.482 and -0.445 e.Å-3 
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Table A23.  Crystal data and structure refinement for 23. 
 
Empirical formula  C16 H15 N3 O 
Formula weight  265.31 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 9.9852(13) Å α= 90°. 
 b = 15.912(2) Å β= 93.480(9)°. 
 c = 8.3680(13) Å γ = 90°. 
Volume 1327.1(3) Å3 
Z 4 
Density (calculated) 1.328 g/cm3 
Absorption coefficient 0.086 mm-1 
F(000) 560 
Crystal size 0.40 x 0.10 x 0.10 mm3 
Theta range for data collection 2.41 to 28.58°. 
Index ranges -13<=h<=13, -20<=k<=20, -11<=l<=10 
Reflections collected 9462 
Independent reflections 3155 [R(int) = 0.1088] 
Completeness to theta = 28.58° 92.8 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3155 / 0 / 188 
Goodness-of-fit on F2 0.895 
Final R indices [I>2sigma(I)] R1 = 0.0514, wR2 = 0.1119 
R indices (all data) R1 = 0.1462, wR2 = 0.1480 
Extinction coefficient 0.062(5) 
Largest diff. peak and hole 0.226 and -0.212 e.Å-3 
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Table A24.  Crystal data and structure refinement for 24. 
 
Empirical formula  C15 H12 Cl N3 O 
Formula weight  285.73 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.8067(7) Å α= 74.800(4)°. 
 b = 11.8803(12) Å β= 72.485(5)°. 
 c = 14.0856(15) Å γ = 68.786(4)°. 
Volume 1290.5(2) Å3 
Z 4 
Density (calculated) 1.471 g/cm3 
Absorption coefficient 0.294 mm-1 
F(000) 592 
Crystal size 0.20 x 0.40 x 0.40 mm3 
Theta range for data collection 2.21 to 28.25°. 
Index ranges -11<=h<=11, -15<=k<=15, -17<=l<=18 
Reflections collected 9203 
Independent reflections 5752 [R(int) = 0.0485] 
Completeness to theta = 28.25° 90.1 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5752 / 0 / 373 
Goodness-of-fit on F2 1.007 
Final R indices [I>2sigma(I)] R1 = 0.0438, wR2 = 0.1209 
R indices (all data) R1 = 0.0653, wR2 = 0.1305 
Largest diff. peak and hole 0.221 and -0.389 e.Å-3 
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Table A25.  Crystal data and structure refinement for 25. 
 
Empirical formula  C15 H14 Cl N3 O2 
Formula weight  303.74 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 6.0212(10) Å α= 90°. 
 b = 12.4652(19) Å β= 90°. 
 c = 19.166(3) Å γ = 90°. 
Volume 1438.5(4) Å3 
Z 4 
Density (calculated) 1.402 g/cm3 
Absorption coefficient 0.273 mm-1 
F(000) 632 
Crystal size 0.40 x 0.25 x 0.10 mm3 
Theta range for data collection 2.68 to 28.33°. 
Index ranges -7<=h<=7, -15<=k<=16, -25<=l<=16 
Reflections collected 6885 
Independent reflections 3255 [R(int) = 0.0484] 
Completeness to theta = 28.33° 94.4 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3255 / 0 / 204 
Goodness-of-fit on F2 0.937 
Final R indices [I>2sigma(I)] R1 = 0.0382, wR2 = 0.0755 
R indices (all data) R1 = 0.0602, wR2 = 0.0821 
Absolute structure parameter 0.28(7) 
Extinction coefficient 0.044(2) 
Largest diff. peak and hole 0.225 and -0.201 e.Å-3 
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Table A26.  Crystal data and structure refinement for 26. 
 
Empirical formula  C22 H18 N4 O5 
Formula weight  418.40 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.5178(9) Å α= 105.516(6)°. 
 b = 9.1850(11) Å β= 100.600(7)°. 
 c = 15.0850(15) Å γ = 100.339(8)°. 
Volume 957.36(19) Å3 
Z 2 
Density (calculated) 1.451 g/cm3 
Absorption coefficient 0.106 mm-1 
F(000) 436 
Crystal size 0.30 x 0.25 x 0.20 mm3 
Theta range for data collection 2.36 to 28.25°. 
Index ranges -9<=h<=10, -12<=k<=12, -17<=l<=19 
Reflections collected 7257 
Independent reflections 4292 [R(int) = 0.0629] 
Completeness to theta = 28.25° 90.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4292 / 0 / 290 
Goodness-of-fit on F2 0.977 
Final R indices [I>2sigma(I)] R1 = 0.0529, wR2 = 0.1338 
R indices (all data) R1 = 0.0794, wR2 = 0.1513 
Extinction coefficient 0.031(5) 
Largest diff. peak and hole 0.371 and -0.325 e.Å-3 
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Table A27.  Crystal data and structure refinement for 27. 
 
Empirical formula  C30 H25 N5 O9 
Formula weight  599.55 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.5292(5) Å α= 81.865(4)°. 
 b = 11.0980(8) Å β= 77.854(3)°. 
 c = 17.2512(11) Å γ = 74.581(4)°. 
Volume 1352.89(16) Å3 
Z 2 
Density (calculated) 1.472 g/cm3 
Absorption coefficient 0.111 mm-1 
F(000) 624 
Crystal size 0.40 x 0.35 x 0.05 mm3 
Theta range for data collection 2.43 to 28.27°. 
Index ranges -9<=h<=9, -14<=k<=14, -22<=l<=22 
Reflections collected 10285 
Independent reflections 6089 [R(int) = 0.0677] 
Completeness to theta = 28.27° 91.2 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6089 / 0 / 410 
Goodness-of-fit on F2 0.837 
Final R indices [I>2sigma(I)] R1 = 0.0491, wR2 = 0.1016 
R indices (all data) R1 = 0.1211, wR2 = 0.1269 
Extinction coefficient 0.0140(13) 
Largest diff. peak and hole 0.339 and -0.272 e.Å-3 
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Table A28.  Crystal data and structure refinement for 28. 
 
Empirical formula  C30 H24 Cl2 N4 O7 
Formula weight  623.43 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 21.633(2) Å α= 90°. 
 b = 9.6239(10) Å β= 98.655(6)°. 
 c = 13.3888(14) Å γ = 90°. 
Volume 2755.8(5) Å3 
Z 4 
Density (calculated) 1.503 g/cm3 
Absorption coefficient 0.293 mm-1 
F(000) 1288 
Crystal size 0.40 x 0.40 x 0.15 mm3 
Theta range for data collection 1.90 to 28.28°. 
Index ranges -27<=h<=28, -12<=k<=12, -17<=l<=15 
Reflections collected 19818 
Independent reflections 6399 [R(int) = 0.0957] 
Completeness to theta = 28.28° 93.7 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6399 / 0 / 401 
Goodness-of-fit on F2 0.942 
Final R indices [I>2sigma(I)] R1 = 0.0496, wR2 = 0.1221 
R indices (all data) R1 = 0.0743, wR2 = 0.1368 
Extinction coefficient 0.0102(10) 
Largest diff. peak and hole 0.386 and -0.334 e.Å-3 
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Table A29.  Crystal data and structure refinement for 29. 
 
Empirical formula  C32 H30 Ag B F4 N6 O5.40 
Formula weight  779.70 
Temperature  163(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 40.141(3) Å α= 90°. 
 b = 4.9633(5) Å β= 96.855(6)°. 
 c = 18.6857(19) Å γ = 90°. 
Volume 3696.1(6) Å3 
Z 4 
Density (calculated) 1.401 g/cm3 
Absorption coefficient 0.612 mm-1 
F(000) 1581 
Crystal size 0.46 x 0.16 x 0.14 mm3 
Theta range for data collection 2.04 to 28.23°. 
Index ranges -51<=h<=47, -6<=k<=6, -24<=l<=24 
Reflections collected 12547 
Independent reflections 4292 [R(int) = 0.0324] 
Completeness to theta = 28.23° 93.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.577 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4292 / 20 / 261 
Goodness-of-fit on F2 1.292 
Final R indices [I>2sigma(I)] R1 = 0.0574, wR2 = 0.1715 
R indices (all data) R1 = 0.0835, wR2 = 0.1863 
Largest diff. peak and hole 1.532 and -0.819 e.Å-3 
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Table A30.  Crystal data and structure refinement for 30. 
 
Empirical formula  C32 H30 Ag B F4 N6 O2 
Formula weight  725.30 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 11.666(2) Å α= 109.136(13)°. 
 b = 12.237(2) Å β= 114.266(8)°. 
 c = 13.013(2) Å γ = 92.310(14)°. 
Volume 1566.6(5) Å3 
Z 2 
Density (calculated) 1.538 g/cm3 
Absorption coefficient 0.708 mm-1 
F(000) 736 
Crystal size 0.46 x 0.20 x 0.10 mm3 
Theta range for data collection 1.80 to 27.48°. 
Index ranges -14<=h<=15, -14<=k<=15, -16<=l<=16 
Reflections collected 11253 
Independent reflections 6860 [R(int) = 0.0408] 
Completeness to theta = 27.48° 95.5 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6860 / 20 / 448 
Goodness-of-fit on F2 0.918 
Final R indices [I>2sigma(I)] R1 = 0.0385, wR2 = 0.0844 
R indices (all data) R1 = 0.0634, wR2 = 0.0929 
Largest diff. peak and hole 0.398 and -0.944 e.Å-3 
 
 
 
 
 
 
 
 
 
 255
Table A31.  Crystal data and structure refinement for 31. 
 
Empirical formula  C33 H34 Ag As F6 N6 O3 
Formula weight  859.45 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 7.3084(4) Å α= 90°. 
 b = 18.5828(11) Å β= 96.8060(10)°. 
 c = 25.1620(15) Å γ = 90°. 
Volume 3393.2(3) Å3 
Z 4 
Density (calculated) 1.682 g/cm3 
Absorption coefficient 1.639 mm-1 
F(000) 1728 
Crystal size 0.10 x 0.15 x 0.26 mm3 
Theta range for data collection 1.96 to 30.02°. 
Index ranges -10<=h<=10, -24<=k<=26, -35<=l<=34 
Reflections collected 38915 
Independent reflections 9874 [R(int) = 0.0316] 
Completeness to theta = 30.02° 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.791 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9874 / 25 / 486 
Goodness-of-fit on F2 1.079 
Final R indices [I>2sigma(I)] R1 = 0.0382, wR2 = 0.1073 
R indices (all data) R1 = 0.0472, wR2 = 0.1133 
Largest diff. peak and hole 1.379 and -0.840 e.Å-3 
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Table A32.  Crystal data and structure refinement for 32. 
 
Empirical formula  C32.50 H32 Ag As F6 N6 O2.50 
Formula weight  843.43 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 11.8443(8) Å α= 66.333(3)°. 
 b = 12.1157(7) Å β= 69.670(3)°. 
 c = 13.3329(8) Å γ = 87.960(3)°. 
Volume 1631.16(17) Å3 
Z 2 
Density (calculated) 1.717 g/cm3 
Absorption coefficient 1.702 mm-1 
F(000) 846 
Crystal size 0.35 x 0.25 x 0.20 mm3 
Theta range for data collection 1.85 to 27.88°. 
Index ranges -15<=h<=14, -15<=k<=15, -16<=l<=17 
Reflections collected 11734 
Independent reflections 7133 [R(int) = 0.0330] 
Completeness to theta = 27.88° 91.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.639 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7133 / 4 / 458 
Goodness-of-fit on F2 1.043 
Final R indices [I>2sigma(I)] R1 = 0.0481, wR2 = 0.1286 
R indices (all data) R1 = 0.0590, wR2 = 0.1361 
Largest diff. peak and hole 0.682 and -1.195 e.Å-3 
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Table A33.  Crystal data and structure refinement for 33. 
 
Empirical formula  C32 H30 Ag F6 N6 O5 Sb 
Formula weight  922.24 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 7.5069(5) Å α= 90°. 
 b = 18.6924(12) Å β= 98.4920(10)°. 
 c = 24.9808(17) Å γ = 90°. 
Volume 3466.9(4) Å3 
Z 4 
Density (calculated) 1.767 g/cm3 
Absorption coefficient 1.426 mm-1 
F(000) 1824 
Crystal size 0.40 x 0.29 x 0.20 mm3 
Theta range for data collection 1.98 to 30.01°. 
Index ranges -10<=h<=10, -26<=k<=26, -34<=l<=35 
Reflections collected 39338 
Independent reflections 10098 [R(int) = 0.0361] 
Completeness to theta = 30.01° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.768 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10098 / 21 / 488 
Goodness-of-fit on F2 1.427 
Final R indices [I>2sigma(I)] R1 = 0.0623, wR2 = 0.1714 
R indices (all data) R1 = 0.0731, wR2 = 0.1773 
Largest diff. peak and hole 2.298 and -0.971 e.Å-3 
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Table A34.  Crystal data and structure refinement for 34. 
 
Empirical formula  C32 H30 Ag F6 N6 O2 Sb 
Formula weight  874.24 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.2644(4) Å α= 74.5580(10)°. 
 b = 13.2045(6) Å β= 81.7510(10)°. 
 c = 14.2022(6) Å γ = 72.2750(10)°. 
Volume 1591.47(12) Å3 
Z 2 
Density (calculated) 1.824 g/cm3 
Absorption coefficient 1.540 mm-1 
F(000) 864 
Crystal size 0.34 x 0.22 x 0.08 mm3 
Theta range for data collection 1.96 to 30.01°. 
Index ranges -12<=h<=13, -18<=k<=18, -19<=l<=19 
Reflections collected 18528 
Independent reflections 9123 [R(int) = 0.0216] 
Completeness to theta = 30.01° 98.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.796 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9123 / 0 / 445 
Goodness-of-fit on F2 1.017 
Final R indices [I>2sigma(I)] R1 = 0.0313, wR2 = 0.0775 
R indices (all data) R1 = 0.0366, wR2 = 0.0806 
Largest diff. peak and hole 1.242 and -0.497 e.Å-3 
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Table A35.  Crystal data and structure refinement for 35. 
 
Empirical formula  C44 H50 Cu2 N4 O8.20 
Formula weight  893.16 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.3782(5) Å α= 91.000(3)°. 
 b = 9.4085(5) Å β= 101.071(2)°. 
 c = 13.7176(8) Å γ = 104.723(3)°. 
Volume 1023.84(10) Å3 
Z 1 
Density (calculated) 1.449 g/cm3 
Absorption coefficient 1.098 mm-1 
F(000) 466 
Crystal size 0.30 x 0.30 x 0.15 mm3 
Theta range for data collection 1.52 to 27.47°. 
Index ranges -10<=h<=10, -12<=k<=12, -17<=l<=15 
Reflections collected 7172 
Independent reflections 4437 [R(int) = 0.0457] 
Completeness to theta = 27.47° 94.7 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4437 / 0 / 267 
Goodness-of-fit on F2 1.052 
Final R indices [I>2sigma(I)] R1 = 0.0403, wR2 = 0.1082 
R indices (all data) R1 = 0.0511, wR2 = 0.1148 
Extinction coefficient 0.015(2) 
Largest diff. peak and hole 0.415 and -0.601 e.Å-3 
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Table A36.  Crystal data and structure refinement for 36. 
 
Empirical formula  C24 H16 Cu F12 N4 O4 
Formula weight  715.95 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 8.486(4) Å α= 90°. 
 b = 12.203(6) Å β= 102.63(3)°. 
 c = 13.094(5) Å γ = 90°. 
Volume 1323.0(10) Å3 
Z 2 
Density (calculated) 1.797 g/cm3 
Absorption coefficient 0.951 mm-1 
F(000) 714 
Crystal size 0.40 x 0.10 x 0.10 mm3 
Theta range for data collection 2.31 to 28.21°. 
Index ranges -11<=h<=11, -16<=k<=15, -16<=l<=16 
Reflections collected 8786 
Independent reflections 3045 [R(int) = 0.0912] 
Completeness to theta = 28.21° 93.2 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3045 / 0 / 205 
Goodness-of-fit on F2 0.907 
Final R indices [I>2sigma(I)] R1 = 0.0435, wR2 = 0.0927 
R indices (all data) R1 = 0.0793, wR2 = 0.1054 
Largest diff. peak and hole 0.355 and -0.835 e.Å-3 
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Table A37.  Crystal data and structure refinement for 37. 
 
Empirical formula  C54 H44 Cu N4 O4 
Formula weight  876.47 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.8140(7) Å α= 112.687(5)°. 
 b = 10.8479(9) Å β= 90.197(4)°. 
 c = 11.0899(9) Å γ = 95.503(6)°. 
Volume 1083.22(15) Å3 
Z 1 
Density (calculated) 1.344 g/cm3 
Absorption coefficient 0.557 mm-1 
F(000) 457 
Crystal size 0.35 x 0.25 x 0.05 mm3 
Theta range for data collection 2.23 to 27.48°. 
Index ranges -12<=h<=12, -14<=k<=12, -13<=l<=13 
Reflections collected 7706 
Independent reflections 4718 [R(int) = 0.0507] 
Completeness to theta = 27.48° 95.1 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4718 / 0 / 286 
Goodness-of-fit on F2 0.857 
Final R indices [I>2sigma(I)] R1 = 0.0428, wR2 = 0.0879 
R indices (all data) R1 = 0.0837, wR2 = 0.0984 
Largest diff. peak and hole 0.381 and -0.553 e.Å-3 
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Table A38.  Crystal data and structure refinement for 38. 
 
Empirical formula  C70 H68 Co N6 O8 
Formula weight  1180.23 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.9670(6) Å α= 75.533(3)°. 
 b = 11.2006(7) Å β= 80.377(4)°. 
 c = 15.3238(9) Å γ = 79.221(4)°. 
Volume 1452.18(16) Å3 
Z 1 
Density (calculated) 1.350 g/cm3 
Absorption coefficient 0.360 mm-1 
F(000) 621 
Crystal size 0.40 x 0.18 x 0.12 mm3 
Theta range for data collection 1.38 to 27.48°. 
Index ranges -11<=h<=10, -14<=k<=14, -19<=l<=19 
Reflections collected 10224 
Independent reflections 6254 [R(int) = 0.0877] 
Completeness to theta = 27.48° 93.8 %  
Absorption correction Numerical 
Max. and min. transmission 0.942 and 0.915 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6254 / 20 / 380 
Goodness-of-fit on F2 1.334 
Final R indices [I>2sigma(I)] R1 = 0.0746, wR2 = 0.2005 
R indices (all data) R1 = 0.0930, wR2 = 0.2109 
Largest diff. peak and hole 0.439 and -0.666 e.Å-3 
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Table A39.  Crystal data and structure refinement for 39. 
 
Empirical formula  C70 H68 N6 Ni O8 
Formula weight  1180.01 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.9948(19) Å α= 75.737(9)°. 
 b = 11.185(2) Å β= 79.844(13)°. 
 c = 15.409(3) Å γ = 78.971(16)°. 
Volume 1461.1(5) Å3 
Z 1 
Density (calculated) 1.341 g/cm3 
Absorption coefficient 0.397 mm-1 
F(000) 622 
Crystal size 0.40 x 0.25 x 0.15 mm3 
Theta range for data collection 1.38 to 27.40°. 
Index ranges -11<=h<=11, -13<=k<=14, -19<=l<=19 
Reflections collected 9284 
Independent reflections 6080 [R(int) = 0.0576] 
Completeness to theta = 27.40° 91.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.481 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6080 / 20 / 380 
Goodness-of-fit on F2 1.042 
Final R indices [I>2sigma(I)] R1 = 0.0829, wR2 = 0.2003 
R indices (all data) R1 = 0.1359, wR2 = 0.2274 
Largest diff. peak and hole 0.991 and -1.080 e.Å-3 
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Table A40.  Crystal data and structure refinement for 40. 
 
Empirical formula  C13 H13 N3 O 
Formula weight  227.26 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 16.9569(10) Å α= 90°. 
 b = 13.4777(8) Å β= 119.4630(10)°. 
 c = 11.3934(7) Å γ = 90°. 
Volume 2267.1(2) Å3 
Z 8 
Density (calculated) 1.332 g/cm3 
Absorption coefficient 0.088 mm-1 
F(000) 960 
Crystal size 0.08 x 0.20 x 0.35 mm3 
Theta range for data collection 2.05 to 30.01°. 
Index ranges -23<=h<=23, -18<=k<=18, -16<=l<=16 
Reflections collected 12901 
Independent reflections 3298 [R(int) = 0.0280] 
Completeness to theta = 30.01° 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.810 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3298 / 0 / 165 
Goodness-of-fit on F2 1.214 
Final R indices [I>2sigma(I)] R1 = 0.0494, wR2 = 0.1285 
R indices (all data) R1 = 0.0558, wR2 = 0.1330 
Largest diff. peak and hole 0.525 and -0.225 e.Å-3 
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Table A41.  Crystal data and structure refinement for 41. 
 
Empirical formula  C13 H12 Cl N3 O 
Formula weight  261.71 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 9.659(2) Å α= 90°. 
 b = 11.329(2) Å β= 113.523(10)°. 
 c = 11.948(2) Å γ = 90°. 
Volume 1198.9(4) Å3 
Z 4 
Density (calculated) 1.450 Mg/m3 
Absorption coefficient 0.309 mm-1 
F(000) 544 
Crystal size 0.35 x 0.25 x 0.20 mm3 
Theta range for data collection 2.31 to 28.26°. 
Index ranges -12<=h<=12, -14<=k<=14, -15<=l<=15 
Reflections collected 8552 
Independent reflections 2784 [R(int) = 0.0650] 
Completeness to theta = 28.26° 94.2 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2784 / 0 / 170 
Goodness-of-fit on F2 1.063 
Final R indices [I>2sigma(I)] R1 = 0.0397, wR2 = 0.0995 
R indices (all data) R1 = 0.0496, wR2 = 0.1057 
Extinction coefficient 0.053(5) 
Largest diff. peak and hole 0.346 and -0.236 e.Å-3 
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Table A42.  Crystal data and structure refinement for 42. 
 
Empirical formula  C27 H21 N5 O8 
Formula weight  543.49 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.6633(4) Å α= 87.5430(10)°. 
 b = 11.0661(6) Å β= 80.3330(10)°. 
 c = 12.9218(7) Å γ = 84.1120(10)°. 
Volume 1214.35(11) Å3 
Z 2 
Density (calculated) 1.486 g/cm3 
Absorption coefficient 0.112 mm-1 
F(000) 564 
Crystal size 0.30 x 0.28 x 0.27 mm3 
Theta range for data collection 1.85 to 30.00°. 
Index ranges -12<=h<=12, -15<=k<=15, -18<=l<=18 
Reflections collected 14130 
Independent reflections 6969 [R(int) = 0.0208] 
Completeness to theta = 30.00° 98.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.810 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6969 / 0 / 367 
Goodness-of-fit on F2 1.031 
Final R indices [I>2sigma(I)] R1 = 0.0455, wR2 = 0.1268 
R indices (all data) R1 = 0.0516, wR2 = 0.1332 
Largest diff. peak and hole 0.505 and -0.404 e.Å-3 
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Table A43.  Crystal data and structure refinement for 43. 
 
Empirical formula  C22 H21 N3 O2 
Formula weight  359.42 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.6581(12) Å α= 84.007(2)°. 
 b = 9.9523(12) Å β= 65.713(2)°. 
 c = 10.7006(13) Å γ = 73.066(2)°. 
Volume 896.73(19) Å3 
Z 2 
Density (calculated) 1.331 g/cm3 
Absorption coefficient 0.087 mm-1 
F(000) 380 
Crystal size 0.36 x 0.24 x 0.24 mm3 
Theta range for data collection 2.09 to 30.00°. 
Index ranges -13<=h<=13, -13<=k<=13, -14<=l<=15 
Reflections collected 10393 
Independent reflections 5127 [R(int) = 0.0187] 
Completeness to theta = 30.00° 98.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.849 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5127 / 0 / 247 
Goodness-of-fit on F2 1.025 
Final R indices [I>2sigma(I)] R1 = 0.0473, wR2 = 0.1245 
R indices (all data) R1 = 0.0519, wR2 = 0.1286 
Largest diff. peak and hole 0.462 and -0.305 e.Å-3 
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Table A44.  Crystal data and structure refinement for 44. 
 
Empirical formula  C23 H24 N4 O2 
Formula weight  388.46 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.6685(9) Å α= 91.689(5)°. 
 b = 10.7168(9) Å β= 109.241(5)°. 
 c = 11.6225(9) Å γ = 115.952(4)°. 
Volume 1000.72(15) Å3 
Z 2 
Density (calculated) 1.289 Mg/m3 
Absorption coefficient 0.085 mm-1 
F(000) 412 
Crystal size 0.35 x 0.25 x 0.15 mm3 
Theta range for data collection 1.90 to 27.86°. 
Index ranges -12<=h<=12, -14<=k<=13, -15<=l<=15 
Reflections collected 7150 
Independent reflections 4346 [R(int) = 0.0676] 
Completeness to theta = 27.86° 91.2 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4346 / 0 / 266 
Goodness-of-fit on F2 1.047 
Final R indices [I>2sigma(I)] R1 = 0.0681, wR2 = 0.1684 
R indices (all data) R1 = 0.0934, wR2 = 0.1840 
Extinction coefficient 0.059(8) 
Largest diff. peak and hole 0.402 and -0.343 e.Å-3 
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Table A45.  Crystal data and structure refinement for 45. 
 
Empirical formula  C28 H21 N7 O12 
Formula weight  647.52 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 23.5249(17) Å α= 90°. 
 b = 5.7765(4) Å β= 99.351(5)°. 
 c = 20.5203(14) Å γ = 90°. 
Volume 2751.5(3) Å3 
Z 4 
Density (calculated) 1.563 Mg/m3 
Absorption coefficient 0.125 mm-1 
F(000) 1336 
Crystal size 0.35 x 0.25 x 0.12 mm3 
Theta range for data collection 1.75 to 28.29°. 
Index ranges -31<=h<=31, -7<=k<=6, -26<=l<=24 
Reflections collected 19500 
Independent reflections 6433 [R(int) = 0.0776] 
Completeness to theta = 28.29° 94.0 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6433 / 0 / 431 
Goodness-of-fit on F2 1.004 
Final R indices [I>2sigma(I)] R1 = 0.0485, wR2 = 0.1150 
R indices (all data) R1 = 0.0782, wR2 = 0.1282 
Extinction coefficient 0.0117(10) 
Largest diff. peak and hole 0.275 and -0.269 e.Å-3 
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Table A46.  Crystal data and structure refinement for 46. 
 
Empirical formula  C37 H43 N3 O4 
Formula weight  593.74 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.5326(7) Å α= 93.446(2)°. 
 b = 11.1399(9) Å β= 98.810(2)°. 
 c = 17.5311(14) Å γ = 103.366(2)°. 
Volume 1594.2(2) Å3 
Z 2 
Density (calculated) 1.237 g/cm3 
Absorption coefficient 0.080 mm-1 
F(000) 636 
Crystal size 0.44 x 0.40 x 0.36 mm3 
Theta range for data collection 1.89 to 30.01°. 
Index ranges -11<=h<=11, -15<=k<=15, -24<=l<=24 
Reflections collected 17348 
Independent reflections 9077 [R(int) = 0.0188] 
Completeness to theta = 30.01° 97.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.825 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9077 / 0 / 403 
Goodness-of-fit on F2 1.047 
Final R indices [I>2sigma(I)] R1 = 0.0514, wR2 = 0.1448 
R indices (all data) R1 = 0.0571, wR2 = 0.1505 
Largest diff. peak and hole 0.571 and -0.349 e.Å-3 
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Table A47.  Crystal data and structure refinement for 47. 
 
Empirical formula  C27 H19 N7 O12 
Formula weight  633.49 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 23.6268(12) Å α= 90°. 
 b = 7.4221(4) Å β= 107.4780(10)°. 
 c = 16.1594(8) Å γ = 90°. 
Volume 2702.9(2) Å3 
Z 4 
Density (calculated) 1.557 g/cm3 
Absorption coefficient 0.126 mm-1 
F(000) 1304 
Crystal size 0.11 x 0.23 x 0.36 mm3 
Theta range for data collection 2.52 to 30.02°. 
Index ranges -33<=h<=33, -10<=k<=10, -22<=l<=22 
Reflections collected 29845 
Independent reflections 7875 [R(int) = 0.0298] 
Completeness to theta = 30.02° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.754 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7875 / 0 / 421 
Goodness-of-fit on F2 1.173 
Final R indices [I>2sigma(I)] R1 = 0.0606, wR2 = 0.1518 
R indices (all data) R1 = 0.0704, wR2 = 0.1575 
Largest diff. peak and hole 0.588 and -0.368 e.Å-3 
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Table A48.  Crystal data and structure refinement for 48. 
 
Empirical formula  C28 H25 N5 O9 
Formula weight  575.53 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.627(3) Å α= 81.802(14)°. 
 b = 10.053(3) Å β= 81.015(19)°. 
 c = 14.062(4) Å γ = 74.507(18)°. 
Volume 1288.0(6) Å3 
Z 2 
Density (calculated) 1.484 g/cm3 
Absorption coefficient 0.113 mm-1 
F(000) 600 
Crystal size 0.40 x 0.30 x 0.05 mm3 
Theta range for data collection 1.47 to 28.36°. 
Index ranges -12<=h<=12, -11<=k<=12, -18<=l<=18 
Reflections collected 9617 
Independent reflections 5768 [R(int) = 0.0833] 
Completeness to theta = 28.36° 89.5 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5768 / 0 / 392 
Goodness-of-fit on F2 0.887 
Final R indices [I>2sigma(I)] R1 = 0.0652, wR2 = 0.1516 
R indices (all data) R1 = 0.1113, wR2 = 0.1722 
Extinction coefficient 0.017(3) 
Largest diff. peak and hole 0.467 and -0.397 e.Å-3 
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Table A49.  Crystal data and structure refinement for 49. 
 
Empirical formula  C18 H12 N6 O6 
Formula weight  408.34 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.5160(5) Å α= 76.258(3)°. 
 b = 9.1032(5) Å β= 88.904(4)°. 
 c = 12.9495(8) Å γ = 82.037(4)°. 
Volume 852.25(9) Å3 
Z 2 
Density (calculated) 1.591 g/cm3 
Absorption coefficient 0.124 mm-1 
F(000) 420 
Crystal size 0.40 x 0.15 x 0.15 mm3 
Theta range for data collection 2.33 to 27.85°. 
Index ranges -9<=h<=9, -11<=k<=11, -16<=l<=14 
Reflections collected 6230 
Independent reflections 3758 [R(int) = 0.0483] 
Completeness to theta = 27.85° 92.7 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3758 / 0 / 275 
Goodness-of-fit on F2 1.091 
Final R indices [I>2sigma(I)] R1 = 0.0470, wR2 = 0.1284 
R indices (all data) R1 = 0.0557, wR2 = 0.1372 
Largest diff. peak and hole 0.261 and -0.398 e.Å-3 
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Table A50.  Crystal data and structure refinement for 50. 
 
Empirical formula  C25 H18 N6 O8 
Formula weight  530.45 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 6.3823(3) Å α= 96.4250(10)°. 
 b = 8.5498(4) Å β= 91.8040(10)°. 
 c = 21.4246(9) Å γ = 98.6340(10)°. 
Volume 1147.19(9) Å3 
Z 2 
Density (calculated) 1.536 g/cm3 
Absorption coefficient 0.118 mm-1 
F(000) 548 
Crystal size 0.40 x 0.34 x 0.21 mm3 
Theta range for data collection 1.92 to 30.02°. 
Index ranges -8<=h<=8, -12<=k<=12, -28<=l<=30 
Reflections collected 13277 
Independent reflections 6547 [R(int) = 0.0178] 
Completeness to theta = 30.02° 98.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.853 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6547 / 0 / 358 
Goodness-of-fit on F2 1.063 
Final R indices [I>2sigma(I)] R1 = 0.0417, wR2 = 0.1166 
R indices (all data) R1 = 0.0461, wR2 = 0.1203 
Largest diff. peak and hole 0.498 and -0.300 e.Å-3 
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Table A51.  Crystal data and structure refinement for 51. 
 
Empirical formula  C27 H20 N6 O10 
Formula weight  588.49 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.7602(11) Å α= 82.064(3)°. 
 b = 15.269(2) Å β= 81.610(3)°. 
 c = 22.456(3) Å γ = 78.915(3)°. 
Volume 2566.7(6) Å3 
Z 4 
Density (calculated) 1.523 g/cm3 
Absorption coefficient 0.119 mm-1 
F(000) 1216 
Crystal size 0.37 x 0.21 x 0.06 mm3 
Theta range for data collection 1.56 to 30.14°. 
Index ranges -10<=h<=10, -21<=k<=21, -31<=l<=31 
Reflections collected 30029 
Independent reflections 14779 [R(int) = 0.0932] 
Completeness to theta = 30.14° 97.7 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 14779 / 3 / 796 
Goodness-of-fit on F2 0.886 
Final R indices [I>2sigma(I)] R1 = 0.0544, wR2 = 0.0980 
R indices (all data) R1 = 0.0911, wR2 = 0.1090 
Largest diff. peak and hole 0.341 and -0.379 e.Å-3 
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Table A52.  Crystal data and structure refinement for 52. 
 
Empirical formula  C29 H26 N6 O8 
Formula weight  586.56 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.1324(7) Å α= 95.489(4)°. 
 b = 10.8110(9) Å β= 90.318(5)°. 
 c = 15.3761(13) Å γ = 91.503(5)°. 
Volume 1345.2(2) Å3 
Z 2 
Density (calculated) 1.448 g/cm3 
Absorption coefficient 0.108 mm-1 
F(000) 612 
Crystal size 0.35 x 0.35 x 0.15 mm3 
Theta range for data collection 1.33 to 27.51°. 
Index ranges -10<=h<=10, -14<=k<=13, -17<=l<=19 
Reflections collected 9845 
Independent reflections 5871 [R(int) = 0.0691] 
Completeness to theta = 27.51° 94.8 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5871 / 0 / 394 
Goodness-of-fit on F2 0.974 
Final R indices [I>2sigma(I)] R1 = 0.0628, wR2 = 0.1587 
R indices (all data) R1 = 0.1044, wR2 = 0.1840 
Largest diff. peak and hole 0.305 and -0.322 e.Å-3 
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Table A53.  Crystal data and structure refinement for 53. 
 
Empirical formula  C28 H20 N6 O8 
Formula weight  568.50 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.7854(5) Å α= 80.936(3)°. 
 b = 15.4355(10) Å β= 82.691(5)°. 
 c = 22.0882(13) Å γ = 81.375(5)°. 
Volume 2577.0(3) Å3 
Z 4 
Density (calculated) 1.465 g/cm3 
Absorption coefficient 0.111 mm-1 
F(000) 1176 
Crystal size 0.40 x 0.30 x 0.20 mm3 
Theta range for data collection 1.35 to 27.49°. 
Index ranges -10<=h<=10, -18<=k<=19, -28<=l<=26 
Reflections collected 17386 
Independent reflections 10885 [R(int) = 0.0969] 
Completeness to theta = 27.49° 92.1 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10885 / 0 / 769 
Goodness-of-fit on F2 0.805 
Final R indices [I>2sigma(I)] R1 = 0.0562, wR2 = 0.1164 
R indices (all data) R1 = 0.1248, wR2 = 0.1347 
Largest diff. peak and hole 0.303 and -0.331 e.Å-3 
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Table A54.  Crystal data and structure refinement for 54. 
 
Empirical formula  C28 H22 N6 O10 
Formula weight  602.52 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 7.7318(8) Å α= 90°. 
 b = 7.0062(7) Å β= 91.012(6)°. 
 c = 49.395(5) Å γ = 90°. 
Volume 2675.3(5) Å3 
Z 4 
Density (calculated) 1.496 g/cm3 
Absorption coefficient 0.116 mm-1 
F(000) 1248 
Crystal size 0.35 x 0.35 x 0.10 mm3 
Theta range for data collection 1.65 to 28.26°. 
Index ranges -10<=h<=9, -9<=k<=8, -65<=l<=64 
Reflections collected 18644 
Independent reflections 6183 [R(int) = 0.1180] 
Completeness to theta = 28.26° 93.2 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6183 / 0 / 404 
Goodness-of-fit on F2 0.891 
Final R indices [I>2sigma(I)] R1 = 0.0613, wR2 = 0.1298 
R indices (all data) R1 = 0.1162, wR2 = 0.1511 
Extinction coefficient 0.0202(13) 
Largest diff. peak and hole 0.341 and -0.410 e.Å-3 
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Table A55.  Crystal data and structure refinement for 55. 
 
Empirical formula  C27.65 H20 Cl N5 O6.70 
Formula weight  564.94 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.2974(4) Å α= 74.4900(10)°. 
 b = 11.4200(6) Å β= 77.9330(10)°. 
 c = 14.6930(7) Å γ = 73.8090(10)°. 
Volume 1274.67(11) Å3 
Z 2 
Density (calculated) 1.472 g/cm3 
Absorption coefficient 0.208 mm-1 
F(000) 583 
Crystal size 0.32 x 0.30 x 0.26 mm3 
Theta range for data collection 2.58 to 30.00°. 
Index ranges -11<=h<=11, -16<=k<=16, -18<=l<=20 
Reflections collected 14729 
Independent reflections 7305 [R(int) = 0.0323] 
Completeness to theta = 30.00° 98.1 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7305 / 0 / 388 
Goodness-of-fit on F2 1.054 
Final R indices [I>2sigma(I)] R1 = 0.0459, wR2 = 0.1293 
R indices (all data) R1 = 0.0560, wR2 = 0.1338 
Largest diff. peak and hole 0.643 and -0.371 e.Å-3 
 
 
 
 
 
 
 
 
 
 280
Table A56.  Crystal data and structure refinement for 56. 
 
Empirical formula  C31 H25 N7 O8 
Formula weight  623.58 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.7196(9) Å α= 86.704(5)°. 
 b = 10.7696(9) Å β= 84.042(6)°. 
 c = 13.6374(12) Å γ = 88.924(6)°. 
Volume 1417.3(2) Å3 
Z 2 
Density (calculated) 1.461 g/cm3 
Absorption coefficient 0.109 mm-1 
F(000) 648 
Crystal size 0.40 x 0.20 x 0.15 mm3 
Theta range for data collection 1.50 to 28.29°. 
Index ranges -11<=h<=12, -14<=k<=14, -17<=l<=16 
Reflections collected 8850 
Independent reflections 5523 [R(int) = 0.0912] 
Completeness to theta = 28.29° 78.5 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5523 / 0 / 422 
Goodness-of-fit on F2 1.296 
Final R indices [I>2sigma(I)] R1 = 0.0701, wR2 = 0.1898 
R indices (all data) R1 = 0.0885, wR2 = 0.2054 
Extinction coefficient 0.007(2) 
Largest diff. peak and hole 0.475 and -0.412 e.Å-3 
 
